10-K - GLRE - Equibles

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K

x	ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2019

OR	o	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number 001-33493

Greenlight Capital Re, Ltd.

(Exact Name of Registrant as Specified in Its Charter)

Cayman Islands	N/A
(State or Other Jurisdiction of<br><br>Incorporation or Organization)	(I.R.S. Employer<br><br>Identification No.)

65 Market Street, Suite 1207, Jasmine Court, Camana Bay

P.O. Box 31110

Grand Cayman, KY1-1205

Cayman Islands

(Address of Principal Executive Offices)

Registrant’s telephone number, including area code: 345-943-4573

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of exchange
Class A ordinary shares	GLRE	The Nasdaq Stock Market LLC

Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No ☒

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of ‘‘large accelerated filer,’’ ‘‘accelerated filer,’’ ‘‘smaller reporting company’’ and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐ Accelerated filer ☒ Non-accelerated filer ☐ Smaller reporting company ☐

Emerging Growth Company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☒

The aggregate market value of voting and non-voting Class A ordinary shares held by non-affiliates of the registrant as of June 30, 2019 was $242,450,450 based on the closing price of the registrant’s Class A ordinary shares reported on the Nasdaq Global Select Market on June 30, 2019, the last business day of the registrant’s most recently completed second fiscal quarter. Solely for the purpose of this calculation and for no other purpose, the non-affiliates of the registrant are assumed to be all shareholders of the registrant other than (i) directors of the registrant, (ii) executive officers of the registrant who are identified as ‘‘named executives’’ pursuant to Item 11 of this Form 10-K, (iii) any shareholder that beneficially owns 10% or more of the registrant’s common shares and (iv) any shareholder that has one or more of its affiliates on the registrant’s board of directors. Such exclusion is not intended, nor shall it be deemed, to be an admission that such persons are affiliates of the registrant.

Class A Ordinary Shares, $0.10 par value	30,739,395
Class B Ordinary Shares, $0.10 par value	6,254,715
(Class)	Outstanding as of March 6, 2020

DOCUMENTS INCORPORATED BY REFERENCE

Certain information required by Part III will be included in a definitive proxy statement for the Registrant’s 2020 annual meeting of shareholders, or an amendment to this Annual Report on Form 10-K, in either case filed with the Securities and Exchange Commission, or the SEC, within 120 days after the close of the fiscal year pursuant to Regulation 14A, under the Securities Exchange Act of 1934, as amended, or the Exchange Act, and is incorporated by reference herein.

GREENLIGHT CAPITAL RE, LTD.

TABLE OF CONTENTS

		Page
PART I		3
ITEM 1.	BUSINESS	4
	GLOSSARY OF SELECTED REINSURANCE TERMS	18
ITEM 1A.	RISK FACTORS	21
ITEM 1B.	UNRESOLVED STAFF COMMENTS	45
ITEM 2.	PROPERTIES	45
ITEM 3.	LEGAL PROCEEDINGS	45
ITEM 4.	MINE SAFETY DISCLOSURES	45
PART II		45
ITEM 5.	MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES	46
ITEM 6.	SELECTED FINANCIAL DATA	48
ITEM 7.	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	50
ITEM 7A.	QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK	72
ITEM 8.	FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA	73
ITEM 9.	CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE	73
ITEM 9A.	CONTROLS AND PROCEDURES	74
ITEM 9B.	OTHER INFORMATION	75
PART III		75
ITEM 10.	DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE	75
ITEM 11.	EXECUTIVE COMPENSATION	75
ITEM 12.	SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS	75
ITEM 13.	CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE	75
ITEM 14.	PRINCIPAL ACCOUNTING FEES AND SERVICES	76
PART IV		77
ITEM 15.	EXHIBITS AND FINANCIAL STATEMENT SCHEDULES	77
ITEM 16.	10-K SUMMARY	77
EXHIBIT INDEX		78
SIGNATURES		82

Link to Table of Contents

PART I

Special Note About Forward-Looking Statements

Certain statements in Management’s Discussion and Analysis, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives and expected operating results, and the assumptions upon which those statements are based, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These forward-looking statements generally are identified by the words “believe,” “project,” “predict,” “expect,” “anticipate,” “estimate,” “intend,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties which may cause actual results to differ materially from the forward-looking statements. A detailed discussion of risks and uncertainties that could cause actual results and events to differ materially from such forward-looking statements is included in the section entitled “Risk Factors” (refer to Part I, Item 1A) and include but are not limited to:

●	The ongoing strategic review may not result in a successful transaction and could adversely affect our business, financial condition and results of operations;
●	Rating agency may downgrade or withdraw either of our ratings;
●	Our results of operations will likely fluctuate from period to period and may not be indicative of our long-term prospects;
●	Under our investment management structure, we have limited control over Solasglas Investments, LP (“SILP”);
●	SILP may be concentrated in a few large positions, which could result in large losses;
●	Competitors with greater resources may make it difficult for us to effectively market our products or offer our products at a profit;
●	If our losses and loss adjustment expenses greatly exceed our loss reserves, our financial condition may be significantly and negatively affected;
●	We may face risks from future strategic transactions such as acquisitions, dispositions, mergers or joint ventures;
●	The effect of emerging claim and coverage issues on our business is uncertain;
●	The property and casualty reinsurance market may be affected by cyclical trends;
●	Loss of key executives could adversely impact our ability to implement our business strategy; and
●	Currency fluctuations could result in exchange rate losses and negatively impact our business.

We caution that the foregoing list of important factors is not intended to be and is not exhaustive. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise and all subsequent written and oral forward-looking statements attributable to us or individuals acting on our behalf are expressly qualified in their entirety by this paragraph. If one or more risks or uncertainties materialize, or if our underlying assumptions prove to be incorrect, actual results may vary materially from what we projected. Any forward-looking statements in this Form 10-K reflect our current view with respect to future events and are subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth, strategy and liquidity. Readers are cautioned not to place undue reliance on the forward-looking statements which speak only to the dates on which they were made.

We intend to communicate certain events that we believe may have a material adverse impact on our operations or financial position, including property and casualty catastrophic events and material losses in our investment portfolio, in a timely manner through a public announcement. Other than as required by the Exchange Act, we do not intend to make public announcements regarding reinsurance or investment events that we do not believe, based on management’s estimates and current information, will have a material adverse impact on our operations or financial position.

Link to Table of Contents

Item 1. BUSINESS

Unless otherwise indicated or unless the context otherwise requires, all references in this annual report on Form 10-K to “the Company,” “we,” “us,” “our” and similar expressions are references to Greenlight Capital Re, Ltd. and its consolidated subsidiaries. Unless otherwise indicated or unless the context otherwise requires, all references in this annual report to entity names are as set forth in the following table:

Reference	Entity’s legal name
Greenlight Capital Re	Greenlight Capital Re, Ltd.
Greenlight Re	Greenlight Reinsurance, Ltd.
GRIL	Greenlight Reinsurance Ireland, Designated Activity Company
Verdant	Verdant Holding Company, Ltd.

We have included a Glossary of Selected Reinsurance Terms at the end of “Part 1, Item 1. Business” of this Form 10-K.

Company Overview

Greenlight Capital Re is a holding company that was incorporated in July 2004 under the laws of the Cayman Islands. In August 2004, we raised gross proceeds of $212.2 million from private placements of Greenlight Capital Re’s Class A ordinary shares and Class B ordinary shares, or, collectively, the ordinary shares. On May 24, 2007, Greenlight Capital Re raised proceeds of $208.3 million, net of underwriting fees, in an initial public offering of Class A ordinary shares, as well as an additional $50.0 million from a private placement of Class B ordinary shares.

We are a global specialty property and casualty reinsurer, headquartered in the Cayman Islands, with a reinsurance and investment strategy that we believe differentiates us from most of our competitors. We conduct our reinsurance operations through two licensed and regulated reinsurance entities: Greenlight Re, based in the Cayman Islands, and GRIL, based in Dublin, Ireland. Greenlight Re provides multi-line property and casualty reinsurance globally, while GRIL focuses mainly on the European market. Our goal is to build long-term shareholder value by providing risk management products and services to the insurance, reinsurance and other risk marketplaces. We focus on delivering risk solutions to clients and brokers who value our expertise, analytics and customer service offerings.

Historically, we have aimed to complement our underwriting results with a non-traditional investment approach in order to achieve higher rates of return over the long term than reinsurance companies that employ more traditional investment strategies. Our investment portfolio is managed according to a value-oriented philosophy, in which our investment advisor takes long positions in perceived undervalued securities and short positions in perceived overvalued securities. During the second quarter of 2019, A.M. Best revised its rating outlook of the Company’s subsidiaries’ Financial Strength Rating of A- (Excellent) from “stable” to “negative.” The Company’s Board of Directors has initiated a strategic review to address the risk of a downgrade. Additionally, to reduce volatility near-term, the Company determined to de-risk its investment portfolio. As of the date of this Annual Report, the majority of our investable assets are held in cash and short-term treasuries which we expect to maintain until the strategic review is complete. We do not intend to discuss or disclose developments with respect to the strategic review process unless and until we determine that further disclosure is appropriate or required by regulation or law.

From time to time, we make long-term strategic investments in insurance companies and general agents to complement our strategy and strengthen our client relationships. In certain instances, we utilize Verdant to facilitate strategic investments in property and casualty insurers, general agents and other entities domiciled in the United States.

Because we adapt our portfolio in response to market conditions and our risk appetite, period-to-period comparisons of our underwriting results may not be meaningful. In addition, our historical investment results may not necessarily be indicative of future performance. Due to the nature of our reinsurance and investment strategies, our operating results will likely fluctuate from period to period.

Description of Business

Greenlight Re is licensed and regulated by the Cayman Islands Monetary Authority (“CIMA”) to write property and casualty reinsurance business as well as long term business (e.g., life insurance, long term disability, long term care, etc.); however, to date, we have not written any long term business. GRIL is licensed and regulated by the Central Bank of Ireland (“CBI”) to write property and casualty reinsurance business. Currently, we manage our business on the basis of one operating segment: property and casualty reinsurance. Within that segment, we employ a two-pillar strategy:

Link to Table of Contents

1. Underwriting traditional property and casualty reinsurance

We offer excess of loss and quota share products across a range of classes in the property and casualty market. Our underwriting approach varies by class and type of opportunity:

●	where we have domain-specific expertise and a high level of market access, we may seek to act as the lead underwriter to achieve greater influence in negotiating pricing, terms and conditions;
●	where our expertise is sufficient to thoroughly evaluate the risk, we will generally seek to participate on syndicated placements that have been negotiated and priced by another party that we judge to have market-leading expertise in the class, or as a quota share retrocessionaire of a market-leading reinsurer.

Risk innovation and strategic partnerships

We seek to develop a range of risk products, via strategic partnerships and other methods, with the objective of gaining access to fee income, a stream of underwriting business, and/or the potential for investment upside.

Our initiatives in this space generally aim to meet at least one of several criteria:

●	the value we add to a partnership primarily comes from application of our risk expertise, not solely capital or reinsurance support;
●	the partnership adds expertise to our company, in specific risk areas, technology, product innovation, and/or other areas;
●	the partnership provides access to a pool of capital, to products and/or to distribution;
●	overall, the partnership creates a combined effort that generates durable strategic and/or competitive position in one or more markets, and increases our opportunity for revenue growth and margin expansion.

Our investment strategy, like our reinsurance strategy, is designed to maximize returns over the long term while minimizing the risk of capital loss. Unlike the investment strategies of many of our traditional competitors, which invest primarily in fixed-income securities either directly or through fixed-fee arrangements with one or more investment managers, our investment strategy is to invest (directly or indirectly) in long and short positions primarily in publicly-traded equity and corporate debt instruments.

We measure our success by long-term growth in book value per share, which we believe is the most comprehensive gauge of the performance of our business. Accordingly, our incentive compensation plans are designed to align employee and shareholder interests. Compensation under our cash bonus plan is largely dependent on the ultimate underwriting returns of our business measured over a multi-year period, rather than premium targets or estimated underwriting profitability for the year in which we initially underwrite the business.

We seek to grow and diversify our portfolio. Our allocation of risk will vary based on our perception of the opportunities available in each line of business at each point in time. As our focus on certain lines fluctuates based upon market conditions, we may only offer or underwrite a limited number of lines in any given period. We seek to:

●	target markets and lines of business where we believe an appropriate risk/reward profile exists;
●	attract and retain clients with expertise in their respective lines of business;
●	employ strict underwriting discipline; and
●	select reinsurance opportunities with anticipated favorable returns on capital over the life of the contract.

Link to Table of Contents

The following table sets forth our gross premiums written by line of business, further broken down by class of business:

	Year ended December 31
	2019				2018				2017
	( in thousands)
Property
Commercial			2.7	%	$	10,487	1.8	%	$	12,256	1.8	%
Motor	59,402		11.3		76,425		13.5		71,188		10.2
Personal	12,390		2.4		14,118		2.5		49,491		7.2
Total Property	85,957		16.4		101,030		17.8		132,935		19.2
Casualty
General Liability	2,401		0.5		1,429		0.3		4,753		0.7
Motor Liability	233,591		44.6		291,690		51.4		281,551		40.6
Professional Liability (1)	(448	)	(0.1	)	3,068		0.5		8,703		1.3
Workers' Compensation	50,369		9.6		24,101		4.3		24,803		3.6
Multi-line	76,461		14.6		57,497		10.1		123,340		17.8
Total Casualty	362,374		69.2		377,785		66.6		443,150		64.0
Other
Accident & Health	39,175		7.5		69,605		12.2		66,800		9.6
Financial	23,087		4.4		16,611		2.9		48,380		7.0
Marine	160		—		394		0.1		—		—
Other Specialty	13,224		2.5		2,106		0.4		1,386		0.2
Total Other	75,646		14.4		88,716		15.6		116,566		16.8
			100.0	%	$	567,531	100.0	%	$	692,651	100.0	%

All values are in US Dollars.

(1) The negative balances represent the reversal of premiums due to premium adjustments, termination of contracts and/or premium returned upon novation or commutation of contracts.

The following table sets forth our gross premiums written by the geographic area of the risk insured:

	Year ended December 31
	2019				2018					2017
	( in thousands)
U.S. and Caribbean			83.1	%	$	507,705		89.5	%	$	606,510		87.6	%
Worldwide (1)	84,728		16.2		59,366			10.5		86,714			12.5
Europe (2)	(13	)	—		506			—		(612		)	(0.1	)
Asia (2)	3,804		0.7		(46		)	—		39			—
			100.0	%	$	567,531		100.0	%	$	692,651		100.0	%

All values are in US Dollars.

(1)	“Worldwide” is composed of contracts that reinsure risks in more than one geographic area and may include risks in the U.S.
(2)	The negative balances represent the reversal of premiums due to premium adjustments, termination of contracts and/or premium returned upon novation or commutation of contracts.

Additional information about our business is set forth in “Item 7 — Management’s Discussion and Analysis of Financial Condition and Results of Operations”.

Marketing and Distribution

Business transacted using intermediaries

A majority of our business is sourced through reinsurance brokers. Brokerage distribution channels provide us with access to an efficient, variable cost and global distribution system without the significant time and expense that would be incurred in creating a wholly-owned distribution network. In some cases, intermediaries also provide other valuable services including risk analytics, processing and clearing.

Link to Table of Contents

We aim to build and strengthen long-term relationships with global reinsurance brokers. Our management team has relationships with most of the primary and specialty broker intermediaries in the reinsurance marketplace. We believe that by maintaining close relationships with brokers we will be able to continue to obtain access to a broad range of reinsurance clients and opportunities.

We seek to strengthen our broker relationships and become the preferred choice of brokers and clients by providing, where applicable:

●	customized solutions that address the specific business needs of our clients;
●	demonstrated expertise in the underlying reinsured exposures and in the operation of the contracts;
●	rapid response to risk submissions;
●	timely payment of claims;
●	financial security; and
●	clear indication of risks we will and will not underwrite.

We focus on the quality and financial strength of any brokerage firm with which we do business. Brokers do not have the authority to bind us to any reinsurance contract. Reinsurance brokers receive a brokerage commission that is usually a percentage of gross premiums written.

The following table sets forth the premiums generated through our largest brokers and their subsidiaries and affiliates:

	Year ended December 31
	2019			2018				2017
	( in thousands)
Guy Carpenter (Marsh)		56.7	%	$	376,696	66.4	%	$	366,390	52.9	%
Trean Re	85,323	16.3		45,446		8.0		54,799		7.9
Aon Benfield	41,071	7.8		70,554		12.4		125,320		18.1
Total of largest brokers		80.8	%	$	492,696	86.8	%	$	546,509	78.9	%
All others	100,433	19.2	%	74,835		13.2	%	146,142		21.1	%
Total	523,977	100.0	%	567,531		100.0	%	692,651		100.0	%

All values are in US Dollars.

We meet frequently in the Cayman Islands, Ireland and elsewhere with brokers and senior representatives of clients and prospective clients. All contract submissions are received, reviewed and approved in our offices in the Cayman Islands or Ireland. Due to our dependence on brokers, the inability to obtain business from them could adversely affect our business strategy. See “Item 1A. Risk Factors — Risks Related to Our Business — The inability to obtain business provided from brokers could adversely affect our business strategy and results of operations.” In addition, we may assume a degree of the credit risk of our reinsurance brokers. See “Item 1A. Risk Factors — Risks Related to Our Business — We are subject to the credit risk of our brokers, cedents, agents and other counterparties.”

Underwriting and Risk Management

We have established an underwriting platform composed of experienced underwriters and actuaries. We have underwriting operations in two locations, Cayman Islands and Dublin, Ireland that respectively provide proximity to key markets in the U.S. and Europe. Our experienced team allows us to deploy our capital in a variety of lines of business and to capitalize on opportunities that we believe offer favorable returns on equity over the long term. Our underwriters and actuaries have expertise in multiple lines of business, and we also look to outside consultants on a fee-for-service basis to help us with niche areas of expertise when we deem it appropriate. We generally apply the following underwriting and risk management principles:

Economics of Results

Our primary underwriting goal is to build a reinsurance portfolio that maximizes economic results within certain risk and volatility constraints.

Link to Table of Contents

Underwriting Analysis

Our approach to underwriting analysis begins at the class-of-business level. This analysis includes identifying and assessing the structural drivers of risk and emerging loss trends, as well as obtaining an understanding of the market participants and results, capacity conditions for supply and demand, and other factors. Our underwriting professionals specialize in lines of business and are supported by quantitative professionals. Combined with cross-line management and insights, we believe this approach allows the building and deployment of deeper expertise and more thorough insight into the risk dynamics of the line and on external risk factors that will affect each transaction.

Each potential transaction is assigned to a deal team composed of underwriting and quantitative professionals to evaluate underwriting, pricing and structuring. Prior to committing capital to any transaction, the deal team must obtain approval from the Chief Executive Officer and Chief Underwriting Officer. In seeking this approval, the deal team presents the key components of the proposed transaction, including assumptions and threats, market and individual deal risk factors, market capacity dynamics, transaction structure and pricing, maximum downside, and other factors.

We spend a significant amount of time with our current and prospective clients and brokers to understand the risks associated with each potential transaction and structure each contract on the basis of this understanding. Where appropriate, we conduct or contract for on-site audits or reviews of the clients’ underwriting files, systems and operations. We usually obtain significant amounts of data from our clients to conduct a thorough actuarial modeling analysis. As part of our pricing and underwriting process, we assess, among other factors:

●	the client’s and industry’s historical loss data;
●	the expected duration for claims to fully develop;
●	the client’s pricing and underwriting strategies;
●	the geographic areas in which the client is doing business and its market share;
●	the reputation and financial strength of the client and its management and underwriting teams;
●	the reputation and expertise of the broker;
●	the likelihood of establishing a long-term relationship with the client and the broker; and
●	reports provided by independent industry specialists.

We have developed and use proprietary quantitative models, and also use several commercially available tools to price our business. Our models consider conventional underwriting and risk metrics, and incorporate various class specific and/or market specific aspects from our line of business analyses. In using quantitative models, we consider the quality and predictive power of the quantitative work, including explicit assessment of the data quality, and we place greater weight on scenarios that result in greater losses. We price each transaction based on our view of the merits and structure of the transaction.

Underwriting Authorities

The Underwriting Committee of our Board of Directors, which we refer to as the Underwriting Committee, sets parameters for aggregate property catastrophic caps and limits for maximum loss potential under any individual contract. The Underwriting Committee must approve any exceptions to the established limits. The maximum underwriting authorities, as set by our Underwriting Committee, may be amended from time to time, including as and when our capital base changes. Our underwriting authorities are designed to ensure that the premium we receive is appropriate on a risk-adjusted basis.

Retrocessional Coverage

We purchase retrocessional coverage for one or more of the following reasons: to manage our overall catastrophe events exposure, to reduce our net liability on individual risks, to obtain additional underwriting capacity and/or to balance our underwriting portfolio.

The amount of retrocessional coverage that we purchase varies based on numerous factors, some of which include the inherent volatility and risk accumulation of the portfolio of business we write and the level of our capital base. Our portfolio,

Link to Table of Contents

and by extension our gross risk position, will change in size from year to year depending on market opportunities, so it is not possible to predict the level of retrocessional coverage that we will purchase in any future year.

We generally purchase uncollateralized retrocessional coverage from reinsurers with a minimum financial strength ratings of “A- (Excellent)” from A.M. Best Company, Inc. (“A.M. Best”) or an equivalent rating from a recognized rating service. For lower rated or non-rated reinsurers, we endeavor to obtain and monitor collateral in the form of cash, funds withheld, letters of credit, regulatory trusts or other collateral in the form of guarantees. As of December 31, 2019, the aggregate amount due from reinsurers from retrocessional coverages represents 5.9% (2018: 9.1%) of our gross loss reserves. For further details please see Note 8 to the consolidated financial statements. We regularly evaluate the financial condition of our reinsurers to assess their ability to honor their obligations. At December 31, 2019 and 2018, no provision for uncollectible losses recoverable was considered necessary.

Claims Management

Our claims management process begins upon receipt of claims notifications from our clients or third-party administrators. Reserving and settlement authority are reviewed in accordance with the requirements of the individual contract and, as necessary, discussed with the underwriter. Our in-house claims officer is responsible for overseeing the review of claims and providing approval for complex or large claim settlements. Claims in excess of the claims officer’s authority are referred to the general counsel, together with the claims officer’s recommendations, for secondary approval. Claim payments above a certain threshold must be approved by our Chief Executive Officer. We believe that this process ensures that we pay claims consistently within the terms and conditions of each contract.

Where appropriate, we conduct or contract for on-site claims audits at cedents and third-party administrators, particularly for large accounts and for those whose performance differs from our expectations. Through these audits, we evaluate and monitor the third-party administrators’ and ceding companies’ claims-handling practices, including the organization of their claims departments, their fact-finding and investigation techniques, their loss notifications, the adequacy of their reserves, their negotiation and settlement practices and their adherence to claims-handling guidelines.

We recognize that fair interpretation of our reinsurance agreements with our clients and timely payment of covered claims are valuable services to our clients.

Reserves

Our reserving philosophy is to set reserves that represent our best estimate of the amount we will ultimately be required to pay in connection with risks we have underwritten. Our actuarial staff performs quarterly reviews of our portfolio and provide reserving estimates in line with our stated reserving philosophy. In doing so, our actuarial staff groups our portfolio of business into reserving analysis segments based primarily on homogeneity considerations. Currently, this process involves analysis at the individual client or transaction level.

We engage independent external actuaries who review and provide an opinion on these reserve estimates at least once a year. Due to the use of different assumptions and loss experience, the amount we establish as reserves with respect to individual risks, clients, transactions or classes of business may be greater or less than those established by our clients or ceding companies. Reserves include claims reported but not yet paid, claims incurred but not reported and claims in the process of settlement. Additional underwriting liabilities include unearned premiums, premium deposits and profit commissions earned but not yet paid.

Reserves represent an estimate rather than an exact quantification. Although the methods for establishing reserves are well tested, many of the assumptions about anticipated loss emergence patterns are subject to unanticipated fluctuation. We base our estimates on our assessment of facts and circumstances known at the time of the estimate, as well as estimates of future trends in claim severity and frequency, judicial theories of liability and other factors, including the actions of third parties, which are beyond our control. See Note 7 of the accompanying consolidated financial statements for a reconciliation of claims reserves, loss development tables by accident year and for explanations of significant prior period loss development movements. See “Item 1A. Risk Factors — Risks Relating to Our Business — If our losses and loss adjustment expenses greatly exceed our loss reserves, our financial condition may be materially and adversely affected.

Link to Table of Contents

Collateral Arrangements and Letter of Credit Facilities

We are licensed and admitted as an insurer only in the Cayman Islands and the European Economic Area. Many jurisdictions, including the United States, do not permit clients to take credit for reinsurance on their statutory financial statements if such reinsurance is obtained from unlicensed or non-admitted insurers, without appropriate collateral. As a result, we anticipate that all of our U.S. clients and a portion of our non-U.S. clients will require us to provide collateral for the contracts we bind with them. This collateral can be provided as funds withheld, trust arrangements or letters of credit. As of December 31, 2019, we had one letter of credit facility with an aggregate capacity of $400.0 million (2018: two facilities with an aggregate capacity of $414.9 million). Effective November 30, 2018, we amended the Butterfield Bank letter of credit facility to reduce the facility limit from $50.0 million to $14.9 million and subsequently canceled the facility effective April 25, 2019. As of December 31, 2019, we had issued letters of credit totaling $204.5 million (2018: $208.3 million) to clients. Additionally, as of December 31, 2019, we had pledged $528.7 million (2018: $463.4 million) as collateral through trust arrangements. The failure to maintain, replace or increase our collateral arrangements on commercially acceptable terms may significantly and negatively affect our ability to implement our business strategy. See “Item 1A. Risk Factors — Risks Relating to Our Business — Our failure to maintain sufficient collateral arrangements or to increase our collateral capacity on commercially acceptable terms as we grow could significantly and negatively affect our ability to implement our business strategy. ”

Competition

The reinsurance industry is highly competitive. We compete with major reinsurers, most of which are well established, have significant operating histories and strong financial strength ratings, and have developed long-standing client relationships.

Our competitors vary according to the individual market and situation, but generally include Arch, Axis, Everest Re, Hamilton Re, Hannover Re, Partner Re, Renaissance Re and Third Point Re as well as smaller companies, other niche reinsurers and Lloyd’s syndicates and their related entities. Although we seek to provide coverage where capacity and alternatives are limited, we directly compete with these and other larger companies due to the breadth of their coverage across the property and casualty market in substantially all lines of business. See "Item 1A – Risk Factors – Risks Relating to Our Business – Competitors with greater resources may make it difficult for us to effectively market our products or offer our products at a profit.”

Ratings

During the second quarter of 2019, A.M. Best revised its rating outlook of the Company’s subsidiaries’ Financial Strength Rating of A- (Excellent) from “stable” to “negative.” Our current “A- (Excellent)” rating from A.M. Best is the fourth highest of 13 ratings. We believe that a strong rating is an important factor in the marketing of reinsurance products to clients and brokers. These ratings reflect the rating agency’s opinion of our reinsurance subsidiaries’ financial strength, operating performance and ability to meet obligations. It is not an evaluation directed toward the protection of investors or a recommendation to buy, sell or hold our Class A ordinary shares.

The failure to maintain a strong rating may significantly and negatively affect our ability to implement our business strategy. See “Item 1A. Risk Factors — Risks Relating to Our Business —“A downgrade or withdrawal of either of our A.M. Best ratings may significantly and negatively affect our ability to implement our business strategy successfully. ”

Regulations

Cayman Islands Insurance Regulation

The legislative framework for conducting insurance and reinsurance business in and from within the Cayman Islands is composed of The Insurance Law, 2010 (as amended) and underlying regulations thereto (the “Law”) which became effective in the Cayman Islands effective November 1, 2012.

Greenlight Re holds a Class D insurer license issued in accordance with the terms of the Law and is subject to regulation and supervision by CIMA.

As the holder of a Class D insurer license, Greenlight Re is permitted to carry on reinsurance business from the Cayman Islands, but, except with the prior written approval of CIMA, may not carry on any insurance or reinsurance business where the underlying risk originates and resides in the Cayman Islands.

Link to Table of Contents

Greenlight Re is required to comply with the following principal requirements under the Law:

●	to maintain capital and a margin of solvency in accordance with the capital and solvency requirements prescribed by the Law;
●	to carry on its business in accordance with the laws of the Cayman Islands, including the regulatory laws, regulations, rules and statements of guidance, where applicable;
●	to maintain adequate arrangements, including internal controls, for the management of risks and a system of governance as approved by CIMA;
●	to maintain a minimum of at least two directors and to seek the prior approval of CIMA in respect of the appointment of directors and officers and to provide CIMA with information in connection therewith and notification of any changes thereto;
●	to have a place of business in the Cayman Islands and to maintain such resources, including staff and facilities, books and records as CIMA considers appropriate having regard for the nature and scale of the business of Greenlight Re;
●	to submit to CIMA an annual return in the prescribed form together with:
	- financial statements prepared in accordance with internationally recognized accounting standards, audited by an independent auditor approved by CIMA;
	- an actuarial valuation of Greenlight Re’s assets and liabilities, certified by an actuary approved by CIMA;
	- certification of solvency prepared by a person approved by CIMA in accordance with the prescribed requirements;
	- confirmation that the information contained in Greenlight Re’s license application, as modified by any subsequent changes, remains correct and up to date;
	- such other information as may be prescribed by CIMA; and
●	to pay an annual license fee.

It is the duty of CIMA:

●	to maintain a general review of insurance practices in the Cayman Islands;
●	to examine the affairs or business of any licensee or other person carrying on, or who has carried on, insurance business in order to ensure that the Law has been complied with and that the licensee is in a sound financial position and is carrying on its business in a fit and proper manner;
●	to examine and report on the annual returns delivered to CIMA in terms of the Law; and
●	to examine and make recommendations with respect to, among other things, proposals for the revocation of licenses and cases of suspected insolvency of licensed entities.

Greenlight Re is also required to comply with the Rule on Corporate Governance for Insurers and the Rule on Risk Management for Insurers. Respectively, these rules require regulated insurers to establish and maintain (a) a corporate governance framework which provides for the sound and prudent management and oversight of the insurer's business, including outsourcing and internal controls, and which adequately recognizes and protects the interests of its policyholders, and (b) a risk management framework that is capable of promptly identifying, measuring, assessing, reporting, monitoring and controlling all sources of risks that could have a material impact on its operations.

Where CIMA believes that a licensee is committing, or is about to commit or pursue, an act that is an unsafe or unsound business practice, CIMA may direct the licensee to cease or refrain from committing the act or pursuing the offending course of conduct. Failure to comply with such a CIMA direction may be punishable on summary conviction by a fine of up to 100,000 Cayman Islands dollars (approximately US$120,000) or to imprisonment for a term of five years or to both, and on conviction on indictment to a fine of 500,000 Cayman Islands dollars (approximately US$600,000) or to imprisonment for a term of ten years or to both and to an additional 10,000 Cayman Islands dollars (approximately US$12,000) for every day after conviction that the breach continues.

In addition, CIMA may impose fines and penalties on a licensee in certain circumstances, ranging from a fixed fine of 5,000 Cayman Islands dollars (approximately US$6,000) or a discretionary fine depending on the severity of the breach. Regulations passed under the Monetary Authority Law determine the circumstances under which CIMA can impose administrative fines. Under the current regulations, administrative fines can only be imposed for breaches of the Cayman Islands anti-money laundering regime (the "AML regime") and, as a reinsurance business, the AML regime does not apply to Greenlight Re. The circumstances in which fines can be imposed are currently undergoing a private sector consultation and are expected to expand in future years.

Link to Table of Contents

Whenever CIMA believes that a licensee is or may become unable to meet its obligations as they fall due, is carrying on business in a manner likely to be detrimental to the public interest or to the interest of its creditors or policyholders, has contravened the terms of the Law or has otherwise behaved in such a manner so as to cause CIMA to call into question the licensee’s fitness, CIMA may take one of a number of steps, including requiring the licensee to take steps to rectify the matter, suspending the license of the licensee, revoking the license, imposing conditions upon the license and amending or revoking any such condition, requiring the substitution of any director, manager or officer of the licensee, at the expense of the licensee, appointing a person to advise the licensee on the proper conduct of its affairs and to report to CIMA thereon, at the expense of the licensee, appointing a person to assume control of the licensee’s affairs or otherwise requiring such action to be taken by the licensee as CIMA considers necessary. To date, we have not been subject to any such actions from CIMA.

Other Regulations in the Cayman Islands

As Cayman Islands exempted companies, Greenlight Capital Re and Greenlight Re may not carry on business or trade locally in the Cayman Islands except in furtherance of their business outside the Cayman Islands, and are prohibited from soliciting the public of the Cayman Islands to subscribe for any of their securities or debt. We are further required to file a return with the Registrar of Companies in January of each year (“Annual Return”) and to pay an annual registration fee at that time.

Economic substance law requiring a “relevant entity” conducting “relevant activity” to file notifications and, unless exempt, to report to the Tax Information Authority (“TIA”) and maintain economic substance has been introduced in the Cayman Islands.

The International Tax Co-operation (Economic Substance) Law, 2018 and International Tax Co-operation (Economic Substance) (Prescribed Date) Regulations, 2018 were published on 27 December 2018 and amended on 22 February 2019 by the International Tax Co-operation (Economic Substance) (Amendment of Schedule) Regulations, 2019 and on 30 April 2019 by the International Tax Co-operation (Economic Substance) (Amendment of Schedule) (No. 2) Regulations, 2019 (together, the “ES Law”). Economic substance Guidance on Economic Substance for Geographically Mobile Activities (“ES Guidance”) was published on 22 February 2019 and updated on 30 April 2019.

Commencing January 2020, Greenlight Capital Re and Greenlight Re are required to confirm their economic substance classification and submit this classification to the TIA as a prerequisite to the Annual Return filing.

The Cayman Islands has no exchange controls restricting dealings in currencies or securities.

Ireland Insurance Regulations

Our Irish subsidiary, GRIL, is authorized as a non-life reinsurance undertaking by the CBI in accordance with the European Union (Insurance and Reinsurance) Regulations 2015 (the "Irish Regulations"). The Irish Regulations give effect in Ireland to EU Directive 2009/138/EC (known as "Solvency II"), which introduced a new European regulatory regime for insurers and reinsurers with effect from January 1, 2016. Solvency II is supplemented by the European Commission Delegated Regulation (EU) 2015/35, other European Commission “delegated acts” and binding technical standards, and guidelines issued by the European Insurance and Occupational Pensions Authority (“Delegated Acts and Guidelines”). GRIL is required to comply at all times with the Irish Regulations, the Irish Insurance Acts 1909 to 2018, regulations relating to insurance business or reinsurance business promulgated under the European Communities Act 1972, the Irish Central Bank Acts 1942 to 2015 as amended, regulations promulgated thereunder and directions, guidelines and codes of conduct issued by CBI (collectively the “Irish Insurance Acts and Regulations”). In addition, GRIL is required to comply with the Delegated Acts and Guidelines and must meet risk-based solvency requirements imposed under Solvency II on insurers and reinsurers across all member states, including Ireland. Solvency II and the Delegated Acts and Guidelines set out classification and eligibility requirements, including the characteristics which capital, including any capital contribution, must display to qualify as regulatory capital.

GRIL is also required to comply with the European Union (Insurance Distribution) Regulations 2018 (the "2018 Regulations") which apply to distributors of insurance and reinsurance products (including insurers and reinsurers). The 2018 Regulations give effect in Ireland to Directive (EU) 2016/97 (known as the "IDD") and strengthen the regulatory regime applicable to distribution activities through increased transparency, information and conduct requirements. As of 25 May 2018, the General Data Protection Regulation (the "GDPR") came into force across the EU. The GDPR significantly increases the obligations and responsibilities for organizations in how they collect, use and protect personal data. Organizations in breach of the GDPR may incur sizable financial penalties.

Link to Table of Contents

Overview of Investments

Our investment portfolio is managed by DME Advisors, LP (“DME Advisors”), a value-oriented investment advisor that analyzes companies’ available financial data, business strategies and prospects in an effort to identify undervalued and overvalued securities. DME Advisors is controlled by David Einhorn, the Chairman of our Board of Directors and the President of Greenlight Capital, Inc.

Prior to September 1, 2018, substantially all of our investable assets were invested through a joint venture arrangement in which DME Advisors, LLC (“DME”) acted as the investment advisor. We were party to a joint venture agreement (the “venture agreement”) with DME Advisors and DME under which the Company, its reinsurance subsidiaries and DME were participants in a joint venture (the “Joint Venture”) for the purpose of managing certain jointly held assets. In addition to the venture agreement, we had entered into an amended and restated investment advisory agreement (the “advisory agreement”) with DME Advisors to provide discretionary advisory services relating to the assets and liabilities of the venture. The advisory agreement term period mirrored that of the venture agreement. On September 1, 2018, the Company and DME entered into a termination agreement (the “Termination Agreement”) for the Joint Venture.

On September 1, 2018, we entered into an amended and restated exempted limited partnership agreement (the “SILP LPA”) of Solasglas Investments, LP (“SILP”), with DME Advisors II, LLC (“DME II”), as General Partner, Greenlight Re, GRIL and the initial limited partner (each, a “Partner”). The SILP LPA, in conjunction with a participation agreement, replaced the venture agreement and assigned and/or transferred Greenlight Re’s and GRIL’s net invested assets in the Joint Venture to SILP. Pursuant to the Termination Agreement, the Joint Venture terminated on January 2, 2019 and substantially all investments were transferred to SILP. The investment in SILP is recorded on the consolidated balance sheets under the caption “Investment in related party investment fund”.

On September 1, 2018, SILP entered into a SILP investment advisory agreement (the “IAA”) with DME Advisors, with an initial term ending on August 31, 2023 subject to automatic extensions for successive three-year terms. DME Advisors has the contractual right to manage substantially all of our investable assets, and is required to follow our investment guidelines and to act in a manner that is fair and equitable in allocating investment opportunities to SILP. However, DME Advisors is not otherwise restricted with respect to the nature or timing of making investments for SILP.

On February 26, 2019, effective as of September 1, 2018, we entered into Amendment No. 1 to the SILP LPA. The

amendment was intended to revise the mechanics for calculating the Carryforward Account and Performance Allocation (as

defined in the SILP LPA) to take into account withdrawals from and subsequent recontributions of capital to SILP, consistent

with the treatment under the Joint Venture. In addition, we have entered into a letter agreement with DME Advisors and DME II whereby during the period from June 1, 2019 to June 30, 2020, (a) at least 50% of the Investment Portfolio (as defined in the SILP LPA) shall be held in cash and cash equivalents and (b) the portion of the Investment Portfolio held in cash or cash equivalents will not be subject to any management fee or performance allocation.

DME Advisors receives a monthly management fee at an annual rate of 1.5% of each limited partner’s Investment Portfolio, as provided in the SILP LPA. In addition, DME II receives a performance allocation based on the positive performance change of each limited partner’s capital account equal to 20% of net profits calculated per annum, subject to a loss carry forward provision.

The loss carry forward provision allows DME II to earn a reduced performance allocation of 10% on net profits in any year subsequent to the year in which a limited partner’s capital accounts incurs a loss, until all the losses are recouped and an additional amount equal to 150% of the loss is earned. DME II is not entitled to a performance allocation in a year in which a capital account incurs a loss.

DME Advisors is required to follow our investment guidelines and act in a manner that it considers fair and equitable in allocating investment opportunities to us and SILP, but the IAA does not otherwise impose any specific obligations or requirements concerning the allocation of time, effort or investment opportunities to us and SILP or any restrictions on the nature or timing of investments for our or SILP’s account, or other accounts that DME Advisors or its affiliates may manage. In addition, DME Advisors can outsource to sub-advisors without our consent or approval. In the event that DME Advisors and any of its affiliates attempt to simultaneously invest in the same opportunity, the opportunity may be allocated pro-rata as reasonably determined by DME Advisors and its affiliates. Affiliates of DME Advisors presently serve as general partner or investment advisor of Greenlight Capital, L.P., Greenlight Capital Qualified, L.P., Greenlight Capital Offshore, Ltd., Greenlight Capital Offshore Qualified, Ltd., Greenlight Capital Offshore Partners, Greenlight Capital Investors, L.P., Greenlight Capital Offshore Investors, Ltd., Greenlight Capital Offshore Master, Ltd., Greenlight Masters, L.P., Greenlight Masters Qualified, L.P., Greenlight Masters Offshore, Ltd., Greenlight Masters Offshore I, Ltd., Greenlight Masters Offshore Partners and Greenlight Masters Partners (collectively, the “Greenlight Funds”).

Link to Table of Contents

We have agreed to use commercially reasonable efforts to cause all of our current and future subsidiaries to enter into the SILP LPA. Under the SILP LPA, we are contractually obligated to use commercially reasonable efforts to cause substantially all investable assets of Greenlight Re and GRIL, with limited exceptions, to be contributed to SILP.

We have agreed to release DME, DME II and DME Advisors and their affiliates from, and to indemnify and hold them harmless against, any liability arising out of the venture agreement and the advisory agreement, subject to certain exceptions. Furthermore, DME, DME II and DME Advisors and their affiliates have agreed to indemnify us against any liability incurred in connection with certain actions.

In accordance with the SILP LPA, either of the GLRE Limited Partners may voluntarily withdraw all or part of its capital account for its operating needs by giving DME II at least 3 business days notice. In addition, either of the GLRE Limited Partners may withdraw as a partner and fully withdraw all of its capital account from SILP on 3 business days notice if the Board of the limited partner declares that a cause for withdrawal exists as per the SILP LPA.

Investment Strategy

DME Advisors implements a value-oriented investment strategy by taking long positions in perceived undervalued securities and short positions in perceived overvalued securities. DME Advisors aims to achieve high absolute rates of return while minimizing the risk of capital loss. DME Advisors attempts to determine the risk/return characteristics of potential investments by analyzing factors such as the risk that expected cash flows will not be obtained, the volatility of the cash flows, the leverage of the underlying business and the security’s liquidity, among others.

Our Board of Directors conducts reviews of our investment portfolio activities and oversees our investment guidelines to meet our investment objectives. We believe our investment approach, while less predictable than traditional fixed-income portfolios, complements our reinsurance business and will achieve higher rates of return over the long term than reinsurance companies that invest predominantly in fixed-income securities. Our investment guidelines are designed to maintain adequate liquidity to fund our reinsurance operations.

DME Advisors, which is contractually obligated to adhere to our investment guidelines, makes investment decisions on our behalf, which may include buying publicly listed equity securities and corporate debt, selling securities short and investing in private placements, futures, currencies, commodities, credit default swaps, interest rate swaps, sovereign debt, derivatives and other instruments. As of December 31, 2019, DME Advisors was in compliance with our investment guidelines.

During the year ended December 31, 2019, SILP’s investment portfolio was de-risked in order to reduce our investment volatility in the near-term. As a result, a large proportion of our invested assets in SILP was held in cash and short-term treasuries as of December 31, 2019.

Investment Guidelines

The investment guidelines adopted by the respective Boards of Directors of Greenlight Re and GRIL, which may be amended or modified from time to time, take into account restrictions imposed on us by regulators, our liability mix, requirements to maintain an appropriate claims paying rating by ratings agencies and requirements of lenders.

As of the date hereof, Greenlight Re’s investment guidelines, which may be amended by the board of directors of Greenlight Re at any time, are as follows:

Link to Table of Contents

●	Composition of Investments: At least 80% of the assets in its Investment Portfolio (as defined in the Limited Partnership Agreement) will be held in debt or equity securities (including swaps) of publicly-traded companies (or their subsidiaries), governments of the Organization of Economic Co-operation and Development high income countries, cash, cash equivalents and gold. No more than 10% of the assets in its Investment Portfolio will be held in private equity securities.
●	Concentration of Investments: Other than cash, cash equivalents, United States government obligations and gold, no single investment in its Investment Portfolio will constitute more than 20% of the Investment Portfolio.
●	Liquidity: Assets will be invested in such fashion that Greenlight Re has a reasonable expectation that it can meet any of its liabilities as they become due. Greenlight Re will review with the Investment Advisor the liquidity of the portfolio on a periodic basis.
●	Monitoring: Greenlight Re will require the Investment Advisor to re-evaluate each position in its Investment Portfolio and to monitor changes in intrinsic value and trading value and provide monthly reports on its Investment Portfolio to Greenlight Re as Greenlight Re may reasonably determine.
●	Leverage: Greenlight Re’s Investment Portfolio may not employ greater than 15% indebtedness for borrowed money, including net margin balances, for extended time periods. The Investment Advisor may employ, in the normal course of business, up to 30% indebtedness for periods of less than 30 days.
	Currency hedging activities are excluded from leverage calculations. Where the Investment Advisor enters into a secondary investment with the primary purpose of reducing the risk of another existing investment then the investment advisor may exclude the secondary investment from the calculation of leverage provided that the Investment Advisor receives approval from Greenlight Re’s Chief Financial Officer. Such authority is limited such that no more than 10% of indebtedness may be excluded from leverage calculations for such secondary investments.

The investment guidelines for GRIL are identical to Greenlight Re’s except for Concentration of Investments, Leverage and Credit default swaps, which for GRIL are as follows:

●	Concentration of Investments: Other than cash, cash equivalents and United States government obligations, (1) no single investment in its Investment Portfolio will constitute more than 10% of its Investment Portfolio, (2) the 10 largest investments shall not constitute greater than 50% of its total Investment Portfolio, and (3) its Investment Portfolio shall at all times be composed of a minimum of 50 debt or equity securities of publicly traded companies (or their subsidiaries).*
●	Leverage: GRIL’s Investment Portfolio may not employ greater than 5% indebtedness for borrowed money, including net margin balances, for extended time periods. The Investment Advisor may use, in the normal course of business, an aggregate of up to 20% net margin leverage for periods of less than 30 days.
●	Credit default swaps: The sale of credit default swaps is prohibited.

●

Concentration of Investments: Other than cash, cash equivalents and United States government obligations, (1) no single investment in its Investment Portfolio will constitute more than 10% of its Investment Portfolio, (2) the 10 largest investments shall not constitute greater than 50% of its total Investment Portfolio, and (3) its Investment Portfolio shall at all times be composed of a minimum of 50 debt or equity securities of publicly traded companies (or their subsidiaries).*

●

Leverage: GRIL’s Investment Portfolio may not employ greater than 5% indebtedness for borrowed money, including net margin balances, for extended time periods. The Investment Advisor may use, in the normal course of business, an aggregate of up to 20% net margin leverage for periods of less than 30 days.

●

Credit default swaps: The sale of credit default swaps is prohibited.

* GRIL’s board of directors has temporarily waived the guideline requiring the Investment Portfolio to be composed of a minimum of 50 debt and equity securities of publicly traded companies since at least 50% of the Investment Portfolio is being held in cash and cash equivalents during the period from June 1, 2019 to June 30, 2020.

Investment Results

Composition

The following table summarizes the investments as reported in the consolidated financial statements:

	December 31
	2019			2018
	( in thousands)
Investment in related party investment fund		93.6	%	$	235,612	79.9	%
Equities - listed	—	—		36,908		12.5
Private investments and unlisted equity funds	10,681	4.2		6,405		2.2
Equity method investment	5,703	2.2		5,003		1.7
	256,440	100.0		283,928		96.3
Funds and cash held with brokers and swap counterparties	—	—		10,920		3.7
Total long investments		100.0	%	$	294,848	100.0	%

All values are in US Dollars.

DME Advisors also reports the composition of SILP’s portfolio on a delta adjusted basis, which it believes is the appropriate manner in which to assess the exposure and profile of investments and is the way in which it manages the portfolio.

Link to Table of Contents

The delta of an option is the sensitivity of the option price to the underlying stock (or commodity) price. The delta adjusted basis is the number of shares underlying the option multiplied by the delta and the underlying stock (or commodity) price.

This exposure analysis does not include cash (U.S. dollar and foreign currencies), gold and other commodities, credit default swaps, sovereign debt, foreign currency derivatives, interest rate options and other macro positions. In addition, under this methodology, the exposure for total return swaps is reported at its full notional amount. Options are reported at their delta adjusted basis.

The following table represents the composition of SILP’s investments as of December 31, 2019 and December 31, 2018:

	December 31
	2019				2018
	Long %		Short %		Long %		Short %
Debt instruments	0.2	%	—	%	0.4	%	(1.7	)%
Equities & related derivatives	25.7		(7.9	)	78.0		(50.0	)
Private and unlisted equity securities	2.4		—		5.3		—
Total	28.3	%	(7.9	)%	83.7	%	(51.7	)%

As of December 31, 2019, SILP’s exposure to gold on a delta adjusted basis was 0.0% (2018: 18.3% ).

The following table represents the composition of SILP by industry sector, as of December 31, 2019:

Sector	Long %		Short %		Net %
Communication Services	—	%	(0.8	)%	(0.8	)%
Consumer Discretionary	9.6		(3.2	)	6.4
Consumer Staples	0.3		—		0.3
Energy	1.9		—		1.9
Financial	9.4		(1.6	)	7.8
Industrials	0.8		(2.3	)	(1.5	)
Materials	5.0		—		5.0
Technology	0.2		—		0.2
Other	1.1		—		1.1
Total	28.3	%	(7.9	)%	20.4	%

The following table represents the composition of our investments in SILP, by the market capitalization of the underlying security, as of December 31, 2019:

Capitalization	Long %		Short %		Net %
Mega Cap Equity (≥$25 billion)	2.6	%	(5.0	)%	(2.4	)%
Large Cap Equity (≥$10 billion and <$25 billion)	0.3		(1.3	)	(1.0	)
Mid Cap Equity (≥$2 billion and <$10 billion)	14.3		(1.6	)	12.7
Small Cap Equity (<$2 billion)	8.5		—		8.5
Debt Instruments	0.2		—		0.2
Other Investments	2.4		—		2.4
Total	28.3	%	(7.9	)%	20.4	%

Link to Table of Contents

Investment Returns

In accordance with the SILP LPA, DME Advisors constructs a levered investment portfolio as agreed with the Company (the “Investment Portfolio” as defined in the SILP LPA). Effective from September 1, 2018, the investment return is calculated by dividing the investment income or loss (net of fees and expenses) by the Investment Portfolio. Our investment return is based on the total assets in our Investment Portfolio. Investment returns, net of all fees and expenses, by quarter and for the last five years are as follows: ^(1)^

Quarter	2019		2018		2017		2016		2015
1st	6.2	%	(11.8	)%	0.9	%	2.5	%	(1.8	)%
2nd	2.7		(3.8	)	(3.4	)	(3.4	)	(1.5	)
3rd	1.2		(8.4	)	5.5		3.1		(14.2	)
4th	(1.0	)	(10.2	)	(1.3	)	5.0		(4.0	)
Full Year	9.3	%	(30.3	)%	1.5	%	7.2	%	(20.2	)%

^(1)^ Investment returns are calculated monthly based on cash flows into and out of the investment accounts and compounded to calculate the quarterly and annual returns generated by our Investment Portfolio. Past performance is not necessarily indicative of future results.

Internal Risk Management

Our Chief Risk Officer is responsible for the construction and review of our internal risk management function. A primary objective of our risk management function is to ensure that our underwriting efforts comply with explicitly stated underwriting appetites. These appetites, in turn, are designed to balance our risk position size with our expertise and the available margins, while containing the cost of being wrong. In doing so, our risk management function designs, implements and oversees a range of operational and underwriting controls to support the organization. We frequently review our investment and underwriting portfolios to assess the impact to capital under stressed scenarios. With the assistance of DME Advisors, we analyze both our investment assets and liabilities including the numerous components of risk in our portfolio, such as concentration risk and liquidity risk.

Information Technology

Our information technology infrastructure is primarily housed at an off-site, secure data center in Grand Cayman, Cayman Islands. Our use of cloud based services is increasing as the security and reliability of these services improves.

We have implemented backup procedures to ensure that key data is saved on a daily basis and can be restored promptly .

We have a disaster recovery plan with respect to our information technology infrastructure that includes data and systems replication between our Cayman Islands office and Dublin office and other off-site locations. We believe we can access our core systems with insignificant outages and restore operation of our secondary systems in the event that our primary systems are unavailable due to a disaster or otherwise.

We protect our information systems with physical, electronic and software safeguards considered appropriate by our management. We employ a specialist vendor to monitor our systems for security events and risks from within our network. We regularly provide our staff security risk awareness education and training. Despite these efforts, computer viruses, hackers, employee misuse or misconduct and other internal or external hazards could expose our data systems to security breaches, cyber-attacks or other disruptions. See “Item 1A. Risk Factors — Risks Related to Our Business — Operational risks, including human or systems failures, are inherent in our business.”

Employees

As of March 6, 2020, we had 40 full-time employees, 33 who were based in Grand Cayman, Cayman Islands and 7 who were based in Dublin, Ireland. We believe that our employee relations are good. None of our employees are subject to collective bargaining agreements, and we are not aware of any current efforts to implement such agreements.

Link to Table of Contents

Additional Information

Our website address is www.greenlightre.com and we make available, free of charge, on or through our website, links to our annual reports on Form 10-K and quarterly reports on Form 10-Q, current reports on Form 8-K and other documents we file with or furnish to the SEC, as soon as reasonably practicable after such material is electronically filed with or furnished to the SEC.

Additionally, our Code of Business Conduct and Ethics is available on our website.

Glossary of Selected Reinsurance Terms

Accident & Health insurance	Insurance against loss by illness or bodily injury. Health insurance provides<br><br>coverage for medicine, visits to the doctor or emergency room, hospital stays and<br><br>other medical expenses.
Acquisition costs	Ceding commission, profit commissions, brokerage fees, premium taxes and other direct expenses relating directly to the production of premiums.
Acquisition cost ratio	The acquisition cost ratio is calculated by dividing net acquisition costs by net premiums earned.
Actuary	A person professionally trained in the mathematical and technical aspects of insurance and related fields particularly in the calculation of premiums, loss reserves and other values.
Broker	An intermediary who negotiates contracts of insurance or reinsurance, receiving a commission for placement and other services rendered, between (1) a policyholder and a primary insurer, on behalf of the policyholder, (2) a primary insurer and a reinsurer, on behalf of the primary insurer, or (3) a reinsurer and a retrocessionaire, on behalf of the reinsurer.
Capacity	Capacity is the percentage of surplus that an insurer or reinsurer is willing or able to place at risk or the dollar amount of exposure it is willing to assume. Capacity may apply to a single risk, a program, a line of business or an entire book of business. Capacity may be constrained by legal restrictions, corporate restrictions, or indirect financial restrictions such as capital adequacy requirements.
Casualty reinsurance	Casualty reinsurance is primarily concerned with the losses caused by injuries to third persons (persons other than the policyholder) and the legal liability imposed on the policyholder resulting therefrom. This includes, but is not limited to workers’ compensation, automobile liability, and general liability. A greater degree of unpredictability is generally associated with casualty risks known as ‘‘long-tail risks,’’ where losses take time to become known and a claim may be separated from the circumstances that caused it by several years. An example of a long-tail casualty risk includes the use of certain drugs that may cause cancer or birth defects. There tends to be greater delay in the reporting and settlement of casualty reinsurance claims due to the long-tail nature of the underlying casualty risks and their greater potential for litigation.
Catastrophe	A severe loss, typically involving multiple claimants. Common perils include earthquakes, hurricanes, tsunamis, hailstorms, tornados, severe winter weather, floods, fires, explosions, volcanic eruptions and other natural or man-made disasters. Catastrophe losses may also arise from acts of war, acts of terrorism and political instability.
Cede; cedent	When a party reinsures its liability to another party, it ‘‘cedes’’ business to the reinsurer and is referred to as the ‘‘client.’’
Claim	Request by an insured or reinsured for indemnification by an insurance or reinsurance company for loss incurred from an insured peril or event.
Client	A party whose liability is reinsured by a reinsurer. Also known as a cedent.
Combined ratio	The combined ratio is the sum of the loss ratio, acquisition cost ratio and underwriting expense ratio.
Composite ratio	The composite ratio is the ratio of underwriting losses incurred, loss adjustment expenses and acquisition costs, excluding underwriting related general and administrative expenses, to net premiums earned, or equivalently, the sum of the loss ratio and acquisition cost ratio.
Corporate expenses	Corporate expenses include those costs associated with operating as a publicly listed entity as well as an allocation of other general and administrative expenses.

Link to Table of Contents

Development	The difference between the amount of reserves for losses and loss adjustment expenses initially estimated by an insurer or reinsurer and the amount re-estimated in an evaluation at a later date.
Excess of loss reinsurance	Reinsurance that indemnifies the reinsured against all or a specified portion of losses in excess of a specified dollar or percentage loss ratio amount.
Financial strength rating	The opinion of rating agencies regarding the financial ability of an insurance or reinsurance company to meet its financial obligations under its policies.
Gross premiums written	Total premiums for assumed reinsurance during a given period.
Health insurance	Insurance against loss by illness or bodily injury. Health insurance provides coverage for medicine, visits to the doctor or emergency room, hospital stays and other medical expenses.
Incurred but not reported (IBNR)	Reserves for estimated loss and loss adjustment expenses that have been incurred by insureds and reinsureds but not yet reported to the insurer or reinsurer, including unknown future developments on loss and loss adjustment expenses which are known to the insurer or reinsurer.
Loss adjustment expenses (LAE)	The expenses of settling claims, including legal and other fees and the portion of general expenses allocated to claim settlement costs. Also known as claim adjustment expenses.
Loss ratio	The loss ratio is calculated by dividing net loss and loss adjustment expenses incurred by net premiums earned.
Loss reserves and loss adjustment expense reserves	Liabilities established by insurers and reinsurers to reflect the estimated cost of claims payments and the related expenses that the insurer or reinsurer will ultimately be required to pay in respect of insurance or reinsurance contracts it has written. Reserves are established for losses and for loss adjustment expenses, and consist of reserves established with respect to individual reported claims and incurred but not reported losses.
Multi-line	Contracts that cover more than one line of business.
Net financial impact	The net impact of prior period loss development after taking into account net losses and loss expenses incurred, earned reinstatement premiums assumed and ceded, and adjustments to assumed and ceded acquisition costs and profit commissions.
Net premiums written	An insurer’s gross premiums written less premiums ceded to reinsurers.
Non-admitted insurers	An insurer not licensed to do business in the jurisdiction in question. Also known as an unauthorized insurer and unlicensed insurer.
Premiums; written, earned and unearned	Premiums represent the cost of insurance that is paid by the cedent or insured to the insurer or reinsurer. Written represents the complete amount of premiums received, and earned represents the amount recognized as income over a period of time. Unearned is the difference between written and earned premiums.
Probable maximum loss (PML)	PML is the anticipated loss, taking into account contract terms and limits, caused by a natural catastrophe affecting a broad geographic area, such as that caused by an earthquake or hurricane.
Professional liability insurance	Professional liability insurance protects a company and its representatives against legal claims arising from error or misconduct in providing or failing to provide professional services. This type of coverage includes errors and/or omissions policies, directors and officers coverage and specialty coverage like employment practices liability insurance.
Profit commission	A commission paid by a reinsurer to a ceding insurer based on a predetermined percentage of the profit realized by the reinsurer on the ceded business.
Property insurance	Property insurance covers a business’s building and its contents—money and securities, records, inventory, furniture, machinery, supplies and even intangible assets such as trademarks—when damage, theft or loss occurs.
Property catastrophe reinsurance	Property catastrophe reinsurance contracts are typically ‘‘all risk’’ in nature, meaning that they protect against losses from natural and/or man-made catastrophes. Losses on these contracts typically stem from direct property damage and business interruption.

Link to Table of Contents

Proportional reinsurance	All forms of reinsurance in which the reinsurer shares a proportional part of the original premiums and losses of the reinsured. In proportional reinsurance, the reinsurer generally pays the client a ceding commission. The ceding commission generally is based on the client’s cost of acquiring the business being reinsured (including commissions, premium taxes, assessments and miscellaneous administrative expenses) and also may include a profit component. Frequently referred to as quota-share reinsurance.
Quota-share reinsurance	A form of proportional reinsurance in which the reinsurer assumes an agreed percentage of each underlying insurance contract being reinsured.
Reinstatement premium	A Premium charged for the reinstatement of the amount of reinsurance coverage to its full amount reduced as a result of a reinsurance loss payment.
Reinsurance	An arrangement in which a reinsurer agrees to indemnify an insurance company, the client, against all or a portion of the insurance risks underwritten by the client under one or more policies. Reinsurance can provide a client with several benefits, including a reduction in net liability on individual risks and catastrophe protection from large or multiple losses. Reinsurance also provides a client with additional underwriting capacity by permitting it to accept larger risks and write more business than would be possible without a related increase in capital and surplus, and facilitates the maintenance of acceptable financial ratios by the client. Reinsurance does not legally discharge the client from its liability with respect to its obligations to the insured.
Reinsurer	An insurance company that assumes part of the risk in exchange for part of the premium to a primary insurer.
Retrocession; retrocessional coverage	A transaction whereby a reinsurer cedes to another reinsurer, commonly referred to as the retrocessionaire, all or part of the reinsurance that the first reinsurer has assumed. Retrocessional reinsurance does not legally discharge the ceding reinsurer from its liability with respect to its obligations to the reinsured.
Risk-free rate	The interest rate on a riskless, or safe, asset, usually taken to be a short-term U.S. government security.
Risk transfer	The shifting of all or a part of a risk to another party.
Severity business	Insurance/reinsurance that is characterized by contracts containing the potential for significant losses emanating from one event.
Surety and fidelity insurance	Surety and fidelity includes (1) insurance guaranteeing the fidelity of persons holding positions of public or private trust; (2) insurance guaranteeing the performance of contracts, other than insurance policies, and guaranteeing and executing bonds, undertakings and contracts of suretyship; and (3) insurance indemnifying banks, bankers, brokers, financial or moneyed corporations or associations against loss.
Underwriter	An employee of an insurance or reinsurance company who examines, accepts or rejects risks and classifies risks in order to charge an appropriate premium for each accepted risk.
Underwriting	The process of evaluating, defining, and pricing reinsurance risks including, where appropriate, the rejection of such risks, and the acceptance of the obligation to pay the reinsured under the terms of the contract.
Underwriting expense	Underwriting expenses include those expenses directly related to underwriting activities which are not eligible to be capitalized, as well as an allocation of other general and administrative expenses.
Underwriting expense ratio	The underwriting expense ratio includes those expenses directly related to underwriting activities as well as an allocation of other general and administrative expenses. Therefore, the underwriting expense ratio is the ratio of underwriting expenses to net premiums earned. In addition, the underwriting expense ratio incorporates gains and losses resulting from deposit accounted contracts.
Workers’ compensation insurance	Workers’ compensation insurance provides medical, disability and lost-wage benefits to employees for injuries and illness sustained in the course of their employment.

Link to Table of Contents

ITEM 1A. RISK FACTORS

Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations.

Risks Relating to Our Business

We cannot assure you that our strategic review will result in a transaction or that any such transaction would be successful, and the process of exploring strategic alternatives or its conclusion could adversely impact our business and our stock price.

In August 2019, we announced the engagement of Credit Suisse Securities (USA) LLP to assist us in identifying and evaluating a range of potential strategic alternatives. This strategic review is ongoing and no timetable has been established for its completion. There can be no assurances that the strategic review will yield additional value for shareholders. Any potential transaction would be dependent on a number of factors that may be beyond our control, including, among other things, market conditions, industry trends, and interest of third parties in a potential transaction.

The strategic review could adversely affect our business, financial condition and results of operations. We could incur substantial expenses associated with evaluating potential strategic alternatives. In addition, the process may be time consuming and disruptive to our business operations, could divert the attention of management and the Board of Directors from our business, could negatively affect our ability to attract, retain and motivate key employees, and could expose us to potential litigation in connection with this process or any resulting transaction. Further, speculation regarding any developments related to the review of strategic alternatives and perceived uncertainties related to the future of the Company could cause our stock price to fluctuate significantly.

In connection with our strategic review, we have implemented steps to preserve shareholder value and improve our position. The implementation of any changes based on our strategic review may involve substantial uncertainties and risk, and our results of operations, business and financial strength rating may be materially and adversely impacted if we do not succeed in implementing such initiatives.

During the second quarter of 2019, A.M. Best revised its rating outlook of the Company’s subsidiaries’ Financial Strength Rating of A- (Excellent) from “stable” to “negative.” Companies, insurers and reinsurance brokers use ratings from independent rating agencies as an important means of assessing the financial strength and quality of reinsurers. These ratings reflect the rating agency’s opinion of our reinsurance subsidiaries’ financial strength, operating performance and ability to meet obligations. They are not evaluations directed toward the protection of investors or a recommendation to buy, sell or hold our Class A ordinary shares.

As a result of A.M. Best’s revision, we implemented steps designed to preserve shareholder value, including exploring strategic alternatives, de-risking our investment portfolio and conducting an analysis of our business lines, their positioning and internal operations. These initiatives and their implementation involve significant uncertainties and risks that may result in unforeseen expenses and costs, complications or delays. If we do not succeed in concluding our strategic review and implementing resulting initiatives on a timely basis, our results of operations, business and financial strength rating may be materially and adversely impacted. Even if we successfully implement these measures, there can be no assurance that they will improve our results of operations, preserve shareholder value or maintain or improve our financial strength rating.

Our results of operations will likely fluctuate from period to period and may not be indicative of our long-term prospects.

The performance of our operations will likely fluctuate from period to period. Fluctuations in our results of operations will result from a variety of factors, including:

●	our assessment of the quality of available reinsurance opportunities;
●	loss experience on our reinsurance liabilities;
●	reinsurance contract pricing;
●	the volume and mix of reinsurance products we underwrite;
●	the performance of our investment portfolio; and
●	our ability to assess and integrate our risk management strategy properly.

Link to Table of Contents

In particular, we seek attractive opportunities to underwrite products and make investments to achieve favorable returns on equity over the long term. Our investment strategy to invest primarily in long and short positions in publicly-traded equity and debt instruments is subject to market volatility and is likely to be more volatile than traditional fixed-income portfolios that are composed primarily of investment grade bonds. In addition, our differentiated strategy and focus on long-term growth in book value will result in fluctuations in total premiums written from period to period as we concentrate on underwriting contracts that we believe will generate better long-term, rather than short-term, results. Additionally, if actual renewals do not meet expectations or if we choose not to write on a renewal basis because of pricing conditions, our premiums written in future years and our future operations could be materially adversely affected. Accordingly, our short-term results of operations may not be indicative of our long-term prospects.

A downgrade in our ratings below specified levels or a significant decrease in our capital or surplus could enable certain clients to terminate reinsurance agreements or to require additional collateral.

Certain of our assumed reinsurance contracts contain provisions that permit our clients to cancel the contract or require additional collateral in the event of a downgrade in our ratings below specified levels or a reduction of our capital or surplus below specified levels over the course of the agreement. We expect that similar provisions will also be included in some contracts in the future. Whether a client would exercise such cancellation rights would likely depend, among other things, on the reason the provision is triggered, the prevailing market conditions, the degree of unexpired coverage and the pricing and availability of replacement reinsurance coverage.

The decrease in our surplus during 2018 triggered, in certain contracts, our client’s right to terminate and/or request additional collateral. During 2018 and 2019 we increased the amount of collateral provided to certain clients. We cannot predict how many of our clients would ultimately exercise such rights. The exercise of such rights in aggregate could have a significant effect on our financial condition, results of operations and our underwriting capacity.

A downgrade or withdrawal of either of our A.M. Best ratings may significantly and negatively affect our ability to implement our business strategy successfully.

If A.M. Best downgrades or withdraws either of our ratings, we could be severely limited or prevented from writing any new reinsurance contracts, which would significantly and negatively affect our ability to implement our business strategy. Additionally, if A.M. Best downgrades our ratings, we cannot provide assurance that our regulators, the Cayman Islands Monetary Authority and the Central Bank of Ireland, would continue to authorize our current business strategy.

Greenlight Re’s A.M. Best rating of “A- (Excellent)” is the fourth highest of 13 ratings that A.M. Best issues. A.M. Best periodically reviews our ratings and may revise one or more of our ratings downward or revoke them at its sole discretion based primarily on its analysis of our balance sheet strength, operating performance and business profile. Factors that may affect such an analysis include:

●	if A.M. Best alters its capital adequacy assessment methodology in a manner that would adversely affect the rating of our reinsurance entities;
●	if our actual losses significantly exceed our loss reserves;
●	if unfavorable financial or market trends impact us;
●	if we change our business practices from our organizational business plan in a manner that no longer supports our A.M. Best ratings;
●	if we are unable to retain our senior management and other key personnel; or
●	if our investments incur significant losses.

Link to Table of Contents

Competitors with greater resources may make it difficult for us to effectively market our products or offer our products at a profit.

The reinsurance industry is highly competitive. We compete with major reinsurers, many of which have substantially greater financial, marketing and management resources than we do. Competition in the types of business that we underwrite is based on many factors, including:

●	the general reputation and perceived financial strength of the reinsurer;
●	ratings assigned by independent rating agencies;
●	relationships with reinsurance brokers;
●	pricing;
●	ability to obtain terms and conditions appropriate with the risk being assumed and in accordance with our underwriting guidelines;
●	actual and perceived speed with which we pay claims; and
●	the experience and reputation of the members of our underwriting team in the particular lines of reinsurance we seek to underwrite.

Additionally, although the members of our underwriting deal teams have experience across many property and casualty lines, they may not have the requisite or specialized experience or expertise to compete for all transactions that fall within our strategy at times and in markets where capacity and alternatives may be limited.

Further, our ability to compete may be harmed if insurance industry participants continue to consolidate. Consolidated entities may try to use their enhanced market power to negotiate price reductions for our products and services. If competitive pressures reduce our prices, we would expect to write less business. If and when the insurance industry further consolidates, competition for customers may become more intense, and the importance of acquiring and properly servicing each customer may become greater. We could incur greater expenses relating to customer acquisition and retention, further reducing our operating margins. In addition, insurance companies that merge may be able to spread their risks across a consolidated, larger capital base so that they require less reinsurance. The number of companies offering retrocessional reinsurance may decline. Reinsurance intermediaries could also consolidate, potentially adversely impacting our ability to access business and distribute our products. We could also experience more robust competition from larger, better capitalized competitors. Any of the foregoing could significantly, and negatively, affect our business or our results of operations.

We cannot provide assurance that we will be able to compete successfully in the reinsurance market. Our failure to compete effectively could significantly and negatively affect our financial condition and results of operations and may increase the likelihood that we may be deemed to be a passive foreign investment company or an investment company. See “Item 1A. Risk Factors - Risks Relating to Taxation - United States persons who own Class A ordinary shares may be subject to United States federal income taxation on our undistributed earnings and may recognize ordinary income upon disposition of Class A ordinary shares.” and “Item 1A. Risk Factors - Risks Relating to Insurance and Other Regulations — We are subject to the risk of possibly becoming an investment company under U.S. federal securities law.”

If our losses and loss adjustment expenses greatly exceed our loss reserves, our financial condition may be materially and adversely affected.

Our results of operations and financial condition depend upon our ability to accurately assess the potential losses and loss adjustment expenses associated with the risks we reinsure. Reserves are estimates at a given time of claims an insurer ultimately expects to pay, based upon facts and circumstances then known, predictions of future events, estimates of future trends in claim severity and other variable factors. The inherent uncertainties associated with estimating loss reserves are generally greater for reinsurance companies than for primary insurance companies primarily due to:

Link to Table of Contents

●	the reporting delays that occur between the occurrence of an event or claim, its reporting to the primary insurance company and subsequent reporting to the reinsurance company by the primary insurance company;
●	the settlement delays associated with the reporting delays;
●	the diversity of development patterns among different types of reinsurance treaties; and
●	the necessary reliance on the client for information regarding claims.

Our estimation of reserves may be less reliable than the reserve estimations of a reinsurer with a greater volume of business and an established loss history. Actual losses and loss adjustment expenses paid may deviate substantially from the estimates of our loss reserves contained in our financial statements and could negatively affect our results of operations. If we determine our loss reserves to be inadequate, we will increase our loss reserves with a corresponding reduction in our net income and capital in the period in which we identify the deficiency, and such a reduction would also negatively affect our results of operations. If our losses and loss adjustment expenses greatly exceed our loss reserves, our financial condition may be significantly and negatively affected. For a summary of the effects of reserve re-estimation on prior year reserves and net income, see “Part II. Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations - Critical Accounting Estimates, Loss and Loss Adjustment Expense Reserves”

We may face risks arising from future strategic transactions such as acquisitions, dispositions, mergers or joint ventures.

We may pursue strategic transactions in the future, which could involve acquisitions or dispositions of businesses or assets. Any strategic transactions could have an adverse impact on our reputation, business, results of operation or financial condition. We face a number of risks arising from these types of transactions, including financial, accounting, tax and regulatory challenges; difficulties with integration, business retention, execution of strategy, unforeseen liabilities or market conditions; and other managerial or operating risks and challenges. Any future transactions could also subject us to risks such as failure to obtain appropriate value, post-closing claims being levied against us and disruption to our other businesses during the negotiation or execution process or thereafter. Accordingly, these risks and difficulties may prevent us from realizing the expected benefits from such strategic transactions. For example, businesses that we acquire or our strategic alliances or joint ventures may underperform relative to the price paid or resources committed by us; we may not achieve anticipated cost savings; or we may otherwise be adversely affected by transaction-related charges.

Through strategic transactions, we may also assume unknown or undisclosed business, operational, tax, regulatory and other liabilities, fail to properly assess known contingent liabilities, or assume businesses with internal control deficiencies. Risk-mitigating provisions that we put in place in the course of negotiating and executing these transactions, such as due diligence efforts and indemnification provisions, may not be sufficient to fully address these liabilities and contingencies.

The effect of emerging claim and coverage issues on our business is uncertain.

As industry practices and social, political, legal, judicial and regulatory conditions change, unexpected issues related to claims and coverage have emerged and we believe such changes have adversely affected and may continue to adversely affect our results. We have seen increased levels of abuse and fraud, as well as other forms of social inflation, in multiple U.S. jurisdictions. For example, Florida insureds have been assigning the benefit of their insurance policies to attorneys and other third parties. This practice is referred to as an “assignment of benefits,” or “AOB,”. In recent years, we believe AOB abuse has resulted in increases in the size and number of claims ceded to us. In the future, AOB abuse and related insurance fraud may directly affect us, potentially materially.

Additionally, various provisions of our contracts, such as limitations or exclusions from coverage or choice of forum, may be difficult to enforce in the manner we intend, due to, among other things, disputes relating to coverage and choice of legal forum. These issues may adversely affect our business by either extending coverage beyond the period that we intended or by increasing the number or size of claims. In some instances, these changes may not manifest themselves until many years after we have issued reinsurance contracts that are affected by these changes. As a result, we may not be able to ascertain the full extent of our liabilities under our reinsurance contracts for many years following the issuance of our contracts.

The effects of unforeseen developments or substantial government intervention could adversely impact our ability to attain our goals. For example, on January 30, 2020, the World Health Organization declared the outbreak of coronavirus (the “COVID-19”) to be a public health emergency of international concern. Due to the evolving and highly uncertain nature of this event, it is currently not possible to estimate the direct or indirect impacts this outbreak may have on our business. However, if the COVID-19 were to develop into a global pandemic, it could materially and adversely affect our results of operations and financial condition due to the disruptions to commerce, reduced economic activity and other consequences of a pandemic.

Link to Table of Contents

The property and casualty reinsurance market may be affected by cyclical trends.

We write reinsurance in the property and casualty markets, which are subject to pricing cycles. Primary insurers’ underwriting results, prevailing general economic and market conditions, liability retention decisions of companies and primary insurers and reinsurance premium rates influence the demand for property and casualty reinsurance. Prevailing prices and available surplus to support assumed business influence reinsurance supply. Supply may fluctuate in response to changes in return on capital realized in the reinsurance industry, the frequency and severity of losses and prevailing general economic and market conditions.

As a result, the reinsurance business historically has been a cyclical industry characterized by periods of intense price competition due to high levels of available underwriting capacity as well as periods when shortages of capacity have permitted favorable premium levels and changes in terms and conditions. The supply of available reinsurance capital has increased over the past several years and may increase further, either as a result of capital provided by new entrants or by the commitment of additional capital by existing insurers or reinsurers.

Continued increases in the supply of reinsurance may have consequences for the reinsurance industry generally and for us, including fewer contracts written, lower premium rates, increased expenses for customer acquisition and retention, less favorable policy terms and conditions and/or lower premium volume.

Unpredictable developments, including courts granting increasingly larger awards for certain damages, natural disasters (such as catastrophic hurricanes, windstorms, tornadoes, earthquakes, wildfires and floods), fluctuations in interest rates, changes in the investment environment that affect market prices of investments and inflationary pressures, affect the industry’s profitability. The effects of cyclicality could significantly and negatively affect our financial condition and results of operations.

Global economic downturns and any significant weakness in the U.S. economy could harm our business, our liquidity and financial condition and our stock price.

Weak economic conditions may adversely affect (among other aspects of our business) the demand for and claims made under our products, the ability of customers, counterparties and others to establish or maintain their relationships with us, our ability to access and efficiently use internal and external capital resources and our investment performance. Volatility in the U.S. and other securities markets may adversely affect our investment portfolio and our stock price.

Operational risks, including human or systems failures, are inherent in our business.

Operational risks and losses can result from, among other things, fraud, errors, failure to document transactions properly or to obtain proper internal authorization, failure to comply with regulatory requirements, information technology failures or external events.

We believe that our modeling, underwriting and information technology and application systems are critical to our business. We utilize modeling tools to facilitate our pricing, reserving, and risk management tools to manage risks in our reinsurance portfolio. These models help us to control risk accumulation, inform management and other stakeholders of capital requirements and to improve the risk/return profile or minimize the amount of capital required to cover the risks in each reinsurance contract. However, given the inherent uncertainty of modeling techniques and the application of such techniques, these models and databases may not accurately address the emergence of a variety of matters which might be deemed to impact certain of our coverages. These models have been developed internally and in some cases they make use of third party software. The construction of these models and the selection of assumptions requires significant actuarial judgment. Furthermore, these models typically rely on either cedent or industry data, both of which may be incomplete or may be subject to errors. Accordingly, these models may understate the exposures we are assuming and our financial results may be adversely impacted, perhaps significantly.

Moreover, our information technology and application systems have been an important part of our underwriting process and our ability to compete successfully. We have also licensed certain systems and data from third parties. We cannot be certain that we will have access to these, or comparable, service providers, or that our information technology or application systems will continue to operate as intended. Like all companies, our information technology and application systems may be vulnerable to data breaches, interruptions or failures due to events that may be beyond our control, including, but not limited to, natural disasters, theft, terrorist attacks, malicious cyber-attacks, computer viruses, hackers and general technology failures. A major defect or failure in our internal controls or information technology and application systems could result in management distraction, a violation of applicable privacy or other laws, harm our reputation, cause a loss of customers or give rise to

Link to Table of Contents

monetary fines or penalties or otherwise increase expenses. We believe appropriate controls and mitigation procedures are in place to prevent significant risk of data breaches, interruptions or failures in, information technology and application systems, but internal controls provide only a reasonable, not absolute, assurance as to the absence of errors or irregularities and any ineffectiveness of such controls and procedures could have a material adverse effect on our business.

The inability to obtain business provided from brokers could adversely affect our business strategy and results of operations.

Substantially all of our business is placed through brokered transactions, which involve a limited number of reinsurance brokers which exposes us to concentration risk. Our two largest brokers each accounted for more than 10% of our gross written premiums, and in the aggregate they accounted for approximately 73.0% and 78.8% of our gross premiums written in 2019 and 2018, respectively. Because broker-produced business is concentrated with a small number of brokers, we are exposed to concentration risk. To lose or fail to expand all or a substantial portion of the business provided through brokers, could significantly and negatively affect our business and results of operations.

We may need additional capital in the future in order to operate our business, and such capital may not be available to us or may not be available to us on favorable terms.

We may need to raise additional capital in the future through public or private equity or debt offerings or otherwise in order to:

●	fund liquidity needs caused by underwriting or investment losses;
●	meet rating agency capital requirements;
●	replace capital lost in the event of significant reinsurance losses or adverse reserve developments or significant investment losses;
●	satisfy collateral requirements that may be imposed by our clients or by regulators;
●	meet applicable statutory jurisdiction requirements; or
●	respond to competitive pressures.

Additional capital may not be available on terms favorable to us, or at all. Further, any additional capital raised through the sale of equity could dilute existing ownership interest in our company and may cause the market price of our Class A ordinary shares to decline. Additional capital raised through the issuance of debt may result in creditors having rights, preferences and privileges senior or otherwise superior to those of our Class A ordinary shares.

Our property and property catastrophe reinsurance operations make us vulnerable to losses from catastrophes and may cause our results of operations to vary significantly from period to period.

Certain of our reinsurance operations expose us to claims arising out of unpredictable catastrophic events, such as hurricanes, hailstorms, tornadoes, typhoons, windstorms, severe winter weather, earthquakes, floods, droughts, fires, explosions, volcanic eruptions and other natural or man-made disasters such as acts of war or terrorism, cyber attacks, major aircraft crashes, riots or political unrest or outbreaks of pandemic or contagious diseases. The incidence and severity of catastrophes are inherently unpredictable, and there may be increases in the frequency and severity of natural catastrophes and the losses that result from them. Further, such catastrophes could impact the affordability and availability of homeowners insurance, which could have an impact on pricing. We monitor and adjust our risk management models to reflect our judgment of how to interpret current developments and information. We believe that factors including increases in the value and geographic concentration of insured property, particularly along coastal regions, the possibility of an increase in the frequency and/or severity of extreme weather events, and the effects of inflation may increase the severity of claims from catastrophic events in the future.

Claims from catastrophic events such as hurricanes, typhoons and wildfires in 2017, 2018 and 2019 have reduced our earnings and caused substantial volatility in our results of operations and have affected our financial condition. Future catastrophic events may significantly reduce our earnings and cause further volatility in our results of operations and the corresponding reductions in our surplus levels could impact our ability to write new reinsurance policies.

Catastrophic losses are a function of the insured exposure in the affected area and the severity of the event. Because accounting regulations do not permit reinsurers to reserve for catastrophic events until they occur, claims from catastrophic events could cause substantial volatility in our financial results for any fiscal quarter or year and could significantly and negatively affect our financial condition and results of operations.

Link to Table of Contents

We depend on our clients’ evaluations of the risks associated with their insurance underwriting, which may subject us to reinsurance losses.

In our proportional reinsurance business, in which we assume an agreed percentage of each underlying insurance contract being reinsured, or quota share contracts, we do not expect to separately evaluate each of the original individual risks assumed under these reinsurance contracts. Therefore, we are largely dependent on the original underwriting decisions made by ceding companies. We are subject to the risk that the clients may not have adequately evaluated the insured risks and that the premiums ceded may not adequately compensate us for the risks we assume. We also do not separately evaluate each of the individual claims made on the underlying insurance contracts under quota share contracts. Therefore, we are dependent on the claims decisions made by our clients.

We could face unanticipated losses from political instability which could have a material adverse effect on our financial condition and results of operations.

We could be exposed to unexpected losses on our reinsurance contracts resulting from political instability and other politically driven events globally. These risks are inherently unpredictable and it is difficult to predict the timing of these events or to estimate the amount of loss that any given occurrence will generate. To the extent that losses from these risks occur, our financial condition and results of operations could be significantly and negatively affected.

Our failure to maintain sufficient collateral arrangements or to increase our collateral capacity on commercially acceptable terms as we grow could significantly and negatively affect our ability to implement our business strategy.

We are not licensed or admitted as a reinsurer in any jurisdiction other than the Cayman Islands and the European Economic Area. Certain jurisdictions, including the United States, do not permit insurance companies to take credit for reinsurance obtained from unlicensed or non-admitted insurers on their statutory financial statements unless appropriate security measures are implemented. Consequently, certain clients will require us to provide collateral often in the form of a letter of credit, a trust agreement or funds withheld. When we provide collateral, we are customarily required to provide collateral to the letter of credit provider or beneficiary of the trust agreement. Our ability to provide collateral, and the costs at which we provide collateral, are primarily dependent on the composition of our investment portfolio.

Typically, letters of credit are collateralized and trust agreements are funded with fixed-income securities or cash. Banks may be willing to accept our investment portfolio as collateral, but on terms that may be less favorable to us than reinsurance companies that invest solely or predominantly in fixed-income securities. The inability to renew, maintain or obtain letters of credit collateralized by our investment portfolio or to fund trust agreements may significantly limit the amount of reinsurance we can write or require us to modify our investment strategy.

Our access to funds under our existing credit facility is dependent on the ability of the bank that is a party to the facility to meet its funding commitments. The bank may not be able to meet its funding commitments if it experiences shortages of capital and liquidity or if it experiences excessive volumes of borrowing requests within a short period of time, and we might be forced to replace credit sources in a difficult market.

Any significant consolidation in the financial industry could lead to increased reliance on and exposure to particular institutions. If we cannot obtain adequate capital or sources of credit on favorable terms, or at all, our business, operating results and financial condition could be adversely affected. It is possible that, in the future, rating agencies may reduce our existing ratings. If one or more of our ratings were downgraded, we could incur higher borrowing costs and our ability to access the capital markets could be impacted. Our inability to obtain adequate capital could have a significant and negative effect on our business, financial condition and results of operations.

We may need additional collateral capacity as we grow, and if we are unable to renew, maintain or increase our collateral facilities or are unable to do so on commercially acceptable terms we may need to liquidate all or a portion of our investment portfolio and invest in a fixed-income portfolio or other forms of investment acceptable to our clients and banks as collateral, which could significantly and negatively affect our ability to implement our business strategy.

Our failure to comply with restrictive covenants contained in our current or future credit facilities could trigger prepayment obligations, which could adversely affect our business, financial condition and results of operations.

Our credit facility requires us and/or certain of our subsidiaries to comply with certain covenants, including restrictions on our ability to place a lien or charge on pledged assets, issue debt and in certain circumstances on the payment of dividends. Our failure to comply with these or other covenants could result in an event of default under the credit facility or any credit

Link to Table of Contents

facility we may enter into in the future, which, if not cured or waived, could result in us being required to repay the amounts outstanding under these facilities prior to maturity. As a result, our business, financial condition and results of operations could be significantly and negatively affected.

If we lose or are unable to retain our senior management and other key personnel and are unable to attract qualified personnel, our ability to implement our business strategy could be delayed or hindered, which, in turn, could significantly and negatively affect our business.

Our future success depends, to a significant extent, on the efforts of our senior management and other key personnel to implement our business strategy. We believe there are only a limited number of available, qualified executives with substantial experience in our industry. We could face challenges attracting and retaining personnel in the Cayman Islands and/or in Dublin, Ireland. Accordingly, the loss of the services of one or more of the members of our senior management or other key personnel, or our inability to hire and retain other key personnel, could prevent us from continuing to implement our business strategy and, consequently, significantly and negatively affect our business.

We do not currently maintain key man life insurance with respect to any of our senior management, including our Chief Executive Officer, Chief Financial Officer, Chief Underwriting Officer, Chief Risk Officer or General Counsel. If any member of senior management dies or becomes incapacitated, or leaves the Company to pursue employment opportunities elsewhere, we would be solely responsible for locating an adequate replacement for such senior management and for bearing any related cost. To the extent that we are unable to locate an adequate replacement or are unable to do so within a reasonable period of time, our business may be significantly and negatively affected.

Our ability to implement our business strategy could be adversely affected by Cayman Islands employment restrictions.

Under Cayman Islands law, persons who are not Caymanian, do not possess Caymanian status, or are not otherwise entitled to reside and work in the Cayman Islands pursuant to provisions of the Immigration Law (2015 Revision) of the Cayman Islands, which we refer to as the Immigration Law, may not engage in any gainful occupation in the Cayman Islands without an appropriate governmental work permit. Such a work permit may be granted or extended on a continuous basis for a maximum period of nine years (after having been legally and ordinarily resident in the Cayman Islands for a period of eight years a person may apply for permanent residence in accordance with the provisions of the Immigration Law) upon showing that, after proper public advertisement, no Caymanian or person of Caymanian status, or other person legally and ordinarily resident in the Cayman Islands who meets the minimum standards for the advertised position is available. The failure of these work permits to be granted or extended could prevent us from continuing to implement our business strategy.

We are subject to the credit risk of our brokers, cedents, agents and other counterparties.

In accordance with industry practice, we frequently pay amounts owed on claims under our policies to reinsurance brokers, and these brokers, in turn, remit these amounts to the ceding companies that have reinsured a portion of their liabilities with us. In some jurisdictions, if a broker fails to make such a payment, we might remain liable to the client for the deficiency notwithstanding the broker’s obligation to make such payment. Conversely, in certain jurisdictions, when the client pays premiums for policies to reinsurance brokers for payment to us, these premiums are considered to have been paid and the client will no longer be liable to us for these premiums, whether or not we have actually received them. Consequently, we assume a degree of credit risk associated with brokers around the world.

In addition, we are also exposed to the credit risk of our cedents and agents, who, pursuant to their contracts with us, may be required to pay us profit commission, additional premiums, reinstatement premiums, and adjustments to ceding commissions over a period of time, which in some cases may extend beyond the initial period of risk coverage. Insolvency, liquidity problems, distressed financial condition or the general effects of an economic recession may increase the risk that our cedents or agents may not pay a part of or the full amount of their obligations to us. To the extent our cedents or agents become unable to pay us, we would be required to recognize a downward adjustment to our premiums receivable or reinsurance recoverables, as applicable, in our financial statements. While we generally seek to mitigate this risk through, among other things, collateral agreements, funds withheld, corporate guarantees and right of offset of receivables against any losses payable, an increased inability of customers to fulfill their obligations to us could have an adverse effect on our financial condition and results of operations.

From time to time, we extend credit in the form of promissory notes and other credit facilities to certain counterparties in connection with our reinsurance activities. We have recognized losses due to counterparties’ inability to repay us, and we may incur such losses in the future.

Link to Table of Contents

Our reinsurance balances receivable from brokers and cedents at December 31, 2019 totaled $230.4 million, which included premiums and ceding commissions receivable, a majority of which are not collateralized. We cannot provide assurance that such receivables will be collected or that valuation allowances or write downs for uncollectible recoverable amounts will not be required in future periods.

We may be unable to purchase reinsurance for the liabilities we reinsure, and if we successfully purchase such reinsurance, we may be unable to collect, which could adversely affect our business, financial condition and results of operations.

We purchase reinsurance for certain liabilities we reinsure, which we refer to as retrocessional coverage, in order to mitigate the effect of a potential concentration of losses upon our financial condition. The insolvency or inability or refusal of a retrocessionaire to make payments under the terms of its agreement with us could have an adverse effect on us because we remain liable to our client. From time to time, market conditions have limited, and in some cases have prevented, reinsurers from obtaining the types and amounts of retrocessional coverage that they consider necessary for their business needs. Accordingly, we may not be able to obtain our desired amounts of retrocessional coverage or negotiate terms that we deem appropriate or acceptable or obtain retrocessional coverage from entities with satisfactory creditworthiness. Our failure to establish adequate retrocessional arrangements or the failure of our retrocessional arrangements to protect us from overly concentrated risk exposure could significantly and negatively affect our business, financial condition and results of operations.

The failure of any risk management and loss limitation methods we employ, as well as an unexpected accumulation of attritional losses, could have a material adverse effect on our financial condition and results of operations.

We seek to limit our loss exposure in a variety of ways, including by writing many of our reinsurance contracts on an excess of loss basis, adhering to maximum limitations on policies written in defined geographical zones, limiting program size for each client, establishing per risk and per occurrence limitations for each event, employing coverage restrictions and following prudent underwriting guidelines for each program written. In the case of proportional treaties, we generally seek per occurrence limitations or loss ratio caps to limit the impact of losses from any one event. We also seek to limit our loss exposure through geographic diversification. Notwithstanding these loss limitation techniques, one or more future catastrophic or other events could result in claims that substantially exceed our expectations in ways limiting the applicability of these techniques, which could have a material adverse effect on our financial condition and results of operations.

Non-compliance with laws, regulations and taxation regarding transactions with international counter-parties may adversely affect our business.

As we provide reinsurance on a worldwide basis, we are subject to an expanding legal, regulatory and tax environment intended to help detect and prevent anti-trust activity, money laundering, terrorist financing, proliferation financing, fraud, tax avoidance and other illicit activity. These requirements include, among others, regulations promulgated and administered by CIMA, the U.S. Department of the Treasury's Office of Foreign Assets Control, The Foreign Corrupt Practices Act of 1977, the Iran Freedom and Counter-Proliferation Act of 2012, and the Foreign Account Tax Compliance Act. These and other programs prohibit or restrict dealings with certain persons, entities, countries, their governments and, in certain circumstances, their nationals and may require detailed reporting to various administrative parties. Non-compliance with any of these regulations could have a material adverse effect on our ability to conduct our business.

Currency fluctuations could result in exchange rate losses and negatively impact our business.

Our functional currency is the U.S. dollar. However, we expect that we will write a portion of our business and receive premiums and pay claims in currencies other than the U.S. dollar. We may incur foreign currency exchange gains or losses as we ultimately receive premiums and settle claims in foreign currencies. In addition, DME Advisors may invest a portion of our portfolio in securities or cash denominated in currencies other than the U.S. dollar. Consequently, we may experience exchange rate losses to the extent any of our foreign currency exposure is not hedged, which could significantly and negatively affect our business. If we do seek to hedge our foreign currency exposure through the use of forward foreign currency exchange contracts or currency swaps, we will be subject to the risk that our counterparties to the arrangements fail to perform.

There are differences under Cayman Islands corporate law and Delaware corporate law with respect to interested party transactions which may benefit certain of our shareholders at the expense of other shareholders.

Under Cayman Islands corporate law, a director may vote on a contract or transaction where the director has an interest as a shareholder, director, officer or employee provided such interest is disclosed. None of our contracts will be deemed to be

Link to Table of Contents

void because any director is an interested party in such transaction and interested parties will not be held liable for monies owed to the Company.

Under Delaware law, interested party transactions are voidable.

Risks Relating to Insurance and Other Regulations

Any suspension or revocation of our reinsurance license would materially impact our ability to do business and implement our business strategy.

We are presently licensed as a reinsurer only in the Cayman Islands and the European Economic Area. The suspension or revocation of our licenses to do business as a reinsurance company in either of these jurisdictions for any reason would mean that we would not be able to enter into any new reinsurance contracts in that jurisdiction until the suspension ended or we became licensed in another jurisdiction. The process of obtaining licenses is time consuming and costly, and we may not be able to become licensed in another jurisdiction in the event we chose to. Any such suspension or revocation of our license would negatively impact our reputation in the reinsurance marketplace and could have a material adverse effect on any potential license application and on our results of operations.

CIMA and CBI may take a number of actions, including suspending or revoking a reinsurance license whenever the regulatory body believes that a licensee is or may become unable to meet its obligations, is carrying on business in a manner likely to be detrimental to the public interest or to the interest of its creditors or policyholders, has contravened the terms of the Law or has otherwise behaved in such a manner so as to cause such regulatory body to call into question the licensee’s fitness to conduct regulated activity.

Further, based on statutes, regulations and policies in their respective jurisdictions, CIMA and CBI may suspend or revoke our license if:

●	we cease to carry on reinsurance business;
●	the direction and management of our reinsurance business has not been conducted in a fit and proper manner;
●	a person holding a position as a director, manager or officer is not a fit and proper person to hold the respective position; or
●	we become bankrupt or go into liquidation or we are wound up or otherwise dissolved.

Similarly, if CIMA suspended or revoked our license, we could lose our exemption under the Investment Company Act of 1940, as amended (the “Investment Company Act”) (See “— We are subject to the risk of possibly becoming an investment company under U.S. federal securities law.”)

Our reinsurance subsidiaries are subject to minimum capital and surplus requirements, and our failure to meet these requirements could subject us to regulatory action.

The Insurance (Capital and Solvency) (Classes B, C, and D Insurers) Regulations, (2018 Revision) (the “Capital and Solvency Regulations”) impose on Greenlight Re a minimum capital requirement of US$50 million, a prescribed capital requirement of US$200.9 million and a requirement to maintain solvency equal to or in excess of the total prescribed capital requirement (the “Capital Requirements”). As of December 31, 2019, Greenlight Re was in compliance with the Capital Requirements.

Under the prudential regime applying prior to the introduction of Solvency II, GRIL, our Irish subsidiary, was required to maintain statutory reserves, particularly in respect of underwriting liabilities. Effective January 1, 2016, Solvency II introduced risk-based solvency requirements which GRIL is required to comply with, including calculating and maintaining a minimum capital requirement and solvency capital requirement. As of December 31, 2019, GRIL’s minimum capital requirement and solvency capital requirement was approximately $5.4 million and $21.8 million, respectively. As of December 31, 2019, GRIL has been in compliance with the capital requirements required under the Irish Insurance Acts and Regulations.

Any failure to meet applicable requirements or minimum statutory capital requirements could subject us to further examination or action by regulators, including restrictions on dividend payments, limitations on our writing of additional business or engaging in financial or other activities, enhanced supervision, financial or other penalties or liquidation. Further, any changes in existing risk based capital requirements or minimum statutory capital requirements may require us to increase our statutory capital levels, which we might be unable to do.

Link to Table of Contents

We are a holding company that depends on the ability of our subsidiaries to pay dividends.

We are a holding company and do not have any significant operations or assets other than our ownership of the shares of our subsidiaries. Dividends and other permitted distributions from our subsidiaries are our primary source of funds to meet ongoing cash requirements, including future debt service payments, if any, and other expenses, and to pay dividends to our shareholders if we choose to do so. Some of our subsidiaries are subject to significant regulatory restrictions limiting their ability to declare and pay dividends. The inability of our subsidiaries to pay dividends in an amount sufficient to enable us to meet our cash requirements at the holding company level could have an adverse effect on our operations and our ability to pay dividends to our shareholders if we choose to do so and/or meet our debt service obligations, if any.

To the extent any of our subsidiaries located in jurisdictions other than the Cayman Islands consider declaring dividends, such subsidiaries are required to comply with restrictions set forth under applicable law and regulations in such other jurisdictions. These restrictions could adversely impact the Company.

We are subject to the risk of possibly becoming an investment company under U.S. federal securities law.

In the United States, the Investment Company Act regulates certain companies that invest in or trade securities. We rely on an exemption under the Investment Company Act for an entity organized and regulated as a foreign insurance company which is engaged primarily and predominantly in the reinsurance of risks on insurance agreements. The law in this area is subjective and there is a lack of guidance as to the meaning of “primarily and predominantly” under the relevant exemption to the Investment Company Act. For example, there is no standard for the amount of premiums that need to be written relative to the level of an entity’s capital in order to qualify for the exemption. If this exemption were deemed inapplicable, we would have to register under the Investment Company Act as an investment company. Registered investment companies are subject to extensive, restrictive and potentially adverse regulation relating to, among other things, operating methods, management, capital structure, leverage, dividends and transactions with affiliates. Registered investment companies are not permitted to operate their business in the manner in which we operate our business, nor are registered investment companies permitted to have many of the relationships that we have with our affiliated companies. Accordingly, we likely would not be permitted to engage DME Advisors as our investment advisor, unless we obtained board and shareholder approvals under the Investment Company Act. If DME Advisors were not our investment advisor, we would seek to identify and retain another investment advisor with a value-oriented investment philosophy. If we could not identify or retain such an advisor, we would be required to make substantial modifications to our investment strategy. Any such changes to our investment strategy could significantly and negatively impact our investment results, financial condition and our ability to implement our business strategy.

If at any time it were established that we had been operating as an investment company in violation of the registration requirements of the Investment Company Act, there would be a risk, among other material adverse consequences, that we could become subject to monetary penalties or injunctive relief, or both, or that we would be unable to enforce contracts with third parties or that third parties could seek to obtain rescission of transactions with us undertaken during the period in which it was established that we were an unregistered investment company.

To the extent that the laws and regulations change in the future so that contracts we write are deemed not to be reinsurance contracts, we will be at greater risk of not qualifying for the Investment Company Act exception. Additionally, it is possible that our classification as an investment company would result in the suspension or revocation of our reinsurance license.

Insurance regulations to which we are, or may become, subject, and potential changes thereto, could have a significant and negative effect on our business.

We currently are admitted to do business in the Cayman Islands and the European Economic Area. Our operations in each of these jurisdictions are subject to varying degrees of regulation and supervision. The laws and regulations of the jurisdictions in which our subsidiaries are domiciled require that, among other things, these subsidiaries maintain minimum levels of statutory or regulatory capital, surplus and liquidity, meet solvency standards, submit to periodic examinations of their financial condition and restrict payments of dividends and reductions of capital. Statutes, regulations and policies that our subsidiaries are subject to may also restrict the ability of these subsidiaries to write insurance and reinsurance policies, make certain investments and distribute funds.

More specifically with respect to our Irish subsidiary, European legislation known as “Solvency II”, was introduced with effect from January 1, 2016 and governs the prudential regulation of insurers and reinsurers, and requires insurers and reinsurers in Europe to meet risk-based solvency requirements. It also imposes group solvency and governance requirements on groups with insurers and/or reinsurers operating in the European Economic Area. A number of European Commission delegated

Link to Table of Contents

acts and technical standards have been adopted, which set out more detailed requirements based on the overarching provisions of the Solvency II Directive. However, further delegated acts, technical standards and guidance are likely to be published on an ongoing basis.

Although we do not presently expect that we will be admitted to do business in any other jurisdiction other than the Cayman Islands and the European Economic Area, we cannot provide assurance that insurance regulators in the United States or elsewhere will not review our activities and claim that we are subject to such jurisdiction’s licensing requirements. In addition, we are subject to indirect regulatory requirements imposed by jurisdictions that may limit our ability to provide reinsurance. For example, our ability to write reinsurance may be subject, in certain cases, to arrangements satisfactory to applicable regulatory bodies, and proposed legislation and regulations may have the effect of imposing additional requirements upon, or restricting the market for, non-U.S. reinsurers such as Greenlight Re and GRIL, with whom domestic companies may place business. We do not know of any such proposed legislation pending at this time.

We may not be able to comply fully with, or obtain desired exemptions from, revised statutes, regulations and policies that currently, or may in the future, govern the conduct of our business. Failure to comply with, or to obtain desired authorizations and/or exemptions under, any applicable laws could result in restrictions on our ability to do business or undertake activities that are regulated in one or more of the jurisdictions in which we operate and could subject us to fines and other sanctions. The Monetary Authority Law (2018 revision) includes amendments that provide for a specific administrative fines framework whereby CIMA has been granted the power to issue monetary penalties up to 1 million Cayman Dollars for a very serious breach.

In addition, governmental authorities worldwide have become increasingly interested in potential risks posed by the insurance industry as a whole, and to the commercial and financial systems in general. While we cannot predict the exact nature, timing or scope of possible governmental initiatives, there may be increased regulatory intervention in our industry in the future. Changes in the laws or regulations to which our subsidiaries are subject or may become subject, or in the interpretations thereof by enforcement or regulatory agencies, could have a material adverse effect on our business.

The U.K.’s exit from the EU could impact our business.

On January 31, 2020, the UK formally exited from the EU (“Brexit”) and entered an 11-month transition period (unless a single extension of one to two years to this transition period is agreed between the U.K. government and the EU, by June 30, 2020). During the transition period, the U.K.’s trading relationship with the EU is expected to remain largely unchanged while the negotiations to determine the terms of the U.K.’s future relationship with the EU continue. As a result, we face risks associated with the potential uncertainty and consequences that may follow Brexit, including with respect to volatility in financial markets, exchange rates and interest rates. These uncertainties could increase the volatility of, or reduce, our investment results in particular periods or over time.

Brexit could adversely affect European or worldwide political, regulatory, economic or market conditions and could contribute to instability in global political institutions and regulatory agencies. Brexit could also lead to legal uncertainty and differing laws and regulations between the U.K. and the EU, and could impair or adversely affect the ability of the Lloyd’s market and the wider London market to transact business in EU countries.

These uncertainties could affect the operations, strategic position or results of insurers or reinsurers on whom we ultimately rely to access underlying insured coverages. Any of these potential effects of Brexit, and others we cannot anticipate, could adversely affect our results of operations or financial condition.

Risks Relating to Our Investment Strategy and Our Investment Advisor

Our investment management structure could subject us to various risks and uncertainties, any of which could impact our investment results and could materially and adversely affect our business, financial condition and results of operations.

On September 1, 2018, each of GLRE, Greenlight Re and GRIL entered into the SILP LPA with DME II as general partner. Commencing on September 1, 2018, all new investments to be made on behalf of Greenlight Re and GRIL have been made through SILP, pursuant to the SILP LPA, and not through the Joint Venture.

In accordance with the SILP LPA, substantially all the assets and related liabilities that comprise our investment portfolio have been transferred to SILP as of January 2, 2019. However, assets required to provide collateral for underwriting activities were not transferred to SILP but rather were transferred to accounts designated by each of Greenlight Re and GRIL for use by the companies to operate their respective businesses.

As a result of the change in our investment management structure, we may derive a significant portion of our income

Link to Table of Contents

from our investment in SILP. Our operating results will, therefore, depend in part on the performance of SILP and on DME Advisors as the investment advisor of SILP. SILP is not, and is not expected to be, registered as an “investment company” under the Investment Company Act of 1940 or any comparable regulatory requirements. Therefore, investors in SILP, including Greenlight Re and GRIL, will not have the benefit of the protections afforded by such registration and regulation. In addition, we will be subject to various existing and new risks and uncertainties, some of which we may not be able to identify at this time.

SILP may be concentrated in a few large positions, which could result in large losses.

Our investment guidelines provide that SILP may commit up to 20% of Greenlight Re’s capital account (10% for GRIL) to any one investment. In addition, GRIL’s investment guidelines require that the 10 largest investments shall not constitute more than 50% of the total investment portfolio and GRIL’s investment portfolio shall at all times, unless waived by the GRIL board of directors, be composed of a minimum of 50 debt or equity securities of publicly traded companies. From time to time SILP may hold a few, relatively large security positions in relation to our capital accounts. Since SILP may not be widely diversified by security or by industry, it may be subject to more rapid changes in value than would be the case if our investment portfolio were required to maintain a wide diversification among companies, securities industries and types of securities.

Under the SILP LPA, we are contractually obligated to invest substantially all our assets in SILP with certain exceptions. SILP’s performance depends on the ability of DME Advisors to select and manage appropriate investments.

In connection with the SILP LPA, DME Advisors acts as the exclusive investment advisor for our investment portfolio. Pursuant to the SILP LPA, we are contractually obligated to use commercially reasonable efforts to cause substantially all investable assets of Greenlight Re and GRIL, with limited exceptions, to be contributed to SILP. Additionally, we are restricted from making additional contributions of assets that would cause the capital account balances of Greenlight Re and GRIL to represent more than 90% of the aggregate capital account balances of all of the partners of SILP. Although DME Advisors is contractually obligated to follow the investment guidelines of both Greenlight Re and GRIL, we cannot provide assurance as to how DME Advisors will allocate our investable assets to different investment opportunities. DME Advisors may allocate our capital accounts to long and short equity positions, debt and derivatives, which could increase the level of risk to which our investment portfolio will be exposed.

The performance of our investment portfolio depends to a great extent on the ability of DME Advisors to select and manage appropriate investments for SILP. We cannot provide assurance that DME Advisors will be successful in meeting our investment objectives. The failure of DME Advisors to perform adequately could significantly and negatively affect our business, results of operations and financial condition.

Our investment performance depends in part on the performance of SILP, and may suffer as a result of adverse financial market developments or other factors that impact our liquidity, which could in turn adversely affect our financial condition and results of operations.

Our operating results depend in part on the performance of SILP. We cannot provide assurance that DME Advisors on behalf of SILP will successfully structure investments in relation to our liquidity needs or liabilities. Failure to do so could force us to withdraw investments from SILP at a significant loss or at prices that are not optimal, which could significantly and adversely affect our financial results.

The risks associated with the value-oriented investment strategy expected to be employed by SILP may be substantially greater than the risks associated with traditional fixed-income investment strategies. In addition, long equity investments may generate losses if the market declines. Similarly, short equity investments may generate losses in a rising market. The success of the investment strategy may also be affected by general economic conditions. Unexpected market volatility and illiquidity associated with our investment in SILP could significantly and negatively affect our investment results, financial condition or results of operations.

Under our new investment management structure, we have limited control over SILP.

Under the SILP LPA, subject to the investment guidelines and certain other conditions, DME II has complete and exclusive power and responsibility for all investment and investment management decisions to be undertaken on behalf of SILP and for managing and administering the affairs of SILP, and has the power and authority to do all things that it, as the general partner, considers necessary or desirable to carry out its duties thereunder. These broad rights of DME II include the power to delegate its authorities under the SILP LPA. Pursuant to the IAA, DME II has delegated to DME Advisors the authority to direct the investments of SILP and other day-to-day business. In addition, DME II may resign or withdraw from SILP and may admit new limited partners to SILP without our consent, which may cause SILP to be deemed an “investment company” under

Link to Table of Contents

the Investment Company Act of 1940.

We have no right to remove DME II as general partner of SILP and do not have any right to participate in the conduct or management of SILP, other than by amending our investment guidelines.

The historical performance of DME Advisors and its affiliates should not be considered as indicative of the future results of our investment portfolio or of our future results or of any returns expected on our Class A ordinary shares.

The historical returns of the funds managed by DME Advisors and its affiliates are not directly linked to our Class A ordinary shares. Results for our investment in SILP could differ from results of the other funds managed by DME Advisors and its affiliates as a result of restrictions imposed by our investment guidelines and other factors.

Even if our investment in SILP generates investment income in a given period, our overall performance could be adversely affected by losses generated by our reinsurance operations. Poor performance of SILP will cause a decline in our revenue and will therefore have a negative effect on our financial performance.

The historical performance of DME Advisors and its affiliates may impact our A.M. Best rating.

The historical performance of DME Advisors and its funds is not necessarily indicative of future results, but losses incurred to date may be taken into account by A.M. Best & Co. and may adversely affect our financial strength rating. See “Item 1A. Risk Factors - Risks Relating to Our Business - “A downgrade or withdrawal of either of our A.M. Best ratings may significantly and negatively affect our ability to implement our business strategy successfully.”.

If A.M. Best downgrades our ratings, we cannot provide assurance that our regulators, Cayman Islands Monetary Authority and the Central Bank of Ireland, would continue to authorize our current investment strategy.

Apart from funds required for collateral purposes, substantially all of our investable assets are or are expected to be invested with SILP and, as a result, we depend upon DME II to implement our investment strategy.

Apart from funds required for collateral purposes, risk management and other operational needs, substantially all of our investable assets are or are expected to be invested with SILP and, as a result, we depend upon DME II to implement our investment strategy. Accordingly, the diminution or loss of the services of DME II could significantly affect SILP and our business. DME II, in turn, is dependent on the talents, efforts and leadership of DME Advisors’ principals. The diminution or loss of the services of DME Advisors’ principals, or diminution or loss of their reputation or any negative market or industry perception arising from that diminution or loss, could have a material adverse effect on our business. In addition, the loss of DME Advisors’ key personnel, or DME Advisors’ inability to hire and retain other key personnel, over which we have no control, could delay or prevent DME Advisors from fulfilling its obligations pursuant to the IAA, which could significantly and negatively affect SILP’s performance and correspondingly our business and financial performance.

Our investment performance may suffer as a result of adverse financial market developments or other factors that impact our liquidity, which could in turn adversely affect our financial condition and results of operations.

We may derive a significant portion of our income from our investment portfolio. As a result, our operating results depend in part on the performance of our investment portfolio. We strive to structure our investments in a manner that recognizes our liquidity needs for future liabilities. We cannot provide assurance that DME Advisors will successfully structure our investments in relation to our anticipated liabilities. Failure to do so could force us to liquidate investments at a significant loss or at prices that are not optimal, which could significantly and adversely affect our financial results.

The risks associated with DME Advisors’ value-oriented investment strategy may be substantially greater than the risks associated with traditional fixed-income investment strategies. In addition, long equity investments may generate losses if the market declines. Similarly, short equity investments may generate losses in a rising market. The success of our investment strategy may also be affected by general economic conditions. Unexpected market volatility and illiquidity associated with our investments could significantly and negatively affect our investment portfolio results.

Potential conflicts of interest with DME Advisors may exist that could adversely affect us.

In addition to managing SILP, DME Advisors, its principals and their affiliates may engage in investment and trading activities for their own accounts and/or for the accounts of third parties. None of DME Advisors or its principals, including David Einhorn, Chairman of our Board of Directors and the President of Greenlight Capital, Inc., are obligated to devote any specific amount of time to our investment in SILP. Affiliates of DME Advisors, including Greenlight Capital, Inc., manage and expect to continue to manage other client accounts, some of which have objectives similar to SILP, including collective

Link to Table of Contents

investment vehicles managed by DME Advisors’ affiliates and in which DME Advisors or its affiliates may have an equity interest. Pursuant to the SILP LPA and the IAA, DME Advisors has the exclusive right to manage SILP and is required to follow our investment guidelines and act in a manner that is fair and equitable in allocating investment opportunities to us, but neither the SILP LPA or the IAA impose any specific obligations or requirements concerning allocation of time, effort or investment opportunities to us or any restriction on the nature or timing of investments for accounts that DME Advisors or its affiliates may manage. If we compete for any investment opportunity with another entity that DME Advisors or its affiliates manage, DME Advisors is not required to afford SILP exclusivity or priority. DME Advisors’ interest and the interests of its affiliates, including Greenlight Capital, Inc., may at times conflict, possibly to DME Advisors’ detriment, which, in turn, may potentially adversely affect SILP’s investment opportunities and returns, and correspondingly, our investment portfolio.

Mr. Einhorn, Chairman of our Board of Directors, is not, under Cayman Islands law, legally restricted from participating in making decisions with respect to Greenlight Re’s investment guidelines. Accordingly, his involvement as a member of the Boards of Directors of Greenlight Capital Re, Ltd. and Greenlight Re may lead to a conflict of interest.

DME Advisors and its affiliates may also manage accounts whose advisory fee schedules, investment objectives and policies differ from those of SILP, which may cause DME Advisors and its affiliates to effect trading in one account that may have an adverse effect on another account, including SILP. We do not have the contractual right to inspect the trading records of DME Advisors or its principals.

If DME Advisor’s risk management systems are ineffective, we may be exposed to material unanticipated losses.

DME Advisors continually refines its risk management techniques, strategies and assessment methods. However, its risk management techniques and strategies do not fully mitigate the risk exposure of its funds and managed accounts, including SILP, in all economic or market environments, or against all types of risk, including risks that it might fail to identify or anticipate. Any failures in DME Advisors’ risk management techniques and strategies to accurately quantify risk exposure could limit the risk-adjusted returns of SILP. In addition, any risk management failures could cause losses to be significantly greater than historical measures predict. DME Advisors’ approach to managing those risks could prove insufficient, exposing SILP, and correspondingly our investment portfolio, to material unanticipated or material losses.

We and SILP are exposed to credit risk primarily from the possibility that counterparties may default on their obligations to us.

We and SILP are exposed to credit risk primarily from the possibility that counterparties may default on their obligations to us or it. The amount of the maximum exposure to credit risk is indicated by the carrying value of our and SILP’s financial assets. In addition, SILP holds the securities of our investment portfolio with prime brokers and have credit risk from the possibility that one or more of them may default on their obligations to SILP. Other than our investment in derivative contracts and corporate debt, if any, and the fact that our investments are held by prime brokers and custodians on our behalf, we have no other significant concentrations of credit risk in our investment portfolio.

Issuers or borrowers whose securities or debt SILP holds, customers, reinsurers, clearing agents, exchanges, clearing houses and other financial intermediaries and guarantors may default on their obligations to us and/or SILP due to bankruptcy, insolvency, lack of liquidity, adverse economic conditions, operational failure, fraud or other reasons. Such defaults could have a significant and negative effect on us and/or SILP, and, correspondingly, our investment portfolio and our results of operations, financial condition and cash flows.

SILP may trade on margin and use other forms of financial leverage, which could potentially adversely affect our revenues.

Our investment guidelines provide SILP with the ability to trade on margin and use other forms of financial leverage. Fluctuations in the market value of our investment in SILP could have a disproportionately large effect in relation to our capital. Any event which may adversely affect the value of positions SILP holds could significantly and negatively affect the net asset value of our investment portfolio and thus our results of operations.

SILP effectuates short sales that subject our capital accounts to unlimited loss potential.

SILP enters into transactions in which it sells a security it does not own, which we refer to as a short sale, in anticipation of a decline in the market value of the security. Short sales for our account theoretically will involve unlimited loss potential since the market price of securities sold short may continuously increase. SILP may mitigate such losses by replacing the securities sold short before the market price has increased significantly but we have no control over such mitigation, if any. Under adverse market conditions, SILP might have difficulty purchasing securities to meet short sale delivery obligations and may have to cover short sales at suboptimal prices.

Link to Table of Contents

SILP may transact in derivatives trading, which may increase the risk of our investment portfolio.

Derivative instruments, or derivatives, include futures, options, swaps, structured securities and other instruments and contracts that derive their value from one or more underlying securities, financial benchmarks, currencies, commodities or indices. There are a number of risks associated with derivatives trading. Because many derivatives are leveraged, a relatively small adverse market movement may result in a substantial loss, and may potentially expose us to a loss exceeding the original amount invested. Derivatives may also expose SILP, and correspondingly, our investment portfolio, to liquidity risk as there may not be a liquid market within which to close or dispose of outstanding derivative contracts. The counterparty risk lies with each party with whom SILP contracts for the purpose of making derivative investments. In the event of the counterparty’s default, SILP will generally only rank as an unsecured creditor and risk the loss of all or a portion of the amounts SILP is contractually entitled to receive.

The compensation arrangements of SILP may create an incentive to effect transactions that are risky or speculative.

Pursuant to the SILP LPA each of Greenlight Re and GRIL is obligated to pay a performance allocation to DME II at the end of each performance period based on its positive performance change to its capital account, subject to a modified loss carry forward provision.

The loss carry forward provision contained in the SILP LPA allows DME II to earn reduced performance allocation of 10% of profits in any year subsequent to the year in which SILP has incurred a loss, until all losses are recouped and an additional amount equal to 150% of the loss is earned.

While the performance compensation arrangement contained in the SILP LPA provides that losses will be carried forward as an offset against net profits in subsequent periods, DME II and DME Advisors generally will not otherwise be penalized for losses or decreases in the value of our portfolio under the SILP LPA. These performance compensation arrangements may create an incentive for DME Advisors to engage in transactions that focus on the potential for short-term gains rather than long-term growth or that are particularly risky or speculative. The losses incurred under the venture agreement have been carried over to SILP and must be recouped in accordance with the loss carry forward provisions contained in the SILP LPA.

DME Advisors’ representatives’ service on boards and committees may place trading restrictions on our investments and may subject us to indemnification liability.

DME Advisors may from time to time place its or its affiliates’ representatives on creditors’ committees and/or boards of certain companies in which SILP has invested. While such representation may enable DME Advisors to enhance the sale value of SILP’s investments, it may also prevent SILP from freely disposing of our investments and may subject us to indemnification liability. The IAA provides for the indemnification of DME Advisors or any other person designated by DME Advisors for claims arising from such board representation.

The ability to use “soft dollars” may provide DME Advisors with an incentive to select certain brokers that may take into account benefits to be received by DME Advisors.

DME Advisors is entitled to use so-called “soft dollars” generated by commissions paid in connection with transactions for SILP to pay for certain of DME Advisors’ operating and overhead costs, including the payment of all or a portion of its costs and expenses of operation. “Soft dollars” are a means of paying brokerage firms for their services through commission revenue, rather than through direct payments. DME Advisors only uses soft dollars to pay for expenses that would otherwise be borne by SILP and certain other co-managed funds. However, DME Advisors’ right to use soft dollars may give DME Advisors an incentive to select brokers or dealers for our transactions, or to negotiate commission rates or other execution terms, in a manner that takes into account the soft dollar benefits received by DME Advisors rather than giving exclusive consideration to the interests of our investment portfolio and, accordingly, may create a conflict.

The SILP LPA limits our ability to use another investment manager.

The SILP LPA restricts our ability to manage our investment portfolio outside of SILP. Because the SILP LPA contains exclusivity and limited termination provisions, we are unable to use other investment managers for so long as Greenlight Re and GRIL are limited partners in SILP. Although we may withdraw funds from SILP for operational purposes by giving three days notice, Greenlight Re or GRIL may withdraw as a limited partner upon notice only on the Greenlight Re Relevant Date or the GRIL Relevant Date (as defined in the SILP LPA) or “for cause”, which is defined as:

Link to Table of Contents

●	a material violation of applicable law relating to DME II’s or DME Advisors’ advisory business;
●	DME II’s or DME Advisors’ gross negligence, willful misconduct or reckless disregard of DME II’s obligations under the SILP LPA or DME Advisors’ obligations under the IAA;
●	a material breach by DME II or DME Advisors of Greenlight Re’s or GRIL’s investment guidelines that is not cured within a 15-day period; or
●	a material breach by DME II or DME Advisors of its obligations under 5.2 of the SILP LPA, which relate to timely redemption of partnership interests.

In addition, GRIL may withdraw as a limited partner in SILP due to unsatisfactory long term performance of DME II or DME Advisors, as determined solely by the Board of Directors of GRIL at the end of each fiscal year during the term of the SILP LPA.

Greenlight Re may not withdraw as a limited partner in SILP on the basis of performance. If Greenlight Re becomes dissatisfied with the results of the investment performance of SILP, we will be unable to hire new investment managers unless the SILP LPA is terminated for cause.

Certain investments made by SILP may have limited liquidity and lack valuation data, which could create a conflict of interest.

Our investment guidelines provide SILP with the flexibility to invest in certain securities with limited liquidity or no public market. This lack of liquidity may adversely affect the ability of SILP to execute trade orders at desired prices and may impact our ability to fulfill our underwriting payment obligations. To the extent that SILP invests in securities or instruments for which market quotations are not readily available, under the terms of the IAA the valuation of such securities and instruments for purposes of compensation will be determined by DME Advisors, whose determination, subject to audit verification, will be conclusive and binding in the absence of bad faith or manifest error. Because the IAA gives DME Advisors the power to determine the value of securities with no readily discernible market value, and because the calculation of DME Advisors’ fee is based on the value of the investment account, a conflict exists as DME Advisors may be incentivized to place a higher valuation on such securities.

In addition, for all securities traded on public exchanges, each exchange typically has the right to suspend or limit trading in all securities it lists. Such a suspension could render it impossible to liquidate positions and thereby expose SILP, and correspondingly us, to losses.

Increased regulation or scrutiny of alternative investment advisors may affect DME II and DME Advisors’ ability to manage SILP or affect our business reputation.

The regulatory environment for investment managers is evolving, and changes in the regulation of managers may adversely affect the ability of DME Advisors to obtain the leverage it might otherwise obtain or to pursue its trading strategies. In addition, the securities and futures markets are subject to comprehensive statutes, regulations and margin requirements. The SEC, other regulators and self-regulatory organizations and exchanges are authorized to take extraordinary actions in the event of market emergencies. The regulation of derivatives transactions and funds that engage in such transactions is an evolving area of law and is subject to modification by government and judicial action. Any future regulatory change could have a significant negative impact on our financial condition and results of operations.

Short sale transactions have been subject to increased regulatory scrutiny, including the imposition of restrictions on short selling certain securities and reporting requirements. Our ability to execute a short selling strategy may be materially and adversely impacted by new temporary and/or permanent rules, interpretations, prohibitions, and restrictions adopted in response to these adverse market events. Temporary restrictions and/or prohibitions on short selling activity may be imposed by regulatory authorities with little or no advance notice and may impact prior and future trading activities of our investment portfolio. Additionally, the SEC, its non-U.S. counterparts, other governmental authorities and/or self-regulatory organizations may at any time promulgate permanent rules or interpretations consistent with such temporary restrictions or that impose additional or different permanent or temporary limitations or prohibitions. The SEC might impose different limitations and/or prohibitions on short selling from those imposed by various non-U.S. regulatory authorities. These different regulations, rules or interpretations might have different effective periods.

Regulatory authorities may, from time-to-time, impose restrictions that adversely affect our ability to borrow certain securities in connection with short sale transactions. In addition, traditional lenders of securities might be less likely to lend securities under certain market conditions. As a result, we may not be able to effectively pursue a short selling strategy due to a limited supply of securities available for borrowing. We may also incur additional costs in connection with short sale

Link to Table of Contents

transactions, including, if SILP is required to enter into a borrowing arrangement in advance of any short sales. Moreover, the ability to continue to borrow a security is not guaranteed and we are subject to strict delivery requirements. The inability to deliver securities within the required time frame may subject us to mandatory close out by the executing broker-dealer. A mandatory close out may subject us to unintended costs and losses. Certain action or inaction by third parties, such as executing broker-dealers or clearing broker-dealers, may materially impact our ability to effect short sale transactions.

SILP may invest in securities based outside the United States which may be riskier than securities of United States issuers.

Under our investment guidelines, SILP may invest in securities of issuers organized or based outside the United States. These investments may be subject to a variety of risks and other special considerations not affecting securities of U.S. issuers. Many foreign securities markets are not as developed or efficient as those in the United States. Securities of some foreign issuers are less liquid and more volatile than securities of comparable U.S. issuers. Similarly, volume and liquidity in many foreign securities markets are less than in the United States and, at times, price volatility can be greater than in the United States. Non-U.S. issuers may be subject to less stringent financial reporting and informational disclosure standards, regulatory oversight, practices and requirements than those applicable to U.S. issuers.

Risks Relating to our Class A Ordinary Shares

Our level of debt may have an adverse impact on our liquidity, restrict our current and future operations, particularly our ability to respond to business opportunities, and increase our vulnerability to adverse economic and industry conditions.

In August 2018, we sold $100 million of convertible notes. Our level of debt and the provisions of such debt could have significant consequences, which include, but are not limited to, the following:

•	limit our ability to obtain additional financing in the future for working capital, capital expenditures, acquisitions or other general corporate purposes;
•	require a substantial portion of our cash flows to be dedicated to debt service payments instead of other purposes, thereby reducing the amount of cash flows available for working capital, capital expenditures, acquisitions and other general corporate purposes;
---	---

•discourage an acquisition of us by a third party;

•place us at a competitive disadvantage to competitors carrying less debt; and

•	make us more vulnerable to economic downturns and limiting our ability to withstand competitive pressures or take advantage of new opportunities to grow our business.

We may from time to time seek to refinance our indebtedness by issuing additional shares of our common stock in one or more securities offerings. Such securities offerings may dilute our existing shareholders, reduce the value of our common stock, or both. Because our decision to issue securities depends on, among other things, market conditions and other factors beyond our control, we cannot predict or estimate the amount, timing or nature of any future securities offerings. Thus, holders of our common stock bear the risk of our future offerings diluting and potentially reducing the value of our common stock.

Conversion of the notes or future sales or issuances of Class A ordinary shares may dilute the ownership interest of existing shareholders, including holders who have previously converted their notes. Such dilution may adversely affect the trading price of our Class A ordinary shares and the notes and the conversion rate of the notes may not be adjusted for all dilutive events.

We may issue equity securities in the future for a number of reasons, including to finance our operations and business strategy, to acquire assets or companies, to adjust our ratio of debt to equity, or in connection with our incentive and stock option plans. Any issuance of equity securities, including the issuance of shares, if any, upon conversion of the notes, could dilute the interests of our existing shareholders, including holders who have previously received shares upon conversion of their notes, and could substantially affect the trading price of our Class A ordinary shares and the notes. In addition, the anticipated conversion of the notes into our Class A ordinary shares could depress the price of our Class A ordinary shares.

We may not be able to pay interest on the notes or settle conversions of the notes in cash or to repurchase the notes upon a fundamental change, and our future debt, if any, may contain limitations on our ability to pay cash upon conversion or repurchase of the notes.

Holders of notes have the right to require us to repurchase all or a portion of their notes for cash upon the occurrence of a fundamental change under the indenture governing the notes. In addition, upon conversion of the notes, unless we elect to

Link to Table of Contents

deliver solely Class A ordinary shares to settle such conversion (other than paying cash in lieu of delivering any fractional share), we will be required to make cash payments in respect of the notes being converted. However, we may not have enough available cash or be able to obtain financing on favorable terms, if at all, at the time we are required to make repurchases of notes surrendered therefor or pay cash with respect to the notes being converted.

In addition, our ability to make the required repurchase upon a fundamental change may be limited by law or the terms of other debt agreements or securities. Our failure to pay interest on the notes or to make the required cash repurchase or cash payment, as the case may be, would constitute an event of default under the indenture governing the notes which, in turn, could constitute an event of default under other debt agreements or securities, thereby resulting in their acceleration and required prepayment and thereby further restricting our ability to make such interest payments and repurchases. If, due to a default, the repayment of related indebtedness were to be accelerated after any applicable notice or grace periods, we may not have sufficient funds to repay such indebtedness and the notes. We may be required to refinance all or part of our debt, sell important strategic assets at unfavorable prices, incur additional indebtedness or issue common stock or other equity securities, which we may be unable to do on terms acceptable to us, in amounts sufficient to meet our needs or at all.

Our ability to meet the debt service obligations contained in our debt agreements depends on our available cash and our future performance, which will be affected by financial, business, economic and other factors. Our inability to service our debt obligations or refinance our debt could have a material adverse effect on our business, operating results and financial condition. Refinancing our indebtedness may also require us to expense previous debt issuance costs or to incur new debt issuance costs.

The accounting method for convertible debt securities that may be settled in cash, such as the notes, could have a material effect on our reported financial results.

Under Accounting Standards Codification (“ASC”) 470-20, Debt with Conversion and Other Options, which we refer to

as ASC 470-20, an entity must separately account for the liability and equity components of the convertible debt instruments (such as the notes) that may be settled entirely or partially in cash upon conversion in a manner that reflects the entity’s economic interest cost. The effect of ASC 470-20 on the accounting for the notes is that the equity component is required to be included in the additional paid-in capital section of shareholders’ equity on our consolidated balance sheet, and the value of the equity component would be treated as original issue discount for purposes of accounting for the debt component of the notes. As a result, we are required to record a greater amount of non-cash interest expense in current periods presented as a result of the amortization of the discounted carrying value of the notes to their face amount over the term of the notes. We report lower net income in our financial results because ASC 470-20 requires interest to include both the current period’s amortization of the debt discount and the instrument’s coupon interest, which could adversely affect our reported or future financial results, the trading price of our Class A ordinary shares and the trading price of the notes.

A shareholder may be required to sell its Class A ordinary shares.

Our Third Amended and Restated Memorandum and Articles of Association, or Articles, provide that we have the option, but not the obligation, to require a shareholder to sell its Class A ordinary shares for their fair market value to us, to other shareholders or to third parties if our Board of Directors determines that ownership of our Class A ordinary shares by such shareholder may result in adverse tax, regulatory or legal consequences to us, any of our subsidiaries or any of our shareholders and that such sale is necessary to avoid or cure such adverse consequences.

Provisions of our Articles, the Companies Law of the Cayman Islands and our corporate structure may each impede a takeover, which could adversely affect the value of our Class A ordinary shares.

Our Articles contain certain provisions that could make it difficult for a third party to acquire us, even if doing so would be beneficial to our shareholders. Our Articles provide that a director may only be removed for “cause” as defined in the Articles, upon the affirmative vote of not less than 50% of the votes cast at a meeting at which more than 50% of our issued and outstanding Class A ordinary shares are represented. Further, under the Amended and Restated Memorandum and Articles of Association of Greenlight Re, a director may only be removed without cause upon the affirmative vote of not less than 80% of the votes cast at a meeting at which more than 50% of our issued and outstanding Class A ordinary shares are represented.

Our Articles permit our Board of Directors to issue preferred shares from time to time, with such rights and preferences as they consider appropriate. Our Board of Directors may authorize the issuance of preferred shares with terms and conditions and under circumstances that could have an effect of discouraging a takeover or other transaction, deny shareholders the receipt of a premium on their Class A ordinary shares in the event of a tender or other offer for Class A ordinary shares and have a depressive effect on the market price of the Class A ordinary shares.

Link to Table of Contents

As compared to mergers under corporate law in the United States, it may be more difficult to consummate a merger of two or more companies in the Cayman Islands or the merger of one or more Cayman Islands companies with one or more overseas companies, even if such transaction would be beneficial to our shareholders. Cayman Islands law has statutory provisions that provide for the reconstruction and amalgamation of companies, which are commonly referred to, in the Cayman Islands, as “schemes of arrangement”. The Companies Law (2020 Revision) of the Cayman Islands (the “Companies Law”) provides for the merger or consolidation of two or more companies that are Cayman Islands entities or the merger of one or more Cayman Islands companies with one or more overseas companies, where the surviving entity is either a Cayman Islands company or an overseas company. Prior to the adoption of certain amendments to the Companies Law, the “scheme of arrangement” was the only vehicle available to consolidate companies and Cayman Islands law did not provide for mergers as that term is understood under corporate law in the United States. Although the current merger provisions have made it faster and more procedurally straightforward for companies to merge or consolidate than by using a “schemes of arrangement” statutory provision, these provisions do not replace the “schemes of arrangement” provision which continues to apply. The procedural and legal requirements necessary to consummate these transactions under the merger and consolidation provisions of the Companies Law or the “schemes of arrangement” provision may be more rigorous and take longer to complete than the procedures typically required to consummate a merger in the United States.

Under Cayman Islands law and practice, a “scheme of arrangement” must be approved at a shareholders’ meeting by each class of shareholders, in each case, by a majority of the number of holders of each class of an entity’s shares that are present and voting, either in person or by proxy, at such a meeting, which holders must also represent 75% in value of such class issued that are present and voting, either in person or by proxy, at such meeting, excluding the shares owned by the parties to the scheme of arrangement. A merger requires approval by a special resolution of the shareholders of each company (which normally requires, as a minimum, a two thirds majority of shareholders voting together as one class) and such other authorization, if any, as may be specified in such constituent company’s articles of association.

Although a merger under the Companies Law does not require court approval, the convening of these meetings and the terms of an amalgamation under the “schemes of arrangement” provision must be sanctioned by the Grand Court of the Cayman Islands. Although there is no requirement to seek the consent of the creditors of the parties involved in the scheme of arrangement, the Grand Court typically seeks to ensure that the creditors have consented to the transfer of their liabilities to the surviving entity or that the scheme of arrangement does not otherwise materially adversely affect the creditors’ interests. Furthermore, the Grand Court will only approve a scheme of arrangement if it is satisfied that:

●	the statutory provisions as to majority vote have been complied with;
●	the shareholders have been fairly represented at the meeting in question;
●	the scheme of arrangement is such as a businessperson would reasonably approve; and
●	the scheme of arrangement is not one that would more properly be sanctioned under some other provision of the Companies Law.

In addition, David Einhorn, Chairman of our Board of Directors, owns all of the outstanding Class B ordinary shares. As a result, we will not be able to enter into a scheme of arrangement without the approval of Mr. Einhorn as the holder of our Class B ordinary shares.

Holders of Class A ordinary shares may have difficulty obtaining or enforcing a judgment against us, and they may face difficulties in protecting their interests because we are incorporated under Cayman Islands law.

Because we are a Cayman Islands company, there is uncertainty as to whether the Grand Court of the Cayman Islands would recognize or enforce judgments of United States courts obtained against us predicated upon the civil liability provisions of the securities laws of the United States or any state thereof, or be competent to hear original actions brought in the Cayman Islands against us predicated upon the securities laws of the United States or any state thereof.

We are incorporated as an exempted company limited by shares under the Companies Law. A significant amount of our assets are located outside of the United States. As a result, it may be difficult for persons purchasing Class A ordinary shares to effect service of process within the United States upon us or to enforce judgments against us or judgments obtained in U.S. courts predicated upon the civil liability provisions of the federal securities laws of the United States or any state of the United States.

Although there is no statutory enforcement in the Cayman Islands of judgments obtained in the United States, the courts of the Cayman Islands will, based on the principle that a judgment by a competent foreign court will impose upon the judgment debtor an obligation to pay the sum for which judgment has been given, recognize and enforce a foreign judgment of a court of

Link to Table of Contents

competent jurisdiction if such judgment is final, for a liquidated sum, not in respect of taxes or a fine or penalty if not inconsistent with a Cayman Islands judgment in respect of the same matters, and was not obtained in a manner, and is not of a kind, the enforcement of which is contrary to the public policy of the Cayman Islands. There is doubt, however, as to whether the courts of the Cayman Islands will, in an original action in the Cayman Islands, recognize or enforce judgments of U.S. courts predicated upon the civil liability provisions of the securities laws of the United States or any state of the United States on the grounds that such provisions are penal in nature.

A Cayman Islands court may stay proceedings if concurrent proceedings are being brought elsewhere.

The Cayman Islands law does specifically provide for shareholder appraisal rights on a merger or consolidation of an entity if minority shareholders exercise their rights to 'dissent' from the merger. Dissenting shareholders to a merger have the right to be paid the fair value of their shares (which, if not agreed between the parties, will be determined by the Cayman Islands court) if they follow the required procedures.

Shareholders of Cayman Islands exempted companies such as ours have no general rights under Cayman Islands law to inspect corporate records and accounts. Our directors have discretion under our Articles to determine whether or not, and under what conditions, the corporate records may be inspected by shareholders, but are not obligated to make them available to shareholders. This fact may make it more difficult for shareholders to obtain the information needed to establish any facts necessary for a shareholder motion or to solicit proxies from other shareholders in connection with a proxy contest.

Subject to limited exceptions, under Cayman Islands law, a minority shareholder may not bring a derivative action against our Board of Directors.

Provisions of our Articles may reallocate the voting power of our Class A ordinary shares and subject holders of Class A ordinary shares to SEC compliance.

In certain circumstances, the total voting power of our Class A ordinary shares held by any one person will be reduced to less than 9.9% of the total issued and outstanding ordinary shares, and the total voting power of the Class B ordinary shares will be reduced to 9.5% of the total voting power of the total issued and outstanding ordinary shares. In the event a holder of our Class A ordinary shares acquires shares representing 9.9% or more of the total voting power of our total ordinary shares or the Class B ordinary shares represent more than 9.5% of the total voting power of our total outstanding shares, there will be an effective reallocation of the voting power of the Class A ordinary shares or Class B ordinary shares which may cause a shareholder to acquire 5% or more of the voting power of the total ordinary shares.

Such a shareholder may become subject to the reporting and disclosure requirements of Sections 13(d) and (g) of the Exchange Act. Such a reallocation also may result in an obligation to amend previous filings made under Section 13(d) or (g) of the Exchange Act. Under our Articles, we have no obligation to notify shareholders of any adjustments to their voting power. Shareholders should consult their own legal counsel regarding the possible reporting requirements under Section 13 of the Exchange Act.

As of December 31, 2019, David Einhorn owned 16.9% of the issued and outstanding ordinary shares, which given that each Class B share is entitled to ten votes, causes him to exceed the 9.5% limitation imposed on the total voting power of the Class B ordinary shares. Thus, the voting power held by the Class B ordinary shares that is in excess of the 9.5% limitation will be reallocated pro-rata to holders of Class A ordinary shares according to their percentage interest in the Company. However, no shareholder will be allocated voting rights that would cause it to have 9.9% or more of the total voting power of our ordinary shares. The allocation of the voting power of the Class B ordinary shares to a holder of Class A ordinary shares will depend upon the total voting power of the Class B ordinary shares outstanding, as well as the percentage of Class A ordinary shares held by a shareholder and the other holders of Class A ordinary shares. Accordingly, we cannot estimate with precision what multiple of a vote per share a holder of Class A ordinary shares will be allocated as a result of the anticipated reallocation of voting power of the Class B ordinary shares.

Risks Relating to Taxation

We may become subject to taxation in the Cayman Islands, which would negatively affect our results.

Under current Cayman Islands law, we are not obligated to pay any taxes in the Cayman Islands on either income or capital gains. The Governor-in-Cabinet of Cayman Islands has granted us an exemption from the imposition of any such tax on us until February 1, 2025. We cannot be assured that after such date we would not be subject to any such tax. If we were to become subject to taxation in the Cayman Islands, our financial condition and results of operations could be significantly and negatively affected.

Link to Table of Contents

Greenlight Capital Re, Greenlight Re and/or GRIL may be subject to United States federal income taxation.

Greenlight Capital Re and Greenlight Re are incorporated under the laws of the Cayman Islands, and GRIL is incorporated under the laws of Ireland. These entities intend to operate in a manner that will not cause us to be treated as engaging in a trade or business within the United States and will not cause us to be subject to current United States federal income taxation on Greenlight Capital Re’s, Greenlight Re’s and/or GRIL’s net income. However, because there are no definitive standards provided by the Internal Revenue Code, regulations or court decisions as to the specific activities that constitute being engaged in the conduct of a trade or business within the United States, and as any such determination is essentially factual in nature, we cannot provide assurance that the United States Internal Revenue Service (the “IRS”), will not successfully assert that Greenlight Capital Re, Greenlight Re and/or GRIL are engaged in a trade or business within the United States. If the IRS were to successfully assert that Greenlight Capital Re, Greenlight Re, and/or GRIL have been engaged in a trade or business within the United States in any taxable year, various adverse tax consequences could result, including the following: Greenlight Capital Re, Greenlight Re and/or GRIL may become subject to current United States federal income taxation on its net income from sources within the United States; Greenlight Capital Re, Greenlight Re and/or GRIL may be subject to United States federal income tax on a portion of its net investment income, regardless of its source; Greenlight Capital Re, Greenlight Re, and/or GRIL may not be entitled to deduct certain expenses that would otherwise be deductible from the income subject to United States taxation; and Greenlight Capital Re, Greenlight Re and/or GRIL may be subject to United States branch profits tax on profits deemed to have been distributed out of the United States.

United States persons who own Class A ordinary shares may be subject to United States federal income taxation on our undistributed earnings and may recognize ordinary income upon disposition of Class A ordinary shares.

Passive Foreign Investment Company. Significant potential adverse United States federal income tax consequences, including certain reporting requirements, generally apply to any United States person who owns shares in a passive foreign investment company, or a PFIC. We do not expect that any of Greenlight Capital Re, Greenlight Re, or GRIL will be a PFIC for the current taxable year. However, we cannot provide assurance that none of Greenlight Capital Re, Greenlight Re, or GRIL will be a PFIC for the current taxable year or any future taxable year.

In general, any of Greenlight Capital Re, Greenlight Re or GRIL would be a PFIC for a taxable year if either (i) 75% or more of its income constitutes “passive income” or (ii) 50% or more of its assets produce “passive income”, or are held for the production of passive income. Passive income generally includes interest, dividends and other investment income but does not include income derived in the active conduct of an insurance business by a corporation predominantly engaged in an insurance business. As of January 1, 2018, the active conduct of an insurance business is defined as an insurance company which has applicable insurance liabilities, as reported on its annual financial statement, exceeding 25% of its total assets. Applicable insurance liabilities means, with respect to our property and casualty reinsurance business, reserves for loss and loss adjustment expenses, and excludes unearned premium reserves.

The exception for insurance companies is intended to ensure that a qualifying insurance entity’s income is not treated as passive income, except to the extent such income is attributable to financial reserves in excess of the reasonable needs of the insurance business. We intend to operate our business with financial reserves and applicable insurance liabilities at levels that should not cause us to be deemed PFICs, although we cannot provide assurance that we will be successful in structuring our operations to meet such levels nor can we ensure that the IRS will not successfully challenge our status. If we are unable to underwrite sufficient amount of risks and maintain a sufficient amount of applicable insurance liabilities, any of Greenlight Capital Re, Greenlight Re or GRIL may become a PFIC.

In addition, sufficient risk must be transferred under an insurance entity’s contracts with its insureds in order to qualify for the insurance exception. Whether our insurance contracts possess adequate risk transfer for purposes of determining whether income under our contracts is insurance income, and whether we are predominantly engaged in an insurance business, are subjective in nature and there is little authoritative tax guidance on these issues. We cannot provide assurance that the IRS will not successfully challenge our interpretation of the scope of the active insurance company exception and our qualification for the exception. Further, the IRS may issue regulatory or other guidance that causes us to fail to qualify for the active insurance company exception on a prospective or retroactive basis. Therefore, we cannot provide assurance that we will satisfy the exception for insurance companies and will not be treated as PFICs currently or in the future.

Controlled Foreign Corporation. United States persons who, directly or indirectly or through attribution rules, own 10% or more of the total combined voting power or value of our shares, which we refer to as United States 10% shareholders, may be subject to the controlled foreign corporation, or CFC, rules. Under the CFC rules, each United States 10% shareholder must

Link to Table of Contents

annually include his pro-rata share of the CFC’s “subpart F income” and “global intangible low-tax income” in his or her gross income in the year earned by the CFC, even if no distributions are made. In general, a foreign insurance company will be treated as a CFC only if during the taxable year United States 10% shareholders collectively own more than 25% of the total combined voting power or total value of the entity’s shares. We believe that the dispersion of our Class A ordinary shares among holders and the restrictions placed on transfer, issuance or repurchase of our Class A ordinary shares , will in most cases prevent shareholders who acquire Class A ordinary shares from being United States 10% shareholders. We cannot provide assurance, however, that these rules will not apply to you if you are or become a United States 10% shareholder. In particular, recent changes to the definition of a United States 10% Shareholder, whereby both vote and value are tested, and recent changes to the constructive ownership rules, whereby shares owned by non-United States persons can be attributed to United States persons, may increase the likelihood of these rules applying. If you are a United States person, we strongly urge you to consult your own tax advisor concerning the CFC rules.

Related Person Insurance Income. If:

●	our gross income attributable to insurance or reinsurance policies where the direct or indirect insureds are our direct or indirect United States shareholders or persons related to such United States shareholders equals or exceeds 20% of our gross insurance income in any taxable year; and
●	direct or indirect insureds and persons related to such insureds owned directly or indirectly 20% or more of the voting power or value of our stock,

a United States person who owns Class A ordinary shares directly or indirectly on the last day of the taxable year would most likely be required to include their pro-rata share of our related person insurance income for the taxable year in their income. This amount would be determined as if such related person insurance income were distributed proportionally to United States persons at that date. We do not expect that we will knowingly enter into reinsurance agreements in which, in the aggregate, the direct or indirect insureds are, or are related to, owners of 20% or more of the Class A ordinary shares. We do not believe that the 20% gross insurance income threshold will be met. However, we cannot provide assurance that this is or will continue to be the case. Consequently, we cannot provide assurance that a person who is a direct or indirect United States shareholder will not be required to include amounts in its income in respect of related person insurance income in any taxable year.

If a United States shareholder is treated as disposing of shares in a foreign insurance corporation that has related person insurance income and in which United States persons own 25% or more of the voting power or value of the entity’s shares, any gain from the disposition will generally be treated as a dividend to the extent of the United States shareholder’s portion of the corporation’s undistributed earnings and profits that were accumulated during the period that the United States shareholder owned the shares. In addition, the shareholder will be required to comply with certain reporting requirements, regardless of the amount of shares owned by the direct or indirect United States shareholder. Although not free from doubt, we believe these rules should not apply to dispositions of Class A ordinary shares because Greenlight Capital Re is not directly engaged in the insurance business and because proposed United States Treasury regulations applicable to this situation appear to apply only in the case of shares of corporations that are directly engaged in the insurance business. We cannot provide assurance, however, that the IRS will interpret the proposed regulations in this manner or that the proposed regulations will not be promulgated in final form in a manner that would cause these rules to apply to dispositions of Class A ordinary shares.

United States tax-exempt organizations who own Class A ordinary shares may recognize unrelated business taxable income.

If you are a United States tax-exempt organization you may recognize unrelated business taxable income if a portion of our subpart F insurance income is allocated to you. In general, subpart F insurance income will be allocated to you if we are a CFC as discussed above and you are a United States 10% shareholder or there is related person insurance income and certain exceptions do not apply. Although we do not believe that any United States persons will be allocated subpart F insurance income, we cannot provide assurance that this will be the case. If you are a United States tax-exempt organization, we advise you to consult your own tax advisor regarding the risk of recognizing unrelated business taxable income.

H.R. 1, the recently passed tax reform bill, is causing us to undertake changes to the manner in which we conduct our business and could subject United States persons who own Class A ordinary shares to United States income taxation on our undistributed earnings.

On December 22, 2017, H.R. 1, commonly referred to as “the Tax Cuts and Jobs Act,” was signed into law. H.R. 1 provides a bright-line test that a non-U.S. insurance company only will receive the benefit, for passive foreign investment company purposes, of being engaged in the active conduct of an insurance business if its applicable insurance liabilities constitute more than 25% of its total assets. For this purpose, the term “applicable insurance liabilities” does not include unearned premium reserves. One of the H.R. 1’s potential impacts is that this limitation could result in the treatment of offshore

Link to Table of Contents

insurers or reinsurers that write business on a low frequency/high severity basis, such as property catastrophe companies and financial guaranty companies, as PFICs, as significant reserves for losses may not be recorded until a catastrophic event actually occurs. Accordingly, subject to any future corrections or clarifications that may be made to H.R. 1, or any regulations that may be promulgated thereunder, the Company will be treated as a PFIC for any taxable year in which it does not meet the bright-line applicable insurance liabilities requirement of H.R. 1.

As of December 31, 2019 and 2018 the Company met the bright-line applicable insurance liabilities test. However, there is still substantial uncertainty regarding the application of the test. The Company cannot guarantee that it will continue to meet the bright-line applicable insurance liabilities test in future periods. In the event that the Company cannot meet this test, shareholders that are United States persons will be subject to United States income taxation on the Company’s undistributed earnings.

Further changes in United States tax regulations and laws including the rules regarding passive foreign investment companies could have a material impact on our ability to qualify for the insurance company exemption and/or change our status for United States persons who own Class A ordinary shares

The IRS or Congress may issue additional regulations or legislation regarding the applicable insurance liabilities bright-line test of the passive foreign investment company (“PFIC”) rules or other aspects of the PFIC rules applicable to foreign insurance companies. On July 11, 2019, the IRS issued proposed regulations that would provide additional guidance and requirements regarding the exclusion from the definition of “passive income” for income derived in the active conduct of an insurance business by a qualified insurance corporation (the “July 2019 Proposed Regulations”). We understand that the additional requirements of the July 2019 Proposed Regulations, as proposed, will be effective (if at all) only on a prospective basis for taxable years beginning on or after the date final or temporary regulations are issued (unless the Company otherwise relies on the July 2019 Proposed Regulations for its 2019 taxable year, which the Company does not intend to do). Accordingly, the July 2019 Proposed Regulations will not be effective for the Company’s 2019 taxable year. We can offer no assurance whether, in what form or when the July 2019 Proposed Regulations could be adopted. We also can offer no assurance as to the potential impact of the July 2019 Proposed Regulations for the Company.

We are monitoring developments with respect to both the applicable insurance liabilities test and the IRS proposed regulations. At this time, we cannot predict whether or what, if any, additional regulations will be adopted or additional legislation will be enacted. If regulations are adopted or legislation enacted that cause us to fail to meet the requirements of the insurance company exception, or if we fail to meet the recently enacted applicable insurance liabilities test such failure could have a material adverse effect on the taxation of our shareholders who are U.S. persons. In that event we may undertake further changes to the manner in which we conduct our business, which also could have a material effect on our results of operations.

The tax laws and interpretations regarding whether an entity is engaged in a United States trade or business, is a CFC, has related party insurance income or is a PFIC are subject to change, possibly on a retroactive basis. New regulations or pronouncements interpreting or clarifying such rules may be forthcoming from the IRS. We are not able to predict if, when or in what form such guidance will be provided and whether such guidance will have a retroactive effect.

H.R. 1 may have a detrimental effect on the Company and its assets.

The regulatory and tax environment globally is evolving, and changes in the regulation or taxation of the Company and its assets may materially adversely shareholders. H.R. 1, among other things, makes significant changes to the rules applicable to the taxation of the Company and its assets, such as changing the rules applicable to active insurance income for passive foreign investment company purposes (discussed above), changing rules applicable to controlled foreign investment company purposes, new base erosion rules, changing the general corporate tax rate to a flat 21% rate, modifying the rules regarding limitations on certain deductions, introducing a capital investment deduction in certain circumstances, placing certain limitations on the interest deduction, modifying the rules regarding the usability of certain net operating losses, and the migration from a worldwide system of taxation to a modified territorial system. At this time the ultimate outcome of the new legislation on the Company and its shareholders is uncertain and could be adverse. Shareholders should consult their own tax advisors regarding potential changes in tax laws.

If investments held by GRIL are determined not to be integral to the reinsurance business carried on by GRIL, additional Irish tax could be imposed and our business and financial results could be materially adversely affected.

Based on administrative practice, taxable income derived from investments made by GRIL is generally taxed in Ireland at the rate of 12.5% on the grounds that such investments either form part of the permanent capital required by regulatory authorities, or are otherwise integral to the reinsurance business carried on by GRIL. GRIL intends to operate in such a manner

Link to Table of Contents

so that the level of investments held by GRIL does not exceed the amount that is integral to the reinsurance businesses carried on by GRIL. If, however, investment income earned by GRIL exceeds these thresholds or if the administrative practice of the Irish Revenue Commissioners changes, Irish corporation tax could apply to such investment income at a higher rate (currently 25%) instead of the general 12.5% rate, and our results of operations could be materially adversely affected.

The impact of the initiative of the OECD and the EU to eliminate harmful tax practices is uncertain and could adversely affect our tax status in the Cayman Islands.

The OECD has published reports and launched a global dialogue among member and non-member countries on measures to limit harmful tax competition. These measures are largely directed at counteracting the effects of tax neutral jurisdictions and preferential tax regimes in countries around the world. While the Cayman Islands is currently on the list of jurisdictions that have substantially implemented the internationally agreed tax standard, we are not able to predict if additional requirements will be imposed, and if so, whether changes arising from such additional requirements will subject us to additional taxes. On February 18, 2020, the EU announced that following a meeting of the EU's Economic and Financial Affairs Council, the Cayman Islands had been moved to Annex 1 of the EU’s list of non-cooperative jurisdictions for tax purposes (“Annex 1”) due to the Cayman Islands not having appropriate measures in place relating to economic substance in the area of collective investment vehicles (“CIVs”). The Cayman Islands Government (“CIG”) has stated that the EU’s concerns over CIVs were addressed by the enactment of The Private Funds Law and The Mutual Funds (Amendment) Law on February 7, 2020, of which the EU was duly notified. The CIG has announced that it has commenced discussions with EU officials to begin the process of having the Cayman Islands removed from Annex 1 as soon as possible, which is expected to be October 2020 at the earliest. The move to Annex 1 appears to be a technical issue arising out of the delay in enacting this legislation and it is therefore expected that the Cayman Islands will be removed from Annex 1 at the first available opportunity. The Cayman Islands’ economic substance legislation had already been evaluated in June 2019 by the OECD’s Forum on Harmful Tax Practices as “not harmful”, which is the highest rating possible. There are no immediate regulatory, tax, trade or other legal impacts to the Company, but we are not able to predict any future EU actions and whether the EU will deem the newly enacted laws to be compliant with its requirements in order to remove the Cayman Islands from Annex 1.

ITEM 1B. UNRESOLVED STAFF COMMENTS

None.

ITEM 2. PROPERTIES

We currently occupy our office space in Grand Cayman, Cayman Islands under operating lease agreements which expired on June 30, 2018. We are in negotiations with the lessor for renewal of the lease and meanwhile both parties have agreed to extend the lease until December 31, 2020. Additionally, we have an operating lease agreement for office space in Dublin, Ireland which expires in 2031, but provides us an option to terminate the lease in 2021 without any penalty. We believe that for the foreseeable future the office spaces in the Cayman Islands and Ireland will be sufficient for conducting our operations.

ITEM 3. LEGAL PROCEEDINGS

From time to time, in the normal course of business, we may be involved in formal and informal dispute resolution procedures, which may include arbitration or litigation, the outcomes of which determine our rights and obligations under our reinsurance contracts and other contractual agreements. In some disputes, we may seek to enforce our rights under an agreement or to collect funds owing to us. In other matters, we may resist attempts by others to collect funds or enforce alleged rights. While the final outcome of legal disputes cannot be predicted with certainty, we do not believe that any of our existing contractual disputes, when finally resolved, will have a material adverse effect on our business, financial condition or operating results.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

PART II

Link to Table of Contents

ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

Market Information and number of holders

Our Class A ordinary shares began publicly trading on the Nasdaq Global Select Market on May 24, 2007 under the symbol “GLRE”.

As of March 6, 2020, the number of holders of record of our Class A ordinary shares was approximately 41, not including beneficial owners of shares registered in nominee or street name who represent approximately 94.6% of the Class A ordinary shares issued and outstanding.

Dividends

Since inception, we have not paid any cash dividends on our Class A ordinary shares or Class B ordinary shares, or collectively, our ordinary shares.

Holders of ordinary shares are entitled to receive dividends when, as and if declared by the Board of Directors in accordance with the provisions of our Articles and the Companies Law. In the event of a liquidation, dissolution or winding-up of the Company, the holders of ordinary shares are entitled to share equally and ratably in our assets, if any remain after the payment of all of our debts and liabilities and the liquidation preference of any outstanding preferred shares.

We currently do not intend to declare and pay dividends on our ordinary shares in the foreseeable future. However, if we decide to pay dividends, we cannot provide assurance that sufficient cash will be available to pay such dividends. In addition, a letter of credit facility prohibits us from paying dividends during an event of default as defined in the letter of credit agreement. Our future dividend policy will also depend on the requirements of any future financing agreements to which we may be a party and other factors considered relevant by our Board of Directors, such as our results of operations and cash flows, our financial position and capital requirements, general business conditions, rating agency guidelines, legal, tax, regulatory and any contractual restrictions on the payment of dividends. Further, any future declaration and payment of dividends is discretionary and our Board of Directors may, at any time, modify or revoke our dividend policy on our ordinary shares. Finally, our ability to pay dividends also depends on the ability of our subsidiaries to pay dividends to us. Although Greenlight Capital Re is not subject to any significant legal prohibitions on the payment of dividends, Greenlight Re and GRIL are subject to regulatory constraints that affect their ability to pay dividends and include minimum net worth requirements. As of December 31, 2019, Greenlight Re and GRIL both exceeded the minimum statutory capital requirements. Any dividends we pay will be declared and paid in U.S. dollars.

Link to Table of Contents

Performance Graph

Presented below is a line graph comparing the yearly change in the cumulative total shareholder return on our Class A ordinary shares for the five year period commencing December 31, 2014 through December 31, 2019 against the total return index for the Russell 2000 Index, or RUT, and the S&P 500 Property & Casualty Insurance Index, or S&P Insurance Index, for the same period. The performance graph assumes $100 invested on December 31, 2014 in the ordinary shares of Greenlight Capital Re, the RUT and the S&P Insurance Index. The performance graph also assumes that all dividends are reinvested.

The performance reflected in the graph above is not necessarily indicative of future performance.

This graph is not “soliciting material,” is not deemed filed with the SEC and is not to be incorporated by reference in any filing by us under the Securities Act or the Exchange Act, whether made before or after the date hereof and irrespective of any general incorporation language in any such filing.

Purchases of Equity Securities by the Issuer and Affiliated Purchasers

Our board of directors has adopted a share repurchase plan authorizing the Company to repurchase Class A ordinary shares. From time to time, the repurchase plan has been re-approved or modified at the election of our Board of Directors. On May 2, 2019, the Board of Directors renewed the share repurchase plan, with effect from July 1, 2019 and expiring on June 30, 2020, authorizing the Company to purchase up to 2.5 million Class A ordinary shares or securities convertible into Class A ordinary shares in the open market, through privately negotiated transactions or Rule 10b5-1 stock trading plans. As of December 31, 2019, 2.5 million Class A ordinary shares remained authorized for repurchase under the share repurchase plan. The Company is not required to repurchase any Class A ordinary shares and the repurchase plan may be modified, suspended or terminated at any time without prior notice. No shares were repurchased by the Company during the year ended December 31, 2019.

Link to Table of Contents

ITEM 6. SELECTED FINANCIAL DATA

The following table sets forth our selected historical consolidated statement of operations data for the fiscal years ended December 31, 2019, 2018, 2017, 2016 and 2015, as well as our selected historical consolidated balance sheet data as of December 31, 2019, 2018, 2017, 2016 and 2015, which are derived from our audited consolidated financial statements. The audited consolidated financial statements are prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and have been audited by BDO USA, LLP, an independent registered public accounting firm.

These historic results presented below are not necessarily indicative of results for any future period, and should be read in conjunction with our consolidated financial statements and related notes thereto contained in “Item 8. Financial Statements and Supplementary Data” and “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in this filing and all other information appearing elsewhere or incorporated into this filing by reference.

	Year ended December 31
	2019		2018			2017			2016			2015
	( in thousands, except per share and share amounts)
Selected Consolidated Statement of Operations Data
Gross premiums written			$	567,531		$	692,651		$	536,072		$	502,124
Net premiums earned	483,580		508,363			626,004			513,118			408,387
Net investment income (loss)	52,267		(323,106		)	20,231			76,183			(281,924		)
Net loss and loss adjustment expenses incurred	388,487		363,873			502,404			380,815			317,097
Acquisition costs	117,084		145,475			161,740			134,534			116,207
General and administrative expenses	29,822		25,173			26,356			25,808			23,434
Net income (loss) attributable to Greenlight Capital Re, Ltd.		)	$	(350,054	)	$	(44,952	)	$	44,881		$	(326,425	)
Earnings (Loss) Per Share Data (1)
Basic		)	$	(9.74	)	$	(1.21	)	$	1.20		$	(8.90	)
Diluted	(0.11	)	(9.74		)	(1.21		)	1.20			(8.90		)
Weighted average number of ordinary shares used in the determination of earnings and loss per share
Basic	36,079,419		35,951,659			37,002,260			37,267,145			36,670,466
Diluted	36,079,419		35,951,659			37,002,260			37,340,018			36,670,466
Underwriting Income (Loss) and Selected Ratios
Underwriting income (loss) *		)	$	(14,384	)	$	(53,628	)	$	(18,814	)	$	(41,909	)
Loss ratio	80.3	%	71.6		%	80.3		%	74.2		%	77.6		%
Acquisition cost ratio	24.2	%	28.6		%	25.8		%	26.2		%	28.5		%
Underwriting expense ratio	2.4	%	2.6		%	2.5		%	3.2		%	4.2		%
Combined ratio	106.9	%	102.8		%	108.6		%	103.6		%	110.3		%

All values are in US Dollars.

(1)

The Company treats its unvested restricted stock awards, which contain non-forfeitable rights to dividends or dividend equivalents, whether paid or unpaid as “participating securities.” Basic earnings per share is calculated on the basis of the weighted average number of common shares and participating securities outstanding during the period.<br><br><br><br>Diluted earnings (or loss) per share includes the dilutive effect of the following: (i) RSUs issued that would convert to common shares upon vesting, (ii) additional potential common shares issuable when stock options are exercised, determined using the treasury stock method, and (iii) those common shares with the potential to be issued by virtue of convertible debt and other such convertible instruments, determined using the treasury stock method. Diluted earnings (or loss) per share contemplates a conversion to common shares of all convertible instruments only if they are dilutive in nature with regards to earnings per share. In the event of a net loss, all RSUs, stock options outstanding, convertible debt and participating securities are excluded from the calculation of both basic and diluted loss per share since their inclusion would be anti-dilutive.

Link to Table of Contents

	December 31
	2019	2018		2017		2016		2015
	( in thousands, except per share and share amounts)
Selected Consolidated Balance Sheet Data
Total investments		$	283,928	$	1,362,984	$	1,022,537	$	1,064,164
Cash and cash equivalents	25,813	18,215		27,285		39,858		112,162
Restricted cash and cash equivalents	742,093	685,016		1,503,813		1,202,651		1,236,589
Reinsurance balances receivable	230,384	300,251		301,762		219,126		187,940
Total assets	1,355,193	1,435,445		3,357,393		2,664,693		2,712,522
Loss and loss adjustment expense reserves (1)	470,588	482,662		464,380		306,641		305,997
Unearned premium reserves	179,460	211,789		255,818		222,527		211,954
Total liabilities	878,010	955,981		2,505,967		1,773,006		1,863,749
Total equity	477,183	477,772		844,257		885,803		836,509
Adjusted book value* (2)		$	477,287	$	831,324	$	874,242	$	825,391
Diluted adjusted book value* (3)	477,183	477,287		845,183		876,362		836,944
Ordinary shares outstanding
Basic	36,994,110	36,384,929		37,359,545		37,366,327		37,027,467
Diluted (4)	37,057,692	36,431,327		38,039,229		37,489,647		37,744,807
Per Share Data
Basic adjusted book value per share* (5)		$	13.12	$	22.25	$	23.40	$	22.29
Fully diluted adjusted book value per share* (6)	12.88	13.10		22.22		23.38		22.17

All values are in US Dollars.

(1)	For a detailed discussion of the change in our loss and loss adjustment expenses, refer to “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations — Financial Condition” and Note 7 to the consolidated financial statements.
(2)	Adjusted book value equals total shareholders’ equity minus non-controlling interest in Joint Venture.
(3)	Diluted adjusted book value is the adjusted book value plus the proceeds from the exercise of in-the-money options issued and outstanding at year end.
(4)	Diluted number of shares outstanding is the sum of basic shares outstanding and the in-the-money options and restricted stock units issued and outstanding at year end.
(5)	Basic adjusted book value per share is calculated by dividing adjusted book value by the number of shares and share equivalents issued and outstanding at year end.
(6)	Fully diluted adjusted book value per share is calculated by dividing the diluted adjusted book value by the diluted number of shares outstanding at year end.
*	Adjusted book value, diluted adjusted book value, basic adjusted book value per share, fully diluted adjusted book value per share and underwriting income (loss) are non-GAAP measures. For a reconciliation of the non-GAAP measures to the most comparable GAAP measures, refer to “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations — Results of Operations”.

Link to Table of Contents

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

References to “we,” “us,” “our,” “our company,” or “the Company” refer to Greenlight Capital Re, Ltd. (“GLRE”) and our wholly-owned subsidiaries, Greenlight Reinsurance, Ltd, (“Greenlight Re”), Greenlight Reinsurance Ireland, Designated Activity Company (“GRIL”) and Verdant Holding Company, Ltd. (“Verdant”), unless the context dictates otherwise. References to our “Ordinary Shares” refers collectively to our Class A Ordinary Shares and Class B Ordinary Shares.

The following discussion should be read in conjunction with the audited consolidated financial statements and accompanying notes, which appear elsewhere in this filing.

The following is a discussion and analysis of our results of operations for the years ended December 31, 2019 and 2018 and financial condition as of December 31, 2019 and 2018.

We have omitted discussion of the earliest of the three years covered by our consolidated financial statements presented in this report because that disclosure was already included in our Form 10-K/A for the fiscal year ended December 31, 2018, filed with the SEC on March 15, 2019. You are encouraged to reference Part II, Item 7, within that report, for a discussion of our financial condition and result of operations for the fiscal year ended December 31, 2018 compared to the fiscal year ended December 31, 2017.

General

We are a global specialty property and casualty reinsurer, headquartered in the Cayman Islands, with a reinsurance and investment strategy that we believe differentiates us from most of our competitors. Our goal is to build long-term shareholder value by providing risk management products and services to the insurance, reinsurance and other risk marketplaces. We focus on delivering risk solutions to clients and brokers who value our expertise, analytics and customer service offerings.

Historically, we have aimed to complement our underwriting results with a non-traditional investment approach in order to achieve higher rates of return over the long term than reinsurance companies that employ more traditional investment strategies. Our investment portfolio is managed according to a value-oriented philosophy, in which our investment advisor takes long positions in perceived undervalued securities and short positions in perceived overvalued securities. During the second quarter of 2019, A.M. Best revised its rating outlook of the Company’s subsidiaries’ Financial Strength Rating of A- (Excellent) from “stable” to “negative.” The Company’s Board of Directors has initiated a strategic review to address the risk of a downgrade. Additionally, to reduce volatility near-term, the Company has de-risked its investment portfolio. As of the date of this Annual Report, the majority of our investable assets are held in cash and short-term treasuries which we expect to maintain until the strategic review is complete.

Because our portfolio will evolve in response to market conditions and underwriting opportunities, period-to-period comparisons of our underwriting results may not be meaningful. In addition, our historical investment results may not necessarily be indicative of future performance. Due to the nature of our reinsurance and investment strategies, our operating results will likely fluctuate from period to period.

Outlook and Trends

The property and casualty reinsurance industry historically has been cyclical in nature, owing to fluctuations in the supply of capital. During 2019, several developments have caused an increase in the demand for capital, including:

•	natural catastrophes in Japan and the Caribbean,
•	increased capital requirements at some Lloyd’s syndicates,
---	---
•	large loss activity in certain non-catastrophe classes, and
---	---
•	the voluntary withdrawal of capital from under performing business.
---	---

We expect the changing environment to provide improved opportunities in many classes including catastrophe, aviation, energy and satellite.

Compared to most of our competitors, we are small and have low overhead expenses. We believe that our expense efficiency, agility and existing relationships support our competitive position and allows us to profitably participate in lines of business that fit within our strategy. Over time we expect our expense advantage to erode as the industry acts to reduce frictional costs.

Link to Table of Contents

We expect that technological, analytical, product and delivery mechanism innovations in the insurance and reinsurance industries will have an increasingly significant impact on the markets in which we operate. The Greenlight Re Innovations unit, our internal effort to develop and implement product and service innovations with insurance applications, is positioned to facilitate some of these market shifts, while we also anticipate benefiting from new underwriting opportunities that are created.

The size of our capital base, combined with A.M Best’s revised outlook on our subsidiaries’ A- (Excellent) rating from “stable” to “negative,” may constrain our capacity and our ability to access underwriting business in the short term. To date these have had minimal impact on our ability to execute our 2019 business plan and the January 1, 2020 renewals. However, our ability to execute our remaining 2020 business plan may be adversely impacted by a prolonged negative outlook from A.M. Best.

We continue to monitor market conditions to best position ourselves to participate where an appropriate risk-reward profile exists. We expect our motor premiums to be lower relative to prior comparative periods due to our decision not to renew certain private passenger motor contracts during third quarter of 2019. Our underlying results and product line concentrations may vary, perhaps significantly, from one period to the next, and therefore our results to date are not necessarily indicative of future portfolio composition and performance.

There are many global economic, investment and political uncertainties that may impact our business and our investment portfolio, including central bank actions and potential trade disputes. Our decision to de-risk our investments has reduced, although not eliminated, our exposure to such uncertainties. We expect to hold a majority of our investable assets in cash and short-term treasuries until the ongoing strategic review being conducted by the Board is complete.

Segments

We manage our business on the basis of one operating segment, Property & Casualty reinsurance, and we analyze our business based on the following categories:

●	Property
●	Casualty
●	Other

Property business covers automobile physical damage, personal lines (including homeowners’ insurance) and commercial lines exposures. Property business includes both catastrophe as well as non-catastrophe coverage. We expect catastrophe business to make up a small proportion of our property business.

Casualty business covers general liability, motor liability, professional liability and workers’ compensation exposures. The Company’s multi-line business predominantly relates to casualty reinsurance and as such all multi-line business is included within the casualty category. Casualty business generally has losses reported and paid over a longer period of time than property business.

Other business covers accident and health, financial lines (including mortgage insurance, surety and trade credit), marine, and to a lesser extent, other specialty business such as aviation, crop, cyber, energy and terrorism exposures.

Revenues

We derive our revenues from two principal sources:

●	premiums from reinsurance on property and casualty business assumed; and
●	income from investments.

Premiums written are recognized as revenues, net of of any applicable underlying reinsurance coverage, and are earned over the term of the related policy or contract. Depending on the contract structure, the earnings period could be the same as the reinsurance contract, or based on the terms of the underlying insurance policies.

Income from our investments is primarily composed of income generated from our investment in SILP and interest income from money market funds and notes receivable. Our investment income also includes income (or losses) from our equity method investment as well as realized and unrealized gains from the investments made by Greenlight Re Innovations.

In addition, we may from time to time derive other income from gains on deposit accounted contracts, fees generated from advisory services and fees relating to overrides, profit commissions and the early termination of contracts.

Link to Table of Contents

Expenses

Our expenses consist primarily of the following:

●	underwriting losses and loss adjustment expenses;
●	acquisition costs;
●	general and administrative expenses;
●	interest expense; and
●	investment-related expenses.

The extent of our loss and LAE is a function of the amount and type of reinsurance contracts we write and of the loss experience of the underlying coverage. As described below, loss and loss adjustment expenses include an actuarially determined estimate of losses incurred, including losses incurred during the period and changes in estimates from prior periods. The period over which loss and LAE reserves are paid depends on the nature of the coverage provided and generally extends over a period of multiple years.

Acquisition costs consist primarily of brokerage fees, ceding commissions, premium taxes, profit commissions, letters of credit and trust fees, and federal excise taxes. We amortize deferred acquisition costs relating to successfully bound reinsurance contracts over the related contract term.

General and administrative expenses consist primarily of salaries and benefits and related costs, including costs associated with our incentive compensation plan, bonuses and stock compensation expenses. General and administrative expenses also include professional fees, travel and entertainment, information technology, rent and other general operating expenses. General and administrative expenses reported on our consolidated statements of operations include both underwriting expenses as well as corporate expenses.

For stock option expenses, we calculate compensation cost using the Black-Scholes option pricing model and expense stock options over their vesting period, which varies and has historically ranged from zero to six years. For restricted stock awards and restricted stock units with only service conditions, we calculate compensation cost using the grant date fair value of each award and recognize the associated expense of the stock awards over their vesting periods, which typically range from one to five years. For restricted stock awards that include both service and performance conditions, the associated expense is recognized when the Company determines that it is probable that the performance conditions will be achieved.

Interest expense consists of interest paid and accrued on senior convertible notes as well as the amortization of (i) issuance expenses and (ii) the note discount.

Investment-related expenses primarily consist of interest expense on borrowings, and management fees and performance compensation paid to the investment advisor. We net these expenses against investment income (loss) in our consolidated financial statements.

Critical Accounting Policies and Estimates

Our consolidated financial statements contain certain amounts that are inherently subjective in nature and have required management to make assumptions and best estimates to determine reported values. If certain factors, including those described in “Part I. Item IA. — Risk Factors”, cause actual events or results to differ materially from our underlying assumptions or estimates, there could be a material adverse effect on our results of operations, financial condition or liquidity. We believe that the following accounting policies affect the more significant estimates used in the preparation of our consolidated financial statements. The descriptions below are summarized and have been simplified for clarity. A more detailed description of our significant accounting policies as well as recently issued accounting standards are included in Note 2 to the consolidated financial statements.

Premium Revenues and Risk Transfer. Our property and casualty reinsurance premiums are recorded as premiums written based upon contract terms and information received from ceding companies and their brokers. For excess of loss reinsurance contracts, premiums are typically stated as a percentage of the subject premiums written by the client, subject to a minimum and deposit premium. The minimum and deposit premium is typically based on an estimate of subject premiums expected to be written by the client during the contract term. The minimum and deposit premium is reported initially as premiums written and adjusted, if necessary, in subsequent periods once the actual subject premium is known.

Link to Table of Contents

Certain contracts provide for reinstatement premiums in the event of a loss. Reinstatement premiums are written and earned when a triggering loss event occurs.

For each quota share or proportional property and casualty reinsurance contract we underwrite, our client estimates gross premiums written at inception of the contract. We generally account for such premiums using our best estimates and then adjust our estimates based on actual reports provided by our client and based on our expectations of industry developments. As the contract progresses, we monitor actual premiums received in conjunction with correspondence from the client in order to refine our estimate. Variances from initial gross premiums written estimates are generally greater for quota share contracts than for excess of loss contracts. All premiums on quota share contracts are earned over the risk coverage period. Unearned premiums represent the unexpired portion of reinsurance provided.

At the inception of each of our reinsurance contracts, we receive premium estimates from the client, which, together with historical and industry data, are used to estimate what we believe will be the ultimate premium payable pursuant to each contract. We receive actual premiums written by each client as the client reports the actual results of the underlying insurance writings to us on a monthly or quarterly basis (depending on the terms of the contract). We book the actual premiums written when we receive them from our client. Each reporting period we estimate the amount of premiums that are written for stub periods that have not yet been reported to us by the client. For example, at year-end we may have to estimate December premiums ceded under certain contracts since the client may not be required to report the actual results to us until after we have issued our audited consolidated financial statements. Typically, premium estimates are only used for unreported stub periods, which account for a small percentage of our total premiums written.

We are able to confirm the accuracy and completeness of premiums reported by our clients by either reviewing the client’s statutory filings and/or performing an audit of the client, in accordance with the terms of the contract. Discrepancies between premiums ceded and reported under a contract are, in our experience, rare. To date, we have not had any material discrepancy in premiums reported by a client that required a formal dispute resolution process.

Assessing whether a reinsurance contract meets the conditions for risk transfer requires judgment. The determination of risk transfer is critical to reporting premiums written and is based, in part, on the use of actuarial and pricing models and assumptions. If we determine that a reinsurance contract does not transfer sufficient risk to merit reinsurance accounting treatment, the premium we receive is reported as a deposit liability. Similarly, for ceded contracts that do not transfer sufficient risk to merit reinsurance accounting, the premium we pay is reported as a deposit asset. Any gains or losses on deposit accounted contracts are calculated using the interest method and recorded in the consolidated statements of operations as other income or expense.

Investments. Our investment in SILP is carried at fair value, based on the most recent net asset value obtained from SILP’s third party administrators. Other investments include private and unlisted equity securities that do not have readily determinable fair values. The carrying values of these private equity securities are determined based on the original cost, reviewed for impairment and any subsequent changes in the valuation based on any recent observable transactions of those securities. For “other investments” any realized and unrealized gains or losses are determined on the basis of specific identification method (by reference to cost or amortized cost, as appropriate) and included in net investment income (loss) in the consolidated statements of operations.

Loss and Loss Adjustment Expense Reserves.The process of estimating our loss and LAE reserves involves a considerable degree of judgment and our estimates as of any given date are inherently uncertain. Estimating loss and LAE reserves requires us to make assumptions regarding reporting and development patterns, frequency and severity trends, claims settlement practices, potential changes in legal environments, inflation, loss amplification, foreign exchange movements and other factors. These estimates and judgments are based on numerous considerations and are often revised as: (i) we receive changes in loss amounts reported by ceding companies and brokers; (ii) we obtain additional information, experience or other data; (iii) new or improved methodologies are developed; or (iv) changes in the legal environment occur.

Our loss and LAE reserves relating to short-tail property risks are typically reported to us and settled more promptly than those relating to our long-tail risks. However, the timeliness of loss reporting can be affected by such factors as the nature of the event causing the loss, the location of the loss, whether the loss is from policies in force with primary insurers or with reinsurers and where our exposure falls within the cedent’s overall reinsurance program.

Our loss and LAE reserves are composed of case reserves (which are based on claims that have been reported to us) and IBNR reserves.

Our case reserve estimates are initially determined on the basis of loss reports received. Our IBNR reserve estimates are determined using various actuarial methods as well as a combination of our own historical and current loss experience,

Link to Table of Contents

insurance industry loss experience, estimates of pricing adequacy trends and our professional judgment. The process we use to estimate our IBNR reserves involves projecting our estimated ultimate loss and LAE reserves and then subtracting paid claims and case reserves as notified by the ceding company, to arrive at our IBNR reserve.

The nature and extent of our judgment in the reserving process depends in part upon the type of business. Some of our property treaty reinsurance contracts represent business which has both a low frequency of claims occurrence and a high potential severity of loss, such as claims arising from natural catastrophes. Given the high-severity, low-frequency nature of these events, the losses typically generated therefrom do not lend themselves to traditional actuarial reserving methods, such as statistical calculations of a range of estimates surrounding the best point estimate of our loss and LAE reserves. Therefore, our reserving approach for this type of business is to estimate the ultimate cost associated with a single loss event rather than analyzing the historical development patterns of past losses as a means of estimating ultimate losses for an entire accident year. We estimate our reserves for these large events on a contract-by-contract basis by means of a review of policies with known or potential exposure to a particular loss event.

For non-catastrophe losses, we often apply trend-based actuarial methodologies in setting reserves, including paid and incurred loss development, Bornheutter-Ferguson and frequency and severity techniques. We also utilize industry loss ratio and development pattern information in conjunction with our own experience. The weight given to a particular method will depend on many factors, including the homogeneity within the class of business, the volume of losses, the maturity of the accident year and the length of the expected development tail. For example, development methods rely on reported losses, while expected loss ratio methods are typically based on expectations established prior to a notification of loss. Therefore, as an accident year matures, we may migrate from an expected loss ratio method to an incurred development method.

Reserving can prove especially difficult should a significant loss take place near the end of a financial reporting period, particularly if the loss involves a catastrophic event. These factors further contribute to the degree of uncertainty in our reserving process.

As a predominantly broker-market reinsurer for both excess-of-loss and proportional contracts, we must rely on loss information reported to brokers by primary insurers who, in turn, must estimate their own losses at the policy level, often based on incomplete and changing information. The information we receive varies by cedent and may include paid losses, estimated case reserves and an estimated provision for IBNR reserves. Reserving practices and the quality of data reporting vary among ceding companies, which adds further uncertainty to the estimation of our ultimate losses. The nature and extent of information received from ceding companies and brokers also vary widely depending on the type of coverage, the contractual reporting terms (which are affected by market conditions and practices) and other factors. Due to the lack of standardization of the terms and conditions of reinsurance contracts, the wide variability of coverage provided to individual clients and the tendency of those coverages to change rapidly in response to market conditions, the ongoing economic impact of such uncertainties and inconsistencies cannot always be reliably measured.

Time lags are inherent in loss reporting, especially in the case of excess-of-loss reinsurance contracts. The combined characteristics of low claim frequency and high claim severity make the available data less useful for predicting ultimate losses. In the case of proportional contracts, we rely on an analysis of a cedent’s historical experience, industry information and the professional judgment of underwriters in estimating reserves for these contracts. In addition, we utilize ultimate loss ratio forecasts when reported by cedents and brokers, which are normally subject to three to six month lags for proportional business. Due to the degree of reliance we place on ceding companies for claims reporting, our reserve estimates are highly dependent on ceding companies’ judgment. Furthermore, during the loss settlement period, which may last several years, additional facts regarding individual claims and trends often will become known and case law may change, which can affect ultimate expected losses.

Since we rely on ceding company estimates of case and IBNR reserves in the process of establishing our own loss and LAE reserves, we maintain certain procedures designed to mitigate the risk that such information is incomplete or inaccurate. These procedures may include: (i) comparisons of expected premiums to reported premiums, which helps us to identify delinquent client periodic reports; (ii) ceding company audits to identify inaccurate or incomplete reporting of claims and ensure that claims are actively and appropriately managed in line with agreed protocols and settlement authority limits; and (iii) underwriting reviews to ascertain that the losses ceded are covered as provided under the contract terms. In addition, each subsequent year of loss experience with a given cedent provides additional insight into the accuracy and timeliness of previously reported information. These procedures are incorporated in our internal controls and are regularly evaluated and amended as market conditions, risk factors, and unanticipated areas of exposure develop.

We monitor the development of our prior-year losses during the course of subsequent calendar years by comparing the actual reported losses against previous estimates. The analysis of this loss development is an important factor in our ongoing refinement of the assumptions underlying our reserving process.

Link to Table of Contents

Estimating loss reserves for our book of longer-tail casualty reinsurance business, which can be written on an excess-of-loss or proportional basis, involves further uncertainties. In addition to the uncertainties inherent in the reserving process referred to above, casualty business can be subject to longer reporting lags than property business and claims often take several years to settle. During this period additional factors and trends will be revealed and, as they become apparent, we may adjust our reserves. There is also the potential for the emergence of new types of losses within our casualty book. Therefore, any factors that extend the time until claims are settled add uncertainty to the reserving process. Furthermore, determining the appropriate level of casualty reserves is largely dependent upon our view of premium rates at any given time. Therefore, overestimating the extent to which premium rates have increased (or decreased) can lead to an understatement (or overstatement) of loss reserves.

The uncertainties inherent in the reserving process, together with the potential for unforeseen developments, including changes in laws and the prevailing interpretation of policy terms, may result in our loss and LAE reserves being materially greater or less than the loss and LAE reserves we initially established. Any adjustments to our loss and LAE reserves are reflected in our financial results during the period in which they are determined. Changes to our prior year loss reserves will impact our current underwriting results by improving our results if the prior year reserves prove to be redundant or impairing our results if the prior year reserves prove to be insufficient.

We believe that our reserves for loss and LAE are sufficient to cover losses that fall within the terms of our policies and agreements with our insured and reinsured customers on the basis of the methodologies used to estimate those reserves. We can provide no assurance, however, that actual losses will not (i) be less than or (ii) exceed our total established reserves.

Please refer to Notes 2 and 7 of our consolidated financial statements for a more detailed explanation of our loss reserving methodology and the loss development tables by accident year, respectively, as required under U.S. GAAP.

Bonus Accruals. Under the Company’s bonus program, most employees’ target bonuses consist of two components: a discretionary component based on a qualitative assessment of each employee’s performance and a quantitative component based on the return on deployed equity (“RODE”) for each underwriting year relating to reinsurance operations. The qualitative portion of an employee’s annual bonus is accrued quarterly at each employee’s prorata target amount and updated to actual at year end . The quantitative portion of each employee’s annual bonus is accrued based on the expected RODE for each underwriting year and adjusted for changes in the expected RODE and actual investment return each quarter until all losses are settled and the underwriting year is declared closed. The quantitative bonus is calculated and paid in annual installments between three to five years from the end of the fiscal year in which the business was underwritten. Any subsequent changes to the quantitative bonus are incorporated into the following open underwriting year. The Compensation Committee of our Board of Directors approves all quantitative bonuses prior to being paid. The initial RODE calculation utilizes proprietary models which require significant estimation and judgment. Actual RODE may vary significantly from the expected RODE and any adjustments to the quantitative bonus estimates, which may be material, are recorded in the period in which they are determined.

Share-Based Payments. We have established a stock incentive plan for directors, employees and consultants. We recognize share-based compensation transactions using the fair value at the grant date of the award. We calculate the compensation for restricted stock awards and restricted stock units (“RSUs”) based on the price of the Company’s common shares at the grant date. We recognize the associated expense, adjusted for estimated forfeitures, over the vesting period and incorporating the probability of any performance conditions being met. We estimate the forfeiture rate for restricted stock awards and RSUs based on our historical experience and our expectations of future forfeitures. The forfeiture rate reduces the unamortized grant date fair value of unvested outstanding restricted stock awards and RSUs as well as the associated stock compensation expense. As restricted shares and RSUs are forfeited, the number of outstanding restricted shares and RSUs is reduced and the remaining unamortized grant date fair value is compared to the assumed forfeiture levels, and if deemed necessary, true-up adjustments are recorded. For the year ended December 31, 2019, we have assumed a forfeiture rate of 7.0% (2018: 7.0% and 2017: 6.0%) for restricted stock awards and RSUs granted, in order to reflect the anticipated forfeitures and more accurately record the share-based compensation expense.

Share purchase options are expensed over the vesting period on a graded vesting basis. Determining the fair value of share option awards at the grant date requires significant estimation and judgment. We use an option-pricing model (Black-Scholes pricing model) to assist in the calculation of fair value. The estimate of expected volatility is based on the daily historical trading data of our Class A ordinary shares from the date that these shares commenced trading (May 24, 2007) to the grant date.

Link to Table of Contents

If actual results differ significantly from these estimates and assumptions, particularly in relation to our estimation of volatility which requires significant judgment, share-based compensation expense, primarily with respect to future share-based awards, could be materially impacted.

Key Financial Measures and Non-GAAP Measures

Management uses certain key financial measures, some of which are not prescribed under U.S. GAAP rules and standards (“non-GAAP financial measures”) to evaluate our financial performance and the change in shareholder value. Generally, a non-GAAP financial measure, as defined in SEC Regulation G, is a numerical measure of a company’s historical or future financial performance, financial position, or cash flows that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with U.S. GAAP. We believe that these measures, which may be calculated or defined differently by other companies, provide a consistent and comparable measure of performance of our business to help shareholders understand performance trends and allow for a more complete understanding of the Company’s business. Non-GAAP financial measures should not be viewed as a substitute for those determined in accordance with U.S. GAAP. The key non-GAAP financial measures used in this report are:

•	Basic adjusted book value per share;
•	Fully diluted adjusted book value per share; and
---	---
•	Net underwriting income (loss).
---	---

These non-GAAP measures are described below.

Basic Adjusted Book Value Per Share and Fully Diluted Adjusted Book Value Per Share

We believe that long-term growth in fully diluted adjusted book value per share is the most relevant measure of our financial performance because it provides management and investors a yardstick by which to monitor the shareholder value generated. In addition, fully diluted adjusted book value per share may be useful to our investors, shareholders and other interested parties to form a basis of comparison with other companies within the property and casualty reinsurance industry.

Basic adjusted book value per share is considered a non-GAAP financial measure because the numerator excludes non-controlling interests in the Joint Venture. The Joint Venture was terminated during the first quarter of 2019, and as a result no such adjustment is required as at December 31, 2019. Fully diluted adjusted book value per share is also considered a non-GAAP financial measure and represents basic adjusted book value per share combined with any dilutive impact of in-the-money stock options and RSUs issued and outstanding as of any period end. In addition, the fully diluted adjusted book value per share includes the dilutive effect, if any, of ordinary shares to be issued upon conversion of the convertible notes. Basic adjusted book value per share and fully diluted adjusted book value per share should not be viewed as substitutes for the comparable U.S. GAAP measures.

Our primary financial goal is to increase fully diluted adjusted book value per share over the long term.

Link to Table of Contents

The following table presents a reconciliation of the non-GAAP financial measures basic adjusted and fully diluted adjusted book value per share to the most comparable U.S. GAAP measure.

	December 31, 2019		December 31, 2018			December 31, 2017
	( in thousands, except per share and share amounts)
Numerator for basic adjusted and fully diluted adjusted book value per share:
Total equity (U.S. GAAP)			$	477,772		$	844,257
Less: Non-controlling interest in joint venture	—		(485		)	(12,933		)
Numerator for basic adjusted book value per share	477,183		477,287			831,324
Add: Proceeds from in-the-money stock options issued and outstanding	—		—			13,859
Numerator for fully diluted adjusted book value per share			$	477,287		$	845,183
Denominator for basic adjusted and fully diluted adjusted book value per share: (1)
Ordinary shares issued and outstanding (denominator for basic adjusted book value per share)	36,994,110		36,384,929			37,359,545
Add: In-the-money stock options and RSUs issued and outstanding	63,582		46,398			679,684
Denominator for fully diluted adjusted book value per share	37,057,692		36,431,327			38,039,229
Basic adjusted book value per share			$	13.12		$	22.25
Increase (decrease) in basic adjusted book value per share ($)		)	$	(9.13	)	$	(1.15	)
Increase (decrease) in basic adjusted book value per share (%)	(1.7	)%	(41.0		)%	(4.9		)%
Fully diluted adjusted book value per share			$	13.10		$	22.22
Increase (decrease) in fully diluted adjusted book value per share ($)		)	$	(9.12	)	$	(1.16	)
Increase (decrease) in fully diluted adjusted book value per share (%)	(1.7	)%	(41.0		)%	(5.0		)%

All values are in US Dollars.

(1) All unvested restricted shares, including those with performance conditions, are included in the “basic adjusted” and “fully diluted adjusted” denominators. As of December 31, 2019, the number of unvested restricted shares with performance conditions was 356,900 (30,660 and 0, as of December 31, 2018 and December 31, 2017, respectively).

Net Underwriting Income (Loss)

One way that we evaluate the Company’s underwriting performance is through the measurement of net underwriting income (loss). We do not use premiums written as a measure of performance. Net underwriting income (loss) is a performance measure used by management as it measures the fundamentals underlying the Company’s underwriting operations. We believe that the use of net underwriting income (loss) enables investors and other users of the Company’s financial information to analyze our performance in a manner similar to how management analyzes performance. Management also believes that this measure follows industry practice and allows the users of financial information to compare the Company’s performance with its those of our industry peer group.

Net underwriting income (loss) is considered a non-GAAP financial measure because it excludes items used in the calculation of net income before taxes under U.S. GAAP. Net underwriting income (loss) is calculated as net premiums earned, plus other income (expense) relating to deposit-accounted contracts, less net loss and loss adjustment expenses, less acquisition costs, and less underwriting expenses. The measure excludes, on a recurring basis: (1) investment income (loss); (2) other income (expense) not related to underwriting, including foreign exchange gains or losses; (3) corporate general and administrative expenses; (4) interest expense and (5) income taxes. We exclude total investment related income or loss and foreign exchange gains or losses as we believe these items are influenced by market conditions and other factors not related to underwriting decisions. We exclude corporate expenses because these expenses are generally fixed and not incremental to or directly related to our underwriting operations. We believe all of these amounts are largely independent of our underwriting process and including them could hinder the analysis of trends in our underwriting operations. Net underwriting income (loss) should not be viewed as a substitute for U.S. GAAP net income.

Link to Table of Contents

The reconciliations of net underwriting income (loss) to income (loss) before income taxes (the most directly comparable U.S. GAAP financial measure) on a consolidated basis is shown below:

	Year ended December 31
	2019		2018			2017
	( in thousands)
Income (loss) before income tax		)	$	(353,997	)	$	(44,825	)
Add (subtract):
Investment related (income) loss	(52,267	)	323,106			(20,231		)
Other non-underwriting (income) expense	467		1,943			210
Corporate expenses	15,560		12,059			11,218
Interest expense	6,263		2,505			—
Net underwriting income (loss)		)	$	(14,384	)	$	(53,628	)

All values are in US Dollars.

Link to Table of Contents

Results of Operations

The table below summarizes our operating results for the years ended December 31, 2019, 2018 and 2017:

	Year ended December 31
	2019			2018			2017
	(in thousands, except percentages)
Underwriting revenue
Gross premiums written	$	523,977		$	567,531		$	692,651
Gross premiums ceded	(48,667		)	(102,788		)	(56,587		)
Net premiums written	475,310			464,743			636,064
Change in net unearned premium reserves	8,270			43,620			(10,060		)
Net premiums earned	483,580			508,363			626,004
Underwriting expenses
Loss and LAE incurred, net
Current year	357,237			363,871			466,247
Prior year *	31,250			2			36,157
Loss and LAE incurred, net	388,487			363,873			502,404
Acquisition costs, net	117,084			145,475			161,740
Underwriting expenses	14,262			13,114			15,138
Deposit accounting expense (income)	(2,773		)	285			350
Underwriting income (loss)	(33,480		)	(14,384		)	(53,627		)
Income (loss) from investment in related party investment fund	46,056			(60,573		)	—
Net investment income (loss)	6,211			(262,533		)	20,231
Net investment result	$	52,267		$	(323,106	)	$	20,231
Net income (loss)	$	(3,986	)	$	(354,329	)	$	(44,374	)
Net income (loss) attributable to Greenlight Capital Re, Ltd.	$	(3,986	)	$	(350,054	)	$	(44,952	)
Loss ratio - current year	73.9		%	71.6		%	74.5		%
Loss ratio - prior year	6.5		%	—		%	5.8		%
Loss ratio	80.3		%	71.6		%	80.3		%
Acquisition cost ratio	24.2		%	28.6		%	25.8		%
Composite ratio	104.5		%	100.2		%	106.1		%
Underwriting expense ratio	2.4		%	2.6		%	2.5		%
Combined ratio	106.9		%	102.8		%	108.6		%

* The net financial impact associated with changes in the estimate of losses incurred in prior years, which incorporates earned reinstatement premiums assumed and ceded, adjustments to assumed and ceded acquisition costs and adjustments to deposit accounted contracts, was $30.1 million, $7.4 million, and $31.5 million in 2019, 2018 and 2017, respectively.

Link to Table of Contents

Results of operations for 2019 compared to 2018

For the year ended December 31, 2019, fully diluted adjusted book value per share decreased by $0.22 per share, or 1.7%, to $12.88 per share from $13.10 per share at December 31, 2018. For the year ended December 31, 2019, the basic adjusted book value per share decreased by $0.22 per share, or 1.7%, to $12.90 per share at December 31, 2019.

For the year ended December 31, 2019, the net loss attributable to the Company was $4.0 million, compared to a net loss attributable to the Company of $350.1 million reported for the year ended December 31, 2018.

The developments that most significantly affected our financial performance during the year ended December 31, 2019, on a comparative basis to 2018, are provided below:

•Underwriting loss - The underwriting loss for the year ended December 31, 2019 was $33.5 million, primarily resulting from adverse loss development on our private automobile business. While we generally consider automobile exposures to be short-tailed, in 2019 we experienced unanticipated losses in this line due to adverse rulings that affected a significant number of claims in Florida, including many claims that previously had been considered closed. The rulings impacted loss events that occurred between 2015 and early 2018. For the year ended December 31, 2019, the overall net financial impact associated with adverse loss development related to prior years was a loss of $30.1 million for the year ended December 31, 2019.

Catastrophe events during the year ended December 31, 2019, including Hurricane Dorian and Typhoons Faxai and Hagibis, contributed $17.4 million to the underwriting loss for the year ended December 31, 2019. By comparison, the catastrophe events during 2018, including Hurricanes Florence, Michael, California wildfires and Typhoon Jebi, contributed $18.9 million to the underwriting loss for the year ended December 31, 2018.

As a result of the underwriting loss, our overall composite ratio was 104.5% for the year ended December 31, 2019, compared to 100.2% during the year ended December 31, 2018. The higher composite ratio included 6.5% loss ratio points relating to prior period loss development and 3.6% loss ratio points relating to catastrophe losses during 2019 fiscal year.

•Investment income and losses - Our net investment related income for the year ended December 31, 2019 was $52.3 million, including a return of 9.3% on our Investment Portfolio, compared to an investment loss of $323.1 million, or a return of (30.3)% on our investments managed by DME Advisors, during the year ended December 31, 2018.

Underwriting results

We analyze our business based on three categories: “property”, “casualty” and “other.”

Gross Premiums Written

Details of gross premiums written are provided in the following table:

	Year ended December 31
	2019			2018
	( in thousands)
Property		16.4	%	$	101,030	17.8	%
Casualty	362,374	69.2		377,785		66.6
Other	75,646	14.4		88,716		15.6
Total		100.0	%	$	567,531	100.0	%

All values are in US Dollars.

As a result of our underwriting philosophy, our premiums written may vary significantly from one period to the next. Additionally, the mix of premiums written between property, casualty and other business may vary from period to period depending on the specific market opportunities that we pursue.

Link to Table of Contents

For the year ended December 31, 2019, our gross premiums written decreased by $43.6 million, or 7.7%, compared to the same period in 2018. The changes in gross premiums written for the year ended December 31, 2019 were attributable to the following:	Gross Premiums Written
Year ended December 31, 2019
	Increase (decrease) <br>($ in millions)	% change	Explanation
Property	$(15.1)	(14.9)%	The decrease in property gross premiums written during the year ended December 31, 2019 over the year ended December 31, 2018 was primarily related to certain motor contracts that we elected not to renew. The decrease from these contracts was partially offset by new and renewed motor contracts written during 2019 as well as an increase in commercial property premiums.
Casualty	$(15.4)	(4.1)%	The decrease in casualty gross premiums written during the year ended December 31, 2019 over the year ended December 31, 2018 was primarily related to certain motor contracts that we elected not to renew. The decrease from these contracts was partially offset by new and renewed motor, workers’ compensation and multi-line contracts written during 2019.
Other	$(13.1)	(14.7)%	The decrease in “other” gross premiums written during the year ended December 31, 2019 over the year ended December 31, 2018 was primarily related to a medical stop-loss contract we elected not to renew. This decrease was partially offset by premiums from new contracts relating to financial, crop, energy and other specialty lines.

Premiums Ceded

For the year ended December 31, 2019, retrocessional premiums ceded decreased by $54.1 million, or 52.7%, to $48.7 million compared to $102.8 million for the year ended December 31, 2018. This decrease in ceded premiums was primarily related to our non-renewal of inward motor contracts in 2019, which resulted in us not renewing the outward retrocession contracts in 2019. We expect the remaining impact of the non-renewed retrocession contracts to flow through during 2020. Additionally, during 2019 we reduced the amount of retrocessional coverage that we purchased relating to catastrophe exposure compared to the same period in 2018. In general, we use retrocessional coverage to manage our net portfolio exposure, to leverage areas of expertise and to improve our strategic position in meeting the needs of clients and brokers.

Net Premiums Written

Details of net premiums written are provided in the following table:

	Year ended December 31
	2019			2018
	( in thousands)
Property		15.7	%	$	76,200	16.4	%
Casualty	325,460	68.5		300,503		64.7
Other	75,048	15.8		88,040		18.9
Total		100.0	%	$	464,743	100.0	%

All values are in US Dollars.

The movement in net premiums written was the net result of the increases or decreases in gross premiums written and premiums ceded as explained in the preceding paragraphs.

Link to Table of Contents

Net Premiums Earned

Details of net premiums earned are provided in the following table:

	Year ended December 31
	2019			2018
	( in thousands)
Property		16.1	%	$	84,116	16.6	%
Casualty	325,575	67.3		321,998		63.3
Other	80,045	16.6		102,249		20.1
Total		100.0	%	$	508,363	100.0	%

All values are in US Dollars.

Net premiums earned are primarily a function of the amount and timing of net premiums previously written. On occasion, there will be a significant difference between the change in net premiums written compared to the change in net premiums earned. The only such difference that occurred during the periods presented related to the motor contracts that we did not renew during 2019 and the premiums written on new contracts during 2019 which will be earned over the remaining contract term in the future. As a result, net premiums written increased by $10.6 million, or 2.3%, from 2018 to 2019, while net premiums earned decreased by $24.8 million, or 4.9%, during the same period.

Loss and Loss Adjustment Expenses Incurred, Net

Details of net losses incurred are provided in the following table:

	Year ended December 31
	2019			2018
	( in thousands)
Property		16.6	%	$	63,563	17.5	%
Casualty	265,021	68.2		243,091		66.8
Other	58,901	15.2		57,219		15.7
Total		100.0	%	$	363,873	100.0	%

All values are in US Dollars.

Our loss ratio fluctuates based on the mix of business, and any favorable or adverse loss development we experience. The below table summarizes the loss ratios for the years ended December 31, 2019 and 2018:

	Year ended December 31
	2019		2018		Increase / (decrease) in loss ratio points
Property	82.8	%	75.6	%	7.2	%
Casualty	81.4	%	75.5	%	5.9	%
Other	73.6	%	56.0	%	17.6	%
Total	80.3	%	71.6	%	8.7	%

Link to Table of Contents

The changes in net losses incurred and loss ratios during the year ended December 31, 2019 compared to the year ended December 31, 2018 were attributable to the following:

	Increase (decrease) <br>($ in millions)	Increase / (decrease) in loss ratio points	Explanation
Property	$1.0	7.2%	The increase in property losses incurred during the year ended December 31, 2019 over the year ended December 31, 2018 related primarily to adverse prior year loss development on private passenger automobile physical damage business. To a lesser extent, the 2019 catastrophe events also increased the property losses during the year ended December 31, 2019. These increases were partially offset by favorable loss development relating to the 2018 wildfires.<br><br><br><br>The adverse prior year loss development on automobile physical damage business was the primary driver of the 7.2% increase in the property loss ratio during the year ended December 31, 2019 as compared to the prior year period.
Casualty	$21.9	5.9%	The increase in casualty losses incurred during the year ended December 31, 2019 over the comparable year ended December 31, 2018 related primarily to adverse prior year loss development on private passenger automobile liability business. To a lesser extent, the increase in workers’ compensation business also contributed to the higher losses incurred during the year ended December 31, 2019. These increases were partially offset by lower losses on professional liability, general liability and multi-line contracts.<br><br><br><br>The adverse loss development experienced on automobile liability business was the primary driver of the 5.9% increase in the casualty loss ratio during the year ended December 31, 2019 as compared to 2018.
Other	$1.7	17.6%	The increase in “other” losses incurred during the year ended December 31, 2019 over the comparable year ended December 31, 2018 related primarily to satellite losses from failed launches during 2019. While some of the legacy health contracts reported adverse loss development, the overall losses incurred from health contracts decreased due to fewer health contracts in force during 2019.<br><br><br><br>The 17.6% increase in loss ratio was driven by (i) adverse development experienced on certain health contracts, (ii) satellite losses from failed launches in 2019, (iii) favorable prior year development on mortgage contracts recognized during 2018, and (iv) a reduction in mortgage business earned during the year ended December 31, 2019. Mortgage contracts generally incorporate relatively low loss ratios.

See “Part II, Item 7. Summary of Critical Accounting Estimates, Loss and Loss Adjustment Expense Reserves” and “Note 7. LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES in our Notes to the consolidated financial statements” for additional discussion of our reserving techniques and prior year development of net claims and claim expenses.

Acquisition Costs, Net

Details of acquisition costs are provided in the following table.

	Year ended December 31
	2019			2018
	( in thousands)
Property		12.4	%	$	20,190	13.9	%
Casualty	77,057	65.8		84,279		57.9
Other	25,531	21.8		41,006		28.2
Total		100.0	%	$	145,475	100.0	%

All values are in US Dollars.

The acquisition cost ratios for the years ended December 31, 2019 and 2018, were as follows:

Link to Table of Contents

	Year ended December 31
	2019		2018		Increase / (decrease)
Property	18.6	%	24.0	%	(5.4	)%
Casualty	23.7	%	26.2	%	(2.5	)%
Other	31.9	%	40.1	%	(8.2	)%
Total	24.2	%	28.6	%	(4.4	)%

The changes in the acquisition cost ratios during the year ended December 31, 2019 compared to the year ended December 31, 2018 were attributable to the following:

	Increase / (decrease) in acquisition cost ratio points	Explanation
Property	(5.4)%	The decrease in the property acquisition cost ratio during the year ended December 31, 2019 as compared to 2018 was due primarily to a decrease in sliding scale ceding commission expenses on private passenger automobile contracts as a result of adverse loss development during the period.
Casualty	(2.5)%	The decrease in the casualty acquisition cost ratio during the year ended December 31, 2019 as compared to 2018 was due primarily to a decrease in sliding scale ceding commission expenses on private passenger automobile contracts as a result of adverse loss development during the period.
Other	(8.2)%	The decrease in the “other” acquisition cost ratio during the year ended December 31, 2019 as compared to 2018 was due primarily to lower profit commissions incurred on mortgage contracts during the current period. The acquisition cost ratio for the comparable year ended December 31, 2018 reflected higher profit commissions on mortgage contracts as a result of favorable prior period loss development recognized during 2018. In addition, the new specialty contracts including crop, energy and space, incorporate a relatively low acquisition cost ratio.

General and Administrative Expenses

Details of general and administrative expenses are provided in the following table:

	Year ended December 31
	2019	2018
	( in thousands)
Underwriting expenses		$	13,114
Corporate expenses	15,560	12,059
General and administrative expenses		$	25,173

All values are in US Dollars.

For the year ended December 31, 2019, the general and administrative expenses increased by $4.6 million, or 18.5%, compared to the same period in 2018. The increase was primarily due to higher legal and other professional fees, personnel costs and information technology expenses. For the years ended December 31, 2019 and 2018, the general and administrative expenses included $3.9 million and $4.6 million, respectively, of expenses related to stock compensation granted to employees and directors.

Link to Table of Contents

Total Investment Related Income (Loss)

A summary of our investment related income (loss) is as follows:

	Year ended December 31
	2019		2018
	( in thousands)
Realized gains (losses)		)	$	(236,887	)
Change in unrealized gains and losses	8,380		(32,597		)
Investment related foreign exchange gains (losses)	20		938
Interest and dividend income, net of withholding taxes	16,059		35,468
Interest, dividend and other expenses	(4,798	)	(17,987		)
Income (loss) from equity method investment	700		(247		)
Investment advisor compensation on joint venture	—		(11,221		)
Net investment income (loss)			$	(262,533	)
Income (loss) from investments in related party investment fund			$	(60,573	)
Net investment related income (loss)			$	(323,106	)

All values are in US Dollars.

For the year ended December 31, 2019, the investment income, net of fees and expenses, represented a gain of 9.3% on the Investment Portfolio managed by DME Advisors, compared to a loss of 30.3% for the year ended December 31, 2018. The investment gain for the year ended December 31, 2019 was driven by SILP’s long portfolio, which reported an investment gain of 16.2%, while the short portfolio reported a loss of 5.3% for the year ended December 31, 2019. Additionally, macro positions reported a gain of 0.8%. The noteworthy contributors to the investment gains for the year ended December 31, 2019 were Brighthouse Financial (BHF), General Motors (GM) and Green Brick Partners (GRBK). The noteworthy detractors for the year ended December 31, 2019 were short positions in Amazon (AMZN), Netflix (NFLX) and a group of perceived overpriced momentum driven short equity positions (the “Bubble Basket”).

Net investment related income for the year ended December 31, 2019 included $14.4 million (2018: $3.7 million) of interest income on cash and cash equivalents posted for collateral to our cedents in the form of trusts and letters of credit.

For the year ended December 31, 2019, the investment income included management fees paid by SILP to DME Advisors of $4.9 million (2018: $3.1 million), and is netted in the caption, “Income (loss) from investments in related party investment fund” in the Company’s consolidated statements of operations.

The caption “Income (loss) from investments in related party investment fund” also includes performance compensation allocated from the Company’s investment in SILP to DME II. For the year ended December 31, 2019, the performance allocation of $5.0 million was deducted from the Company’s investment in SILP and allocated to DME II. No performance compensation was allocated during the year ended December 31, 2018 due to investment losses.

The performance compensation to DME II for subsequent years is reduced to 10% of net profits until all losses have been recouped and an additional amount equal to 150% of the loss is earned. As of December 31, 2019, the reduced performance allocation of 10% is expected to be applied to 168.6% of future net investment returns before reverting to 20%.

For the year ended December 31, 2019 net realized losses of $14.2 million were offset by a corresponding change in unrealized gains and losses. This reclassification resulted from the transfer of assets from the Joint Venture to SILP in January 2019. We expect our investment income (loss), including any change in the net asset value of the investment in SILP and any realized and unrealized gains (or losses), to fluctuate from period to period. The change in unrealized gains and losses for year ended December 31, 2019, also included a net increase in the valuation allowance provision of $6.0 million relating to notes receivable.

Link to Table of Contents

For the years ended December 31, 2019 and 2018, the gross investment returns on our investments managed by DME Advisors (excluding investment advisor performance allocation) were 10.2% and (30.3)%, respectively, and were composed of the following:

	Year ended December 31
	2019		2018
Long portfolio gains (losses)	16.2	%	(14.4	)%
Short portfolio gains (losses)	(5.3	)%	(13.6	)%
Macro gains (losses)	0.8	%	(0.7	)%
Other income and expenses ^1^	(1.5	)%	(1.6	)%
Gross investment return	10.2	%	(30.3	)%
Net investment return ^1^	9.3	%	(30.3	)%

^1^“Other income and expenses” excludes performance compensation but includes management fees. “Net investment return” incorporate both of these amounts.

Income Taxes

We are not obligated to pay taxes in the Cayman Islands on either income or capital gains. We have been granted an exemption by the Governor-In-Cabinet from any income taxes that may be imposed in the Cayman Islands for a period of 20 years, expiring on February 1, 2025.

GRIL is incorporated in Ireland and, therefore, is subject to the Irish corporation tax. GRIL is expected to be taxed at a rate of 12.5% on its taxable trading income, and 25% on its non-trading income, if any.

Verdant is incorporated in Delaware and, therefore, is subject to taxes in accordance with the U.S. federal rates and regulations prescribed by the Internal Revenue Service. Verdant’s future taxable income is expected to be taxed at a rate of 21% (2018: 21%).

As of December 31, 2019, a gross deferred tax asset of $3.6 million (2018: $3.6 million) was included in other assets on the consolidated balance sheets. As of December 31, 2019, a deferred tax asset valuation allowance of $2.6 million was recorded by the Company. Based on the timing of the reversal of the temporary differences and likelihood of generating sufficient taxable income to realize the future tax benefit, management believes it is more likely than not that the recorded deferred tax asset (net of the valuation allowance) will be fully realized in the future. The Company has not taken any other tax positions that management believes are subject to uncertainty or that are reasonably likely to have a material impact to the Company, GRIL or Verdant.

Ratio Analysis

The following table provides the ratios categorized as Property, Casualty and Other:

	Year ended December 31								Year ended December 31
	2019								2018
	Property		Casualty		Other		Total		Property		Casualty		Other		Total
Loss ratio	82.8	%	81.4	%	73.6	%	80.3	%	75.6	%	75.5	%	56.0	%	71.6	%
Acquisition cost ratio	18.6		23.7		31.9		24.2		24.0		26.2		40.1		28.6
Composite ratio	101.4	%	105.1	%	105.5	%	104.5	%	99.6	%	101.7	%	96.1	%	100.2	%
Underwriting expense ratio							2.4								2.6
Combined ratio							106.9	%							102.8	%

The loss ratios for property, casualty and other business can vary depending on the mix of the lines of business written. Additionally, the loss ratios within any line of business can vary significantly from period to period.

The combined ratio measures the total profitability of our underwriting operations. Given the nature of our underwriting strategy, our combined ratio may vary significantly from period to period.

Link to Table of Contents

Financial Condition

Total investments

The total investments reported in the consolidated balance sheets as of December 31, 2019, was $256.4 million, compared to $283.9 million as of December 31, 2018, a decrease of $27.5 million, or 9.7%. The decrease was primarily related to withdrawals from SILP for claim payments and to provide collateral to our ceding insurers. The decrease was partially offset by net investment income from our investment in SILP, transfer of equity securities from the Joint Venture to SILP and additional investments in insurtech companies as part of our innovations initiative during the year ended December 31, 2019.

As of December 31, 2019, 86.2% of SILP’s investments were valued based on quoted prices in actively traded markets (Level 1), 5.9% was composed of instruments valued based on observable inputs other than quoted prices (Level 2) and 2.2% was composed of instruments valued based on non-observable inputs (Level 3). As of December 31, 2019, 5.7% of SILP’s investments were private equity funds valued using the funds’ net asset values as a practical expedient.

During the year ended December 31, 2019, the Company took steps to reduce volatility of the invested assets and as a result, a portion of SILP’s equity portfolio was liquidated and a large proportion of its net assets are currently held in cash and short-term treasuries.

Restricted cash and cash equivalents

As of December 31, 2019, the restricted cash and cash equivalents are used for funding trusts and letters of credits issued to our ceding insurers. Our restricted cash increased by $57.1 million, or 8.3%, from $685.0 million at December 31, 2018 to $742.1 million, as of December 31, 2019, primarily due to increased collateral provided to our ceding insurers. The increase was partially funded by withdrawals from SILP.

Reinsurance balances receivable

During the year ended December 31, 2019, reinsurance balances receivable decreased by $69.9 million, or 23.3%, to $230.4 million from $300.3 million, as of December 31, 2018. The decrease was primarily related to premiums receivable on a large motor contract that we did not renew during 2019 and as a result the premiums receivable decreased as premiums on the expiring contract were collected.

Loss and Loss Adjustment Expense Reserves; Loss and Loss Adjustment Expenses Recoverable

Reserves for loss and loss adjustment expenses were composed of the following:

	December 31, 2019					December 31, 2018
	CaseReserves	IBNR		Total		Case<br>Reserves		IBNR		Total
	( in thousands)
Property		$	27,126	$	75,476	$	57,850	$	30,977	$	88,827
Casualty	152,049	204,574		356,623		133,881		221,212		355,093
Other	17,435	21,054		38,489		20,179		18,563		38,742
Total		$	252,754	$	470,588	$	211,910	$	270,752	$	482,662

All values are in US Dollars.

During the year ended December 31, 2019, the total gross loss and loss adjustment expense reserves decreased by $12.1 million, or 2.5% to $470.6 million from $482.7 million as of December 31, 2018. See Note 7 of the accompanying consolidated financial statements for a summary of changes in outstanding loss and loss adjustment expense reserves and for a description of significant prior period loss developments.

During the year ended December 31, 2019, the total loss and loss adjustment expenses recoverable decreased by $16.2 million, or 37.0%, to $27.5 million from $43.7 million as of December 31, 2018. The decrease primarily related to losses recovered relating to retroceded private passenger automobile contracts that were not renewed during 2019. See Note 8 of the accompanying consolidated financial statements for a description of the credit risk associated with our retrocessionaires.

For most of the contracts we write, our risk exposure is limited by defined limits of liability. Once the loss limit has been reached, we have no further exposure to additional losses from that contract outside of contract failure. However, certain contracts, particularly quota share contracts that relate to first-dollar exposure, may not contain aggregate limits.

Link to Table of Contents

Our property business, and to a lesser extent our casualty and other business, include certain contracts that contain or may contain natural peril loss exposure. We estimate catastrophe loss exposure in terms of the probable maximum loss (“PML”). We define PML as the anticipated loss, taking into account contract terms and limits, caused by a catastrophe affecting a broad geographic area, such as that caused by an earthquake or hurricane. We anticipate that the PML will vary from period to period depending upon the modeled simulated losses and the composition of the in-force book of business. The projected severity levels are described in terms of a 1-in-250 year return period. The 1-in-250 year return period PML means that we believe there is a 0.4% chance in any given year that an occurrence of a natural catastrophe will lead to losses exceeding the stated estimate. In other words, it corresponds to a 99.6% probability that the loss from an event will fall below the indicated PML.

PMLs are estimates and as a result, we cannot provide any assurance that any actual event will align with the modeled event or that actual losses from events similar to the modeled events will not vary materially from the modeled event PML. The PML estimate incorporates all significant exposure from our reinsurance operations, including coverage for property, marine and energy, motor and catastrophe workers’ compensation.

As of January 1, 2020, our estimated PML exposure (net of retrocession and reinstatement premiums) at a 1-in-250 year return period for a single event and in aggregate was $91.9 million and $109.2 million, respectively. The following table provides the PML for single event loss exposure and aggregate loss exposure to natural peril losses for each of the peak zones as of January 1, 2020:

	January 1, 2020
	1-in-250 year return period
Zone	Single Event Loss	Aggregate Loss
	( in thousands)
United States, Canada and the Caribbean		$	99,232
Europe	44,962	46,797
Japan	38,757	41,568
Rest of the world	27,896	30,907
Maximum	91,915	109,155

All values are in US Dollars.

Total Equity

Total equity reported on the consolidated balance sheet decreased by $0.6 million to $477.2 million as of December 31, 2019, compared to $477.8 million as of December 31, 2018. Retained earnings decreased primarily due to a net loss of $4.0 million reported for the year ended December 31, 2019. The non-controlling interest was eliminated as a result of the termination of the Joint Venture.

Liquidity and Capital Resources

General

Greenlight Capital Re is organized as a holding company with no operations of its own. As a holding company, Greenlight Capital Re has minimal continuing cash needs, most of which are related to the payment of administrative and interest expense. All of our underwriting operations are conducted through our wholly-owned reinsurance subsidiaries, Greenlight Re and GRIL, which underwrite property and casualty reinsurance. There are restrictions on each of Greenlight Re’s and GRIL’s ability to pay dividends, which are described in more detail below. It is our current policy to retain earnings to support the growth of our business. We currently do not expect to pay dividends on our ordinary shares.

As of December 31, 2019, Greenlight Re and GRIL were each rated “A- (Excellent)” with a negative outlook, by A.M. Best. The ratings reflect A.M. Best’s opinion of our reinsurance subsidiaries’ financial strength, operating performance and ability to meet obligations and it is not an evaluation directed toward the protection of investors or a recommendation to buy, sell or hold our Class A ordinary shares. If A.M. Best downgrades our ratings below “A- (Excellent)” or withdraws our rating, we could be severely limited or prevented from writing any new reinsurance contracts, which would significantly and negatively affect our business. Our A.M. Best ratings may be revised or revoked at the sole discretion of the rating agency.

Link to Table of Contents

Sources and Uses of Funds

Our sources of funds consist primarily of premium receipts (net of brokerage and ceding commissions), investment income and other income. We use cash from our operations to pay losses and loss adjustment expenses, profit commissions, interest and general and administrative expenses. As of December 31, 2019, all of our investable assets, excluding strategic investments and funds required for business operations and for capital risk management, are invested by DME Advisors in SILP, subject to our investment guidelines. We have the ability to redeem funds from SILP at any time for operational purposes by providing three days’ notice to the general partner. As of December 31, 2019, the majority of SILP’s long investments were composed of cash and cash equivalents, and publicly-traded equity securities, which can be readily liquidated to meet our redemption requests. We record all investment income (loss), including any changes in the net asset value of SILP, and any unrealized gains and losses, in our consolidated statements of operations for each reporting period.

For the years ended December 31, 2019 and 2018, the net cash provided by (used in) operating activities was $1.6 million and $(59.3) million, respectively. The net cash primarily provided by (used for) our underwriting activities (which excludes investment related expenses) was $(9.6) million and $(65.6) million for the years ended December 31, 2019 and 2018, respectively. Generally, if the premiums collected exceed claim payments within a given period, we would generate cash from our underwriting activities. Our underwriting activities represented a net use of cash for the year ended December 31, 2019, as the losses we paid exceeded the premiums we collected. The cash used in, and generated from underwriting activities may vary significantly from period to period depending on the underwriting opportunities available and claims submitted to us by our cedents.

For the year ended December 31, 2019, our net withdrawals from SILP generated cash of $78.3 million which was used to post collateral to our cedents and to pay losses. By comparison, for the same period in 2018 our investing activities used cash of $845.3 million.

As of December 31, 2019, we believe we have sufficient cash flow from operating and investing activities to meet our foreseeable liquidity requirements. We expect that our operational needs for liquidity will be met by cash, funds generated from underwriting activities and investment income, including withdrawals from SILP, if necessary. As of December 31, 2019, we expect to fund our operations for the next twelve months from operating cash flow. However, we may explore various financing alternatives, including capital raising alternatives, to fund our business strategy, improve our capital structure, increase surplus, pay claims or make acquisitions. We can provide no assurances that transactions will occur or, if so, as to the terms of such transactions.

Although GLRE is not subject to any significant legal prohibitions on the payment of dividends, Greenlight Re and GRIL are each subject to regulatory minimum capital requirements and regulatory constraints that affect their ability to pay dividends to us. In addition, any dividend payment would have to be approved by the relevant regulatory authorities prior to payment. As of December 31, 2019, Greenlight Re and GRIL both exceeded the regulatory minimum capital requirements.

Letters of Credit and Trust Arrangements

As of December 31, 2019, neither Greenlight Re nor GRIL was licensed or admitted as a reinsurer in any jurisdiction other than the Cayman Islands and the European Economic Area, respectively. Because many jurisdictions do not permit domestic insurance companies to take credit on their statutory financial statements for loss recoveries or ceded unearned premiums unless appropriate measures are in place for reinsurance obtained from unlicensed or non-admitted insurers, we anticipate that all of our U.S. clients and some of our non-U.S. clients will require us to provide collateral through funds withheld, trust arrangements, letters of credit or a combination thereof.

As of December 31, 2019, we had one (2018: two) letter of credit facility available with an aggregate capacity of $400.0 million (2018: $414.9 million). See Note 15 of the accompanying consolidated financial statements for details on the letter of credit facility. We provide collateral to cedents in the form of letters of credit and trust arrangements. As of December 31, 2019, the aggregate amount of collateral provided to cedents under such arrangements was $733.2 million (2018: $671.6 million). As of December 31, 2019, the letters of credit and trust accounts were secured by restricted cash and cash equivalents with a total fair value of $742.1 million (2018: $685.0 million).

The letter of credit facility contains customary events of default and restrictive covenants, including but not limited to, limitations on liens on collateral, transactions with affiliates, mergers and sales of assets, as well as solvency and maintenance of certain minimum pledged equity requirements, and restricts issuance of any debt without the consent of the letter of credit provider. Additionally, if an event of default exists, as defined in the letter of credit facility, Greenlight Re would be prohibited

Link to Table of Contents

from paying dividends to its parent company. The Company was in compliance with all the covenants of this facility as of December 31, 2019.

Capital

Our capital structure currently consists of senior convertible notes and equity issued in two classes of ordinary shares. We expect that the existing capital base and internally generated funds will be sufficient to implement our business strategy for the foreseeable future. Consequently, we do not presently anticipate that we will incur any additional material indebtedness in the ordinary course of our business. However, in order to provide us with flexibility and timely access to public capital markets should we require additional capital for working capital, capital expenditures, acquisitions or other general corporate purposes, we have filed a Form S-3 registration statement, which expires in July 2021. In addition, as noted above, we may explore various financing alternatives, although there can be no assurance that additional financing will be available on acceptable terms when needed or desired. We did not make any significant commitments for capital expenditures during the year ended December 31, 2019.

On May 2, 2019, the Board of Directors renewed the share repurchase plan, with effect from July 1, 2019 and expiring on June 30, 2020, authorizing the Company to purchase up to 2.5 million Class A ordinary shares or securities convertible into Class A ordinary shares in the open market, through privately negotiated transactions or Rule 10b5-1 stock trading plans. The Company is not required to repurchase any of the Class A ordinary shares and the repurchase plan may be modified, suspended or terminated at the election of our Board of Directors at any time without prior notice. During the year ended December 31, 2019, no Class A ordinary shares were repurchased by the Company. As of March 6, 2020, 2.5 million shares remained available for repurchase under the share repurchase plan.

On April 26, 2017, our shareholders approved an amendment to our stock incentive plan to increase the number of Class A ordinary shares available for issuance by 1.5 million shares from 3.5 million to 5.0 million. As of December 31, 2019, there were 555,805 Class A ordinary shares available for future issuance under the Company’s stock incentive plan. The stock incentive plan is administered by the Compensation Committee of the Board of Directors.

Contractual Obligations and Commitments

The following table shows our aggregate contractual obligations as of December 31, 2019 by time period remaining:

	Less than 1 year	1-3 years		3-5 years		More than<br> 5 years		Total
	( in thousands)
Operating lease obligations (1)		$	124	$	—	$	—	$	803
Interest and convertible note payable (2)	4,000	112,000		—		—		116,000
Loan facility (3)	350	—		—		—		350
Advisory fee (4)	2,000	—		—		—		2,000
Loss and loss adjustment expense reserves (5)	242,823	125,176		48,000		54,589		470,588
		$	237,300	$	48,000	$	54,589	$	589,741

All values are in US Dollars.

^(1)^ Reflects our minimum contractual obligations pursuant to the lease agreements as described below.

^(2)^ Includes interest payments due on $100.0 million of senior convertible note payable at 4.0% per annum, as well as the payment of principal upon maturity on August 1, 2023.

^(3)^	As of December 31, 2019, we had an outstanding commitment to fund $0.4 million under a $6.0 million loan facility (See Note 4 of the accompanying consolidated financial statements). For purposes of the above table, we have assumed that the entire commitment will be made within one year.
^(4)^	Reflects our minimum contractual obligation pursuant to an advisory agreement.
---	---

^(5)^ Due to the nature of our reinsurance operations, the amount and timing of the cash flows associated with our reinsurance contractual liabilities will fluctuate, perhaps materially, and, therefore, are highly uncertain.

Greenlight Re had entered into lease agreements for office space in the Cayman Islands. The leases expired on June 30, 2018 and the Company has agreed to extend the lease until December 31, 2020. The remaining obligations relating to the monthly lease are included in the above table in the caption “Operating lease obligation.”

Link to Table of Contents

Pursuant to the IAA between SILP and DME Advisors, DME Advisors is entitled to a monthly management fee equal to 0.125% (1.5% on an annual basis) of each limited partner’s Investment Portfolio, as provided in the SILP LPA. The IAA has an initial term ending on August 31, 2023 subject to automatic extension for successive three-year terms. For the year ended December 31, 2019 and 2018, management fees paid by SILP to DME Advisors were $4.9 million and $3.1 million, respectively. Pursuant to the SILP LPA, DME II is entitled to a performance allocation equal to 20% of the net profit, calculated per annum, of each limited partner’s share of the capital account managed by DME Advisors, subject to a loss carry forward provision. DME II is not entitled to earn a performance allocation in a year in which SILP incurs a loss. The loss carry forward provision contained in the SILP LPA allows DME II to earn reduced performance allocation of 10% of net profits in years subsequent to the year in which the capital accounts of the limited partners incur a loss, until all losses are recouped and an additional amount equal to 150% of the loss is earned. For the year ended December 31, 2019, a performance allocation of $5.0 million was netted against income in the caption “Investment in related party investment fund” in the Company’s consolidated statement of operations. No performance allocation was recorded for the year ended December 31, 2018 due to the investment loss.

The Company has entered into a letter agreement with DME Advisors and DME II whereby during the period from June 1, 2019 to June 30, 2020, the portion of the Investment Portfolio held in cash or cash equivalents will not be subject to any management fee or performance allocation.

We have entered into a service agreement with DME Advisors pursuant to which DME Advisors will provide investor relations services to us for compensation of $5,000 per month plus expenses. The service agreement had an initial term of one year, and continues for sequential one-year periods until terminated by us or DME Advisors. Either party may terminate the service agreement for any reason with 30 days prior written notice to the other party.

Our related party transactions are presented in Note 9 to the accompanying consolidated financial statements.

Off-Balance Sheet Financing Arrangements

We have no obligations, assets or liabilities which would be considered off-balance sheet arrangements. Other than our investments in SILP and AccuRisk Holdings LLC (see Notes 3 and 4 of the accompanying consolidated financial statements), we have not participated in transactions that created relationships with unconsolidated entities or financial partnerships, including VIEs, established for the purpose of facilitating off-balance sheet arrangements.

Effects of Inflation

Inflation generally affects the cost of claims and claim expenses, as well as asset values in our investment portfolio. The anticipated effects of inflation on our claim costs are considered in our pricing and reserving models. However, the actual effect of increases in claim costs due to inflation cannot be accurately known until claims are ultimately settled, and may differ significantly from our estimate. In addition, the onset, duration and severity of an inflationary period cannot be predicted or estimated with precision.

Link to Table of Contents

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We believe we are principally exposed to the following types of market risk:

•	equity price risk;
•	foreign currency risk;
•	interest rate risk;
•	credit risk; and
•	political risk.

Equity Price Risk

As of December 31, 2019, our investments consisted primarily of an investment in SILP. Among SILP’s holdings are equity securities, the carrying values of which are based primarily on quoted market prices. Generally, market prices of common equity securities are subject to fluctuation, which could cause the amount to be realized upon the closing of a position to differ significantly from its current reported value. This risk is partly mitigated by the presence of both long and short equity securities as part of our investment strategy. As of December 31, 2019, a 10% decline in the price of each of the underlying listed equity securities and equity-based derivative instruments would result in a loss of $9.8 million, or 1.8%, of our Investment Portfolio.

Computations of the prospective effects of hypothetical equity price changes are based on numerous assumptions, including the maintenance of the existing level and composition of investment securities and should not be relied on as indicative of future results.

Foreign Currency Risk

Certain of our reinsurance contracts provide that ultimate losses may be payable or calculated in foreign currencies depending on the country of original loss. Foreign currency exchange rate risk exists to the extent that our foreign currency loss reserves (case reserves and IBNR) are in excess of (or less than) the corresponding foreign currency cash balances and there is an increase (or decrease) in the exchange rate of that foreign currency. As of December 31, 2019, we held GBP currency valued at $5.3 million while our exposure to GBP denominated loss reserves (net of funds withheld by cedents) was $1.2 million. As of December 31, 2019, a 10% decrease in the U.S. dollar against the GBP (all else constant) would result in an estimated $0.5 million foreign exchange gain. Alternatively, a 10% increase in the U.S dollar against the GBP, would result in an estimated $0.5 million foreign exchange loss.

While we do not seek to precisely match our liabilities under reinsurance policies that are payable in foreign currencies with investments denominated in such currencies, we continually monitor our exposure to potential foreign currency losses and may use foreign currency cash and cash equivalents or forward foreign currency exchange contracts in an effort to mitigate against adverse foreign currency movements.

We may also be exposed to foreign currency risk through SILP’s underlying cash, forwards, options and investments in securities denominated in foreign currencies. As of December 31, 2019, some of our currency exposure resulting from foreign denominated securities (longs and shorts) was reduced by offsetting cash balances denominated in the corresponding foreign currencies.

As of December 31, 2019, a 10% increase or decrease in the value of the U.S. dollar against foreign currencies would have no meaningful impact on the value of our Investment Portfolio.

Interest Rate Risk

Our investment in SILP includes interest rate sensitive securities, such as corporate and sovereign debt instruments and interest rate swaps. The primary market risk exposure for any debt instrument is interest rate risk. As interest rates rise, the fair value of a long fixed-income portfolio generally falls. Similarly, falling interest rates generally lead to increases in the fair value of fixed-income securities. Additionally, some of the derivative investments may also be sensitive to interest rates and their value may indirectly fluctuate with changes in interest rates.

Link to Table of Contents

The following table summarizes the impact that a 100 basis point increase or decrease in interest rates would have on the value of our Investment Portfolio as of December 31, 2019:

	100 basis point increasein interest rates	100 basis point decrease<br>in interest rates
	Change infair value	Change in<br>fair value
	( in thousands)
Interest rate swaps	3,039	(3,039		)
Net exposure to interest rate risk		$	(3,039	)

All values are in US Dollars.

We, along with DME Advisors, monitor the net exposure to interest rate risk and generally do not expect changes in interest rates to have a materially adverse impact on our operations.

Credit Risk

Credit risk relates to the uncertainty of a counterparty’s ability to make timely payments in accordance with contractual terms of the instrument or contract. Our maximum exposure to credit risk is the carrying value of our financial assets. We evaluate the financial condition of our notes receivable counterparties and monitor our exposure to them on a regular basis. We are also exposed to credit risk from our business partners and clients relating to balances receivable under our reinsurance contracts, including premiums receivable, losses recoverable and commission adjustments recoverable. We monitor the financial strength of our counterparties and assess the collectability of these balances on a regular basis. We obtain collateral in the form of funds withheld, trusts and letters of credit from our counterparties to mitigate this credit risk.

In addition, the securities, commodities, and cash in SILP’s investment portfolio are held with several prime brokers and derivative counterparties, subjecting SILP, and indirectly us, to significant concentration of credit risk. While we have no direct control over SILP, DME Advisors regularly monitors the concentration of credit risk with each counterparty and, if appropriate, transfers cash or securities between counterparties or requests collateral to diversify and mitigate this credit risk.

Political Risk

We are exposed to political risk to the extent that we underwrite business from entities located in foreign markets and to the extent that DME Advisors, on behalf of SILP and subject to our investment guidelines, trades securities that are listed on various U.S. and foreign exchanges and markets. The governments in any of these jurisdictions could impose restrictions, regulations or other measures, which may have a material adverse impact on our underwriting operations and investment strategy. We currently do not have any material political risk exposure relating to our insurance contracts; however, changes in government laws and regulations may impact our underwriting operations (see “Item 1A. Risk Factors”).

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

Information with respect to this Item is set forth under Part IV Item 15.

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

Not applicable.

Link to Table of Contents

ITEM 9A. CONTROLS AND PROCEDURES

Disclosure Controls and Procedures

As required by Rules 13a-15 and 15d-15 of the Exchange Act, the Company has evaluated, with the participation of management, including the Chief Executive Officer and the Chief Financial Officer, the effectiveness of its disclosure controls and procedures (as defined in such rules) as of the end of the period covered by this report. Based on such evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures are effective to ensure that information required to be disclosed by the Company in reports prepared in accordance with the rules and regulations of the SEC is recorded, processed, summarized and reported within the time periods specified by the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer’s management, including its principal executive officer and principal financial officer, or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure.

Our management, including our Chief Executive Officer and Chief Financial Officer, does not expect that the Company’s disclosure controls and procedures will prevent all errors and all frauds. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake.

Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. The design of any system of controls also is based, in part, upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions; over time, controls may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

Changes in Internal Control Over Financial Reporting

There have been no changes in the Company’s internal control over financial reporting during the fiscal quarter ended December 31, 2019 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting. The Company continues to review its disclosure controls and procedures, including its internal controls over financial reporting, and may from time to time make changes aimed at enhancing their effectiveness and to ensure that the Company’s systems evolve with its business.

Management’s Report on Internal Control Over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting. Our internal control system is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. GAAP and includes those policies and procedures that:

●	pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company;
●	provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with U.S. GAAP, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and
●	provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company’s assets that could have a material effect on its financial statements.

Because of its inherent limitations, a system of internal control over financial reporting can provide only reasonable assurance and may not prevent or detect misstatements. Further, because of changes in conditions, effectiveness of internal control over financial reporting may vary over time. Our system contains self-monitoring mechanisms, and actions are taken to correct deficiencies as they are identified.

Link to Table of Contents

Our management conducted an evaluation of the effectiveness of the system of internal control over financial reporting based on the framework in the Internal Control — Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (the 2013 framework). Based on this evaluation, our management concluded that our system of internal control over financial reporting was effective as of December 31, 2019. The effectiveness of our internal control over financial reporting has been audited by BDO USA, LLP, an independent registered public accounting firm, as stated in their report, which is included herein.

ITEM 9B. OTHER INFORMATION

Disclosure of Certain Activities Under Section 13(r) of the Securities Exchange Act of 1934

Section 13(r) of the Securities Exchange Act of 1934, as amended, requires an issuer to disclose in its annual or quarterly reports whether it or an affiliate knowingly engaged in certain activities described in that section, including certain activities related to Iran during the period covered by the report. During 2016, the Office of Foreign Assets Control of the U.S. Department of the Treasury adopted General License H, which authorizes non-U.S. entities that are owned or controlled by a U.S. person to engage in certain activities with Iran so long as they comply with certain specific requirements set forth therein. During 2018, OFAC reimposed certain sanctions on Iran related activities including providing insurance, reinsurance and underwriting services and required such activities to be wound-down by November 4, 2018.

As and when allowed by the applicable law and regulations, our non-U.S. subsidiaries provide treaty reinsurance coverage to non-U.S. insurers on a worldwide basis, including insurers of liability, marine, aviation and energy risks, and as a result, these underlying reinsurance portfolios may have some exposure to Iran. In addition, we underwrite facultative reinsurance on a global basis to non-U.S. insurers, including for liability, marine, aviation and energy risks. Coverage provided to non-Iranian business may indirectly cover an exposure in Iran. For example, certain of our reinsurance contracts cover global marine hull and cargo policies that provide coverage for vessels navigating into and out of ports worldwide, including Iran.

For the year ended December 31, 2019, we are not aware of any additional premium with respect to underwriting reinsurance activities reportable under Section 13(r). Should any such risks have entered into the stream of commerce covered by these reinsurance activities, we believe that the premiums associated with such business would be immaterial.

PART III

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

This item is omitted because a definitive proxy statement or an amendment to this Annual Report on Form 10-K containing such information will be filed with the SEC not later than 120 days after the close of the fiscal year pursuant to Regulation 14A, and such information is expressly incorporated herein by reference.

ITEM 11. EXECUTIVE COMPENSATION

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

Link to Table of Contents

ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES

Link to Table of Contents

PART IV

ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

The following documents are filed as a part of this Form 10-K


(a)(1)	Financial Statements
	Report of Independent Registered Public Accounting Firm (on internal control over financial reporting)	F-1
	Report of Independent Registered Public Accounting Firm (on the consolidated financial statements)	F-2
	Report of Independent Registered Public Accounting Firm (on the financial statements of Solasglas Investments, LP)	F-3
	Consolidated Balance Sheets as of December 31, 2019 and 2018	F-4
	Consolidated Statements of Operations for the years ended December 31, 2019, 2018 and 2017	F-5
	Consolidated Statements of Shareholders' Equity for the years ended December 31, 2019, 2018 and 2017	F-6
	Consolidated Statements of Cash Flows for the years ended December 31, 2019, 2018 and 2017	F-7
	Notes to the Consolidated Financial Statements	F-8
(a)(2)	Financial Statement Schedules
	Schedule I – Summary of Investments — Other Than Investments in Related Parties	F-52
	Schedule II – Condensed Financial Information of Registrant	F-53
	Schedule III – Supplementary Insurance Information	F-55
	Schedule IV – Supplementary Reinsurance Information	F-55
(a)(3)	The exhibits required to be filed by this Item 15. are set forth in the Exhibit Index accompanying this report.
	The financial statements of Solasglas Investments, LP required by Rule 3-09 of Regulation S-X are included in this filing as Exhibit 99.1.

ITEM 16. 10-K Summary

None

Link to Table of Contents

EXHIBIT INDEX

Exhibit Number	Description of Exhibit
3.1	Third Amended and Restated Memorandum and Articles of Association as revised by special resolution on July 10, 2008 (incorporated by reference to Exhibit 3.1 of the Company’s Form 10-Q filed on August 7, 2008)
---	---
4.1	Form of Specimen Certificate of Class A ordinary shares (incorporated by reference to Exhibit 4.1 of the Company’s Registration Statement No. 333-139993)
4.2	Share Purchase Option, dated August 11, 2004, by and between the Registrant and First International Capital Holdings, Ltd. (incorporated by reference to Exhibit 4.2 of the Company’s Registration Statement No. 333-139993)
4.3	Indenture, dated as of August 7, 2018, between Greenlight Capital Re, Ltd. and Wilmington Savings Fund Society, FSB, as trustee (incorporated by reference to Exhibit 4.1 of the Company Form 8-K filed on August 7, 2018)
4.4	Description of Registrant’s Securities
10.1	Form of Securities Purchase Agreement for Class A ordinary shares by and between the Registrant and each of the subscribers thereto (incorporated by reference to Exhibit 10.2 of the Company’s Registration Statement No. 333-139993)
10.2 (1)	Greenlight Capital Re, Ltd. Amended and Restated 2004 Stock Incentive Plan (incorporated by reference to Appendix A to the Company’s Definitive Proxy Statement filed on March 9, 2017).
10.3 (1)	Form of Restricted Stock Award Agreement by and between the Registrant and the Grantee (incorporated by reference to Exhibit 10.6 of the Company’s Registration Statement No. 333-139993)
10.4 (1)	Form of Stock Option Agreement (incorporated by reference to Exhibit 10.7 of the Company’s Registration Statement No. 333-139993)
10.5 (1)	Greenlight Capital Re, Ltd. Form of Directors’ Restricted Stock Award (incorporated by reference to Exhibit 10.20 of the Company’s Registration Statement No. 333-139993)
10.6 (1)	Greenlight Capital Re, Ltd. Form of Employees’ Restricted Stock Award (incorporated by reference to Exhibit 10.21 of the Company’s Registration Statement No. 333-139993)
10.7	Form of Shareholders’ Agreement, dated August 11, 2004, by and among the Registrant and each of the subscribers (incorporated by reference to Exhibit 10.8 of the Company’s Registration Statement No. 333-139993)
10.8	Form of Deed of Indemnity between the Registrant and each of its directors and certain of its officers (incorporated by reference to Exhibit 10.11 of the Company’s Registration Statement No. 333-139993)
10.9 (1)	Amended and Restated Employment Agreement, dated as of December 30, 2008, by and among Greenlight Capital Re, Ltd., Greenlight Reinsurance, Ltd. and Tim Courtis (incorporated by reference to Exhibit 10.2 of the Company’s Current Report on Form 8-K filed on January 2, 2009)
10.10 (1)	Concurrent Private Placement Stock Purchase Agreement for Class B Ordinary Shares, dated January 11, 2007, by and between the Company and David Einhorn (incorporated by reference to Exhibit 10.16 of the Company’s Registration Statement No. 333-139993)
10.11	Service Agreement, dated as of February 21, 2007, between DME Advisors, LP and Greenlight Capital Re, Ltd. (incorporated by reference to Exhibit 10.17 of the Company’s Registration Statement No. 333-139993)
10.12 (1)	Amendment No. 1, dated February 18, 2009, to the Amended and Restated Employment Agreement, dated as of December 30, 2008, by and among Greenlight Capital Re, Ltd., Greenlight Reinsurance, Ltd. and Tim Courtis (incorporated by reference to Exhibit 10.26 of the Company’s Form 10-K filed on February 23, 2009)
10.13	Letter of Understanding, dated June 10, 2010, between Greenlight Reinsurance, Ltd. and Citibank, N.A (incorporated by reference to Exhibit 10.1 of the Company’s Form 10-Q filed on August 2, 2010)
10.14	Letter of Credit Agreement, dated August 20, 2010, between Greenlight Reinsurance, Ltd. and Citibank Europe plc. (incorporated by reference to Exhibit 10.1 of the Company’s Form 10-Q filed on November 2, 2010)
10.15	Master Reimbursement Agreement, dated August 20, 2010, between Greenlight Reinsurance, Ltd. and Citibank Europe plc (incorporated by reference to Exhibit 10.2 of the Company’s Form 10-Q filed on November 2, 2010)
10.16	Reinsurance Deposit Agreement, dated August 20, 2010, between Greenlight Reinsurance, Ltd. and Citibank Europe plc. (incorporated by reference to Exhibit 10.3 of the Company’s Form 10-Q filed on November 2, 2010)

Link to Table of Contents

10.17 (1)	Amended and Restated Employment Agreement, dated July 26, 2012, by and among Greenlight Capital Re, Ltd., Greenlight Reinsurance, Ltd. and Barton Hedges (incorporated by reference to Exhibit 10.1 of the Company’s Form 10-Q filed on July 30, 2012)
10.18 (1)	Employment Agreement, dated August 15, 2006, by and among Greenlight Capital Re, Ltd., Greenlight Reinsurance, Ltd. and Brendan Barry (incorporated by reference to Exhibit 10.24 of the Company’s Form 10-K filed on February 21, 2012)
10.19 (1)	Employment Agreement, dated July 31, 2014, by and among Greenlight Reinsurance, Ltd. and James McNichols (incorporated by reference to Exhibit 10.1 of the Company’s Form 10-Q filed on November 3, 2014)
10.20	Letter Agreement between Greenlight Capital Re, Ltd., Greenlight Reinsurance, Ltd., Greenlight Reinsurance Ireland, Ltd., DME Advisors, LLC and DME Advisors, LP., dated June 17, 2015 (incorporated by reference to Exhibit 10.3 of the Company’s Form 10-Q filed on August 3, 2015)
10.21	Third Amended and Restated Agreement by and among Greenlight Reinsurance, Ltd., Greenlight Reinsurance Ireland, a Designated Activity Company, Greenlight Capital Re, Ltd. (for limited purposes), DME Advisors, LLC and DME Advisors, LP (for limited purposes), dated as of September 30, 2016 and effective as of January 1, 2017 (incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K filed on October 6, 2016).
10.22	Amended and Restated Investment Advisory Agreement among DME Advisors, LP, The Venture Among Greenlight Reinsurance, Ltd., Greenlight Reinsurance Ireland, a Designated Activity Company, and DME Advisors, LLC, Greenlight Reinsurance, Ltd., Greenlight Reinsurance Ireland, a Designated Activity Company and DME Advisors, LLC., dated as of September 30, 2016 and effective as of January 1, 2017 (incorporated by reference to Exhibit 10.2 to the Company’s Form 8-K filed on October 6, 2016).
10.23	Deed of Settlement and Release dated December 15, 2016, among Barton Hedges, Greenlight Capital Re, Ltd., and Greenlight Reinsurance, Ltd. (incorporated by reference to Exhibit 99.2 to the Company’s Form 8-K filed on December 19, 2016).
10.24	Consulting agreement dated December 16, 2016, among Greenlight Capital Re, Ltd., Greenlight Reinsurance, Ltd. and Leonard Goldberg (incorporated by reference to Exhibit 99.3 to the Company’s Form 8-K filed on December 19, 2016).
10.25 (1)	Employment Agreement by and between Greenlight Capital Re, Ltd, Greenlight Reinsurance, Ltd. and Simon Burton dated July 1, 2017 (incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K filed on June 2, 2017).
10.26 (1)	Employment Agreement by and between Greenlight Capital Re, Ltd., Greenlight Reinsurance, Ltd. and Michael Belfatti dated August 15, 2017 (incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K filed on August 16, 2017)
10.27 (1)	Employment Agreement by and between Greenlight Reinsurance Ireland, DAC and Patrick O’Brien dated February 16, 2018 (incorporated by reference to Exhibit 10.40 to the Company’s Form 10-K filed on Feb 20, 2018)
10.28 (1)	Amendment to Employment Agreement by and between Greenlight Reinsurance, Ltd. and Brendan Barry, dated as of March 15, 2018 and effective as of January 1, 2018 (incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K filed on March 21, 2018)
10.29	Amendment No. 1 to Shareholders’ Agreement, dated June 29, 2018, by and between the Registrant and David Einhorn (incorporated by reference to Exhibit 10.1 of the Company’s Form 8-K filed on June 29, 2018).
10.30	Deed of Settlement and Release, dated July 19, 2018, among Michael Belfatti, Greenlight Capital Re, Ltd and Greenlight Reinsurance, Ltd. (incorporated by reference to Exhibit 10.1 of the Company’s Form 8-K filed on July 20, 2018)
10.31	Amended and Restated Exempted Limited Partnership Agreement of Solasglas Investments, LP, between DME Advisors II, LLC, as General Partner, Greenlight Reinsurance, Ltd., Greenlight Reinsurance Ireland, Designated Activity Company, Greenlight Capital Re, Ltd. and the initial limited partner, dated as of September 1, 2018 (incorporated by reference to Exhibit 10.1 of the Company’s Form 8-K filed on September 4, 2018)
10.32	Investment Advisory Agreement among DME Advisors, LP, and Solasglas Investments, LP, dated as of September 1, 2018 (incorporated by reference to Exhibit 10.2 of the Company’s Form 8-K filed on September 4, 2018)
10.33	Participation Agreement among Greenlight Reinsurance, Ltd., Greenlight Reinsurance Ireland, Designated Activity Company, DME Advisors II, LLC and Solasglas Investments, LP, dated as of September 1, 2018 (incorporated by reference to Exhibit 10.3 of the Company’s Form 8-K filed on September 4, 2018)
10.34	Termination Agreement among Greenlight Reinsurance, Ltd., Greenlight Reinsurance Ireland, Designated Activity Company, Greenlight Capital Re, Ltd., DME Advisors, LLC and DME Advisors, LP, dated as of September 1, 2018 (incorporated by reference to Exhibit 10.4 of the Company’s Form 8-K filed on September 4, 2018)

Link to Table of Contents

10.35 (1)	Employment Agreement by and between Greenlight Capital Re, Ltd., Greenlight Reinsurance, Ltd. and Neil Greenspan dated December 3, 2018 (incorporated by reference to Exhibit 10.1 of the Company’s Form 8-K filed on December 7, 2018)
10.36	Collateral Assets Investment Management Agreement among DME Advisors, LP, Greenlight Reinsurance, Ltd. and Greenlight Reinsurance Ireland DAC dated January 1, 2019 (incorporated by reference to Exhibit 10.49 of the Company’s Form 10-K filed on February 27, 2019)
10.37 (1)	Stock Option Agreement by and between Greenlight Capital Re, Ltd. and Simon Burton dated July 6, 2017 (incorporated by reference to Exhibit 10.50 of the Company’s Form 10-K filed on February 27, 2019)
10.38 (1)	Stock Option Agreements by and between Greenlight Capital Re, Ltd. and Leonard Goldberg dated April 3, 2017 and August 1, 2017 (incorporated by reference to Exhibit 10.51 of the Company’s Form 10-K filed on February 27, 2019)
10.39 (1)	Restricted Stock Award Agreement by and between Greenlight Capital Re, Ltd. and Simon Burton dated March 15, 2018 (incorporated by reference to Exhibit 10.52 of the Company’s Form 10-K filed on February 27, 2019).
10.40 (1)	Employment Agreement among Greenlight Capital Re, Ltd., Greenlight Reinsurance, Ltd. and Laura Accurso dated October 1, 2017, as amended February 18, 2019 (incorporated by reference to Exhibit 10.53 of the Company’s Form 10-K filed on February 27, 2019)
10.41	Amendment No.1 to the Amended and Restated Exempted Limited Partnership Agreement of Solasglas Investments, LP, between DME Advisors II, LLC, as General Partner, Greenlight Reinsurance, Ltd. and Greenlight Reinsurance Ireland, Designated Activity Company, dated Feb 26, 2019, effective as of September 1, 2018 (incorporated by reference to Exhibit 10.54 of the Company’s Form 10-K filed on February 27, 2019)
10.42 (1)	Restricted Stock Unit Award Agreement by and between Greenlight Capital Re, Ltd. and Patrick O’Brien dated March 15, 2018 (incorporated by reference to Exhibit 10.55 of the Company’s Form 10-K filed on February 27, 2019)
10.43 (1)	Restricted Stock Award Agreement by and between Greenlight Capital Re, Ltd. and Simon Burton, dated March 15, 2019. (incorporated by reference to Exhibit 10.1 of the Company’s Form 10-Q filed on May 6, 2019)
10.44 (1)	Greenlight Capital Re, Ltd. Form of Employees’ Restricted Stock Unit Award (incorporated by reference to Exhibit 4.10 of the Company’s Registration Statement No 333-231214 filed on May 3, 2019).
10.45	Letter agreement between Greenlight Reinsurance, Ltd, Greenlight Reinsurance Ireland, DAC, DME Advisors II, LLC and DME Advisors, LP, effective June 1, 2019 (incorporated by reference to Exhibit 10.1 of the Company’s Form 10-Q filed on August 5, 2019).
10.46 (1)	Second Amendment to Employment Agreement, dated as of September 2, 2019, by and among Greenlight Capital Re, Ltd., Greenlight Reinsurance, Ltd. and Laura Accurso (incorporated by reference to Exhibit 10.1 of the Company’s Form 8-K filed on September 3, 2019).
10.47 (1)	Amendment to Employment Agreement, dated as of September 2, 2019, by and between Greenlight Reinsurance Ireland, DAC and Patrick O’Brien (incorporated by reference to Exhibit 10.2 of the Company’s Form 8-K filed on September 3, 2019).
10.48 (1)	Bonus Agreement, dated as of September 22, 2019, by and among Greenlight Capital Re, Ltd., Greenlight Reinsurance, Ltd. and Simon Burton (incorporated by reference to Exhibit 10.1 of the Company’s Form 8-K filed on September 23, 2019).
10.49 (1)	Restricted Stock Award Agreement, effective as of September 22, 2019 by and between Greenlight Capital Re, Ltd. and Simon Burton (incorporated by reference to Exhibit 10.2 of the Company’s Form 8-K filed on September 23, 2019).
10.50	Amended and Restated Letter Agreement, dated as of December 27, 2019, by and among Greenlight Reinsurance, Ltd., Greenlight Reinsurance Ireland, a Designated Activity Company, and Solasglas Investments, LP (incorporated by reference to Exhibit 10.1 of the Company’s Form 8-K filed on December 30, 2019).
10.51 (1)	Greenlight Capital Re, Ltd. Bonus Plan.
10.52 (1)	Greenlight Capital Re, Ltd. Form of Bonus Plan Bonus Agreement.
10.53 (1)	Amendment to Employment Agreement, entered into as of September 2, 2019, by and among Greenlight Capital Re, Ltd., Greenlight Reinsurance, Ltd. and Neil Greenspan
10.54 (1)	Employment Offer, dated March 23, 2009, by and between Greenlight Reinsurance, Ltd. and Tom Curnock.
10.55 (1)	Amendment to Employment Offer entered into as of October 31, 2018 by and between Greenlight Reinsurance, Ltd. and Tom Curnock.
10.56 (1)	Second Amendment to Employment Offer entered into September 10, 2019, by and between Greenlight Reinsurance, Ltd. and Tom Curnock.

Link to Table of Contents

21.1	Subsidiaries of the registrant
23.1	Consent of BDO USA, LLP
23.2	Consent of Ernst & Young Ltd.
31.1	Certification of the Chief Executive Officer of Greenlight Capital Re, Ltd. filed herewith pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2	Certification of the Chief Financial Officer of Greenlight Capital Re, Ltd. filed herewith pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1	Certification of the Chief Executive Officer of Greenlight Capital Re, Ltd. furnished herewith pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2	Certification of the Chief Financial Officer of Greenlight Capital Re, Ltd. furnished herewith pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
99.1*	Audited Financial Statements of Solasglas Investments, LP as of and for the year ended December 31, 2019.
101	The following materials from the Company’s Annual Report on Form 10-K for the year ended December 31, 2019, formatted in XBRL (eXtensible Business Reporting Language): (i) the Consolidated Balance Sheets; (ii) the Consolidated Statements of Operations; (iii) the Consolidated Statements of Shareholders’ Equity; (iv) the Consolidated Statements of Cash Flows; and (v) the Notes to Consolidated Financial Statements.
(1)	Management contract or compensatory plan or arrangement.
*	Exhibit 99.1 is being filed to provide audited financial statements and the related footnotes of Solasglas Investments, LP in accordance with SEC rule 3-09 of Regulation S-X. The management of Solasglas Investments, LP is solely responsible for the form and content of the Solasglas Investments LP financial statements. The Registrant has no responsibility for the form or content of the Solasglas Investments, LP financial statements since it does not control Solasglas Investments, LP.

Link to Table of Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	GREENLIGHT CAPITAL RE, LTD.
By:	/s/ Simon Burton
	Simon Burton<br>Chief Executive Officer
	March 9, 2020

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

/s/ DAVID M. EINHORN	/s/ LEONARD GOLDBERG
David M. Einhorn<br>Director	Leonard Goldberg<br>Director
March 9, 2020	March 9, 2020
/s/ FRANK D. LACKNER	/s/ ALAN BROOKS
Frank D. Lackner<br>Director	Alan Brooks<br>Director
March 9, 2020	March 9, 2020
/s/ IAN ISAACS	/s/ JOSEPH P. PLATT
Ian Isaacs<br>Director	Joseph P. Platt<br>Director
March 9, 2020	March 9, 2020
/s/ TIM COURTIS	/s/ BRYAN MURPHY
Tim Courtis<br>Chief Financial Officer<br>(principal financial and accounting officer)	Bryan Murphy<br>Director
March 9, 2020	March 9, 2020
/s/ SIMON BURTON
Simon Burton<br>Director and Chief Executive Officer<br>(principal executive officer)
March 9, 2020

Link to Table of Contents

Report of Independent Registered Public Accounting Firm

Shareholders and Board of Directors

Greenlight Capital Re, Ltd.

Grand Cayman, Cayman Islands

Opinion on Internal Control over Financial Reporting

We have audited Greenlight Capital Re, Ltd.’s (the “Company’s”) internal control over financial reporting as of December 31, 2019, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (the “COSO criteria”). In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2019, based on the COSO criteria.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (“PCAOB”), the consolidated balance sheets of the Company as of December 31, 2019 and 2018, the related consolidated statements of operations, shareholders’ equity, and cash flows for each of the three years in the period ended December 31, 2019, and the related notes and schedules and our report dated March 9, 2020 expressed an unqualified opinion thereon.

Basis for Opinion

The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying “Item 9A - Controls and Procedures - Management’s Report on Internal Control over Financial Reporting”. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit of internal control over financial reporting in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

Definition and Limitations of Internal Control over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

/s/ BDO USA, LLP

Grand Rapids, Michigan, USA

March 9, 2020

F-1

Link to Table of Contents

Report of Independent Registered Public Accounting Firm

Shareholders and Board of Directors

Greenlight Capital Re, Ltd.

Grand Cayman, Cayman Islands

Opinion on the Consolidated Financial Statements

We have audited the accompanying consolidated balance sheets of Greenlight Capital Re, Ltd. (the “Company”) as of December 31, 2019 and 2018, the related consolidated statements of operations, shareholders’ equity, and cash flows for each of the three years in the period ended December 31, 2019 and the related notes and schedules (collectively referred to as the “consolidated financial statements”). In our opinion, based on our audits and the report of the other auditors, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2019 and 2018, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2019, in conformity with accounting principles generally accepted in the United States of America.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (“PCAOB”), the Company's internal control over financial reporting as of December 31, 2019, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”) and our report dated March 9, 2020 expressed an unqualified opinion thereon.

We did not audit the financial statements of Solasglas Investments, LP, an equity method investment of the Company as of December 31, 2019 and 2018 and for the year ended December 31, 2019 and the period from September 1, 2018 (commencement of operations) to December 31, 2018.The Company’s investment in Solasglas Investments, LP as of December 31, 2019 and 2018 was $240.1 million and $235.6 million, respectively, and its equity in net income (loss) of Solasglas Investment, LP was $46.1 million and $(60.6) million for the year ended December 31, 2019 and the period from September 1, 2018 (commencement of operations) to December 31, 2018, respectively. The financial statements of Solasglas Investments, LP were audited by other auditors whose report has been furnished to us, and our opinion, insofar as it relates to the amounts included for Solasglas Investments, LP is based solely on the report of the other auditors.

Basis for Opinion

These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud.

Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.

/s/ BDO USA, LLP

We have served as the Company's auditor since 2006.

Grand Rapids, Michigan, USA

March 9, 2020

F-2

Link to Table of Contents

Report of Independent Registered Public Accounting Firm

The General Partner

Solasglas Investments, LP

Opinion on the Financial Statements

We have audited the statement of assets, liabilities and partners’ capital of Solasglas Investments, LP (an equity method investee of Greenlight Capital Re, Ltd.) (the “Partnership”), including the condensed schedule of investments, as of December 31, 2019 and 2018, and the related statements of operations, changes in partners’ capital and cash flows for the year ended December 31, 2019 and for the period from September 1, 2018 (commencement of operations) to December 31, 2018, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Partnership at December 31, 2019 and 2018, and the results of its operations, changes in its partners’ capital and its cash flows for the year ended December 31, 2019 and the period from September 1, 2018 (commencement of operations) to December 31, 2018 in conformity with U.S. generally accepted accounting principles.

Basis of Opinion

These financial statements are the responsibility of the Partnership’s management. Our responsibility is to express an opinion on the Partnership’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Partnership in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB and in accordance with auditing standards generally accepted in the United States of America. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

/s/ Ernst & Young Ltd.

We have served as the Partnership’s auditor since 2018.

Grand Cayman, Cayman Islands

March 9, 2020

F-3

Link to Table of Contents

GREENLIGHT CAPITAL RE, LTD.

CONSOLIDATED BALANCE SHEETS

December 31, 2019 and 2018

(expressed in thousands of U.S. dollars, except per share and share amounts)

	2019			2018
Assets
Investments
Investment in related party investment fund	$	240,056		$	235,612
Equity securities, trading, at fair value	—			36,908
Other investments	16,384			11,408
Total investments	256,440			283,928
Cash and cash equivalents	25,813			18,215
Restricted cash and cash equivalents	742,093			685,016
Reinsurance balances receivable	230,384			300,251
Loss and loss adjustment expenses recoverable	27,531			43,705
Deferred acquisition costs	49,665			49,929
Unearned premiums ceded	901			24,981
Notes receivable (net of valuation allowance)	20,202			26,861
Other assets	2,164			2,559
Total assets	$	1,355,193		$	1,435,445
Liabilities and equity
Liabilities
Due to related party investment fund	$	—		$	9,642
Loss and loss adjustment expense reserves	470,588			482,662
Unearned premium reserves	179,460			211,789
Reinsurance balances payable	122,665			139,218
Funds withheld	4,958			16,418
Other liabilities	6,825			5,067
Convertible senior notes payable	93,514			91,185
Total liabilities	878,010			955,981
Redeemable non-controlling interest in related party joint venture	—			1,692
Equity
Preferred share capital (par value $0.10; authorized, 50,000,000; none issued)	—			—
Ordinary share capital (Class A: par value $0.10; authorized, 100,000,000; issued and outstanding, 30,739,395 (2018: 30,130,214): Class B: par value $0.10; authorized, 25,000,000; issued and outstanding, 6,254,715 (2018: 6,254,715))	3,699			3,638
Additional paid-in capital	503,547			499,726
Retained earnings (deficit)	(30,063		)	(26,077		)
Shareholders’ equity attributable to Greenlight Capital Re, Ltd.	477,183			477,287
Non-controlling interest in related party joint venture	—			485
Total equity	477,183			477,772
Total liabilities, redeemable non-controlling interest and equity	$	1,355,193		$	1,435,445

The accompanying Notes to the Consolidated Financial Statements are an

integral part of the Consolidated Financial Statements.

F-4

Link to Table of Contents

GREENLIGHT CAPITAL RE, LTD.

CONSOLIDATED STATEMENTS OF OPERATIONS

Years ended December 31, 2019, 2018 and 2017

(expressed in thousands of U.S. dollars, except per share and share amounts)

	2019			2018			2017
Revenues
Gross premiums written	$	523,977		$	567,531		$	692,651
Gross premiums ceded	(48,667		)	(102,788		)	(56,587		)
Net premiums written	475,310			464,743			636,064
Change in net unearned premium reserves	8,270			43,620			(10,060		)
Net premiums earned	483,580			508,363			626,004
Income (loss) from investment in related party investment fund [net of related party expenses of $9,874, $3,100 and $0, respectively]	46,056			(60,573		)	—
Net investment income (loss) [net of related party expenses of $0, $11,221 and $19,863, respectively]	6,211			(262,533		)	20,231
Other income (expense), net	2,306			(2,228		)	(560		)
Total revenues	538,153			183,029			645,675
Expenses
Net loss and loss adjustment expenses incurred	388,487			363,873			502,404
Acquisition costs	117,084			145,475			161,740
General and administrative expenses	29,822			25,173			26,356
Interest expense	6,263			2,505			—
Total expenses	541,656			537,026			690,500
Income (loss) before income tax	(3,503		)	(353,997		)	(44,825		)
Income tax (expense) benefit	(483		)	(332		)	451
Net income (loss)	(3,986		)	(354,329		)	(44,374		)
Loss (income) attributable to non-controlling interest in related party joint venture	—			4,275			(578		)
Net income (loss) attributable to Greenlight Capital Re, Ltd.	$	(3,986	)	$	(350,054	)	$	(44,952	)
Earnings (loss) per share
Basic	$	(0.11	)	$	(9.74	)	$	(1.21	)
Diluted	$	(0.11	)	$	(9.74	)	$	(1.21	)
Weighted average number of ordinary shares used in the determination of earnings and loss per share
Basic	36,079,419			35,951,659			37,002,260
Diluted	36,079,419			35,951,659			37,002,260

The accompanying Notes to the Consolidated Financial Statements are an

integral part of the Consolidated Financial Statements.

F-5

Link to Table of Contents

GREENLIGHT CAPITAL RE, LTD.

CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY

Years ended December 31, 2019, 2018 and 2017

(expressed in thousands of U.S. dollars)

	Ordinary share capital			Additional paid-in capital			Retained earnings (deficit)			Shareholders’ equity attributable to Greenlight Capital Re, Ltd.			Non-controlling<br>interest in joint venture			Total equity
Balance at December 31, 2016	$	3,737		$	500,337		$	370,168		$	874,242		$	11,561		$	885,803
Issue of Class A ordinary shares, net of forfeitures	13			—			—			13			—			13
Repurchase of Class A ordinary shares	(14		)	(1,861		)	(944		)	(2,819		)	—			(2,819		)
Share-based compensation expense, net of forfeitures	—			4,840			—			4,840			—			4,840
Change in non-controlling interest in related party joint venture	—			—			—			—			1,372			1,372
Net income (loss) attributable to Greenlight Capital Re, Ltd.	—			—			(44,952		)	(44,952		)	—			(44,952		)
Balance at December 31, 2017	$	3,736		$	503,316		$	324,272		$	831,324		$	12,933		$	844,257
Issue of Class A ordinary shares, net of forfeitures	20			—			—			20			—			20
Repurchase of Class A ordinary shares	(118		)	(16,090		)	(295		)	(16,503		)	—			(16,503		)
Share-based compensation expense	—			4,604			—			4,604			—			4,604
Issuance of convertible notes	—			7,896			—			7,896			—			7,896
Change in non-controlling interest in related party joint venture	—			—			—			—			(12,448		)	(12,448		)
Net income (loss) attributable to Greenlight Capital Re, Ltd.	—			—			(350,054		)	(350,054		)	—			(350,054		)
Balance at December 31, 2018	$	3,638		$	499,726		$	(26,077	)	$	477,287		$	485		$	477,772
Issue of Class A ordinary shares, net of forfeitures	61			—			—			61			—			61
Share-based compensation expense	—			3,821			—			3,821			—			3,821
Change in non-controlling interest in related party joint venture	—			—			—			—			(485		)	(485		)
Net income (loss) attributable to Greenlight Capital Re, Ltd.	—			—			(3,986		)	(3,986		)	—			(3,986		)
Balance at December 31, 2019	$	3,699		$	503,547		$	(30,063	)	$	477,183		$	—		$	477,183

The accompanying Notes to the Consolidated Financial Statements are an

integral part of the Consolidated Financial Statements.

F-6

Link to Table of Contents

GREENLIGHT CAPITAL RE, LTD.

CONSOLIDATED STATEMENTS OF CASH FLOWS

Years ended December 31, 2019, 2018 and 2017

(expressed in thousands of U.S. dollars)

	2019			2018			2017
Cash provided by (used in) operating activities
Net income (loss)	$	(3,986	)	$	(354,329	)	$	(44,374	)
Adjustments to reconcile net income or loss to net cash provided by (used in) operating activities
Loss (income) from investments in related party investment fund	(46,056		)	60,573			—
Loss (income) from equity accounted investment	(700		)	247			—
Net change in unrealized gains and losses on investments, financial contracts and notes receivable	(8,380		)	32,597			41,444
Net realized (gains) losses on investments and financial contracts	14,150			236,887			(87,618		)
Foreign exchange (gains) losses on investments	270			186			5,292
Share-based compensation expense	3,882			4,624			4,853
Amortization and interest expense	2,329			2,505			—
Depreciation expense	21			260			368
Net change in
Reinsurance balances receivable	69,867			1,511			(82,636		)
Loss and loss adjustment expenses recoverable	16,174			(14,246		)	(26,755		)
Deferred acquisition costs	264			12,421			(1,328		)
Unearned premiums ceded	24,080			139			(22,743		)
Other assets	374			411			705
Loss and loss adjustment expense reserves	(12,074		)	18,282			157,739
Unearned premium reserves	(32,329		)	(44,029		)	33,291
Reinsurance balances payable	(16,553		)	(4,840		)	102,643
Funds withheld	(11,460		)	(7,161		)	17,652
Other liabilities	1,758			(5,346		)	(4,114		)
Net cash provided by (used in) operating activities	1,631			(59,308		)	94,419
Investing activities
Proceeds from redemptions from related party investment fund	114,077			96,635			—
Contributions to related party investment fund	(35,792		)	(268,317		)	—
Purchases of investments	(4,702		)	(402,244		)	(1,120,549		)
Sales of investments	—			1,002,374			1,036,665
Payments for financial contracts	—			(129,907		)	(24,714		)
Proceeds from financial contracts	—			44,596			82,789
Securities sold, not yet purchased	—			340,693			1,120,506
Dispositions of securities sold, not yet purchased	—			(844,379		)	(1,253,176		)
Change in due to related party investment fund	(9,642		)	—			—
Change in due to prime brokers and other financial institutions	—			(672,700		)	352,870
Net change in notes receivable	671			1,636			5,237
Non-controlling interest contribution into (withdrawal from) related party joint venture, net	(1,278		)	(13,650		)	2,079
Net cash provided by (used in) investing activities	63,334			(845,263		)	201,707
Financing activities
Net proceeds from issuance of convertible senior notes payable, net of costs	—			96,576			—
Repurchase of Class A ordinary shares	—			(16,503		)	(2,819		)
Net cash provided by (used in) financing activities	—			80,073			(2,819		)
Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash	(290		)	(3,369		)	(4,718		)
Net increase (decrease) in cash, cash equivalents and restricted cash	64,675			(827,867		)	288,589
Cash, cash equivalents and restricted cash at beginning of the period (see Note 2)	703,231			1,531,098			1,242,509
Cash, cash equivalents and restricted cash at end of the period (see Note 2)	$	767,906		$	703,231		$	1,531,098
Supplementary information
Interest paid in cash	$	3,933		$	11,088		$	10,062
Income tax paid in cash	—			4			—
Non-cash transfer of investments (Note 3)	36,673			125,008			—
Non-cash addition of right-of-use asset	323			—			—

The accompanying Notes to the Consolidated Financial Statements are an

integral part of the Consolidated Financial Statements.

F-7

Link to Table of Contents

GREENLIGHT CAPITAL RE, LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

Years ended December 31, 2019, 2018 and 2017

1. ORGANIZATION AND BASIS OF PRESENTATION

Greenlight Capital Re, Ltd. (“GLRE”) was incorporated as an exempted company under the Companies Law of the Cayman Islands on July 13, 2004. GLRE’s principal wholly-owned subsidiary, Greenlight Reinsurance, Ltd. (“Greenlight Re”), provides global specialty property and casualty reinsurance. Greenlight Re has a Class D insurer license issued in accordance with the terms of The Insurance Law, 2010 and underlying regulations thereto (the “Law”) and is subject to regulation by the Cayman Islands Monetary Authority, in terms of the Law. Greenlight Re commenced underwriting in April 2006. Verdant Holding Company, Ltd. (“Verdant”), a wholly-owned subsidiary of GLRE, was incorporated in 2008 in the state of Delaware. During 2010, GLRE established Greenlight Reinsurance Ireland, Designated Activity Company (“GRIL”), a wholly-owned reinsurance subsidiary based in Dublin, Ireland. GRIL is authorized as a non-life reinsurance undertaking in accordance with the provisions of the European Union (Insurance and Reinsurance) Regulations 2015. GRIL provides multi-line property and casualty reinsurance capacity to the European broker market and provides GLRE with an additional platform to serve clients located in Europe and North America. As used herein, the “Company” refers collectively to GLRE and its consolidated subsidiaries.

Prior to January 2, 2019, the Company and its reinsurance subsidiaries were party to a joint venture agreement (the “venture agreement”) with DME Advisors, LP (“DME Advisors”) and DME Advisors LLC (“DME”) under which the Company, its reinsurance subsidiaries and DME were participants in a joint venture (the “Joint Venture”) for the purpose of managing certain jointly held assets. The Joint Venture was consolidated in accordance with ASC 810, Consolidation (ASC 810). DME and DME Advisors are related to the Company and each is an affiliate of David Einhorn, Chairman of the Company’s Board of Directors.

On September 1, 2018, the Company entered into an amended and restated exempted limited partnership agreement (the “SILP LPA”) of Solasglas Investments, LP (“SILP”), with DME Advisors II, LLC (“DME II”), as General Partner, Greenlight Re, GRIL and the initial limited partner (each, a “Partner”). The SILP LPA, in conjunction with a participation agreement, replaced the venture agreement and assigned and/or transferred Greenlight Re’s and GRIL’s invested assets in the Joint Venture to SILP. The Joint Venture was terminated on January 2, 2019 by which date all assets were transferred to SILP (see Note 3 for details).

The Class A ordinary shares of GLRE are listed on Nasdaq Global Select Market under the symbol “GLRE.”

These consolidated financial statements are prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The consolidated financial statements include the accounts of GLRE and the consolidated financial statements of its wholly owned subsidiaries, Greenlight Re, GRIL, Verdant and for periods prior to January 2, 2019, the Joint Venture. All significant intercompany transactions and balances have been eliminated on consolidation.

2. SIGNIFICANT ACCOUNTING POLICIES

Use of Estimates

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of income and expenses during the period. Actual results could differ from these estimates.

Cash and Cash Equivalents

Cash and cash equivalents consist of cash and certain short-term, highly liquid investments with original maturity dates of three months or less.

F-8

Link to Table of Contents

Restricted Cash and Cash Equivalents

The Company maintains cash and cash equivalent balances to collateralize regulatory trusts and letters of credit issued to cedents (see Notes 6 and 15). The amount of cash encumbered varies depending on the collateral required by those cedents. Prior to the termination of the Joint Venture on January 2, 2019, the Company maintained cash in segregated accounts with prime brokers and derivative counterparties.

The following table reconciles the cash, cash equivalents, and restricted cash reported within the consolidated balance sheets to the total presented in the consolidated statements of cash flows:

	December 31, 2019	December 31, 2018
	( in thousands)
Cash and cash equivalents		$	18,215
Restricted cash and cash equivalents	742,093	685,016
Total cash, cash equivalents and restricted cash presented in the consolidated statements of cash flows		$	703,231

All values are in US Dollars.

Premium Revenue Recognition

The Company writes excess of loss contracts and quota share contracts, and estimates the ultimate premiums for the contract period. These estimates are based on information received from the ceding companies and actuarial pricing models used by the Company. For excess of loss contracts, the total ultimate estimated premiums are recorded as premiums written at the inception of the contract. For quota share contracts, the premiums are recorded as written in the same periods in which the underlying insurance contracts are written, and are based on cession statements from cedents. These statements are typically received monthly or quarterly depending on the terms specified in each contract. For any reporting lag, premiums written are estimated based on the portion of the ultimate estimated premiums relating to the risks underwritten during the lag period.

Premium estimates are reviewed by management at least quarterly. Such review includes a comparison of actual reported premiums to expected ultimate premiums along with a review of the aging and collection of premiums. Based on management’s review, the appropriateness of the premium estimates is evaluated, and any adjustments to these estimates are recorded in the period in which they are determined. Changes in premium estimates, including premium receivable on both excess of loss and quota share contracts, are not unusual and may result in significant adjustments in any period. A significant portion of amounts included in the caption “Reinsurance balances receivable” in the Company’s consolidated balance sheets represent estimated premiums written, net of commissions and brokerage, and are not currently due based on the terms of the underlying contracts. Additional premiums due on a contract that has no remaining coverage period are earned in full when written.

Certain contracts allow for reinstatement premiums in the event of a loss. Reinstatement premiums are written and earned when a triggering loss event occurs.

Premiums written are generally recognized as earned over the contract period in proportion to the risk covered. Unearned premiums represent the unexpired portion of reinsurance provided.

Reinsurance Premiums Ceded

The Company reduces the risk of future losses on business assumed by reinsuring certain risks and exposures with other reinsurers (retrocessionaires). The Company remains liable to the extent that any retrocessionaire fails to meet its obligations and to the extent the Company does not hold sufficient security for their unpaid obligations.

Ceded premiums are written during the period in which the risks incept and the associated expense is recognized over the contract period in proportion to the protection provided. Unearned premiums ceded represent the unexpired portion of reinsurance obtained.

Acquisition Costs

Policy acquisition costs are costs that vary with, and are directly related to, the successful production of new and renewal business, and consist principally of commissions, taxes and brokerage expenses. Acquisition costs incurred on reinsurance assumed are shown net of commissions earned on reinsurance ceded. However, if the sum of a contract’s expected losses and loss expenses and deferred acquisition costs exceeds associated unearned premiums and expected investment income, a premium deficiency is determined to exist. In this event, deferred acquisition costs are written off to the extent necessary to

F-9

Link to Table of Contents

eliminate the premium deficiency. If the premium deficiency exceeds deferred acquisition costs then a liability is accrued for the excess deficiency. There were no significant premium deficiency adjustments recognized during the periods presented herein.

Policy acquisition costs also include profit commissions, which are recognized on a basis consistent with our estimate of losses and loss expenses. As of December 31, 2019, $1.2 million (2018: $8.5 million) of profit commission reserves were included in the caption “Reinsurance balances payable” in the Company’s consolidated balance sheets. For the year ended December 31, 2019, $6.7 million, (2018: $18.2 million, 2017: $2.0 million) of net profit commission expense was included in the caption “Acquisition costs” in the Company’s consolidated statements of operations.

Funds Withheld

Funds withheld represent reinsurance balances retained as collateral by the Company on retroceded contracts. Any interest expense that the Company incurs while these funds are withheld are included under the caption “Net investment income (loss)” in the consolidated statements of operations.

Loss and Loss Adjustment Expense Reserves and Recoverable

The Company’s loss and loss adjustment expense reserves are composed of:

●	case reserves resulting from claims notified to the Company by its clients; and
●	reserves for estimated loss and loss adjustment expenses that have been incurred by insureds and reinsureds but not yet reported to the insurer or reinsurer (“IBNR”), including unknown future developments on loss and loss adjustment expenses which are known to the insurer or reinsurer.

These reserve estimates are based on the Company’s own actuarial estimates derived from reports received from ceding companies, industry data and historical experience. These estimates are reviewed by the Company’s reserving committee at least quarterly and adjusted as necessary. Since reserves are estimates, the final settlement of losses may vary from the reserves established and any adjustments to the estimates, which may be material, are recorded in the period they are determined.

Loss estimates are based upon actuarial and statistical projections, an assessment of currently available data, predictions of future developments, estimates of future trends and other factors. The final settlement of losses may vary, perhaps materially, from the reserves recorded. All adjustments to the estimates are recorded in the period in which they are determined. U.S. GAAP does not permit establishing loss reserves, which include case reserves and IBNR loss reserves, until the occurrence of an event which may give rise to a claim. As a result, only loss reserves applicable to losses incurred up to the reporting date are established, with no allowance for the establishment of loss reserves to account for expected future loss events.

Loss and loss adjustment expenses recoverable represent the amounts due from retrocessionaires for unpaid loss and loss adjustment expenses on retrocession agreements. Ceded IBNR recoverable is estimated based on the Company’s actuarial estimates. These estimates are reviewed periodically and adjusted when deemed necessary. The Company may ultimately be unable to recover the loss and loss adjustment expense recoverable amounts due to the retrocessionaires’ inability to pay. The Company regularly evaluates the financial condition of its retrocessionaires and records provisions for uncollectible reinsurance expenses recoverable when recovery is no longer probable.

For natural peril exposed business, loss reserves are generally established based on loss payments and case reserves reported by clients when, and if, received. Estimates for IBNR losses are added to the case reserves as the Company deems appropriate. To establish IBNR loss estimates, the Company uses estimates communicated by ceding companies, industry data and information, knowledge of the business written and management’s judgment.

For all non-natural peril business, initial reserves for each individual contract are determined on the basis of a combination of: (i) the pricing analysis of the expected loss ratio performed prior to the contract being bound; (ii) the underwriter’s detailed knowledge of the cedent, its operations and future business plans; and (iii) the professional judgment and recommendation of the Chief Actuary. In the pricing analysis, the Company utilizes information both from the individual client and from industry data. This information typically includes, but is not limited to, data related to premiums, losses, exposure, business mix, industry performance and associated trends covering as much history as deemed appropriate. The level of detail within the data obtained varies greatly depending on the underlying contract, line of business, client and/or coverage provided. In all cases, the Company requests each client to provide data for each reporting period, which, depending on the contract, could be on a monthly or quarterly basis. The exact data reporting requirements are specified in the terms and conditions of each contract. Where practical, historical reserving data that is received from a client is compared to publicly available financial statements of the client to identify, confirm and monitor the accuracy and completeness of the data.

F-10

Link to Table of Contents

Generally, the Company obtains regular updates of premium and loss related information for the current and historical periods, which are utilized to update the initial expected loss ratio. There may be a lag between (i) claims being reported by the underlying insured to the Company’s cedent and (ii) claims being reported by the Company’s cedent to the Company. This lag may impact the Company’s loss reserve estimates. Client reports have pre-determined due dates (for example, fifteen days after each month end). As a result, the lag depends in part upon the terms of the specific contract. The timing of the reporting requirements is designed so that the Company receives premium and loss information as soon as practicable once the client has closed its books. Accordingly, there should be a short lag in such reporting. Additionally, most of the contracts that have the potential for large single event losses have provisions that such loss notifications are provided to the Company immediately upon the occurrence of an event. Once the updated information is received, the Company uses a variety of standard actuarial methods for its analysis each quarter. Such methods may include the following:	●	Paid Loss Development Method. Ultimate losses are estimated by calculating past paid loss development factors and applying them to exposure periods with further expected paid loss development. The paid loss development method assumes that losses are paid in a consistent pattern. It provides an objective test of reported loss projections because paid losses contain no reserve estimates.
●	Reported Loss Development Method. Ultimate losses are estimated by calculating past reported loss development factors and applying them to exposure periods with further expected reported loss development. Since reported losses include payments and case reserves, changes in both of these amounts are incorporated in this method.
●	Expected Loss Ratio Method. Ultimate losses are estimated by multiplying earned premiums by an expected loss ratio. The expected loss ratio is selected using industry data, historical company data and actuarial professional judgment. This method is typically used for lines of business and contracts where there are no historical losses or where past loss experience is not considered applicable to the current period.
●	Bornhuetter-Ferguson Paid Loss Method. Ultimate losses are estimated by modifying expected loss ratios to the extent that paid losses experienced to date differ from what would have been expected to have been paid based upon the selected paid loss development pattern. This method avoids some of the distortions that could result from a large development factor being applied to a small base of paid losses to calculate ultimate losses.
●	Bornhuetter-Ferguson Reported Loss Method. Ultimate losses are estimated by modifying expected loss ratios to the extent reported losses experienced to date differ from what would have been expected to have been reported based upon the selected reported loss development pattern. This method avoids some of the distortions that could result from a large development factor being applied to a small base of reported losses to calculate ultimate losses.
●	Frequency / Severity Method. Ultimate losses are estimated under this method by multiplying the ultimate number of claims (i.e. the frequency multiplied by the exposure base on which the frequency has been determined), by the estimated ultimate average cost per claim (i.e. the severity). This approach enables trends and patterns in the rates of claims emergence (i.e. reporting) and settlement (i.e. closure), as well as in the average cost of claims, to be analyzed separately.

In addition, the Company may supplement its analysis with other reserving methodologies that are deemed to be relevant to specific contracts.

For each contract, the Company utilizes reserving methodologies that are deemed appropriate to calculate a best, or “point,” estimate of reserves. The decision as to whether to use a single methodology or a combination of multiple methodologies depends upon the segment of the portfolio being analyzed and the judgment of the actuaries. The Company’s reserving methodology does not require a fixed weighting of the various methods used. Certain methods are considered more appropriate than others depending on the type, structure, age, maturity and duration of the expected losses on the contract. For example, the ultimate incurred loss for contracts that are relatively new (and therefore have experienced little paid loss development) may be more appropriately estimated using a Bornhuetter-Ferguson reported loss method than a paid loss development method.

The Company’s gross aggregate reserves are the sum of the point estimate reserves of all portfolio exposures. Generally, IBNR loss reserves are calculated by estimating the ultimate incurred losses at any point in time and subtracting cumulative paid claims and case reserves. Each quarter, the Company’s reserving committee, which is led by the Chief Actuary, meets to assess the adequacy of our loss reserves based on the reserve analysis and recommendations prepared by the Company’s reserving department. The reserving committee reviews, discusses and puts forward a loss reserve recommendation for the Audit Committee’s approval.

Additionally, an independent third-party actuarial firm performs a quarterly reserve review and annually opines on the reasonableness and adequacy of the aggregate loss reserves. The Company provides the third-party actuarial firm with its pricing models, reserving analysis and any other data. Additionally, the actuarial firm may inquire as to the various assumptions and estimates used in the reserving analysis. The actuarial firm independently creates its own reserving models based on industry loss information, augmented by specific client loss information as well as its own independent assumptions and estimates. Based on various reserving methodologies that the actuarial firm considers appropriate, it creates a loss reserve

F-11

Link to Table of Contents

estimate for each segment in the portfolio and recommends an aggregate loss reserve, including IBNR. In the event of material differences between the Company's aggregated booked reserves and the actuarial firm's recommended reserves, the reserving committee and Audit Committee would be notified, with the reserves adjusted as deemed appropriate. To date there have been no material differences resulting from the external actuary’s reviews requiring adjustments to the Company’s booked reserves.

We do not typically experience significant claims processing backlogs, although such backlogs may occur following a major catastrophic event. At December 31, 2019 and 2018, we did not have a significant backlog in our claims processing.

There were no significant changes in the actuarial methodology or assumptions relating to the Company’s loss and loss adjustment expense reserves during the year ended December 31, 2019.

Notes Receivable

Notes receivable represent promissory notes receivable from third parties. These notes are recorded at cost plus accrued interest, if any, net of any valuation allowance. Interest income, change in valuation allowance and realized gains or losses on the sale of notes receivable are included in the caption “Net investment income (loss)” in the Company’s consolidated statements of operations.

The Company regularly reviews all notes receivable individually for impairment and records valuation allowance provisions for uncollectible and non-performing notes. When there is uncertainty as to the collection of interest contractually due, the Company places the note on non-accrual status. For notes receivable placed on non-accrual status, the notes are presented excluding any accrued interest amount. The Company resumes the accrual of interest on a note when none of the principal or interest remains past due, and the Company expects to collect the remaining contractual principal and interest. Interest collected on notes that are placed on non-accrual status is recorded as interest income when collected, provided that the recorded value of the note is deemed to be fully collectible. Where doubt exists as to the collectability of the remaining recorded value of the notes placed on non-accrual status, any payments received are applied to reduce the recorded value of the notes.

The following table provides a roll-forward of the Company’s provision for valuation allowance:

	Year ended December 31
	2019	2018		2017
	( in thousands)
Balance at beginning of period		$	9,012	$	9,012
Net increase (decrease) in provision	5,988	—		—
Balance at end of period		$	9,012	$	9,012

All values are in US Dollars.

During the year ended December 31, 2019, the Company increased the valuation allowance for notes receivable by $6.0 million based on management’s assessment of the counterparties’ credit risk, historical experience, the estimated value of any underlying collateral and other relevant factors.

At December 31, 2019, certain notes receivable that were on non-accrual status, had a carrying value (net of valuation allowance) of $0.0 million (2018: $9.8 million).

At December 31, 2019 and 2018, $0.1 million and $0.2 million, respectively, of accrued interest was included in the caption “Notes receivable” in the Company’s consolidated balance sheets. Management has assessed the carrying values of the notes receivable, net of valuation allowance,at December 31, 2019 and 2018, to be fully collectible.

Deposit Assets and Liabilities

The Company applies deposit accounting to reinsurance contracts that do not transfer sufficient insurance risk to merit reinsurance accounting. Under deposit accounting, an asset or liability is recognized based on the consideration paid or received. The deposit asset or liability balance is subsequently adjusted using the interest method with a corresponding income or expense recorded in the Company’s consolidated statements of operations under the caption “Other income (expense).” The Company’s deposit assets and liabilities are recorded in the Company’s consolidated balance sheets in the caption “Reinsurance balances receivable” and “Reinsurance balances payable,” respectively. At December 31, 2019, deposit assets and deposit liabilities were $5.2 million and $56.9 million, respectively (2018: $11.9 million and $52.9 million, respectively). For the year ended December 31, 2019, 2018 and 2017, the interest income (expense) on deposit accounted contracts was as follows:

F-12

Link to Table of Contents

	Year ended December 31
	2019		2018			2017
	( in thousands)
Deposit interest income			$	1,224		$	205
Deposit interest expense	(543	)	(1,510		)	(555		)
Deposit interest income (expense), net			$	(286	)	$	(350	)

All values are in US Dollars.

Equity Method Accounted Investments

Investee companies that are not consolidated, but over which the Company exercises significant influence, are accounted for under the equity method of accounting. Whether the Company exercises significant influence with respect to an investee depends on an evaluation of several factors including, among others, representation on the investee company’s board of directors and ownership level, which is generally a 20% to 50% interest in the voting securities of the investee company. Under the equity method of accounting, an investee company’s accounts are not reflected within the Company’s consolidated balance sheets and statements of operations; however, the Company’s share of the earnings or losses of the investee company is reflected in the caption ‘‘Net investment income (loss)’’ in the consolidated statements of operations. The Company’s carrying value in an equity method investee company is reflected in the caption ‘‘Other investments’’ in the Company’s consolidated balance sheets.

When the Company’s carrying value in an equity method investee company is reduced to zero, no further losses are recorded in the Company’s consolidated financial statements unless the Company guaranteed the obligations of the investee company or has committed additional funding (see Notes 3 and 4).

Variable Interest Entities

The Company accounts for the investments it makes in certain legal entities in which equity investors do not have (1) sufficient equity at risk for the legal entity to finance its activities without additional subordinated financial support, or (2) as a group, the holders of the equity investment at risk do not have either the power, through voting or similar rights, to direct the activities of the legal entity that most significantly impact the entity’s economic performance, or (3) the obligation to absorb the expected losses of the legal entity or the right to receive expected residual returns of the legal entity. These legal entities are referred to as “variable interest entities” or “VIEs.”

The Company would consolidate the results of any such entity in which it determined that it had a controlling financial interest. The Company would have a “controlling financial interest” in such an entity if the Company had both the power to direct the activities that most significantly affect the VIE’s economic performance and the obligation to absorb the losses of, or right to receive benefits from, the VIE that could be potentially significant to the VIE. On a quarterly basis, the Company reassesses whether it has a controlling financial interest in any such entities.

Financial Instruments

The Company invests in debt instruments and equity securities that are classified as “trading securities” and are carried at fair value.

The Company purchases “other investments” which may include investments in private and unlisted equity securities, limited partnerships and commodities, all of which are carried at fair value.

For securities classified as “trading securities” and “other investments,” any realized and unrealized gains or losses are determined on the basis of the specific identification method (by reference to cost or amortized cost, as appropriate) and included in the caption “Net investment income (loss)” in the Company’s consolidated statements of operations.

Interest income and interest expense are recorded on an accrual basis. Prior to the liquidation of the Joint Venture, dividend income and expense were recorded on the ex-dividend date. “Ex-dividend” indicates that the quoted price of a share of stock excludes the value of a declared dividend. Investors purchasing shares between the declaration and ex-dividend dates are entitled to receive the dividend, whereas investors purchasing shares on or after the ex-dividend date are not entitled to the dividend.

F-13

Link to Table of Contents

Transfer of Financial Assets

The Company accounts for transfers of financial assets as sales when it has surrendered control over the related assets. Whether control has been relinquished requires, among other things, an evaluation of relevant legal considerations and an assessment of the nature and extent of the Company’s continuing involvement with the assets transferred. Gains and losses stemming from transfers reported as sales, if any, are included as realized gains (losses) within the caption “Net investment income (loss)” in the accompanying consolidated statements of operations.

In instances where a transfer of financial assets does not qualify for sale accounting, the transaction is accounted for as a collateralized borrowing. Accordingly, the related assets remain on the Company’s consolidated balance sheets and continue to be reported and accounted for as if the transfer had not occurred (see Notes 3 and 4).

Share-Based Compensation

The Company has established a stock incentive plan for directors, employees and consultants.

The Company recognizes share-based compensation costs on the basis of the fair value at the grant date of the award. The Company measures compensation for restricted shares and restricted stock units (“RSUs”) based on the price of the Company’s common shares at the grant date. For restricted shares and RSUs with both service and performance vesting conditions, the expense is recognized based on management’s estimate of the probability of the performance conditions being achieved based on historical results and expectations of future results. If the performance conditions are expected to be met, the expense is attributed to the period for which the requisite service has been rendered. For restricted shares and RSUs with only service vesting conditions, the expense is recognized on a straight line basis over the vesting period, net of any estimated or expected forfeitures.

The forfeiture rate is estimated based on the Company’s historical actual forfeitures relating to restricted shares and RSUs granted to employees. The forfeiture rate is reviewed annually and adjusted as necessary. No forfeiture rate is used for restricted shares granted to directors which vest over a twelve-month period.

Determining the fair value of share purchase options at the grant date requires significant estimation and judgment. The Company uses the Black-Scholes option pricing model to assist in the calculation of fair value for share purchase options. The model requires estimation of various inputs such as estimated term, forfeiture and dividend rates and expected volatility. In determining the grant date fair value, the Company uses the full ten-year life of the options as the estimated term, and assumes no forfeitures and no dividends paid during the life of the options. The estimate of expected volatility is based on the daily historical trading data of the Company’s Class A ordinary shares from the date that these shares commenced trading (May 24, 2007) to the grant date.

For share purchase options issued under the employee stock incentive plan, the compensation cost is calculated and recognized over the vesting periods on a graded vesting basis (see Note 11).

Convertible Notes

The Company has determined that the senior convertible notes’ cash conversion option represents an embedded derivative, which has therefore been bifurcated from the underlying contract for financial reporting purposes. For the debt component, the Company recorded a liability equivalent to the present value of comparable debt without the conversion features at the time of issuance. The remainder of the proceeds, which represented the embedded derivative, were included in the caption “Additional paid-in capital” in the Company’s consolidated balance sheets.

Costs incurred in issuing the convertible notes consisted primarily of underwriting, legal, accounting and printing fees. The Company allocated the costs associated with the debt and derivative components ratably to the liability and shareholders’ equity balances, respectively. The debt-related portion of these costs has been capitalized and deducted from the principal of senior convertible notes payable in the Company’s consolidated balance sheets. These costs are amortized over the term of the debt and are included in the caption “Interest expense” in the Company’s consolidated statements of operations. The issuance costs allocated to the embedded derivative have been deducted from additional paid-in capital.

Foreign Exchange

The reporting and functional currency of the Company and all its subsidiaries is the U.S. dollar. Transactions in foreign currencies are recorded in U.S. dollars at the exchange rates in effect on the transaction date. Monetary assets and liabilities in foreign currencies at the balance sheet date are converted at the exchange rate in effect at the balance sheet date and exchange

F-14

Link to Table of Contents

gains and losses, if any, are included in the caption “Other income (expense), net” in the Company’s consolidated statements of operations.

Other Assets

Other assets consist primarily of prepaid expenses, fixed assets, right-of-use lease assets, other receivables and deferred tax assets.

Other Liabilities

Other liabilities consist primarily of accruals for legal and other professional fees, employee bonuses and lease liabilities.

Comprehensive Income (Loss)

The Company has no comprehensive income or loss, other than the net income or loss disclosed in the consolidated statements of operations.

Earnings (Loss) Per Share

The Company’s unvested restricted stock awards, which contain non-forfeitable rights to dividends or dividend equivalents, whether paid or unpaid, are considered “participating securities” for the purposes of calculating earnings (loss) per share. Basic earnings per share is calculated on the basis of the weighted average number of common shares and participating securities outstanding during the period. Diluted earnings (or loss) per share includes the dilutive effect of the following:

•	Restricted Stock Units (“RSUs”) issued that would convert to common shares upon vesting;
•	additional potential common shares issuable when stock options are exercised, determined using the treasury stock method; and
---	---
•	those common shares with the potential to be issued by virtue of convertible debt and other such convertible instruments, determined using the treasury stock method.
---	---

Diluted earnings (or loss) per share contemplates a conversion to common shares of all convertible instruments only if they are dilutive in nature with regards to earnings per share. In the event of a net loss, all RSUs, stock options outstanding, convertible debt and participating securities are excluded from the calculation of both basic and diluted loss per share as their inclusion would be anti-dilutive.

The table below presents the shares outstanding for the purposes of the calculation of earnings (loss) per share for the years ended December 31, 2019, 2018 and 2017:		Year ended December 31
	2019	2018	2017
Weighted average shares outstanding - basic	36,079,419	35,951,659	37,002,260
Effect of dilutive employee and director share-based awards	—	—	—
Weighted average shares outstanding - diluted	36,079,419	35,951,659	37,002,260
Anti-dilutive stock options outstanding	875,627	935,627	358,741
Participating securities excluded from calculation of loss per share	936,669	432,457	331,510

Taxation

Under current Cayman Islands law, no corporate entity, including GLRE and Greenlight Re, is obligated to pay taxes in the Cayman Islands on either income or capital gains. The Company has an undertaking from the Governor-in-Cabinet of the Cayman Islands, pursuant to the provisions of the Tax Concessions Law, as amended, that, in the event that the Cayman Islands enacts any legislation that imposes tax on profits, income, gains or appreciations, or any tax in the nature of estate duty or inheritance tax, such tax will not be applicable to GLRE, Greenlight Re nor their respective operations, or to the Class A or Class B ordinary shares or related obligations, before February 1, 2025.

F-15

Link to Table of Contents

Verdant is incorporated in Delaware and therefore is subject to taxes in accordance with the U.S. federal rates and regulations prescribed by the U.S. Internal Revenue Service (“IRS”). Verdant’s taxable income is generally expected to be taxed at a marginal rate of 21% (2018: 21%). Verdant’s tax years 2014 and beyond remain open and subject to examination by the IRS.

GRIL is incorporated in Ireland and therefore is subject to the Irish corporation tax rate of 12.5% on its trading income, and 25% on its non-trading income.

The Company records a valuation allowance to the extent that the Company considers it more likely than not that all or a portion of the deferred tax asset will not be realized in the future.

Segment Information

The Company manages its business on the basis of one operating segment, Property and Casualty Reinsurance.

Recent Accounting Pronouncements

Recently Issued Accounting Standards Adopted

In February 2016, the FASB issued ASU 2016-02, “Leases (Topic 842)”. Under the new guidance, lessees are required to recognize the following for all leases (with the exception of short-term leases) at the commencement date: a lease liability, which is a lessee’s obligation to make lease payments arising from a lease, measured on a discounted basis; and a right-of-use asset, which is an asset that represents the lessee’s right to use, or control the use of, a specified asset for the lease term. Leases (Topic 842) is effective for public companies for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The Company adopted Leases (Topic 842) during the first quarter of 2019 using the cumulative-effect adjustment transition method, which applies the provisions of the standard at the effective date without adjusting the comparative periods presented. The Company has adopted the following practical expedients:

•	Carry forward of historical lease classifications and current accounting treatment for existing land easements;
•	Short-term lease accounting policy election allowing lessees to not recognize right-of-use assets and liabilities for leases with a term of 12 months or less; and
---	---	•	Hindsight practical expedient for remeasuring the lease terms on the basis of information obtained between entering into the lease and adopting Leases (Topic 842).
---	---

Adoption of Leases (Topic 842) resulted in the recognition of operating lease right-of-use asset and corresponding lease liability of $0.3 million which were included in the Company’s condensed consolidated balance sheets under the captions “Other Assets” and “Other Liabilities,” respectively, as of December 31, 2019.

Recently Issued Accounting Standards Not Yet Adopted

In June 2016, the FASB issued ASU No. 2016-13, Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”). As compared to current GAAP, which delays the recognition of credit losses until it is probable a loss has been incurred, ASU 2016-13 broadens the information that must be considered in the development of an expected credit loss estimate. Under ASU 2016-13, past events, current conditions, and reasonable and supportable forecasts are all considered in the development of this estimate. ASU 2016-13 is effective for public business entities that are SEC filers for annual and interim periods beginning after December 15, 2019.

The financial assets included in the captions “Reinsurance balances receivable,” “Notes Receivable,” and “Loss and loss adjustment expenses recoverable” in the Company’s consolidated balance sheets are carried at amortized cost and are therefore affected by ASU 2016-13. The Company is currently finalizing its assessment of the impact of this guidance as it relates to these balances; however, any consequent adjustments to these balances are not expected to have a material impact on the Company’s consolidated statements of operations and financial position.

INVESTMENT IN RELATED PARTY INVESTMENT FUND

Effective September 1, 2018, Greenlight Re and GRIL entered into the SILP LPA with DME II. In accordance with the SILP LPA, DME II serves as the general partner of SILP. On September 1, 2018, SILP entered into a SILP investment advisory

F-16

Link to Table of Contents

agreement (“IAA”) with DME Advisors pursuant to which DME Advisors is the investment manager for SILP. In addition, on September 1, 2018, Greenlight Re and GRIL, together the “GLRE Limited Partners,” and SILP executed a Participation Agreement pursuant to which the GLRE Limited Partners transferred a participation interest in the assets that were subject to the Joint Venture (except for certain assets that were mutually agreed and excluded from participating) to SILP (collectively referred to as the “LP Transaction.”) SILP issued limited partner interests to the GLRE Limited Partners proportionate to and based on the net asset value transferred by each such entity effective September 1, 2018. The Joint Venture was terminated on January 2, 2019, the date by which all assets were transferred to SILP in accordance with the SILP LPA.

The Company has concluded that SILP qualifies as a variable interest entity (“VIE”) under U.S. GAAP. In assessing its interest in SILP, the Company noted the following:

•

DME II serves as SILP’s general partner and has the power of appointing the investment manager. The Company does not have the power to appoint, change or replace the investment manager or the general partner except “for cause.” Neither of the GLRE Limited Partners can participate in the investment decisions of SILP as long as SILP adheres to the investment guidelines provided within the SILP LPA. For these reasons, the GLRE Limited Partners are not considered to have substantive participating rights or kick-out rights.

•

DME II holds an interest in excess of 10% of SILP’s net assets which the Company considers to represent an obligation to absorb losses and a right to receive benefits of SILP that are significant to SILP.

---

Consequently, the Company has concluded that DME II’s interests, and not the Company’s, meet both the “power” and “benefits” criteria associated with VIE accounting guidance, and therefore DME II is SILP’s primary beneficiary. The Company’s investment in SILP is presented in the Company’s consolidated balance sheets in the caption “Investment in related party investment fund.”

The Company accounted for the transfer of the investment assets to SILP as a sale. The underlying investment liabilities were extinguished from the Company’s consolidated balance sheet as they were either settled, novated or legally transferred to SILP as part of the LP Transaction. There were no net gains or losses resulting from the transfer of net assets, and there was no cash paid or received by the Company as part of the LP Transaction.

At December 31, 2018, certain assets that were subject to the Participation Agreement for which the GLRE Limited Partners received an interest in SILP had not transferred legal title to SILP. The Company accounted for those assets as collateralized borrowing and recorded a liability in the caption “Due to related party investment fund.” These assets were transferred to SILP during the first quarter of 2019.

During the year ended December 31, 2019, SILP’s investment portfolio was de-risked in order to reduce the Company’s investment volatility in the near-term. As a result, a large proportion of the Company’s investment assets in SILP was held in cash and short-term treasuries as of December 31, 2019.

The Company’s maximum exposure to loss relating to SILP is limited to the net asset value of the GLRE Limited Partners’ investment in SILP. As of December 31, 2019, the net asset value of the GLRE Limited Partners’ investment in SILP was $240.1 million (2018: $235.6 million), representing 81.0% (2018: 84.9%) of SILP’s total net assets. The remaining 19.0% (2018: 15.1%) of SILP’s total net assets was held by DME II. The investment in SILP is recorded at the GLRE Limited Partners’ share of the net asset value of SILP as reported by SILP’s third-party administrator. The GLRE Limited Partners can redeem their assets from SILP for operational purposes by providing three business days’ notice to DME II. As of December 31, 2019, the majority of SILP’s long investments are composed of cash, short-term U.S. treasuries and publicly-traded equity securities, which can be readily liquidated to meet any GLRE Limited Partner’s redemption requests. The Company’s share of the change in the net asset value of SILP for the year ended December 31, 2019 and the period from September 1, 2018 (commencement of operations) to December 31, 2018 was $46.1 million and $(60.6) million, respectively, and shown in the caption “Income (loss) from investment in related party investment fund” in the Company’s consolidated statements of operations.

During the first quarter of 2019, the Company transferred the rights to $36.7 million of remaining net investments from Greenlight Re and GRIL’s Joint Venture investment accounts to SILP in exchange for limited partnership interests of the same amount, resulting in no net gain or loss.

As of December 31, 2019, the Company’s investments in SILP was in excess of 10% of the Company’s total shareholders’ equity, with fair value of $240.1 million (2018: $235.6 million), representing 50.3% (2018: 49.3%), of total shareholders’ equity.

F-17

Link to Table of Contents

The Company has determined that for its fiscal year ended December 31, 2019, the Company’s investment in SILP met at least one of the conditions of a significant subsidiary under SEC’s Regulation S-X, Rule 3-09. Accordingly, the audited financial statements for SILP have been attached as an exhibit (Exhibit 99.1) to this Form 10-K. The summarized financial statements of SILP are presented below.

Summarized Statement of Assets and Liabilities of Solasglas Investments, LP

	December 31, 2019		December 31, 2018
	( in thousands)
Assets
Investments, at fair value			$	401,318
Derivative contracts, at fair value	6,324		63,143
Due from brokers	68,060		77,821
Cash and cash equivalents	111,046		13,200
Interest and dividends receivable	47		2,358
Total assets	348,405		557,840
Liabilities and partners’ capital
Liabilities
Investments sold, not yet purchased, at fair value	(47,834	)	(198,728		)
Notes Payable	—		(30,000		)
Derivative contracts, at fair value	(2,054	)	(26,344		)
Due to brokers	(1,180	)	(23,951		)
Interest and dividends payable	(828	)	(1,238		)
Other liabilities	(101	)	(169		)
Total liabilities	(51,997	)	(280,430		)
Net Assets			$	277,410
GLRE Limited Partners’ share of Net Assets			$	235,612

All values are in US Dollars.

F-18

Link to Table of Contents

Summarized Statement of Operations of Solasglas Investments, LP

	Year ended December 31, 2019		From September 1, 2018 (commencement of operations) to December 31, 2018
	( in thousands)
Investment income
Dividend income (net of withholding taxes)			$	2,160
Interest income	3,884		1,868
Total Investment income	7,063		4,028
Expenses
Management fee	(4,893	)	(3,100		)
Interest	(2,408	)	(2,627		)
Dividends	(1,670	)	(1,608		)
Professional fees and other	(1,141	)	(483		)
Total expenses	(10,112	)	(7,818		)
Net investment income (loss)	(3,049	)	(3,790		)
Realized and change in unrealized gains (losses)
Net realized gain (loss)	34,539		(80,996		)
Net change in unrealized appreciation (depreciation)	28,515		14,789
Net gain (loss) on investment transactions	63,054		(66,207		)
Net income (loss)			$	(69,997	)
GLRE Limited Partners’ share of net income (loss) (1)			$	(60,573	)

All values are in US Dollars.

^1^Net of management fees of $4.9 million and $3.1 million for year ended December 31, 2019 and the period from September 1, 2018 (inception) to December 31, 2018 respectively, and net of accrued performance allocation of $5.0 million and nil for the year ended December 31, 2019 and the period from inception to December 31, 2018, respectively. See Note 14 for further details.

4. FINANCIAL INSTRUMENTS

Prior to the termination of the Joint Venture, the Company, via the Joint Venture, purchased and sold various financial instruments, including listed and unlisted equities, corporate and sovereign debt, commodities, futures, put and call options, currency forwards, other derivatives and similar instruments sold, not yet purchased. These instruments were transferred to SILP as part of the LP Transaction. See Note 3 for further details.

Purchases and sales of investments are disclosed in the Company’s consolidated statements of cash flows. The following table summarizes the change in unrealized gains and losses and the realized gains and losses on financial instruments included in the caption “Net investment income (loss)” in the Company’s consolidated statements of operations for the years ended December 31, 2019, 2018 and 2017:

	Year ended December 31
	2019		2018			2017
	( in thousands)
Gross realized gains			$	303,674		$	267,904
Gross realized losses	(14,150	)	(540,561		)	(180,286		)
Net realized gains (losses)		)	$	(236,887	)	$	87,618
Change in unrealized gains and losses			$	(32,597	)	$	(41,444	)

All values are in US Dollars.

F-19

Link to Table of Contents

Investments

Equity securities, trading

At December 31, 2019, the Company held no equity securities.

At December 31, 2018, the following long positions were included in the caption “Equity securities, trading”:

	Cost	Unrealized<br><br>gains		Unrealized<br><br>losses			Fair<br><br>value
	( in thousands)
Equities – listed		$	1,015	$	(14,628	)	$	36,908
Total equity securities		$	1,015	$	(14,628	)	$	36,908

All values are in US Dollars.

Other Investments

“Other investments” include private securities and investments accounted for under the equity method which are not significant to present separately on the balance sheet.

At December 31, 2019, the following securities were included in the caption “Other investments”:

	Cost	Unrealized<br>gains		Unrealized<br>losses			Fair value / carrying value
	( in thousands)
Private investments and unlisted equities		$	265	$	(4	)	$	10,681
Investment accounted for under the equity method	—	—		—			5,703
Total other investments							$	16,384

All values are in US Dollars.

At December 31, 2018, the following securities were included in the caption “Other investments”:

	Cost	Unrealized<br>gains		Unrealized<br>losses			Fair value / carrying value
	( in thousands)
Private investments and unlisted equity funds		$	—	$	(267	)	$	6,405
Investment accounted for under the equity method	—	—		—			5,003
Total other investments							$	11,408

All values are in US Dollars.

Private and unlisted equity funds include private equity securities that did not have readily determinable fair values and the Company applied the measurement alternative under ASU 2016-01 and ASU 2018-03. The carrying values of the private equity securities are determined based on the original cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. At December 31, 2019 the carrying value of the private equity securities without readily determinable fair value was $10.7 million (December 31, 2018: $6.4 million). The carrying value of these private equity securities included an upward adjustment of $0.2 million based on an observable price change during the year ended December 31, 2019. There were no other significant upward or downward adjustments to the carrying values of the private equity securities for the year ended December 31, 2019.

At December 31, 2019, the Company held a 58% interest in AccuRisk Holdings LLC (“AccuRisk”) and had provided a $6.0 million credit facility to AccuRisk. The Company’s involvement in AccuRisk includes providing capital and funding for AccuRisk’s expansion plans and providing reinsurance to business produced by AccuRisk. The Company has determined that AccuRisk is a VIE, of which the Company is not the primary beneficiary. The Company has accounted for its investment in AccuRisk under the equity method and included it in the caption “Other Investments” in the Company’s consolidated balance

F-20

Link to Table of Contents

sheets. The carrying value of AccuRisk is adjusted based on the Company’s share of ownership, including its share of the income (loss) reported in quarterly management accounts by AccuRisk. The Company’s maximum exposure to loss relating to AccuRisk is limited to the carrying amount of its investment in AccuRisk plus any loans outstanding to AccuRisk (see Note 15). For the year ended December 31, 2019, the Company’s share of AccuRisk’s net income (loss) was $0.7 million (2018: $(0.2) million) which was included in the caption “Net investment income (loss)” in the Company’s consolidated statements of operations.

Fair Value Hierarchy

The fair value of a financial instrument is the amount that would be received in an asset sale or paid to transfer a liability in an orderly transaction between unaffiliated market participants. Assets and liabilities measured at fair value are categorized based on whether the inputs are observable in the market and the degree that the inputs are observable. The categorization of financial instruments within the valuation hierarchy is based on the lowest level of input that is significant to the fair value measurement. The hierarchy is prioritized into three levels (with Level 3 being the lowest) defined as follows:

•	Level 1: Quoted prices in active markets for identical assets or liabilities that the entity has the ability to access.
•	Level 2: Observable inputs other than prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated with observable market data.
---	---
•	Level 3: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets and liabilities. This includes certain pricing models, discounted cash flow methodologies, and similar techniques that use significant unobservable inputs.
---	---

As of December 31, 2019, the Company did not carry any investments at fair value that were assigned a Level within the fair value hierarchy.

The following table presents the Company’s investments, categorized by the level of the fair value hierarchy as of December 31, 2018:

	Fair value measurements as of December 31, 2018
Description	Quoted prices inactive markets(Level 1)	Significant other<br>observable<br>inputs<br>(Level 2)		Significant<br>unobservable<br>inputs<br>(Level 3)		Total
Assets:	( in thousands)
Listed equity securities		$	—	$	—	$	36,908
Private and unlisted equity securities	—	—		664		664
		$	—	$	664	$	37,572
Investment in related party investment fund measured at net asset value (1) (2)						235,612
Equities without readily determinable fair values for which measurement alternative is applied						5,741
Investment accounted for under the equity method						5,003
Total investments						$	283,928

All values are in US Dollars.

^(1)^ Investments measured at fair value using the net asset value practical expedient have not been classified in the fair value hierarchy. The fair value amounts are presented in the above table to facilitate reconciliation to the consolidated balance sheets.

^(2)^^^See Note 3 “Investment in related party investment fund”.

The Company’s ”Investment in related party investment fund” is measured at fair value using the net asset value practical expedient, and is therefore not classified within the fair value hierarchy (See Note 3 for further details).

The carrying value of investments accounted for under the equity method is based on the Company's share of the investees’ net assets.

F-21

Link to Table of Contents

The following table presents the reconciliation of the balances for all investments measured at fair value using significant unobservable inputs (Level 3) for the year ended December 31, 2019:

	Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
	Year ended December 31, 2019
	Assets
	Debt instruments	Private and unlisted equity securities			Total
	( in thousands)
Beginning balance		$	664		$	664
Sales	—	(664		)	(664		)
Total realized and unrealized gains (losses) and amortization included in earnings, net	—	—			—
Transfers out of Level 3	—	—			—
Ending balance		$	—		$	—

All values are in US Dollars.

During the year ended December 31, 2019, the sales of private and unlisted equities measured at fair value using Level 3 inputs were the result of the LP Transaction. There were no other transfers between Level 1, Level 2 or Level 3 during the year ended December 31, 2019.

The following table presents the reconciliation of the balances for all investments measured at fair value using significant unobservable inputs (Level 3) for the year ended December 31, 2018:

	Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
	Year ended December 31, 2018
	Assets
	Debt instruments		Private and unlisted equity securities			Total
	( in thousands)
Beginning balance			$	6,108		$	6,988
Sales		)	$	(1,890	)	$	(2,806	)
Total realized and unrealized gains (losses) and amortization included in earnings, net			$	(304	)	$	(268	)
Transfers out of Level 3			$	(3,250	)	$	(3,250	)
Ending balance			$	664		$	664

All values are in US Dollars.

During the year ended December 31, 2018, the sales of debt instruments and private and unlisted equities measured at fair value using Level 3 inputs were the result of the LP Transaction. For the year ended December 31, 2018 the private and unlisted equity securities without readily determinable fair values, for which measurement alternative is applied, were transferred out of Level 3 fair value hierarchy. There were no other transfers between Level 1, Level 2 or Level 3 during the year ended December 31, 2018.

Financial Instruments Disclosed, But Not Carried, at Fair Value

The captions “Notes receivable (net of valuation allowance)” and “Convertible senior notes payable” are composed of financial instruments that are carried at amortized cost. The carry values of these financial instruments approximate their fair values, which the Company has determined on the basis of Level 2 inputs for its convertible senior notes payable, and Level 3 inputs for its notes receivable.

F-22

Link to Table of Contents

5. CASH AND CASH EQUIVALENTS

The Company’s cash and cash equivalents as of December 31, 2019 and 2018 were composed of the following:

	December 31, 2019	December 31, 2018
	( in thousands)
Cash at banks		$	7,295
Cash held with brokers	—	10,920
Total cash and cash equivalents		$	18,215

All values are in US Dollars.

Due to the short term nature of cash and cash equivalents, the above noted carrying values approximate their fair value. Cash at banks include cash held at non-U.S. financial institutions which are not insured by the FDIC or any other deposit insurance programs.

6. RESTRICTED CASH AND CASH EQUIVALENTS

Restricted cash and cash equivalents include amounts held by the Company but pledged as security to provide collateral required by the cedents in the form of trust accounts and letters of credit (see Note 15). As of December 31, 2019 and 2018, the restricted cash and cash equivalents were composed of the following:

	December 31, 2019	December 31, 2018
	( in thousands)
Cash held as collateral in trust accounts		$	463,361
Cash collateral relating to letters of credit issued	213,407	221,655
Total restricted cash and cash equivalents		$	685,016

All values are in US Dollars.

7. LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES

There were no significant changes in the actuarial methodology or assumptions relating to the Company’s loss and loss adjustment expense reserves for the year ended December 31, 2019.

At December 31, 2019 and 2018, loss and loss adjustment expense reserves were composed of the following:

	2019	2018
	( in thousands)
Case reserves		$	211,910
IBNR	252,754	270,752
Total		$	482,662

All values are in US Dollars.

F-23

Link to Table of Contents

A summary of changes in outstanding loss and loss adjustment expense reserves for all lines of business consolidated

for the years ended December 31, 2019, 2018 and 2017 is as follows:

Consolidated	2019		2018			2017
	( in thousands)
Gross balance at January 1			$	464,380		$	306,641
Less: Losses recoverable	(43,705	)	(29,459		)	(2,704		)
Net balance at January 1	438,957		434,921			303,937
Incurred losses related to:
Current year	357,237		363,871			466,247
Prior years	31,250		2			36,157
Total incurred	388,487		363,873			502,404
Paid losses related to:
Current year	(167,508	)	(160,975		)	(220,298		)
Prior years	(217,998	)	(197,097		)	(154,183		)
Total paid	(385,506	)	(358,072		)	(374,481		)
Foreign currency revaluation	1,119		(1,765		)	3,061
Net balance at December 31	443,057		438,957			434,921
Add: Losses recoverable	27,531		43,705			29,459
Gross balance at December 31			$	482,662		$	464,380

All values are in US Dollars.

The changes in the outstanding loss and loss adjustment expense reserves for health claims for the years ended December 31, 2019, 2018 and 2017 are as follows:

Health	2019		2018			2017
	( in thousands)
Gross balance at January 1			$	22,181		$	18,993
Less: Losses recoverable	—		—			—
Net balance at January 1	24,502		22,181			18,993
Incurred losses related to:
Current year	33,736		56,868			44,539
Prior years	3,569		1,508			3,739
Total incurred	37,305		58,376			48,278
Paid losses related to:
Current year	(17,410	)	(34,696		)	(23,814		)
Prior years	(26,334	)	(21,359		)	(21,276		)
Total paid	(43,744	)	(56,055		)	(45,090		)
Foreign currency revaluation	—		—			—
Net balance at December 31	18,063		24,502			22,181
Add: Losses recoverable	—		—			—
Gross balance at December 31			$	24,502		$	22,181

All values are in US Dollars.

Loss development

Year ended December 31, 2019

During the year ended December 31, 2019, the Company experienced $31.3 million in net adverse development on prior year loss and LAE reserves. This net adverse development resulted primarily from the following:

F-24

Link to Table of Contents

Adverse developments:

•	$39.8 million of adverse loss development on non-standard automobile contracts. These unanticipated automobile losses were the result of adverse rulings that affected a significant number of loss events that occurred in Florida between 2015 and early 2018, including many claims that had previously been considered closed; and
•	$3.6 million of adverse loss development on specialty health contracts arising from an unexpectedly high frequency of medical claims reported.
---	---

Favorable developments:

•	$13.5 million of favorable development on prior year property and multi-line contracts primarily resulting from lower than anticipated losses relating to California wildfires.

The remaining net favorable development on prior year loss and LAE reserves recognized in 2019 related to several smaller adjustments made across various lines of business.

Year ended December 31, 2018

During the year ended December 31, 2018, the Company experienced a modest $2.2 thousand in net adverse development on prior year loss and LAE reserves. This net adverse development resulted primarily from the following:

Adverse developments:

•	$11.9 million of adverse loss development on non-standard automobile contracts stemming from industry-wide issues affecting motor liability claims in Florida over accident years 2015 to 2017;
•	$3.8 million of adverse loss development on solicitors professional indemnity contracts resulting primarily from several large claims being reported on prior accident years;
---	---
•	$2.0 million of adverse loss development on general liability contracts, spread over treaty years 2012-2017, resulting from deteriorations in claims experience; and
---	---
•	$1.8 million of adverse loss development on surety business, net of retrocession recoveries, due to deterioration on several previously reported claims for one contract.
---	---

Favorable developments:

•	$7.5 million of favorable prior period experience on property contracts stemming primarily from accident years 2015 and 2016 where claims experience has been better than expected;
•	$5.9 million of favorable loss development, net of retrocession recoveries, relating to 2017 hurricanes as a result of claims experience being better than initially estimated. The net financial impact of the favorable loss development was partially offset by $1.6 million of return premiums relating to reinstatement premiums previously recorded; and
---	---
•	$4.1 million of favorable loss development on prior period mortgage insurance contracts resulting from ongoing favorable claims experience across all prior accident years.
---	---

The remaining net favorable development on prior year loss and LAE reserves recognized in 2018 related to several smaller adjustments made across various lines of business.

Year ended December 31, 2017

During the year ended December 31, 2017, the Company experienced $36.2 million in net adverse development on prior year loss and LAE reserves. This net adverse development resulted primarily from the following:

•	$10.7 million of adverse loss development associated with various classes of professional liability exposure, driven by additional reporting on individual claims, as well as the Company’s assessment of industry-wide loss ratio performance;

F-25

Link to Table of Contents

•	$4.3 million of adverse loss development associated with motor contracts based on re-projection of ultimate losses using client reporting patterns;
•	$4.1 million of adverse loss development relating to Florida homeowners’ insurance contracts, largely driven by “assignment of benefits” issues whereby homeowners assign their rights for filing and settling claims to attorneys and public adjusters;
---	---
•	$3.7 million of adverse loss development associated with specialty health contracts arising from frequency of medical claims reported; and
---	---
•	$2.2 million of adverse loss development due to large claims reported on a surety contract.
---	---

The remaining net adverse development on prior year loss and LAE reserves recognized in 2017 related to several smaller adjustments made across various lines of business.

Disclosures about Short Duration Contracts

The Company manages its business on the basis of one operating segment, Property & Casualty Reinsurance, and categorizes its business as Property, Casualty and Other. The Company’s loss development tables presented below have been disaggregated by lines of business for the years ended from December 31, 2010 to 2019.

For purposes of the loss development tables, the property business has been further disaggregated into "Property" and "Motor - Physical Damage". The casualty category has been disaggregated into "General Liability", "Motor Liability", "Professional Liability" and "Workers' Compensation". In addition, the incurred and paid claims relating to accident and health business have been presented separately as "Health". Other specialty business including financial, aviation, energy and marine, which are individually insignificant to our overall business, have been grouped together as "Other". Contracts that cover more than one line of business are grouped as "Multi-line".

For each of the categories, the following tables present the incurred and paid claims development as of December 31, 2019, net of retrocession, as well as the total of incurred but not reported liabilities plus expected development on reported claims included within the net incurred claims amount. Health claims have been disaggregated and presented separately.

The information in the tables below about incurred and paid claims development for the years ended December 31, 2010 to 2018, is presented as unaudited supplementary information.

F-26

Link to Table of Contents

Health
	Incurred claims and allocated claim adjustment expenses, net of reinsurance																			December 31, 2019
	For the years ended December 31,																			Total IBNR plus expected development on reported claims
Accident year	2010	2011		2012		2013		2014		2015		2016		2017		2018		2019
	(Unaudited - Supplementary Information)
	( in thousands)
2010		$	35,924	$	36,224	$	36,159	$	36,159	$	36,145	$	36,145	$	36,145	$	36,145	$	36,145	$	—
2011		36,140		36,212		35,821		35,800		35,595		35,595		35,595		35,566		35,566		—
2012				24,712		23,088		22,780		22,681		22,671		22,671		22,658		22,658		—
2013						30,544		33,841		34,203		33,960		33,945		33,945		33,944		—
2014								32,875		30,191		29,514		29,072		29,031		28,970		—
2015										34,097		33,530		34,116		33,894		33,885		9
2016												37,747		40,889		41,255		41,355		193
2017														45,007		46,455		46,687		72
2018																56,868		60,176		1,463
2019																		33,736		16,326
																Total		$	373,122	18,063

All values are in US Dollars.

Health
	Cumulative paid claims and allocated claim adjustment expenses, net of reinsurance
	For the years ended December 31,
Accident year	2010	2011		2012		2013		2014		2015		2016		2017		2018		2019
	(Unaudited - Supplementary Information)
	( in thousands)
2010		$	35,795	$	36,224	$	36,159	$	36,159	$	36,145	$	36,145	$	36,145	$	36,145	$	36,145
2011		26,979		35,542		35,814		35,800		35,595		35,595		35,595		35,566		35,566
2012				14,896		22,691		22,780		22,679		22,671		22,671		22,658		22,658
2013						21,459		33,841		34,024		33,957		33,944		33,944		33,944
2014								19,056		28,515		29,117		29,038		29,032		28,970
2015										14,529		31,802		34,044		33,894		33,876
2016												21,881		39,988		41,255		41,162
2017														23,834		44,125		46,615
2018																34,696		58,713
2019																		17,410
																Total		355,059
						All outstanding liabilities before 2010, net of reinsurance												—
		Liabilities for claims and claims adjustment expenses, net of reinsurance (Health)																$	18,063

All values are in US Dollars.

F-27

Link to Table of Contents

Multiline
	Incurred claims and allocated claim adjustment expenses, net of reinsurance																			December 31, 2019
	For the years ended December 31,																			Total IBNR plus expected development on reported claims
Accident year	2010	2011		2012		2013		2014		2015		2016		2017		2018		2019
	(Unaudited - Supplementary Information)
	( in thousands)
2010		$	—	$	—	$	—	$	—	$	—	$	—	$	—	$	—	$	—	$	—
2011		—		—		—		—		—		—		—		—		—		—
2012				—		—		—		—		—		—		—		—		—
2013						—		—		—		—		—		—		—		—
2014								2,390		2,390		2,390		2,609		2,625		2,586		1,173
2015										27,956		28,103		30,536		32,038		30,941		11,885
2016												55,758		60,042		60,757		59,805		26,803
2017														81,836		79,466		83,232		43,596
2018																58,832		50,944		30,215
2019																		46,131		35,096
																Total		$	273,639	$	148,768

All values are in US Dollars.

Multiline
	Cumulative paid claims and allocated claim adjustment expenses, net of reinsurance
	For the years ended December 31,
Accident year	2010	2011		2012		2013		2014		2015		2016		2017		2018		2019
	(Unaudited - Supplementary Information)
	( in thousands)
2010		$	—	$	—	$	—	$	—	$	—	$	—	$	—	$	—	$	—
2011		—		—		—		—		—		—		—		—		—
2012				—		—		—		—		—		—		—		—
2013						—		—		—		—		—		—		—
2014								—		—		145		566		1,092		1,413
2015										30		2,828		9,990		16,107		19,056
2016												5,859		16,577		27,108		33,002
2017														9,562		27,363		39,636
2018																8,134		20,729
2019																		11,035
																Total		124,871
						All outstanding liabilities before 2010, net of reinsurance												—
		Liabilities for claims and claims adjustment expenses, net of reinsurance (Multiline)																$	148,768

All values are in US Dollars.

F-28

Link to Table of Contents

General Liability
	Incurred claims and allocated claim adjustment expenses, net of reinsurance																			December 31, 2019
	For the years ended December 31,																			Total IBNR plus expected development on reported claims
Accident year	2010	2011		2012		2013		2014		2015		2016		2017		2018		2019
	(Unaudited - Supplementary Information)
	( in thousands)
2010		$	14,327	$	17,484	$	19,649	$	21,664	$	25,946	$	28,251	$	28,251	$	28,251	$	28,251	$	—
2011		20,925		30,693		40,756		44,897		61,446		77,105		77,105		77,105		77,105		—
2012				12,626		18,133		16,921		29,554		31,145		31,161		31,274		30,902		—
2013						3,018		2,689		4,666		4,511		4,510		4,916		4,770		—
2014								1,238		1,229		1,174		1,033		1,355		1,000		238
2015										1,699		1,690		1,756		1,979		2,152		1,227
2016												6,203		6,519		7,124		7,867		3,197
2017														5,431		6,525		7,379		4,556
2018																2,901		3,438		2,152
2019																		1,002		976
																Total		$	163,866	$	12,346

All values are in US Dollars.

General Liability
	Cumulative paid claims and allocated claim adjustment expenses, net of reinsurance
	For the years ended December 31,
Accident year	2010	2011		2012		2013		2014		2015		2016		2017		2018		2019
	(Unaudited - Supplementary Information)
	( in thousands)
2010		$	5,096	$	9,356	$	14,051	$	17,471	$	19,228	$	28,251	$	28,251	$	28,251	$	28,251
2011		2,873		11,751		20,030		25,018		32,954		77,105		77,105		77,105		77,105
2012				1,750		9,926		13,142		15,836		30,667		30,687		30,891		30,902
2013						1,371		1,917		2,298		4,191		4,274		4,652		4,770
2014								18		146		413		548		492		762
2015										69		293		532		547		925
2016												122		1,589		3,277		4,670
2017														136		1,412		2,823
2018																165		1,286
2019																		26
																Total		151,520
						All outstanding liabilities before 2010, net of reinsurance												3
	Liabilities for claims and claims adjustment expenses, net of reinsurance (General Liability)																	$	12,349

All values are in US Dollars.

F-29

Link to Table of Contents

Motor Casualty
	Incurred claims and allocated claim adjustment expenses, net of reinsurance																			December 31, 2019
	For the years ended December 31,																			Total IBNR plus expected development on reported claims
Accident year	2010	2011		2012		2013		2014		2015		2016		2017		2018		2019
	(Unaudited - Supplementary Information)
	( in thousands)
2010		$	74,260	$	86,881	$	83,496	$	84,742	$	88,377	$	88,022	$	88,008	$	88,012	$	88,034	$	—
2011		53,035		57,498		57,342		62,921		70,880		70,435		70,495		70,495		70,478		—
2012				132,284		131,196		131,896		131,202		131,305		131,302		131,302		131,302		—
2013						182,833		179,930		174,744		174,782		174,848		174,925		174,931		—
2014								93,718		92,844		94,688		94,385		94,147		94,192		—
2015										128,199		130,410		129,991		132,853		134,951		1,278
2016												166,389		169,294		174,037		179,801		1,001
2017														187,109		188,754		195,258		7,033
2018																150,700		170,016		26,749
2019																		168,154		69,111
																Total		$	1,407,117	$	105,172

All values are in US Dollars.

F-30

Link to Table of Contents

Motor Casualty
	Cumulative paid claims and allocated claim adjustment expenses, net of reinsurance
	For the years ended December 31,
Accident year	2010	2011		2012		2013		2014		2015		2016		2017		2018		2019
	(Unaudited - Supplementary Information)
	( in thousands)
2010		$	44,889	$	60,630	$	70,356	$	79,089	$	82,266	$	88,008	$	88,008	$	88,012	$	88,034
2011		19,082		36,462		49,569		58,244		65,018		70,433		70,433		70,433		70,478
2012				58,585		118,142		126,622		128,913		131,302		131,302		131,302		131,302
2013						86,558		159,200		171,855		174,658		174,848		174,925		174,931
2014								49,994		86,297		89,687		94,385		94,147		94,192
2015										81,093		125,645		129,174		129,571		133,673
2016												97,325		157,948		170,658		178,800
2017														115,204		170,157		188,225
2018																83,652		143,267
2019																		99,043
																Total		1,301,945
						All outstanding liabilities before 2010, net of reinsurance												—
	Liabilities for claims and claims adjustment expenses, net of reinsurance (Motor Casualty)																	$	105,172

All values are in US Dollars.

Motor Property
	Incurred claims and allocated claim adjustment expenses, net of reinsurance																			December 31, 2019
	For the years ended December 31,																			Total IBNR plus expected development on reported claims
Accident year	2010	2011		2012		2013		2014		2015		2016		2017		2018		2019
	(Unaudited - Supplementary Information)
	( in thousands)
2010		$	656	$	671	$	684	$	662	$	662	$	667	$	667	$	667	$	667	$	—
2011		3,276		3,271		3,343		3,285		3,285		3,306		3,306		3,306		3,303		—
2012				36,985		36,129		36,008		35,998		35,922		35,922		35,922		35,922		—
2013						46,189		45,629		44,728		44,656		44,695		44,719		44,478		—
2014								18,870		18,797		19,056		19,000		19,006		19,021		—
2015										22,035		22,516		22,505		23,263		23,939		100
2016												27,853		28,279		29,090		29,051		200
2017														39,986		39,621		40,394		683
2018																42,336		47,209		7,091
2019																		43,103		18,000
																Total		$	287,087	$	26,074

All values are in US Dollars.

F-31

Link to Table of Contents

Motor Property
	Cumulative paid claims and allocated claim adjustment expenses, net of reinsurance
	For the years ended December 31,
Accident year	2010	2011		2012		2013		2014		2015		2016		2017		2018		2019
	(Unaudited - Supplementary Information)
	( in thousands)
2010		$	620	$	620	$	620	$	620	$	644	$	667	$	667	$	667	$	667
2011		1,418		2,944		3,305		3,285		3,285		3,303		3,303		3,303		3,303
2012				16,902		34,588		35,854		35,903		35,922		35,922		35,922		35,922
2013						21,112		41,066		44,363		44,431		44,476		44,476		44,478
2014								10,305		17,621		18,420		19,000		19,006		19,021
2015										13,859		22,013		22,505		22,595		23,839
2016												16,725		27,023		28,609		28,851
2017														23,091		37,058		39,711
2018																23,576		40,118
2019																		25,103
																Total		261,013
						All outstanding liabilities before 2010, net of reinsurance												—
	Liabilities for claims and claims adjustment expenses, net of reinsurance (Motor Property)																	$	26,074

All values are in US Dollars.

Other
	Incurred claims and allocated claim adjustment expenses, net of reinsurance																			December 31, 2019
	For the years ended December 31,																			Total IBNR plus expected development on reported claims
Accident year	2010	2011		2012		2013		2014		2015		2016		2017		2018		2019
	(Unaudited - Supplementary Information)
	( in thousands)
2010		$	3,858	$	4,291	$	4,130	$	4,130	$	4,130	$	3,955	$	4,130	$	3,955	$	3,955	$	—
2011		7,360		8,099		7,525		7,473		7,470		7,468		7,468		7,468		7,468		—
2012				4,017		3,591		3,756		3,773		3,759		3,755		3,782		3,777		42
2013						2,492		2,875		2,840		2,821		2,801		2,755		2,586		46
2014								4,768		3,525		1,776		1,701		1,084		2,125		—
2015										4,794		6,769		6,898		4,519		4,229		298
2016												8,360		10,401		9,142		9,131		1,751
2017														9,087		6,011		6,447		1,913
2018																6,165		7,519		1,931
2019																		19,225		13,828
																Total		$	66,462	$	19,809

All values are in US Dollars.

F-32

Link to Table of Contents

Other
	Cumulative paid claims and allocated claim adjustment expenses, net of reinsurance
	For the years ended December 31,
Accident year	2010	2011		2012		2013		2014		2015		2016		2017		2018		2019
	(Unaudited - Supplementary Information)
	( in thousands)
2010		$	1,593	$	3,123	$	3,130	$	3,406	$	3,477	$	3,955	$	3,955	$	3,955	$	3,955
2011		1,162		7,547		7,513		7,468		7,468		7,468		7,468		7,468		7,468
2012				3,002		3,251		3,676		3,683		3,684		3,688		3,735		3,735
2013						213		1,828		2,426		2,339		2,323		2,578		2,540
2014								197		659		1,124		1,282		1,084		2,125
2015										472		1,387		2,010		3,399		3,931
2016												1,473		3,107		5,646		7,380
2017														484		3,083		4,534
2018																962		5,588
2019																		5,397
																Total		46,653
						All outstanding liabilities before 2010, net of reinsurance												—
		Liabilities for claims and claims adjustment expenses, net of reinsurance (Other)																$	19,809

All values are in US Dollars.

Property
	Incurred claims and allocated claim adjustment expenses, net of reinsurance																			December 31, 2019
	For the years ended December 31,																			Total IBNR plus expected development on reported claims
Accident year	2010	2011		2012		2013		2014		2015		2016		2017		2018		2019
	(Unaudited - Supplementary Information)
	( in thousands)
2010		$	41,983	$	51,698	$	51,483	$	52,263	$	52,507	$	53,723	$	53,574	$	53,495	$	53,506	$	—
2011		73,309		83,261		79,794		80,402		81,894		83,012		83,067		83,006		83,296		—
2012				63,961		50,183		50,874		52,812		53,218		53,473		53,737		53,823		—
2013						60,955		59,002		61,786		62,504		62,491		62,431		62,774		537
2014								41,740		45,153		46,845		47,085		46,874		47,030		510
2015										27,872		30,352		31,752		30,954		30,615		593
2016												25,633		26,127		24,005		23,477		1,450
2017														84,771		78,430		69,042		4,804
2018																28,219		30,291		14,563
2019																		22,738		18,684
																Total		$	476,592	$	41,141

All values are in US Dollars.

F-33

Link to Table of Contents

Property
	Cumulative paid claims and allocated claim adjustment expenses, net of reinsurance
	For the years ended December 31,
Accident year	2010	2011		2012		2013		2014		2015		2016		2017		2018		2019
	(Unaudited - Supplementary Information)
	( in thousands)
2010		$	40,858	$	42,697	$	43,406	$	47,914	$	48,438	$	53,408	$	53,542	$	53,495	$	53,506
2011		49,441		74,383		77,182		79,022		81,214		82,370		82,655		83,006		83,296
2012				32,085		45,887		50,242		52,657		53,211		53,259		53,737		53,823
2013						34,807		55,674		58,533		60,352		61,083		61,996		62,237
2014								20,230		40,172		43,640		45,211		46,301		46,520
2015										12,939		25,453		28,846		29,816		30,022
2016												9,944		18,198		21,040		22,027
2017														43,281		56,397		64,238
2018																5,365		15,728
2019																		4,054
																Total		435,451
						All outstanding liabilities before 2010, net of reinsurance												—
		Liabilities for claims and claims adjustment expenses, net of reinsurance (Property)																$	41,141

All values are in US Dollars.

Professional Liability
	Incurred claims and allocated claim adjustment expenses, net of reinsurance																			December 31, 2019
	For the years ended December 31,																			Total IBNR plus expected development on reported claims
Accident year	2010	2011		2012		2013		2014		2015		2016		2017		2018		2019
	(Unaudited - Supplementary Information)
	( in thousands)
2010		$	3,331	$	3,571	$	3,713	$	3,907	$	3,936	$	3,922	$	3,921	$	3,921	$	3,921	$	424
2011		6,043		6,910		7,367		8,064		8,121		7,950		8,196		8,196		8,023		262
2012				11,236		11,241		11,785		12,221		12,411		13,131		13,131		12,565		885
2013						12,435		13,319		14,844		16,494		17,314		17,489		17,290		2,614
2014								19,229		18,630		18,593		21,149		22,152		22,475		6,017
2015										18,548		18,545		21,100		22,528		22,748		9,952
2016												13,778		16,960		17,328		16,925		9,028
2017														10,252		9,940		9,762		6,673
2018																4,482		4,468		3,327
2019																		586		441
																Total		$	118,763	$	39,623

All values are in US Dollars.

F-34

Link to Table of Contents

Professional Liability
	Cumulative paid claims and allocated claim adjustment expenses, net of reinsurance
	For the years ended December 31,
Accident year	2010	2011		2012		2013		2014		2015		2016		2017		2018		2019
	(Unaudited - Supplementary Information)
	( in thousands)
2010		$	35	$	402	$	834	$	1,112	$	1,478	$	1,620	$	1,740	$	3,497	$	3,497
2011		110		1,331		3,680		5,244		6,580		7,285		7,781		7,830		7,761
2012				533		3,668		6,392		8,836		10,268		11,780		11,947		11,680
2013						710		3,482		7,771		11,175		14,092		14,863		14,676
2014								1,370		5,440		9,716		14,173		16,448		16,458
2015										1,186		3,349		9,012		11,953		12,796
2016												342		2,187		4,915		7,897
2017														228		1,437		3,089
2018																241		1,141
2019																		145
																Total		79,140
						All outstanding liabilities before 2010, net of reinsurance												2,120
	Liabilities for claims and claims adjustment expenses, net of reinsurance (Professional Liability)																	$	41,743

All values are in US Dollars.

Workers' Compensation
	Incurred claims and allocated claim adjustment expenses, net of reinsurance																			December 31, 2019
	For the years ended December 31,																			Total IBNR plus expected development on reported claims
Accident year	2010	2011		2012		2013		2014		2015		2016		2017		2018		2019
	(Unaudited - Supplementary Information)
	( in thousands)
2010		$	11,736	$	12,426	$	13,108	$	13,108	$	13,108	$	13,108	$	13,108	$	13,108	$	13,108	$	—
2011		14,915		15,233		16,861		16,861		16,861		16,861		16,861		16,861		16,861		—
2012				11,763		12,213		12,213		12,213		12,213		12,213		12,213		12,213		—
2013						4,751		4,751		4,751		4,751		4,751		4,751		4,751		—
2014								—		—		—		3		—		—		—
2015										1,014		1,010		948		950		951		174
2016												4,342		4,275		4,266		3,975		701
2017														10,882		10,346		9,603		2,204
2018																13,609		13,499		5,178
2019																		22,927		17,454
																Total		$	97,888	$	25,711

All values are in US Dollars.

F-35

Link to Table of Contents

Workers' Compensation
	Cumulative paid claims and allocated claim adjustment expenses, net of reinsurance
	For the years ended December 31,
Accident year	2010	2011		2012		2013		2014		2015		2016		2017		2018		2019
	(Unaudited - Supplementary Information)
	( in thousands)
2010		$	8,170	$	12,270	$	13,108	$	13,108	$	13,108	$	13,108	$	13,108	$	13,108	$	13,108
2011		5,004		11,175		16,861		16,861		16,861		16,861		16,861		16,861		16,861
2012				2,359		12,213		12,213		12,213		12,213		12,213		12,213		12,213
2013						4,751		4,751		4,751		4,751		4,751		4,751		4,751
2014								—		—		—		—		—		—
2015										28		251		564		688		777
2016												613		1,920		2,782		3,274
2017														2,028		5,356		7,399
2018																4,213		8,321
2019																		5,473
																Total		72,177
						All outstanding liabilities before 2010, net of reinsurance												—
	Liabilities for claims and claims adjustment expenses, net of reinsurance (Workers' Compensation)																	$	25,711

All values are in US Dollars.

For any incurred and paid claims denominated in a currency other than U.S. dollars, the above tables are presented using the foreign exchange rate in effect as of the current year end date. As a result, all prior year information has been restated to reflect the exchange rates as of December 31, 2019. This treatment removes any changes in foreign currency exchange rates from distorting the claims development between the years presented.

For assumed contracts the Company does not generally receive claims information by accident year from the ceding insurers, but instead receives claims information by the treaty year of the contract. Claims reported by the ceding insurer to the Company may have the covered losses occurring in an accident year other than the treaty year. For the purpose of the loss development tables, some incurred and paid claims have been allocated to the accident years based on the proportion of premiums earned for each contract during such accident year.

For example, a one-year treaty incepting on October 1, 2010 (with underlying policies each having a one-year duration), would have a 24-month period over which the premiums would be earned. Therefore, claims would be allocated to accident years 2010, 2011 and 2012 based on the proportion of the premiums earned during each accident year. For illustration of this contract, any claims reported during 2010 would be allocated to the 2010 accident year. For losses reported during 2011, the claims would be allocated between 2010 and 2011 based on the percentage of premiums earned during 2010 and 2011. Similarly, for losses reported during 2012 and thereafter, the losses would be allocated to the 2010, 2011 and 2012 accident years based on the proportion of premiums earned during each of those years. However, natural catastrophe and certain other large losses are addressed separately and are assigned to the accident year in which they occurred.

F-36

Link to Table of Contents

The reconciliation of the net incurred and paid claims development tables to the liability for claims and claim adjustment expenses in the consolidated balance sheet is as follows:

	December 31, 2019
	( in thousands)
Net outstanding liabilities
Health
Multiline	148,768
General Liability	12,349
Motor Casualty	105,172
Motor Property	26,074
Other	19,809
Property	41,141
Professional Liability	41,743
Workers' Compensation	25,711
Liabilities for claims and claims adjustment expenses, net of reinsurance	438,830
Add: Reinsurance recoverable on unpaid claims	27,531
Add: Unallocated claims adjustment expenses	4,227
Total gross liabilities for unpaid claims and claim adjustment expense

All values are in US Dollars.

The average historical annual percentage payout of net incurred claims (excluding health) as of December 31, 2019 is as follows:

Years	1		2		3		4		5		6		7		8		9		10
	(Unaudited - Supplementary Information)
Multiline	10.2	%	19.0	%	18.8	%	16.0	%	13.3	%	22.7	%	—	%	—	%	—	%	—	%
General Liability	4.7	%	13.5	%	12.9	%	11.4	%	18.8	%	29.5	%	6.1	%	2.7	%	0.4	%	—	%
Motor Casualty	45.7	%	33.1	%	8.8	%	5.1	%	3.5	%	1.8	%	1.3	%	0.7	%	—	%	—	%
Motor Property	53.1	%	39.8	%	5.3	%	0.6	%	1.0	%	0.2	%	—	%	—	%	—	%	—	%
Other	21.1	%	39.8	%	19.1	%	9.0	%	2.8	%	5.9	%	2.3	%	—	%	—	%	—	%
Property	51.0	%	32.9	%	7.0	%	2.9	%	2.7	%	0.9	%	2.2	%	0.3	%	0.1	%	—	%
Professional Liability	5.3	%	19.4	%	28.7	%	24.0	%	14.0	%	6.2	%	2.3	%	0.1	%	—	%	—	%
Workers' Compensation	27.9	%	41.6	%	23.0	%	6.1	%	0.9	%	0.5	%	—	%	—	%	—	%	—	%

The historical annual percentage payout pattern for health claims is excluded from the table above because health claims have short settlement periods and including it would skew the results presented.

As a reinsurance entity, the Company generally does not receive detailed claims frequency information or claims counts from ceding insurers and third party claim handlers. Due to the nature of the reinsurance contracts, the underlying insured reports claims to the insurer who cedes losses to the Company. The Company is contractually obligated to reimburse the ceding insurer for its share of the losses. While the Company has the right to conduct audits of the ceding insurer’s claims files, the insurer is generally not obligated to provide detailed listing of claims counts or other claims frequency information to the Company. Therefore it is impracticable for the Company to present the cumulative number of reported claims by accident year.

F-37

Link to Table of Contents

8. RETROCESSION

The Company, from time to time, purchases retrocessional coverage for one or more of the following reasons: to manage its overall exposure, to reduce its net liability on individual risks, to obtain additional underwriting capacity and to balance its underwriting portfolio. Loss and loss adjustment expenses recoverable from retrocessionaires are recorded as assets.

For the year ended December 31, 2019, the Company’s earned ceded premiums were $72.8 million (2018: $102.9 million and 2017: $33.8 million). For the year ended December 31, 2019, loss and loss adjustment expenses incurred of $388.5 million (2018: $363.9 million and 2017: $502.4 million) reported on the Company’s consolidated statements of operations are net of loss and loss expenses recovered and recoverable of $60.7 million (2018: $71.0 million and 2017: $31.8 million).

Retrocession contracts do not relieve the Company from its obligations to the insureds. Failure of retrocessionaires to honor their obligations could result in losses to the Company. At December 31, 2019, the Company’s loss reserves recoverable consisted of (i) $21.2 million (2018: $34.3 million) from unrated retrocessionaires which were secured by cash, letters of credit and collateral held in trust accounts for the benefit of the Company and (ii) $6.4 million (2018: $9.4 million) from retrocessionaires rated A- or above by A.M. Best.

The Company regularly evaluates the financial condition of its retrocessionaires to assess the ability of the retrocessionaires to honor their respective obligations. At December 31, 2019 and 2018, no provision for uncollectible losses recoverable was considered appropriate.

SENIOR CONVERTIBLE NOTES

On August 7, 2018, the Company issued $100.0 million of senior unsecured convertible notes (the “Notes”) which mature on August 1, 2023. The Notes bear interest at 4.0% payable semi-annually on February 1 and August 1 of each year beginning on February 1, 2019.

Note holders have the option, under certain conditions, to redeem the Notes prior to maturity.

If the Notes are converted by the holder, the Company shall have the option to settle the conversion obligation in cash, ordinary shares of the Company, or a combination thereof pursuant to the terms of the indenture governing the Notes. The Company has therefore bifurcated the Notes into liability and equity components.

If converted at December 31, 2019, the face value of the Notes would be cash settled and the Company has assumed that the conversion option will not be exercised due to the share price at December 31, 2019 being lower than the conversion price of $17.19 per share.

The Company’s effective borrowing rate for non-convertible debt at the time of issuance of the Notes was estimated to be 6.0%, which equated to an $8.2 million discount. As of December 31, 2019 and December 31, 2018, the unamortized debt discount was $5.9 million and $7.5 million respectively, and is expected to be amortized through the maturity date. The debt discount also represents the portion of the Note’s principal amount allocated to the equity component.

The Company incurred issuance costs in connection with the issuance of the Notes. As of December 31, 2019, the unamortized portion of these costs attributed to the debt component was $2.3 million (December 31, 2018: $2.9 million), which are expected to be amortized through the maturity date. The portion of these issuance costs attributed to the equity component was netted against the gross proceeds allocated to equity, resulting in $7.9 million being included in the caption “Additional paid-in capital” in the Company’s consolidated balance sheets.

The carrying value of the Notes as of December 31, 2019, including accrued interest of $1.7 million was $93.5 million (December 31, 2018: $91.2 million), which approximates their fair value.

For the year ended December 31, 2019, the Company recognized interest expense of $6.3 million (December 31, 2018: $2.5 million), in connection with the interest coupon, amortization of issuance costs and amortization of the discount.

The Company was in compliance with all covenants relating to the Notes as of December 31, 2019 and December 31, 2018.

F-38

Link to Table of Contents

10. SHARE CAPITAL

The holders of all ordinary shares are entitled to share equally in dividends declared by the Board of Directors. In the event of a winding-up or dissolution of the Company, the ordinary shareholders share equally and ratably in the assets of the Company, after payment of all debts and liabilities of the Company and after the liquidation of any issued and outstanding preferred shares. The Board of Directors is authorized to establish the rights and restrictions for preferred shares as they deem appropriate. At December 31, 2019, no preferred shares were issued or outstanding.

The Third Amended and Restated Memorandum and Articles of Association as revised by special resolution on July 10, 2008 (the “Articles”), provide that the holders of Class A ordinary shares generally are entitled to one vote per share. However, except upon unanimous consent of the Board of Directors, no Class A shareholder is permitted to vote an amount of shares which would cause any United States person to own (directly, indirectly or constructively under applicable United States tax attribution and constructive ownership rules) 9.9% or more of the total voting power of all issued and outstanding ordinary shares. The Articles further provide that the holders of Class B ordinary shares generally are entitled to ten votes per share. However, holders of Class B ordinary shares, together with their affiliates, are limited to voting that number of Class B ordinary shares equal to 9.5% of the total voting power of the total issued and outstanding ordinary shares.

Pursuant to the Shareholders’ Agreement, dated August 11, 2004, by and among the Company and certain of its shareholders (the “Shareholders’ Agreement”), the holders of at least 50% of the outstanding Registrable Securities (as defined in the Shareholders’ Agreement), may, subject to certain conditions, request to have all or part of their Registrable Securities to be registered. The Shareholders’ Agreement requires, among other things, that the Company use its commercially reasonable best efforts to have a registration statement covering such Registrable Securities to be declared effective. The registration rights granted pursuant to the Shareholders’ Agreement are not deemed to be liabilities; therefore, there has been no recognition in the Company’s consolidated financial statements of the registration rights granted pursuant to the Shareholders’ Agreement.

As of December 31, 2019, the Company has an effective Form S-3 registration statement, on file with the SEC, for an aggregate principal amount of $200.0 million in securities.

Shares reserved for issuance are composed of 0.3 million (2018: 0.3 million) Class A ordinary shares in relation to share purchase options granted to a service provider and 5.0 million (2018: 5.0 million) Class A ordinary shares reserved for the Company’s stock incentive plan for eligible employees, directors and consultants. On April 26, 2017, the Company’s shareholders approved an amendment to the stock incentive plan to increase the number of Class A ordinary shares available for issuance by 1.5 million shares from 3.5 million to 5.0 million. As of December 31, 2019 and 2018, there were no remaining Class A ordinary shares available for future issuance relating to share purchase options granted to the service provider as all options granted to service providers had been exercised. As of December 31, 2019 555,805 (2018: 1,122,170) Class A ordinary shares remained available for future issuance under the Company’s stock incentive plan. The stock incentive plan is administered by the Compensation Committee of the Board of Directors.

The Board has adopted a share repurchase plan. On May 2, 2019, the Board of Directors renewed the share repurchase plan, with effect from July 1, 2019 and expiring on June 30, 2020, authorizing the Company to purchase up to 2.5 million Class A ordinary shares or securities convertible into Class A ordinary shares in the open market, through privately negotiated transactions or Rule 10b5-1 stock trading plans. The timing of such repurchases and actual number of shares repurchased will depend on a variety of factors including price, market conditions and applicable regulatory and corporate requirements. The share repurchase plan, which expires on June 30, 2020, does not require the Company to repurchase any specific number of shares and may be modified, suspended or terminated at any time without prior notice. During the year ended December 31, 2019, no Class A ordinary shares were repurchased by the Company. As of December 31, 2019, 2.5 million shares remained available for repurchase under the share repurchase plan. Under the Companies Law of the Cayman Islands, the Company cannot hold treasury shares; therefore, all ordinary shares repurchased are canceled immediately upon repurchase.

F-39

Link to Table of Contents

The following table is a summary of voting ordinary shares issued and outstanding:

	2019		2018			2017
	Class A	Class B	Class A		Class B	Class A		Class B
Balance – beginning of year	30,130,214	6,254,715	31,104,830		6,254,715	31,111,432		6,254,895
Issue of ordinary shares, net of forfeitures	609,181	—	205,384		—	129,530		—
Repurchase of ordinary shares	—	—	(1,180,000	)	—	(136,312	)	—
Class B shares converted to Class A shares	—	—	—		—	180		(180	)
Balance – end of year	30,739,395	6,254,715	30,130,214		6,254,715	31,104,830		6,254,715

Additional paid-in capital includes the premium per share paid by the subscribing shareholders for Class A and B ordinary shares which have a par value of $0.10 each. It also includes share-based awards earned not yet issued.

Statutory Capital and Surplus

Greenlight Re is subject to the Cayman Islands’ Insurance (Capital and Solvency) (Classes B, C, and D Insurers) Regulations, (2018 Revision) (the “Insurance Regulations”). The Insurance Regulations impose a Minimum Capital Requirement (“MCR”) of $50.0 million and a Prescribed Capital Requirement (“PCR”) on Greenlight Re which was $200.9 million as of December 31, 2019 (2018: $191.9 million). As of December 31, 2019, Greenlight Re’s statutory capital and surplus of $519.9 million exceeded the MCR as well as the PCR. For the years ended December 31, 2019, 2018 and 2017, Greenlight Re’s net income (loss) was $9.2 million, $(330.3) million, and $(38.2) million, respectively.

Greenlight Re is not required to prepare separate statutory financial statements for filing with CIMA and there were no material differences between Greenlight Re’s GAAP capital, surplus and net income, and its statutory capital, surplus and net income as of December 31, 2019 and 2018.

As of December 31, 2019, the Company was not restricted from payment of dividends to the Company’s shareholders. However, since most of the Company’s capital and retained earnings are invested in its subsidiaries, a dividend from one or more of the Company’s subsidiaries would likely be required in order to fund a dividend to the Company’s shareholders. Any dividends declared and paid from Greenlight Re to the Company would require approval of CIMA. During the year ended December 31, 2019, no dividends (2018: $0.0 million, 2017: $33.0 million) were declared or paid by Greenlight Re to the Company. As of December 31, 2019 and 2018, $319.0 million and $322.8 million, respectively, of Greenlight Re’s capital and surplus was available for distribution as dividends.

GRIL is obligated to maintain a minimum level of statutory capital. As of December 31, 2019 and 2018, GRIL met such requirements. As of December 31, 2019 and 2018, GRIL’s statutory capital was $35.6 million and $36.6 million, respectively. As of December 31, 2019, GRIL’s statutory minimum capital required under Solvency II was approximately $5.4 million (2018: $5.9 million). GRIL’s statutory net income (loss) was $0.8 million, $(15.4) million and $(3.7) million for the years ended December 31, 2019, 2018 and 2017, respectively. The amount of dividends that GRIL is permitted to distribute is limited to its retained earnings and the Central Bank of Ireland has powers to intervene if a dividend payment were to lead to a breach of regulatory capital requirements. As of December 31, 2019 and 2018, none of GRIL’s capital and surplus was available for distribution as dividends.

11. SHARE-BASED COMPENSATION

The Company has a stock incentive plan for directors, employees and consultants that is administered by the Compensation Committee of the Board of Directors.

Employee and Director Restricted Shares

For the year ended December 31, 2019, 235,701 (2018: 160,595, 2017: 125,371) Class A ordinary shares were issued to employees pursuant to the Company’s stock incentive plan. The majority of these shares contain certain restrictions relating to, among other things, vesting, forfeiture in the event of termination of employment and transferability. The restricted shares cliff

F-40

Link to Table of Contents

vest three years after the date of issuance, subject to the grantee’s continued service with the Company. During the vesting period, the holder of the restricted shares retains voting rights and is entitled to any dividends declared by the Company.

For the year ended December 31, 2019, 326,240 (2018: 30,660, 2017: nil) Class A ordinary shares were issued to the Company’s Chief Executive Officer (“CEO”) pursuant to the Company’s stock incentive plan. These shares contain performance and service conditions and certain restrictions relating to, among other things, vesting, forfeiture in the event of termination of employment and transferability. 89,945 of these restricted shares cliff vest 5 years after the date of issuance, subject to the performance condition being met and the grantee’s continued service with the Company while the remainder of these restricted shares vest upon occurrence of a specified performance condition being met prior to December 15, 2020. During the vesting period, the holder of the restricted shares retains voting rights and is entitled to any dividends declared by the Company. The weighted average grant date fair value of the restricted shares subject to performance conditions was $10.65 (2018: $15.90) per share. No compensation cost was recognized relating to these shares for the year ended December 31, 2019 (2018: nil) based on the performance conditions remaining.

For the year ended December 31, 2019, the Company also issued to non-employee directors an aggregate of 77,556 (2018: 54,720, 2017: 41,396) restricted Class A ordinary shares as part of their remuneration for services to the Company. Each of these restricted shares issued to non-employee directors contains similar restrictions to those issued to employees and will vest on the earlier of the first anniversary of the date of the share issuance or the Company’s next annual general meeting, subject to the grantee’s continued service with the Company.

For the year ended December 31, 2019, 37,502 (2018: 44,644, 2017: 46,943) restricted shares were forfeited by employees and a director who left the Company prior to the expiration of the applicable vesting periods. For the year ended December 31, 2019, $0.2 million stock compensation expense (2018: $0.3 million, 2017: $0.0 million) relating to the forfeited restricted shares was reversed.

The Company recorded $2.8 million of share-based compensation expense, net of forfeiture reversals, relating to restricted shares for the year ended December 31, 2019 (2018: $2.9 million, 2017: $3.3 million). As of December 31, 2019, there was $2.7 million (2018: $2.6 million, 2017: $3.5 million) of unrecognized compensation cost relating to non-vested restricted shares (excluding CEO’s restricted shares with performance conditions) which are expected to be recognized over a weighted average period of 1.6 years (2018: 1.6 years, 2017: 1.6 years). For the year ended December 31, 2019, the total fair value of restricted shares vested was $3.1 million (2018: $2.8 million, 2017: $4.5 million).

The following table summarizes the activity for unvested outstanding restricted share awards during the years ended December 31, 2019 and 2018:

	Number of<br>non-vested<br>restricted<br> shares		Weighted<br> average<br>grant date<br>fair value
Balance at December 31, 2017	331,510		$	23.45
Granted	245,975		15.78
Vested	(100,384	)	27.74
Forfeited	(44,644	)	18.77
Balance at December 31, 2018	432,457		18.58
Granted	639,497		10.69
Vested	(161,365	)	19.44
Forfeited	(37,502	)	14.12
Balance at December 31, 2019	873,087		$	12.83

F-41

Link to Table of Contents

Employee and Director Stock Options

For the year ended December 31, 2019 and 2018, no Class A ordinary share purchase options were granted (2017: 480,000). The Class A ordinary share purchase options granted to the Company’s CEO in 2017 vest 16.7% each on the anniversary thereof in 2018, 2019, 2020, 2021, 2022 and 2023, and expire 10 years after the grant date. The grant date fair value of these options was $9.60, based on the Black-Scholes option pricing model. In addition, for the year ended December 31, 2017, 42,250 Class A ordinary share purchase options were granted to the Company’s former interim Chief Executive Officer, pursuant to his consulting agreement. These options vested 100% on their grant date and expire 10 years after the grant date. The weighted average grant date fair value of these options was $9.90 per share based on the Black-Scholes option pricing model.

For the options granted in 2017, the Company applied the following weighted average assumptions to the options pricing model:

	2017
Risk free rate	2.32	%
Estimated volatility	31.4	%
Expected term (in years)	10
Dividend yield	—	%
Forfeiture rate	—	%

The estimate of expected volatility for options granted during 2017 was based on the daily historical trading data of the Company’s Class A ordinary shares from the date that these shares commenced trading on May 24, 2007 to the grant date.

The Board of Directors does not currently anticipate that any dividends will be declared during the expected term of the options. The Company uses graded vesting for expensing employee stock options. The total compensation cost expensed for the year ended December 31, 2019 was $0.9 million (2018: $1.5 million, 2017: $1.3 million). At December 31, 2019, the total compensation cost related to non-vested options not yet recognized was $1.3 million (2018: $2.2 million) to be recognized over a weighted average period of 2.4 years (2018: 2.9 years) assuming the grantee completes the service period for vesting of the options.

For the year ended December 31, 2019, no stock options were exercised by directors and employees (2018: 0, 2017: 50,000) resulting in no Class A ordinary shares being issued (2018: 0, 2017: 5,011, net of shares surrendered as a result of the cashless exercise of stock options). When stock options are granted, the Company reduces the corresponding number from the shares authorized for issuance as part of the Company’s stock incentive plan.

Employee and director stock option activity during the years ended December 31, 2019, 2018 and 2017 was as follows:

	Number of<br><br>options outstanding		Weighted<br><br>average<br><br>exercise<br><br>price		Weighted<br><br>average<br><br>grant date<br><br>fair value		Intrinsic value ( in millions)	Weighted average remaining contractual term
Balance at December 31, 2016	543,377		$	25.40	$	10.17		4.7 years
Granted	522,250		21.25		9.63
Exercised	(50,000	)	19.60		10.18		0.1
Balance at December 31, 2017	1,015,627		23.55		9.89		—	6.9 years
Expired	(80,000	)	29.39		8.69
Balance at December 31, 2018	935,627		23.05		10.00		—	6.4 years
Expired	(60,000	)	28.44		6.25
Balance at December 31, 2019	875,627		$	22.68	$	10.25		5.8 years

All values are in US Dollars.

F-42

Link to Table of Contents

The following table summarizes information about options exercisable for the periods indicated:		December 31, 2019		December 31, 2018		December 31, 2017
Number of options exercisable	555,627		535,627		535,627
Weighted average exercise price	$	23.54	$	24.43	$	25.66
Weighted average remaining contractual term	4.9		4.9		4.6
Intrinsic value ($ in millions)	$	—	$	—	$	—

During the year ended December 31, 2019, 80,000 (2018: 80,000, 2017: 113,585) options vested which had a weighted average grant date fair value of $9.60 (2018: $9.60, 2017: $10.29).

Employee Restricted Stock Units

The Company issues restricted stock units (“RSUs”) to certain employees as part of the stock incentive plan.

These RSUs contain restrictions relating to vesting, forfeiture in the event of termination of employment, transferability and other matters. Each RSU grant cliff vests three years after the date of issuance, subject to the grantee’s continued service with the Company. On the vesting date, the Company converts each RSU into one Class A ordinary share and issues new Class A ordinary shares from the shares authorized for issuance as part of the Company’s stock incentive plan. For the year ended December 31, 2019, 48,535 (2018: 28,301, 2017: 11,559) RSUs were issued to employees pursuant to the Company’s stock incentive plan. For the year ended December 31, 2019, 24,165 (2018: 648) RSUs were forfeited by employees who left the Company prior to the expiration of the applicable vesting periods.

The Company recorded $0.2 million of share-based compensation expense, net of forfeitures, relating to RSUs for the year ended December 31, 2019 (2018: $0.2 million, 2017: $0.2 million). At December 31, 2019, the total compensation cost related to non-vested RSUs not yet recognized was $0.4 million (2018: $0.4 million) to be recognized over a weighted average period of 1.8 years (2018: 1.9 years) assuming the grantee completes the service period for vesting of the options.

Employee RSU activity during the years ended December 31, 2019 and 2018 was as follows:

	Number of<br>non-vested<br>RSUs		Weighted<br> average<br>grant date<br>fair value
Balance at December 31, 2017	22,798		$	23.50
Granted	28,301		15.90
Vested	(4,053	)	32.21
Forfeited	(648	)	21.65
Balance at December 31, 2018	46,398		18.13
Granted	48,535		10.84
Vested	(7,186	)	21.56
Forfeited	(24,165	)	13.96
Balance at December 31, 2019	63,582		$	13.76

For the years ended December 31, 2019, 2018 and 2017, the combined stock compensation expense (net of forfeitures), which was included in the caption “General and administrative expenses” in the Company’s statements of operations, was $3.9 million, $4.6 million and $4.9 million, respectively.

F-43

Link to Table of Contents

12. NET INVESTMENT INCOME (LOSS)

A summary of net investment income (loss) for the years ended December 31, 2019, 2018 and 2017 is as follows:

	2019		2018			2017
	( in thousands)
Realized gains (losses)		)	$	(236,887	)	$	87,618
Change in unrealized gains and losses	8,380		(32,597		)	(41,444		)
Investment related foreign exchange gains (losses)	20		938			(7,653		)
Interest and dividend income, net of withholding taxes	16,059		35,468			25,510
Interest, dividend and other expenses	(4,798	)	(17,987		)	(23,937		)
Income (loss) from equity method investment	700		(247		)	—
Investment advisor compensation on joint venture	—		(11,221		)	(19,863		)
Net investment related income (loss)	6,211		(262,533		)	20,231
Income (loss) from investments in related party investment fund	46,056		(60,573		)	—
Total net investment related income (loss)			$	(323,106	)	$	20,231

All values are in US Dollars.

Income (loss) from investments in related party investment fund reflects the equity in earnings (loss) of SILP (see Note 3).

Investment returns are calculated monthly based on cash flows into or out of the investment accounts and compounded to calculate the annual returns generated by the Company’s investments managed by DME Advisors. Effective from September 1, 2018, the investment return is calculated by dividing the investment income or loss (net of fees and expenses) by the Investment Portfolio. For the year ended December 31, 2019, the total investment related income includes a gain of 9.3% on the investments managed by DME Advisors. This return compares to a loss of 30.3% and a gain of 1.5% reported for the years ended December 31, 2018 and 2017, respectively. The change in unrealized gains and losses for year ended December 31, 2019, included a net increase in the valuation allowance provision of $6.0 million (2018: $nil, 2017: $nil) relating to notes receivable.

13. TAXATION

Each of the Company and Greenlight Re intends to conduct all of its operations in a manner that will not cause it to be treated as engaging in a trade or business within the United States and will not cause it to be subject to current U.S. federal income taxation on its net income. However, because there are no definitive standards provided by the Internal Revenue Code, regulations or court decisions as to the specific activities that constitute being engaged in the conduct of a trade or business within the United States, and as any such determination is essentially factual in nature, there can be no assurance that the IRS will not successfully assert that the Company or Greenlight Re is engaged in a trade or business within the U.S.

As of December 31, 2019, a gross deferred tax asset of $3.6 million (2018: $3.6 million) and a deferred tax asset valuation allowance of $2.6 million (2018: $2.2 million) was recorded by the Company. The net deferred tax asset is included in the caption “Other assets” in the Company’s consolidated balance sheets. Based on the timing of the reversal of the temporary differences and likelihood of generating sufficient taxable income to realize the future tax benefit, management believes it is more likely than not that the recorded deferred tax asset (net of the valuation allowance) will be fully realized in the future. The Company currently believes that it has no uncertain tax positions which, if challenged, would cause a material change to the Company’s consolidated financial statements.

At December 31, 2019, GRIL had a net operating loss carry forward of $28.2 million (2018: $28.6 million) which can be carried forward indefinitely. At December 31, 2019 and 2018, no taxes recoverable were included in the Company’s consolidated balance sheets.

At December 31, 2019, Verdant had a net operating loss carry forward totaling $4.6 million available to offset future taxable income. Of the total $4.6 million, $2.9 million expire at various dates from 2033 to 2037 and the remaining $1.7 million have no expiration date. The deferred tax asset associated with the net operating loss carried forward, has been offset by a valuation allowance as management does not anticipate that the carried forward amount will be realized.

F-44

Link to Table of Contents

The following table sets forth our current and deferred income tax benefit (expense) on a consolidated basis for the years ended December 31, 2019, 2018 and 2017:

	2019		2018			2017
	( in thousands)
Current tax (expense) benefit		)	$	1,840		$	465
Deferred tax (expense) benefit	(8	)	(4		)	(14		)
Increase in deferred tax valuation allowance	(432	)	(2,168		)	—
Income tax (expense) benefit		)	$	(332	)	$	451

All values are in US Dollars.

Federal Excise Taxes

The United States imposes an excise tax on reinsurance premiums paid to non-U.S. insurers or reinsurers with respect to risks located in the United States. The rate of tax, unless exempted or reduced by an applicable U.S. tax treaty, is 1.0% for all reinsurance premiums. The Company incurs federal excise taxes on certain of its reinsurance transactions, including amounts ceded through intercompany transactions. For the years ended 2019, 2018 and 2017, the Company incurred approximately $3.8 million, $3.6 million and $5.0 million, respectively, of federal excise taxes, net of any refunds received. These amounts are included in the caption “Acquisition costs” in the Company’s consolidated statements of operations.

14. RELATED PARTY TRANSACTIONS

Investment Advisory Agreement

DME, DME II and DME Advisors are related to the Company and each is an affiliate of David Einhorn, Chairman of the Company’s Board of Directors.

Prior to September 1, 2018, the Company and its reinsurance subsidiaries were party to the venture agreement with DME Advisors under which the Company, its reinsurance subsidiaries and DME were participants of the Joint Venture for the purpose of managing certain jointly held assets. In addition, prior to September 1, 2018, the Company, its reinsurance subsidiaries and DME had entered into a separate investment advisory agreement with DME Advisors (the “advisory agreement”). On September 1, 2018, the Company, DME and DME Advisors entered into a termination agreement to terminate the Joint Venture and the advisory agreement on January 2, 2019.

On September 1, 2018, the Company entered into the SILP LPA with DME II, as General Partner. DME II receives a performance allocation equal to (with capitalized terms having the meaning provided under the SILP LPA) (a) 10% of the portion of the Positive Performance Change for each limited partner’s capital account that is less than or equal to the positive balance in such limited partner’s Carryforward Account, plus (b) 20% of the portion of the Positive Performance Change for each limited partner’s capital account that exceeds the positive balance in such limited partner’s Carryforward Account. The Carryforward Account for Greenlight Re and GRIL include the amount of losses that were to be recouped under the Joint Venture as well as any loss generated on the assets invested in SILP, subject to adjustments for redemptions. The loss carry forward provision contained in the SILP LPA allows DME II to earn a reduced performance allocation of 10% of profits in years subsequent to any year in which SILP has incurred a loss, until all losses are recouped and an additional amount equal to 150% of the loss is earned. For the year ended December 31, 2019, performance allocation of $5.0 million, (2018: nil) was deducted from the Company’s investment in SILP and allocated to DME II.

In accordance with the SILP LPA, DME Advisors constructs a levered investment portfolio as agreed by the Company (the “Investment Portfolio” as defined in the SILP LPA). On September 1, 2018, SILP entered into the IAA with DME Advisors which entitles DME Advisors to a monthly management fee equal to 0.125% (1.5% on an annual basis) of each limited partner’s Investment Portfolio. The IAA has an initial term ending on August 31, 2023 subject to an automatic extension for successive three-year terms. For the year ended December 31, 2019, management fees paid by SILP to DME Advisors of $4.9 million, (2018: $3.1 million) were included in the caption “Income (loss) from investment in related party investment fund” in the Company’s consolidated statement of operations.

F-45

Link to Table of Contents

Pursuant to the SILP LPA and the IAA, the Company has agreed to indemnify DME, DME II and DME Advisors for any expense, loss, liability, or damage arising out of any claim asserted or threatened in connection with DME Advisors serving as the Company’s or SILP’s investment advisor. The Company will reimburse DME, DME II and DME Advisors for reasonable costs and expenses of investigating and/or defending such claims, provided such claims were not caused due to gross negligence, breach of contract or misrepresentation by DME, DME II or DME Advisors. There were no indemnification amounts incurred by the Company during any of the periods presented.

Non-controlling Interest in Related Party Joint Venture

Non-controlling interests in related party joint venture represented DME’s share of the jointly held assets under the venture agreement. A portion of the non-controlling interest was subject to contractual withdrawal rights whereby DME, at its sole discretion, could withdraw its interest above the minimum capital required to be maintained in its capital accounts. This interest was recorded on the Company’s consolidated balance sheets under the caption “Redeemable non-controlling interest in related party joint venture.” The remaining portion without any withdrawal rights associated with it, was recorded under the caption “Non-controlling interest in related party joint venture” within the equity section on the Company’s consolidated balance sheet.

The following table is a reconciliation of the beginning and ending carrying amounts of redeemable non-controlling interest in related party, non-controlling interest in related party and total non-controlling interest in related party for the years ended December 31, 2019, 2018 and 2017:

	Redeemable non-controlling interest in related party joint venture									Non-controlling interest in related party joint venture									Total non-controlling interest in related party joint venture
	Year ended December 31									Year ended December 31									Year ended December 31
	2019			2018			2017			2019			2018			2017			2019			2018			2017
Opening balance	$	1,692		$	7,169		$	5,884	—	$	485		$	12,933		$	11,561	—	$	2,177		$	20,102		$	17,445
Income (loss) attributed to non-controlling interest	—			(2,680		)	201		—	—			(1,595		)	378		—	—			(4,275		)	579
Net contribution into (withdrawal from) non-controlling interest	(1,692		)	(2,797		)	1,084		—	(485		)	(10,853		)	994		—	(2,177		)	(13,650		)	2,078
Ending balance	$	—		$	1,692		$	7,169		$	—		$	485		$	12,933		$	—		$	2,177		$	20,102

Green Brick Partners, Inc.

David Einhorn also serves as the Chairman of the Board of Directors of Green Brick Partners, Inc. (“GRBK”), a publicly traded company. As of December 31, 2019, SILP, along with certain affiliates of DME Advisors, collectively owned 47.8% of the issued and outstanding common shares of GRBK. Under applicable securities laws, DME Advisors may be limited at times in its ability to trade GRBK shares on behalf of SILP.

Service Agreement

The Company has entered into a service agreement with DME Advisors, pursuant to which DME Advisors provides certain investor relations services to the Company for compensation of five thousand dollars per month (plus expenses). The agreement is automatically renewed annually until terminated by either the Company or DME Advisors for any reason with 30 days prior written notice to the other party.

Collateral Assets Investment Management Agreement

Effective January 1, 2019, the Company (and its subsidiaries) entered into a collateral assets investment management agreement (the “CMA”) with DME Advisors, pursuant to which DME Advisors manages certain assets of the Company that are not subject to the SILP LPA and are held by the Company to provide collateral required by the cedents in the form of trust accounts and letters of credit. In accordance with the CMA, DME Advisors receives no fees and is required to comply with the collateral investment guidelines. The CMA can be terminated by any of the parties upon 30 days’ prior written notice to the other parties.

F-46

Link to Table of Contents

15. COMMITMENTS AND CONTINGENCIES

Letters of Credit and Trusts

At December 31, 2019, the Company had one letter of credit facility, which automatically renews each year unless terminated by either party in accordance with the applicable required notice period:

	Facility	Notice period required for termination
	( in thousands)
Citibank Europe plc	400,000	120 days prior to termination date

All values are in US Dollars.

During 2019 the Butterfield Bank letter of credit facility was terminated. As of December 31, 2019, an aggregate amount of $204.5 million (2018: $208.3 million) in letters of credit were issued under the above facility. As of December 31, 2019, total cash and cash equivalents with a fair value in the aggregate of $213.4 million (2018: $221.7 million) were pledged as collateral against the letters of credit issued and included in the caption “Restricted cash and cash equivalents” in the Company’s consolidated balance sheets. The facility contains customary events of default and restrictive covenants, including but not limited to, limitations on liens on collateral, transactions with affiliates, mergers and sales of assets, as well as solvency and maintenance of certain minimum pledged equity requirements, and restricts issuance of any debt without the consent of the letter of credit provider. Additionally, if an event of default exists, as defined in the letter of credit facility, Greenlight Re will be prohibited from paying dividends to its parent company. The Company was in compliance with all the covenants of the facility as of December 31, 2019 and 2018.

The Company has also established regulatory trust arrangements for certain cedents. As of December 31, 2019, collateral of $528.7 million (2018: $463.4 million) was provided to cedents in the form of regulatory trust accounts and included in the caption “Restricted cash and cash equivalents” in the Company’s consolidated balance sheets.

Lease Obligations

Greenlight Re has entered into lease agreements for office space in the Cayman Islands. The leases expired on June 30, 2018. The Company is currently in negotiations with the lessor for renewal of the leases and meanwhile both parties have agreed to extend the leases until December 31, 2020. The Company has determined that the current arrangement qualifies as a short term lease upon adoption of Leases (Topic 842) on January 1, 2019. The short-term lease expense for the year ended December 31, 2019 was $0.5 million.

GRIL has entered into a lease agreement for office space in Dublin, Ireland. Under the terms of this lease agreement, GRIL is committed to minimum annual rent payments denominated in Euros approximating €0.1 million until May 2021, and adjusted to the prevailing market rates for the subsequent five-year term. GRIL has the option to terminate the lease agreement in 2021. The Company has determined that this lease was an operating lease on January 1, 2019 and has recorded a right-of-use asset and a corresponding lease liability of $0.3 million. The operating lease expense for the year ended December 31, 2019 and 2018 was insignificant. Included in the “Schedule of Commitments and Contingencies,” below, are the net minimum lease payment obligations relating to this lease as of December 31, 2019.

Loan Facility

From time to time, the Company makes investments in the form of equity or debt in private entities as part of its strategic investments and innovation initiatives. As part of the Company’s participation in such investments, the Company may make funding commitments. As of December 31, 2019, the Company had committed to a loan facility (the “Loan Facility”) of $6.0 million to AccuRisk (see Note 4). As of December 31, 2019, $0.4 million of the Loan Facility was available to AccuRisk. Included in the schedule below is the obligation relating to the Loan Facility as of December 31, 2019 on the assumption that the entire Loan Facility will be drawn by AccuRisk during 2020.

Advisory fee

The Company has entered into an advisory agreement whereby the Company is obligated to pay a minimum of $2.0 million, no earlier than March 2020. Pursuant to the advisory agreement, additional fees may be payable depending on certain events occurring. Included in the schedule below is the minimum obligation relating to the advisory agreement as of December 31, 2019.

F-47

Link to Table of Contents

Schedule of Commitments and Contingencies

The following is a schedule of future minimum payments required under the above commitments:

	2020	2021		2022		2023		2024		Thereafter		Total
	( in thousands)
Operating lease obligations		$	62	$	62	$	—	$	—	$	—	$	803
Interest and convertible note payable	4,000	4,000		4,000		104,000		—		—		116,000
Loan facility	350	—		—		—		—		—		350
Advisory fee	2,000	—		—		—		—		—		2,000
		$	4,062	$	4,062	$	104,000	$	—	$	—	$	119,153

All values are in US Dollars.

Litigation

From time to time in the normal course of business, the Company may be involved in formal and informal dispute resolution procedures, which may include arbitration or litigation, the outcomes of which determine the rights and obligations under the Company’s reinsurance contracts and other contractual agreements. In some disputes, the Company may seek to enforce its rights under an agreement or to collect funds owing to it. In other matters, the Company may resist attempts by others to collect funds or enforce alleged rights. While the final outcome of legal disputes cannot be predicted with certainty, the Company does not believe that any existing dispute, when finally resolved, will have a material adverse effect on the Company’s business, financial condition or operating results.

16. SEGMENT REPORTING

The Company manages its business on the basis of one operating segment, Property & Casualty Reinsurance.

Substantially all of the business is sourced through reinsurance brokers. The following table sets forth the premiums generated through our largest brokers and their subsidiaries and affiliates:

	Year ended December 31
	2019			2018				2017
	( in thousands)
Guy Carpenter (Marsh)		56.7	%	$	376,696	66.4	%	$	366,390	52.9	%
Trean Re	85,323	16.3		45,446		8.0		54,799		7.9
Aon Benfield	41,071	7.8		70,554		12.4		125,320		18.1
Total of largest brokers		80.8	%	$	492,696	86.8	%	$	546,509	78.9	%
All others	100,433	19.2		74,835		13.2		146,142		21.1
Total		100.0	%	$	567,531	100.0	%	$	692,651	100.0	%

All values are in US Dollars.

F-48

Link to Table of Contents

The following tables provide a breakdown of the Company’s gross premiums written by line and class of business, and by geographic area of risks insured for the periods indicated:

Gross Premiums Written by Line of Business

	Year ended December 31
	2019				2018				2017
	( in thousands)
Property
Commercial			2.7	%	$	10,487	1.8	%	$	12,256	1.8	%
Motor	59,402		11.3		76,425		13.5		71,188		10.2
Personal	12,390		2.4		14,118		2.5		49,491		7.2
Total Property	85,957		16.4		101,030		17.8		132,935		19.2
Casualty
General Liability	2,401		0.5		1,429		0.3		4,753		0.7
Motor Liability	233,591		44.6		291,690		51.4		281,551		40.6
Professional Liability (1)	(448	)	(0.1	)	3,068		0.5		8,703		1.3
Workers' Compensation	50,369		9.6		24,101		4.3		24,803		3.6
Multi-line	76,461		14.6		57,497		10.1		123,340		17.8
Total Casualty	362,374		69.2		377,785		66.6		443,150		64.0
Other
Accident & Health	39,175		7.5		69,605		12.2		66,800		9.6
Financial	23,087		4.4		16,611		2.9		48,380		7.0
Marine	160		—		394		0.1		—		—
Other Specialty	13,224		2.5		2,106		0.4		1,386		0.2
Total Other	75,646		14.4		88,716		15.6		116,566		16.8
			100.0	%	$	567,531	100.0	%	$	692,651	100.0	%

All values are in US Dollars.

^(1)^ The negative balance represents the reversal of premiums due to premium adjustments, termination of contracts or premium returned upon novation or commutation of contracts.

Gross Premiums Written by Geographic Area of Risks Insured

	Year ended December 31
	2019				2018					2017
	( in thousands)
U.S. and Caribbean			83.1	%	$	507,705		89.5	%	$	606,510		87.6	%
Worldwide (1)	84,728		16.2		59,366			10.5		86,714			12.5
Europe (2)	(13	)	—		506			—		(612		)	(0.1	)
Asia (2)	3,804		0.7		(46		)	—		39			—
			100.0	%	$	567,531		100.0	%	$	692,651		100.0	%

All values are in US Dollars.

^(1)^ “Worldwide” is composed of contracts that reinsure risks in more than one geographic area and may include risks in the U.S.

^(2)^ The negative balances represent the reversal of premiums due to premium adjustments, termination of contracts or premium returned upon novation or commutation of contracts.

F-49

Link to Table of Contents

17. QUARTERLY FINANCIAL RESULTS (UNAUDITED)

The following table presents the quarterly financial results for each of the quarters ended during 2019:

	2019
	Quarter ended
	March 31		June 30			September 30			December 31
	( in thousands, except per share amounts)
Revenues
Gross premiums written			$	152,340		$	110,607		$	98,470
Gross premiums ceded	(21,401	)	(23,141		)	(4,035		)	(90		)
Net premiums written	141,159		129,199			106,572			98,380
Change in net unearned premium reserves	(15,797	)	(8,758		)	22,582			10,243
Net premiums earned	125,362		120,441			129,154			108,623
Income (loss) from investment in related party investment fund	30,756		14,405			6,609			(5,714		)
Net investment income (loss)	1,567		4,386			3,312			(3,054		)
Other income (expense), net	1,069		1,117			(887		)	1,007
Total revenues	158,754		140,349			138,188			100,862
Expenses
Net loss and loss adjustment expenses incurred	122,865		78,476			92,962			94,184
Acquisition costs	21,526		37,172			30,962			27,424
General and administrative expenses	6,840		7,919			7,725			7,338
Interest expense	1,544		1,562			1,578			1,579
Total expenses	152,775		125,129			133,227			130,525
Income (loss) before income tax expense	5,979		15,220			4,961			(29,663		)
Income tax (expense) benefit	(73	)	94			179			(683		)
Net income (loss) attributable to Greenlight Capital Re, Ltd.			$	15,314		$	5,140		$	(30,346	)
Earnings (loss) per share
Basic			$	0.42		$	0.14		$	(0.84	)
Diluted			$	0.42		$	0.14		$	(0.84	)
Weighted average number of ordinary shares used in the determination of earnings and loss per share
Basic	35,972,665		36,100,665			36,841,623			36,121,023
Diluted	36,364,358		36,829,963			36,921,490			36,121,023

All values are in US Dollars.

F-50

Link to Table of Contents

The following table presents the quarterly financial results for each of the quarters ended during 2018:

	2018
	Quarter ended
	March 31		June 30			September 30			December 31
	( in thousands)
Revenues
Gross premiums written			$	142,109		$	115,154		$	135,143
Gross premiums ceded	(29,843	)	(27,237		)	(15,456		)	(30,252		)
Net premiums written	145,282		114,872			99,698			104,891
Change in net unearned premium reserves	562		13,944			14,406			14,708
Net premiums earned	145,844		128,816			114,104			119,599
Income (loss) from investment in related party investment fund	—		—			(10,025		)	(50,548		)
Net investment income (loss)	(145,216	)	(40,656		)	(70,851		)	(5,810		)
Other income (expense), net	(487	)	(76		)	(683		)	(982		)
Total revenues	141		88,084			32,545			62,259
Expenses
Net loss and loss adjustment expenses incurred	95,824		84,815			86,780			96,454
Acquisition costs	44,209		34,623			28,331			38,312
General and administrative expenses	5,956		6,958			7,136			5,123
Interest expense	—		—			927			1,578
Total expenses	145,989		126,396			123,174			141,467
Income (loss) before income tax	(145,848	)	(38,312		)	(90,629		)	(79,208		)
Income tax (expense) benefit	770		323			355			(1,780		)
Net income (loss)	(145,078	)	(37,989		)	(90,274		)	(80,988		)
Loss (income) attributable to non-controlling interest in related party joint venture	2,326		621			1,159			169
Net income (loss) attributable to Greenlight Capital Re, Ltd.		)	$	(37,368	)	$	(89,115	)	$	(80,819	)
Earnings (loss) per share
Basic		)	$	(1.01	)	$	(2.48	)	$	(2.25	)
Diluted		)	$	(1.01	)	$	(2.48	)	$	(2.25	)
Weighted average number of ordinary shares used in the determination of earnings and loss per share
Basic	37,087,169		36,952,472			35,952,472			35,952,472
Diluted	37,087,169		36,952,472			35,952,472			35,952,472

All values are in US Dollars.

F-51

Link to Table of Contents

SCHEDULE I

GREENLIGHT CAPITAL RE, LTD.

SUMMARY OF INVESTMENTS — OTHER THAN INVESTMENTS IN RELATED PARTIES

AS OF DECEMBER 31, 2019

(expressed in thousands of U.S. dollars)

Type of Investment	Cost	Fair Value		Balance<br>Sheet Value
	( in thousands)
Other investments
Private investments and unlisted equities		$	10,681	$	10,681
Investment accounted for under the equity method	NA	5,703		5,703
Total other investments	10,420	16,384		16,384
Total investments		$	16,384	$	16,384

All values are in US Dollars.

F-52

Link to Table of Contents

SCHEDULE II

GREENLIGHT CAPITAL RE, LTD.

CONDENSED FINANCIAL INFORMATION OF REGISTRANT

CONDENSED BALANCE SHEETS — PARENT COMPANY ONLY

(expressed in thousands of U.S. dollars)

	December 31, 2019		December 31, 2018
	( in thousands)
Assets
Other investments			$	800
Cash and cash equivalents	2		3
Investment in subsidiaries	557,835		553,323
Notes receivable (net of valuation allowance)	10,469		21,965
Due from subsidiaries	8,200		—
Total assets			$	576,091
Liabilities and equity
Liabilities
Convertible senior notes payable			$	91,185
Other liabilities	1,611		—
Due to subsidiaries	5,198		7,619
Total liabilities	100,323		98,804
Shareholders’ equity
Share capital	3,699		3,638
Additional paid-in capital	503,547		499,726
Retained earnings (deficit)	(30,063	)	(26,077		)
Total shareholders’ equity	477,183		477,287
Total liabilities and equity			$	576,091

All values are in US Dollars.

GREENLIGHT CAPITAL RE, LTD.

CONDENSED FINANCIAL INFORMATION OF REGISTRANT

CONDENSED STATEMENT OF OPERATIONS — PARENT COMPANY ONLY

(expressed in thousands of U.S. dollars)

	Year ended December 31
	2019		2018			2017
	( in thousands)
Revenue
Net investment income			$	1,574		$	34,487
Total revenues	522		1,574			34,487
Expenses
General and administrative expenses	6,496		4,445			4,691
Interest expense	6,263		2,505			—
Total expenses	12,759		6,950			4,691
Net income (loss) before equity in earnings of consolidated subsidiaries	(12,237	)	(5,376		)	29,796
Equity in earnings of consolidated subsidiaries	8,251		(344,678		)	(74,748		)
Consolidated net income (loss)		)	$	(350,054	)	$	(44,952	)

All values are in US Dollars.

F-53

Link to Table of Contents

SCHEDULE II (continued)

GREENLIGHT CAPITAL RE, LTD.

CONDENSED FINANCIAL INFORMATION OF REGISTRANT

CONDENSED STATEMENTS OF CASH FLOWS — PARENT COMPANY ONLY

(expressed in thousands of U.S. dollars)

	Year Ended December 31
	2019	2018		2017
	( in thousands)
Cash provided by (used in) operating activities
Net income (loss)	(3,986	(350,054	)	(44,952	)
Adjustments to reconcile net income or loss to net cash provided by (used in) operating activities
Equity in earnings of consolidated subsidiaries	(8,251	344,678		74,748
Net change in unrealized gains and losses on investments	(200	—		—
Share-based compensation expense	3,686	4,382		4,691
Amortization and interest expense	2,329	2,505		—
Net change in
Due from subsidiaries	(8,200	876		(876	)
Other liabilities	1,611	—		—
Due from subsidiaries	(2,421	7,619		(29,023	)
Net cash provided by (used in) operating activities	(15,432	10,006		4,588
Investing activities
Purchase of investments	—	(800	)	—
Change in note receivable	11,496	(6,610	)	(191	)
Contributed surplus to subsidiaries, net	3,935	(82,750	)	(1,500	)
Net cash provided by (used in) investing activities	15,431	(90,160	)	(1,691	)
Financing activities
Net proceeds from issuance of convertible senior notes payable, net of costs	—	96,576		—
Repurchase of Class A ordinary shares	—	(16,503	)	(2,819	)
Net cash provided by (used in) financing activities	—	80,073		(2,819	)
Net increase (decrease) in cash and cash equivalents	(1	(81	)	78
Cash and cash equivalents at beginning of the year	3	84		6
Cash and cash equivalents at end of the year	2	3		84
Supplementary information
Non cash consideration from (to) subsidiaries, net	(196	(242	)	(162	)

All values are in US Dollars.

F-54

Link to Table of Contents

SCHEDULE III

GREENLIGHT CAPITAL RE, LTD.

SUPPLEMENTARY INSURANCE INFORMATION

AS OF AND FOR THE YEARS ENDED DECEMBER 31, 2019, 2018 AND 2017

(expressed in thousands of U.S. dollars)

Year	Segment	Deferred<br>acquisition<br>costs, net		Reserves<br>for losses<br>and loss<br>adjustment<br>expenses<br>– gross		Unearned<br>premiums<br>– gross		Net<br>premiums<br>earned		Total<br>investment related<br>income (loss)			Net losses,<br>and loss<br>adjustment<br>expenses		Amortization<br>of deferred<br>acquisition<br>costs		Other<br>operating<br>expenses		Gross<br>premiums<br>written
2019	Property & Casualty	$	49,665	$	470,588	$	179,460	$	483,580	$	52,267		$	388,487	$	117,084	$	29,822	$	523,977
2018	Property & Casualty	$	49,929	$	482,662	$	211,789	$	508,363	$	(323,106	)	$	363,873	$	145,475	$	25,173	$	567,531
2017	Property & Casualty	$	62,350	$	464,380	$	255,818	$	626,004	$	20,231		$	502,404	$	161,740	$	26,356	$	692,651

SCHEDULE IV

GREENLIGHT CAPITAL RE, LTD.

SUPPLEMENTARY REINSURANCE INFORMATION

AS OF AND FOR THE YEARS ENDED DECEMBER 31, 2019, 2018 AND 2017

(expressed in thousands of U.S. dollars)

Year	Segment	Direct gross<br> premiums		Premiums<br> ceded to<br> other companies		Premiums<br>assumed from<br>other companies		Net written premiums		Percentage of<br> amount<br>assumed to net
2019	Property & Casualty	$	—	$	48,667	$	523,977	$	475,310	110	%
2018	Property & Casualty	$	—	$	102,788	$	567,531	$	464,743	122	%
2017	Property & Casualty	$	—	$	56,587	$	692,651	$	636,064	109	%

F-55

		Exhibit

Exhibit 4.4

DESCRIPTION OF THE REGISTRANT’S SECURITIES

The following is a description of the material terms and provisions relating to our Class A and Class B ordinary shares. Because it is a summary, the following description is not complete and is subject to and qualified in its entirety by reference to our Third Amended and Restated Memorandum and Articles of Association, or our Articles, which define the rights of our shareholders. Our Articles are incorporated by reference as an exhibit to the Annual Report on Form 10-K of which this Exhibit 4.4 forms a part.

Authorized Capital

Our authorized share capital consists of (i) 125 million ordinary shares, par value $0.10 per share; and (ii) 50 million preferred shares, par value $0.10 per share. As of March 6, 2020, we had 30,739,395 Class A ordinary shares issued and outstanding and 6,254,715 Class B ordinary shares issued and outstanding and no preferred shares issued or outstanding. As of March 6, 2020, there were approximately 41 record holders of our ordinary shares, not including beneficial owners of shares registered in nominee or street name who represent approximately 94.6% of the Class A ordinary shares issued and outstanding.

Ordinary Shares

Our ordinary shares are divided into 100,000,000 Class A ordinary shares, [30,739,395] of which are issued and outstanding, and 25,000,000 Class B ordinary shares, 6,254,715 of which are issued and outstanding as of March 6, 2020. Except as set forth in “Class B ordinary shares” below, the holders of all ordinary shares are entitled:

(i)	to share equally in dividends (whether payable in cash, property or our securities) as our board of directors (“Board of Directors”) may from time to time declare in accordance with the provisions of our Articles and the Companies Law (2020 Revision) of the Cayman Islands, or the Companies Law;
(ii)	in the event of our winding-up or dissolution, whether voluntary or involuntary or for the purpose of an amalgamation, reorganization or otherwise or upon any distribution of share capital and surplus, to share equally and ratably in our assets, if any, remaining after the payment of all of our debts and liabilities and the liquidation preference of any issued and outstanding preferred shares; and
---	---
(iii)	generally to enjoy all of the rights attaching to such shares.
---	---

Holders of ordinary shares have no pre-emptive, redemption, conversion or sinking fund rights.

Class A Ordinary Shares

Each Class A ordinary share is entitled to one vote per share. However, except upon unanimous consent of the Board of Directors, no holder shall be permitted to acquire an amount of shares which would cause any person to own (directly, indirectly or constructively under applicable United States tax attribution and constructive ownership rules) 9.9% or more of the total voting power of the total issued and outstanding ordinary shares (a “9.9% Shareholder”). The Board of Directors shall reduce the voting power of any holder that is a 9.9% Shareholder to the extent necessary such that the holder ceases to be a 9.9% Shareholder. In connection with this reduction, the voting power of the other shareholders of the Company may be adjusted pursuant to the terms of the Articles. Accordingly, certain holders of Class A Ordinary Shares may be entitled to more than one vote per share subject to the 9.9% restriction in the event that the Board of Directors is required to make an adjustment on the voting power of any 9.9% Shareholder or the voting power of a holder of Class B Ordinary Shares as described below.

Our Board of Directors has adopted a share repurchase plan authorizing the Company to repurchase up to 2.5 million Class A ordinary shares or securities convertible into Class A ordinary shares in the open market, through privately negotiated transactions or Rule 10b5-1 stock trading plans. On May 2, 2019, the Board of Directors renewed the share repurchase plan for a subsequent one year period and will expire on June 30, 2020 unless further renewed by the Board of Directors. As of December 31, 2019, 2.5 million Class A ordinary shares remained authorized for repurchase under the repurchase plan. The Company is not required to repurchase any of the Class A ordinary shares and the repurchase plan may be modified, suspended or terminated at the election of our Board of Directors at any time without prior notice. No shares were repurchased by the Company during the year ended December 31, 2019.

Shares reserved for issuance are composed of 0.3 million Class A ordinary shares in relation to share purchase options granted to a service provider and 5.0 million Class A ordinary shares reserved for the Company’s stock incentive plan for eligible employees, directors and consultants. On April 26, 2017, our shareholders approved an amendment to our stock incentive plan to increase the number of Class A ordinary shares available for issuance by 1.5 million shares from 3.5 million to 5.0 million. As of December 31, 2019, there were no remaining Class A ordinary shares available for future issuance relating to share purchase options granted to the service provider as all options granted to service providers had been exercised. As of December 31, 2019, 555,805 Class A ordinary shares remained available for future issuance under the Company’s stock incentive plan.

Class B Ordinary Shares

Each Class B ordinary share is entitled to ten votes per share. However, the total voting power of all Class B ordinary shares, as a class, shall not exceed 9.5% of the total voting power of the total issued and outstanding ordinary shares. The voting power of any Class A ordinary shares held by any holder of Class B ordinary shares (whether directly, or indirectly or constructively under applicable United States tax attribution and constructive ownership rules) shall be included for purposes of measuring the total voting power of the Class B ordinary shares. The Board of Directors shall reduce the voting power of any holder of Class B ordinary shares that owns more than 9.5% of the total voting power of the total issued and outstanding ordinary shares to the extent necessary such that the holder ceases to own more than 9.5% of the outstanding ordinary shares. In connection with this reduction, the voting power of the other holders of ordinary shares of the Company shall be adjusted pursuant to the terms of the Articles.

In the event of a sale, transfer, exchange or other disposition, of any Class B ordinary shares by a holder thereof, other than a transfer to a permitted transferee, as defined in our Articles, the Class B ordinary shares shall be automatically converted into an equal number of Class A ordinary shares.

The one-for-one conversion ratio for the conversion of Class B ordinary shares into Class A ordinary shares will be equitably adjusted in the event of any recapitalization of the company by means of a share dividend on, or a share split or combination of, outstanding Class A ordinary shares or Class B Ordinary Shares, or in any amalgamation, or other reorganization of the company with another company.

We will reserve and keep available sufficient authorized, but unissued, Class A ordinary shares to effectuate the conversion of Class B ordinary shares into Class A ordinary shares. If any Class B ordinary shares are converted, the converted Class B ordinary shares will be cancelled.

Limitation on Share Ownership

Under our Articles, except upon unanimous consent by the Board of Directors:

•	no person shall be allowed to acquire Class A ordinary shares if such acquisition would cause any person to own (directly, indirectly or constructively under applicable United States tax attribution and constructive ownership rules) 9.9% or more of the issued and outstanding ordinary shares; and
•	no person shall be allowed to acquire Class A ordinary shares if such acquisition would cause such person to own directly 9.9% or more of the issued and outstanding ordinary shares.
---	---

Under our Articles, our Board of Directors may send a repurchase notice in the event that it determines in its absolute discretion that:

•	a transfer would violate the ownership limitations described above; or
•	a transfer would result in an increased risk of adverse tax, regulatory or legal consequences to us. In the event the Board of Directors determines an ownership limitation has been violated, we have the option, but not the obligation, to purchase all or any part of the shares, to the extent we determine it is necessary or advisable to avoid or cure any adverse or potentially adverse consequences.
---	---

Preferred Shares

Pursuant to our Articles and Cayman Islands law, our board of directors may establish one or more series of preferred shares having such number of shares, designations, relative voting rights, dividend rates, liquidation and other rights, preferences, powers and limitations as may be fixed by the board of directors without any further shareholder approval; provided that certain shareholder approval may be required for a new class of shares that have superior rights over existing shares. Any preferred shares issued will include restrictions on voting and transfer intended to avoid having us constitute a ‘‘controlled foreign corporation’’ for United States federal income tax purposes. Such rights, preferences, powers and limitations as may be established could have the effect of discouraging an attempt to obtain control of us. The issuance of preferred shares could also adversely affect the voting power of the holders of the ordinary shares, deny shareholders the receipt of a premium on their ordinary shares in the event of a tender or other offer for the ordinary shares and have a depressive effect on the market price of the ordinary shares.

Options

As of December 31, 2019, options to purchase 875,627 Class A ordinary shares at a weighted average exercise price of $22.68 were outstanding.

Restricted Stock Units

As of December 31, 2019, restricted share units, convertible into 63,582 Class A ordinary shares at a weighted average grant date fair value of $13.76 were outstanding.

Corporate Governance

Our Articles provide for the corporate governance of the Company, including the establishment of share rights, modification of such rights, issuance of share certificates, the transfer of shares, alterations to capital, the calling and

conduct of general and special meetings, proxies, the appointment and removal of directors, conduct and powers of directors, the payment of dividends and the winding-up of the company.

Our Articles provide that the Board of Directors will be elected annually. Shareholders may remove a director for cause as defined in the Articles prior to the expiration of such director’s term at a meeting of shareholders at which a quorum is present and more than 50% of the total voting power entitled to vote is cast in favor of such action. A general meeting of shareholders may be convened by the chairman of the Board of Directors or any two directors or any director and the secretary of the Board of Directors.

The provisions contained in our Articles may only be amended upon the affirmative vote of sixty-six and two thirds percent of the votes cast at a meeting of shareholders where a quorum is present.

Subject to the provisions of our Articles, the directors, secretary and officers shall be held harmless for any acts or omissions in the performance of their duties in the absence of willful negligence, willful default, fraud or dishonesty. Our Articles contain provisions for the indemnification of directors, officers and the secretary against liabilities to third parties arising in connection with the performance of their services by us, to the extent approved by a majority of the disinterested members of the board of directors. Expenses may be advanced to indemnified parties if approved by a majority of the disinterested directors.

Registration Rights

The holders of our ordinary shares prior to our initial public offering were given certain registration rights pursuant to a shareholders’ agreement, dated August 11, 2004, or our Shareholders’ Agreement. Pursuant to our Shareholders’ Agreement, Greenlight Capital Investors, LLC, or GCI, had the right to unlimited demand registration rights once we were eligible to use Form S-3 (or similar short form registration statements). GCI assigned its demand registration rights under the Shareholders’ Agreement, with our consent, to David Einhorn, our chairman of the board, on January 3, 2007. Pursuant to the Shareholders’ Agreement, David Einhorn is entitled to registration rights for all of his Class B ordinary shares, including those acquired in a private placement in May 2007. We will not be required to effect more than two registrations pursuant to the demand rights in any 12 month period.

The registration rights described above can be modified on a pro rata basis if the managing underwriters for the registered offering believe modification is necessary due to market considerations. We are required to bear all expenses of all registration (exclusive of underwriting discounts and commissions, transfer taxes and fees and expenses of more than one counsel (and one local counsel, as reasonably required) for all selling shareholders).

On June 29, 2018, we entered into an amendment to the Shareholders’ Agreement to extend the term of David Einhorn’s registration rights to June 30, 2021.

Transfer Restrictions

Our Articles contain several provisions restricting the transferability of our ordinary shares. Our Articles provide that, if our Board of Directors determines in its sole and absolute discretion that:

•	any transfer of shares would violate the ownership limitations described above; or
•	the transfer would result in an increased risk of adverse tax, regulatory or legal consequences to us or any of our shareholders,
---	---

they may decline to register such transfer and, if not registered, would be of no effect. Our Articles also provide that in the event that our Board of Directors determines that an ownership limitation has been violated as a result of any transfer, we shall have the option, but not the obligation, to purchase all or any part of the ordinary shares, to the extent we determine it is necessary or advisable to avoid or cure any adverse or potentially adverse consequences resulting from such transfer.

In connection with any transfer of ordinary shares, and in addition to the certification requirement described above, holders of ordinary shares will only be able to transfer their ordinary shares in compliance with the provisions of the Securities Act.

Differences in Corporate Law

The Companies Law, which applies to us, differs in certain material respects from laws generally applicable to United States corporations and their shareholders. Set forth below is a summary of certain significant provisions of Companies Law (including modifications adopted pursuant to our Articles) applicable to us which differ in certain respects from provisions of Delaware corporate law. Because the following statements are summaries, they do not purport to deal with all aspects of Cayman Islands law that may be relevant to us and our shareholders.

Interested Party Transactions

No one will be disqualified from being elected director or appointed an alternate director because he or she has contracted with us. Likewise, none of our contracts will be deemed void because any director or alternate director is an interested party in such transaction. We will not hold any interested party liable for monies owed to us under such contract or transaction. A director (or his or her alternate director in his or her absence) may participate in the vote in respect of the contract or transaction in which he or she is interested as long as he or she disclosed his or her interest before that matter is considered or voted upon.

A director or alternate director may vote on a contract or transaction where he or she has an interest as a shareholder, director, officer or employee provided he or she disclosed the interest.

Under Delaware law such a transaction would be voidable unless:

•	the material facts as to such interested director’s relationship or interests are disclosed or are known to the board of directors and the board in good faith authorizes the transaction by the affirmative vote of a majority of the disinterested directors;
•	such material facts are disclosed or are known to the shareholders entitled to vote on such transaction and the transaction is specifically approved in good faith by vote of the majority of shares entitled to vote thereon; or
---	---
•	the transaction is fair as to the corporation as of the time it is authorized, approved or ratified. Under Delaware law, such interested director could be held liable for a transaction in which such director derived an improper personal benefit.
---	---

Mergers and Similar Arrangements

We may petition the Cayman Islands courts to allow us to enter into a scheme of arrangement whereby we amalgamate with another Cayman Islands company or with a body incorporated outside of the Cayman Islands if each class of shareholders representing 75% in number and in value of each class of shareholder of the company is present and voting at a general meeting of each class of shareholders’ vote in favor of the proposed scheme. Assuming that shareholder approval is obtained, we must request a court hearing sanctioning the scheme of arrangement. Any shareholder may attend and be heard at this hearing to argue that the scheme ought not to be sanctioned and the Cayman Islands court can take any matter into account when considering whether or not to sanction the scheme of arrangement. If the court sanctions such a scheme then it becomes binding on all the shareholders whether or not they voted for or voted against the scheme. If the scheme of arrangement receives sanction of the Cayman Islands court, the court order must be filed with the Cayman Islands Registrar of Companies in order to become effective. Thereafter, the provisions of the scheme of arrangement can be put into place.

We may also enter into a merger (the merging of two or more constituent companies with one company remaining as the surviving company) or consolidation (the combination of two or more companies into a consolidated company) without court approval in certain circumstances. Under this method, each constituent board of directors must adopt a written plan describing the terms and conditions of the proposed merger or consolidation and each constituent company’s shareholders must authorize the plan by way of a special resolution (normally, and as a minimum, a two thirds majority of the shareholders voting together as one class). In some circumstances a shareholder may dissent and be entitled to appraisal rights where such shareholder receives cash in the amount of fair value of the shares held by such shareholder as determined by the Cayman Islands Court. The valuation approach and the determination of fair value adopted by the Cayman Islands Court may be different to the approach and outcome of a Delaware Court.

Under Delaware law, with certain exceptions, a merger, consolidation or sale of all or substantially all the assets of a corporation must be approved by the board of directors and a majority of the outstanding shares entitled to vote thereon. Under Delaware law, a stockholder of a corporation participating in certain major corporate transactions may, under certain circumstances, be entitled to appraisal rights pursuant to which such stockholder may receive cash in the amount of the fair value of the shares held by such stockholder (as determined by a court) in lieu of the consideration such stockholder would otherwise receive in the transaction.

Shareholders’ Suits

Under Cayman Islands law the general principle is that a shareholder cannot bring an action in his or her own name against those in control of the company if the cause of action is vested in the company and relief is accordingly sought on behalf of the company.

The exceptions to this general principle are:

•	where the alleged wrong is illegal or ultra vires the company;
•	where the applicable transaction required, but did not receive, sanction by a special resolution or special majority of shareholders;
---	---

•	where what has been done amounts to a fraud on the minority shareholders and the wrongdoers are in control of the company as directors or majority shareholder (in this context, fraud has its wider equitable meaning); or
•	where the act complained of infringes a personal right of the shareholder seeking to bring the action. In any of these situations, the Grand Court may grant permission for the aggrieved shareholder(s) to bring a derivative action for the benefit of the company against the wrongdoers. The court may order the legal costs of commencing and progressing the action to be paid by the company.
---	---

Class actions are generally not available to shareholders under the laws of the Cayman Islands, although there is power under the Grand Court rules to make a representation order pursuant to which one person is appointed to represent other persons who have the same interest in the proceedings. The Grand Court rules also provide a regime for the recovery of costs by a successful party in litigation against an unsuccessful party. Although an order for costs is at the discretion of the court, a winning party will usually be entitled to recover a portion of attorneys’ fees for the litigation.

An alternative remedy available to shareholders under Cayman Islands law is to petition the Grand Court for an order that it is just and equitable to wind up the company. If a winding up order is made, the company will go into liquidation.

Indemnification of Directors

We may indemnify our directors or officers in their capacity as such in respect of any loss arising or liability attaching to them by virtue of any rule of law, save in respect of any act or omission involving willful negligence, willful default, fraud or dishonesty. Under Delaware law, a corporation may indemnify a director or officer of the corporation against expenses (including attorneys’ fees), judgments, fines and amounts paid in settlement actually and reasonably incurred in defense of an action, suit or proceeding by reason of such position if:

•	such director or officer acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the best interests of the corporation; and
•	with respect to any criminal action or proceeding, such director or officer had no reasonable cause to believe his or her conduct was unlawful.
---	---

We will indemnify each of our directors, agents and officers out of our assets against any liability incurred by them as a result of any act or failure to act in carrying out their functions other than such liability (if any) that they may incur by their own willful negligence, willful default, fraud or dishonesty. No such director, agent or officer shall be liable to us for any loss or damage in carrying out his or her functions unless their liability arises through willful negligence, willful default, fraud or dishonesty of such director, agent or officer.

Inspection of Corporate Records

Members of the general public do not have the right to inspect our corporate or constitutive documents with

the exception of the register of directors. The Registrar of Companies shall make a list of the names of the current directors (and alternate directors where applicable) available for inspection by any person on payment of a fee and subject to such conditions as the Registrar may impose. A shareholder of a Cayman Islands company has the right to request the company send him a copy of its memorandum and articles of association in force, on payment of a maximum sum of one Cayman Islands dollar for each copy. In addition, our Articles provide that our board of directors shall from time to time determine whether and to what extent and at what times and places and under what conditions or regulations our accounts and books or any of them shall be open to the inspection of shareholders and no shareholder shall have any right of inspecting any of our accounts or books or documents except as conferred by statute, or authorized by our board of directors or by us in general meeting. Also, the directors may from time to time cause to be prepared and to be laid before us in general meeting financial statements and such other reports and accounts as may be required by law. We are also required to keep a register of mortgages and charges, which is open to inspection by any creditor or shareholder at all reasonable times.

We are not required to, but may, maintain our share register in the Cayman Islands. We are required to keep at our registered office a register of our directors and officers, which is not open for inspection by members of the public. Our registered office is located at 65 Market Street, Suite 1207, Camana Bay, P.O. Box 31110, Grand Cayman, KY1-1205, Cayman Islands.

Delaware law permits any shareholder to inspect or obtain copies of a corporation’s shareholder list and its other books and records for any purpose reasonably related to such person’s interest as a shareholder.

Conversion Rights

If applicable, the terms of preferred shares of any series that are convertible into or exchangeable for our Class A ordinary shares or our other securities will be described in an applicable prospectus supplement. These terms will describe whether conversion or exchange is mandatory, at the option of the holder, or at our option. These terms may include provisions pursuant to which the number of shares of our Class A ordinary shares or our other securities to be received by the holders of preferred shares would be subject to adjustment. Any such conversion or exchange will comply with applicable Cayman Islands law and our Articles.

Transfer Agent and Registrar

The transfer agent and registrar for our Class A ordinary shares is Computershare. Its address is 480 Washington Boulevard, Jersey City, NJ 07310 and its telephone number at this location is (201) 680-2464.

Listing

Our Class A ordinary shares are listed on the Nasdaq Global Select Market under the trading symbol “GLRE.”

		Exhibit

GREENLIGHT CAPITAL RE, LTD.

BONUS PLAN

1.Purpose. The purpose of this Greenlight Capital Re, Ltd. Bonus Plan (as amended, restated or otherwise modified from time to time, the “Plan”) is to foster and promote the financial success of Greenlight Capital Re, Ltd. (the “Company”) and its subsidiaries (together with the Company, collectively, the “Greenlight Group”) and reward certain employees of the Greenlight Group for their on-going efforts in connection with the exploration of potential strategic alternatives which could result in the payment of the Transaction Fee (as defined below).

2. Definitions.

a)	“Board” means the Board of Directors of the Company.
b)	“Bonus” means a cash incentive payable under the Plan to a Participant if the Transaction Fee becomes due and payable, subject to the terms and conditions set forth in the Plan and the Bonus Agreement, the amount of which is set forth in the Bonus Agreement.
---	---
c)	“Bonus Agreement” means a written agreement entered into between the Company and the Participant in connection with a Bonus.
---	---
d)	“Cause” means the definition of Cause provided in the Participant’s employment agreement, offer letter or similar agreement for services with a member of the Greenlight Group.
---	---
e)	“CEO” means Chief Executive Officer of the Company.
---	---
f)	“Committee” means the Compensation Committee of the Board.
---	---
g)	“Credit Suisse” means Credit Suisse Securities (USA) LLC.
---	---
h)	“Disability” means, if the Participant is a party to an employment agreement, offer letter or similar agreement for services with a member of the Greenlight Group and such agreement or letter provides for a definition of Disability, the definition therein contained, or if no such agreement or letter exists or such term is not defined therein, it shall mean the failure of any Participant to perform the Participant’s duties due to physical or mental incapacity as determined by the Committee.
---	---
i)	“Engagement Letter” means that certain letter agreement by and between Credit Suisse and the Company, dated as of May 28, 2019, as it may be amended from time to time.
---	---
j)	“Fee Date” means the date on which the Transaction Fee becomes due and payable pursuant to and in connection with the Engagement Letter.
---	---
k)	“Release” means a general release of claims against the Company and its affiliates in such form as the Board may reasonably determine.
---	---
l)	“Transaction Fee” has the meaning set forth in the Engagement Letter.
---	---

3. Administration. The Plan shall be interpreted and administered by the Committee. The Committee shall have full power and authority to (i) designate Participants in accordance with Section 4 below, (ii) determine the amount of any Bonus under any Bonus Agreement in accordance with Section 4 below, (iii) interpret and administer the Plan and/or any Bonus Agreement, (iv) make factual determinations with respect to the Plan and/or any Bonus Agreement, (v) waive any terms or conditions under the Plan and/or any Bonus Agreement, (vi) resolve any disputes, correct any defect, reconcile any inconsistency, and supply any omissions under the Plan and/or any Bonus Agreement, (vii) prescribe or amend forms or procedures as it deems necessary or appropriate for the proper administration of the Plan and/or any Bonus Agreement, and (viii) make any other determinations and take such other actions as it deems necessary or advisable under or with respect to the Plan and/or any Bonus Agreement. Any action required of the Company under the Plan or any Bonus Agreement need not be uniformly applied to similarly situated individuals. All determinations, interpretations or other actions made or taken (including, but not limited to, any failure to make any determination or interpretation or failure to make or take any other action) by the Committee, including with respect to the resolution of disputes under the Plan and/or any Bonus Agreement, shall be within the sole discretion of the Committee, shall be final, conclusive and binding upon the Company, all Participants and all other interested individuals and/or entities, including, without limitation, all Eligible Employees, and shall be given deference in any proceeding with respect thereto.

4. Eligibility and Amount of Bonus.

a)	Eligible Employees. Each employee, other than the CEO, of the Greenlight Group shall be eligible to participate in the Plan (each, an “Eligible Employee”).
b)	Designation of Participants and Amount of Bonuses. Prior to the Fee Date, based upon recommendations made by the CEO to the Committee, the Committee shall determine (i) whether an Eligible Employee shall be designated to receive a Bonus, subject to the terms and conditions of this Plan and the Bonus Agreement, and (ii) the individual amount of such Bonus. Notwithstanding the foregoing, an Eligible Employee who is a United States taxpayer shall not be eligible to be designated to receive a Bonus under clause (i) of the preceding sentence prior to January 1, 2020. An Eligible Employee who is provided with, and executes and delivers to the Company, a Bonus Agreement (and any other supporting documentation contemplated thereby) prior to the Fee Date, shall be referred to herein as a “Participant”.
---	---
c)	For the avoidance of doubt, with respect to the designation of Eligible Employees who are designated to become Participants in the Plan, the allocation of the individual amount of Bonuses, and the Bonus Agreements, the CEO shall make recommendations to the Committee, but the designation of Eligible Employees as Participants, allocations of the individual amount of Bonuses, and the Bonus Agreements are subject to approval by the Committee.
---	---
d)	If any Participant’s Bonus is forfeited in accordance with the terms of the Plan and/or the Bonus Agreement, such amounts will not be eligible for reallocation and will not again be available for grant under the Bonus Pool.
---	---

5. Maximum Amount of Bonus Pool. Notwithstanding anything herein or in any Bonus Agreement to the contrary, (a) the aggregate maximum amount of Bonuses that may be allocated and paid under the Plan and the Bonus Agreements shall not exceed US$1,000,000 (the “Bonus Pool”), (b) the Bonus Pool will not be required to be fully allocated, and (c) the aggregate maximum amount that may be paid out to Participants under the Plan and the Bonus Agreements may be less than the Bonus Pool amount (but in no event more than the Bonus Pool amount) to the extent (x) the Transaction Fee does not become due and payable, (y) the Bonus Pool amount has not been fully allocated prior to the Fee Date, and/or (z) a Participant’s Bonus is forfeited in accordance with the terms of the Plan and/or the Bonus Agreement.

6. Terms and Conditions for Payment of Bonus. Except as set forth below in Section 7(a), the Participant’s receipt of the Bonus shall be subject to (a) the Transaction Fee becoming due and payable, (b) the Participant having signed and agreed to be bound by a Release (save that any such Release shall not limit, release or waive the Participant’s right to indemnification as provided for by the Participant’s employment agreement, offer letter or other similar agreement for services with a member of the Greenlight Group, as applicable, or otherwise by law or contract and shall not impose additional restrictive covenants of the type provided for in the Participant’s employment agreement, offer letter or other similar agreement for services with a member of the Greenlight Group, as applicable) (such Release, the “Transaction Release”) within the time period referenced in Section 7(c)(iii), (c) the Participant’s continuous employment with a member of the Greenlight Group in good standing until and on the Fee Date (and not having given notice of termination for any reason or received notice of termination for Cause or due to Disability), and (iv) the Participant’s compliance with any and all confidentiality, non-competition, non-solicitation, non-disparagement, and assignment of inventions provisions by which the Participant may be bound howsoever arising, through the Payment Date (as defined below). If all of the foregoing conditions are satisfied, the Participant’s Bonus shall be paid to the Participant in a lump sum cash payment on the sixtieth (60th) day following the Fee Date (such date, the “Payment Date”).

7.	Termination of Employment and Forfeiture of Bonus.
a.	Termination of Employment without Cause (other than due to death or Disability). If, prior to the Fee Date, the Participant’s employment with the Greenlight Group is terminated by a member of the Greenlight Group without Cause (other than due to death or Disability), then, subject to (i) the Transaction Fee becoming due and payable, (ii) the Participant (x) having signed and agreed to be bound by a Release in connection with the termination of employment (save that any such Release shall not limit, release or waive the Participant’s right to indemnification as provided for by the Participant’s employment agreement, offer letter or other similar agreement for services with a member of the Greenlight Group, as applicable, or otherwise by law or contract and shall not impose additional restrictive covenants of the type provided for in the Participant’s employment agreement, offer letter, or other similar agreement for services with a member of the Greenlight Group, as applicable) (such Release, the “Termination Release”) within the time period referenced in Section 7(c)(iv) and (y) having signed and agreed to be bound by the Transaction Release within the time period referenced in Section 7(c)(iii), and (iii) the Participant’s compliance with any and all confidentiality, non-competition, non-solicitation, non-disparagement, and assignment of inventions provisions by which the Participant may be bound howsoever arising through the Payment Date, the Participant’s Bonus shall be paid to the Participant in a lump sum cash payment on the Payment Date.
---	---
b.	Forfeiture. Notwithstanding anything herein to the contrary, (i) except as otherwise set forth in Section 7(a), if (x) the Participant’s employment with a member of the Greenlight Group terminates for any reason at any time or (y) the Participant has given notice of termination for any reason or received notice of termination by a member of the Greenlight Group for Cause or due to Disability, in any such case, the Participant shall cease to be a Participant in the Plan, the Participant’s Bonus shall be forfeited, the Participant’s Bonus Agreement shall automatically terminate without any further action, and the Participant shall have no further rights hereunder or thereunder, (ii) if a transaction has not been consummated on or prior to December 15, 2020, the Participant shall cease to be a Participant in the Plan, the Participant’s Bonus shall be forfeited, the Participant’s Bonus Agreement shall automatically terminate without any further action, and the Participant shall have no further rights hereunder or thereunder, (iii) if the Participant should fail to execute and be bound by the Transaction Release within 45 days following the later of (x) the Fee Date, and (y) the date the Participant actually receives an execution copy of such Transaction Release (which shall be delivered to the Participant within ten (10) business days following the Fee Date, and, if not timely delivered, the Transaction Release condition will be deemed waived by the Company), the Participant shall cease to be a Participant in the Plan, the Participant’s Bonus shall be forfeited, the Participant’s Bonus Agreement shall automatically terminate without any further action, and the Participant shall have no further rights hereunder or thereunder, (iv) if the Participant should fail to execute the Termination Release within 45 days following the later of (x) the Participant’s termination date, and (y) the date the Participant actually receives an execution copy of such Release (which shall be delivered to the Participant within ten (10) business days following the Participant’s termination date, and, if not timely delivered, the Termination Release condition will be deemed waived by the Company), the Participant shall cease to be a Participant in the Plan, the Participant’s Bonus shall be forfeited, the Participant’s Bonus Agreement shall automatically terminate without any further action, and the Participant shall have no further rights hereunder or thereunder, and (v) if the Participant breaches any confidentiality, non-competition, non-solicitation, non-disparagement, and assignment of inventions provisions by which the Participant may be bound howsoever arising, the Participant shall cease to be a Participant in the Plan, the Participant’s Bonus shall be forfeited, the Participant’s Bonus Agreement shall automatically terminate without any further action, and the Participant shall have no further rights hereunder or thereunder.
---	---

8. Successors: All rights and interests of the Participants shall be non-assignable, and non-transferable, and otherwise not subject to pledge or encumbrance, whether voluntary or involuntary, other than by will or by laws of descent and distribution. This Plan shall be binding upon, and inure to the benefit of, the successors and assigns of the Company, and shall be assignable by the Company to any entity acquiring substantially all of the assets of the Company, whether by merger, consolidation, sale of assets or similar transactions.

9. Notice. For the purposes of the Plan and any Bonus Agreement, notices, demands and all other communications provided for in the Plan and any Bonus Agreement shall be in writing and shall be deemed to have been duly given when delivered either personally or by overnight, certified or registered mail, return receipt requested, postage prepaid, addressed, in the case of the applicable Participant, to the last address on file with the Greenlight Group and if to the Company, to its executive offices or to such other address as any party may have furnished to the other in writing in accordance herewith, except that notices of change of address shall be effective only upon receipt.

10. Governing Law. This Plan and all Bonus Agreements shall be governed by and construed in accordance with the laws of the Cayman Islands.

11. Taxes. The Company or any other member of the Greenlight Group shall have the right to deduct from any compensation paid to the Participant pursuant to the Plan and any Bonus Agreement the amount of taxes required by law in any jurisdiction to be withheld therefrom.

12. Section 409A. Notwithstanding anything herein or in any Bonus Agreement to the contrary, to the extent applicable, this Plan and any Bonus Agreement are intended to comply with or be exempt from and shall be administered in a manner that is intended to comply with or be exempt from Section 409A of the Internal Revenue Code of 1986, as amended, and the rules and regulations promulgated thereunder (collectively, “Section 409A”) and the Plan and any Bonus Agreement shall be limited, construed and interpreted with such intent. Notwithstanding the foregoing, no member of the Greenlight Group guarantees that any payment under the Plan or Bonus Agreement complies with or is exempt from Section 409A, and neither the Company, its subsidiaries or affiliates, nor their respective executives, members, partners, directors, officers, or affiliates shall have any liability with respect to any failure of any payments or benefits under the Plan or any Bonus Agreement to comply with or be exempt from Section 409A. If any provision hereunder or under any Bonus Agreement results in the imposition of an additional income or other tax on any Participant under Section 409A, to the extent permitted by Section 409A, such provision shall be reformed to the extent practicable to avoid any such imposition in such manner as the Company determines is appropriate to comply with Section 409A. Each payment under the Plan or any Bonus Agreement to which Section 409A applies shall be treated as a separate identified payment for purposes of Section 409A. In no event may any Participant, directly or indirectly, designate the calendar year of any payment to be made under this Plan or any Bonus Agreement which constitutes a “deferral of compensation” within the meaning of Section 409A. To the extent any payment under the Plan or any Bonus Agreement is subject to Section 409A, any reference to termination of service or similar terms shall mean a “separation from service” under Section 409A.

13. No Right to Employment. Nothing in this Plan or in any Bonus Agreement shall be deemed by implication or otherwise to impose any limitation on any right of any member of the Greenlight Group to terminate any Participant’s employment at any time.

14. No Obligation; Company Discretion. No provision of this Plan or any Bonus Agreement shall be interpreted to impose an obligation on the Company to accept, agree to or otherwise consummate a transaction. The decision to consummate a transaction, if any, and all terms and conditions of such transaction, including the amount, timing and form of consideration to be provided in connection therewith, shall be within the sole and absolute discretion of the Company.

15. Unfunded Status. No Participant in the Plan or any other person or entity claiming a benefit under or through a Participant or otherwise shall have any right, title or interest by reason of his, her or its participation to any particular assets of the Company or any of its subsidiaries or affiliates. Neither the Company nor any of its subsidiaries or affiliates shall be required to establish any fund or make any other segregation of assets to assure satisfaction of the obligations under the Plan. Nothing in the Plan or any Bonus Agreement gives any Participant or any other person or entity claiming a benefit under or through a Participant any rights that are greater than those of a general unsecured creditor of the Company or any of its subsidiaries or affiliates.

16. Amendment/Termination. The Board at any time, and from time to time, and for any reason or no reason, may amend, modify, or terminate the Plan and/or any Bonus Agreement; provided, however, a Participant’s rights under the Plan and/or any Bonus Agreement granted before amendment, modification or termination shall not be materially impaired by any such amendment, modification or termination of the Plan and/or any Bonus Agreement unless (i) the Company requests the consent of the Participant and (ii) the Participant consents in writing. Notwithstanding the foregoing, the Plan shall automatically terminate upon the earlier of (x) the satisfaction of all obligations hereunder and under any Bonus Agreement and (y) December 16, 2020. No waiver by the Company at any time of any breach by any Participant of any condition or provision of this Plan and/or any Bonus Agreement to be performed by such Participant shall be deemed a waiver of similar or dissimilar provisions or conditions at the same or at any prior or subsequent time.

17. Effective Date of Plan. The Plan is effective as of September 22, 2019 and shall continue until terminated in accordance with Section 16.

18. Severability. Every provision of this Plan is intended to be severable and any illegal or invalid term shall not affect the validity or legality of the remaining terms.

19. Headings. The headings of the Sections hereof are provided for convenience only and are not to serve as a basis for interpretation of construction, and shall not constitute a part of this Agreement.

		Exhibit

GREENLIGHT CAPITAL RE, LTD.

BONUS PLAN

BONUS AGREEMENT

This Bonus Agreement (this “Agreement”) is entered into by and between Greenlight Capital Re, Ltd. (the “Company”) and [●] (the “Participant”), as of the last date set forth below. Each capitalized term not otherwise defined in this Agreement will have the meaning ascribed to such term in the Greenlight Capital Re, Ltd. Bonus Plan (as amended, restated or otherwise modified from time to time, the “Plan”).

1.Notice of Participation/Bonus Eligibility. In accordance with the terms and conditions of the Plan, the Committee has designated the Participant as a Participant in the Plan eligible to receive a Bonus under the Plan in the amount of US$[●], subject to and in accordance with the terms, conditions, and provisions of the Plan and this Agreement and subject to the Participant’s execution and delivery of this Agreement to the Company prior to the Fee Date.

2. Plan and Bonus Agreement. The terms and provisions of the Plan are hereby incorporated into this Agreement by reference as if set forth herein in their entirety. This Agreement shall be, in all respects, subject to the terms and conditions of the Plan. In the event of a conflict or inconsistency between the terms, conditions, and provisions of the Plan and this Agreement, the Plan shall govern and control.

3. Other Benefits. The Bonus is a special incentive payment to the Participant and shall not be taken into account in computing the amount of salary or compensation for purposes of determining severance or any bonus, incentive, pension, retirement, death or other benefit under any other bonus, incentive, pension, retirement, insurance or other employee benefit plan of any member of the Greenlight Group, unless such plan or agreement expressly provides otherwise.

4. Entire Agreement. This Agreement and the Plan constitute the entire agreement of the parties with respect to the subject matter hereof and supersede all prior undertakings and agreements with respect to the subject matter hereof.

5. Amendments. This Agreement may be amended in accordance with the terms and conditions set forth in the Plan.

6. Representations and Warranties of the Participant. The Participant acknowledges receipt of a copy of the Plan and represents that the Participant is familiar with its terms, conditions, and provisions, and hereby accepts this Agreement subject to all of its and the Plan’s terms, conditions, and provisions and agrees to be bound by all of the terms and conditions of the Plan. The Participant has reviewed the Plan and this Agreement in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Agreement and fully understands all terms, conditions, and provisions of the Plan and this Agreement. The Participant hereby agrees to accept as final, conclusive and binding all determinations, interpretations or other actions made or taken by the Committee upon any questions arising under the Plan or this Agreement. The Participant further agrees to notify the Company upon any change in the address.

7. Signature in Counterparts. This Agreement may be signed in counterparts, each of which shall be deemed an original, with the same effect as if the signatures thereto and thereto were upon the same instrument.

[SIGNATURE PAGE FOLLOWS]

IN WITNESS WHEREOF, the parties have executed this Agreement as of the last date set forth below.

GREENLIGHT CAPITAL RE, LTD.

By: Name:

Title:

Date:

PARTICIPANT

By: ________________________________

Name:

Date:

		Exhibit

AMENDMENT TO EMPLOYMENT AGREEMENT

This AMENDMENT TO THE EMPLOYMENT AGREEMENT (this "Amendment"), dated as of September 2, 2019 (the "Amendment Date"), is entered into by and among GREENLIGHT CAPITAL RE, LTD. (the "Company"), GREENLIGHT REINSURANCE, LTD. (the "Subsidiary") and NEIL GREENSPAN (the "Executive").

RECITALS

WHEREAS, the Company, the Subsidiary, and the Executive have entered into that certain Employment Agreement, dated as of December 3, 2018 (the "Employment Agreement"); and

WHEREAS, the Company, the Subsidiary and Executive desire to make certain changes to the Employment Agreement as set forth herein.

NOW, THEREFORE, in consideration of the premises and the mutual agreements contained herein and in the Employment Agreement, the parties hereto agree as follows:

SECTION 1. Definitions. All capitalized terms not otherwise defined herein are used as defined in the Employment Agreement.

SECTION 2. Amendment to Employment Agreement. The Employment Agreement is hereby amended as follows on the date as set forth below:

2.1 The first sentence of Section 8.3 of the Employment Agreement is hereby amended and restated in its entirety as follows, effective as of the Amendment Date:

"The Executive may terminate his employment with the Employer for "Good Reason" within thirty (30) days after Executive has knowledge of the occurrence, without Executive's written consent, of any one of the events defined below that has not been cured, if curable, within thirty (30) days after written notice thereof has been given by the Executive to the Employer (the "Cure Period") and such termination, which shall occur promptly at the end of the Cure Period, in and of itself shall not be, nor shall it be deemed to be, a breach of this Agreement."

2.2 The first sentence of Section 9.5.2 of the Employment Agreement is hereby amended and restated in its entirety as follows, effective as of the Amendment Date:

"provided the Executive does not breach the Agreement following the Termination Date (in which case all payments under this clause shall cease) and subject to Sections 9.2 and 9.3, the Subsidiary shall pay to the Executive an amount equal to one hundred percent (100%) of the sum of Executive's Base Salary and Target Bonus (assuming targets have been achieved), which amount shall be paid in substantially equal monthly installments over the twelve (12) month period following the Termination Date with the first payment commencing on the 60^th^ day following the Termination Date (the "Initial Payment Date") and with amounts in respect of the period preceding the Initial Payment Date to be

paid in a lump sum on the Initial Payment Date. Any payments pursuant to this clause shall be in addition to any statutory entitlements arising upon termination, including but not limited to severance pay;"

SECTION 3. Miscellaneous.

3.1 Effect on Employment Agreement. Except as specifically amended by this Amendment, the Employment Agreement shall remain in full force and effect and is hereby ratified and confirmed.

3.2 Entire Agreement; Amendment. The Employment Agreement, as amended by the terms of this Amendment, will supersede the prior terms of the Employment Agreement and sets forth the entire agreement and understanding of the parties relating to the subject matter herein and therein. No modification of or amendment to this Amendment, nor any waiver of any rights under this Amendment, shall be effective unless given in a writing signed by the party to be charged.

3.3 Governing This Amendment shall be governed by and

construed in accordance with, the laws of the Cayman Islands and any controversy or claim related hereto shall be resolved in accordance with Section 14 of the Employment Agreement.

3.4 Successors and Assigns. This Amendment shall be binding upon and shall inure to the benefit of the parties hereto and the successors and assigns of the Company and the Subsidiary.

3.5 Headings. Section headings are for convenience of reference only and shall in no way affect the interpretation of this Amendment.

3.6 Counterparts. This Amendment may be executed in any number of counterparts, all of which when taken together shall constitute one and the same agreement, and any of the parties hereto may execute this Amendment by signing any such counterpart. Electronic signatures shall be effective as originals.

[SIGNATURE PAGE FOLLOWS]

IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed effective as of the Amendment Date.

GREENLIGHT CAPITAL RE, LTD.

By: /s/ Simon Burton

Name: Simon Burton

Title: CEO

GREENLIGHT REINSURANCE, LTD

By: /s/ Simon Burton

Name: Simon Burton

Title: CEO

By: /s/ Neil Greenspan

NEIL GREENSPAN

[SIGNATURE PAGE TO AMENDMENT TO EMPLOYMENT AGREEMENT]

		Exhibit

Tom Curnock

116 Liberty View Drive

Jersey City, NJ 07302

March 23, 2009

Dear Mr. Curnock:

I am pleased to offer you the position of Vice President Underwriter at Greenlight Reinsurance, Ltd. (the "Company"), subject to our customary background checks which you authorize us to conduct and immigration approval. This position reports directly to the President. The following letter outlines the key terms and conditions of your employment relationship with the Company.

◦	Start Date: Provisionally June 1, 2009, subject to Immigration Approval
◦	Place of Employment: The Company's principal offices located in The Grand Pavilion, 802 West Bay Road, Grand Cayman Island, B.W.I. or such other location in Grand Cayman island at which the Company's principal offices may be located.
---	---
◦	Job Description: See attached Schedule A — to be provided
---	---
◦	Employment Status: Employee at will. Your employment may be terminated by the Company for any reason upon 90 days written notice, and may be terminated immediately by the Company for "Cause." For purposes of this agreement, "Cause" shall mean the employee's (i) drug or alcohol use which impairs the ability of the employee to perform his/her duties hereunder; (ii) conviction by a court of competent jurisdiction, or plea of "no contest" or guilty to a criminal offense; (iii) engaging in fraud or embezzlement or any other illegal conduct with respect to the Company; (iv) violation of the Company's Code of Conduct, the Tax Operating Guidelines or any other Operating Guidelines; (v) or the revocation of your Cayman Work permit or (vi) a breach of any representation made by Employee contained in that certain Non-Competition, Non-Solicitation, Intellectual Property and Confidentiality Agreement dated as of the date herewith. If notice of termination is given prior to one year from the initial date of employment, the notice period will be deemed to be the greater of (a) 90 days and (b) the number of days between the date of notice and the date one year after the initial date of employment.
---	---

P.O. Box 1109 GT, Grand Cayman, BWI
The Grand Pavilion, Seven Mile Beach
Phone (345)745-4573, Fax (345) 745-4573

◦	Work Hours: The standard work hours are 8:30 a.m. to 6:00 p.m., Monday through Friday. As a professional employee you will be expected to work overtime without any additional remuneration. Cayman does not observe Daylight Savings Time, so the Company may switch the normal hours of operation to 7:30 a.m. to 5:00 p.m. during the summer months.
◦	Holidays: The Company will observe a mixture of Caymanian and US holidays totaling at least 10 clays each year.
---	---
◦	Travel and Expenses: You may be required to travel as necessary to perform your
---	---

job duties. The Company will reimburse you for reasonable and customary expenses incurred during the course of business travel upon presentation of expense statements or vouchers or such other information as the Company may reasonably require in accordance with Company policies.

◦	Vacation: You will be entitled to 20 days of vacation leave per year. Scheduling of vacation time will be subject to prior approval of the President. Vacation time does not rollover without prior approval of the President.
◦	Sick days: You will be entitled to 10 sick days per year for actual illness. If you are absent from work for more than three consecutive days, you will be required to produce a doctor's note.
---	---
◦	Benefits: You will be entitled to participate in such employee benefit plans and insurance programs offered by the Company, or which it may adopt from time to time, for its employees, in accordance with the eligibility requirements for participation therein and applicable law.
---	---
◦	Remuneration:
---	---
◦	Base Salary: Annual Base Salary of $200,000, which will be paid monthly on or about the 23^rd^ of each month to a local Caymanian bank account in $US. Salary reviews are expected to take place annually in February of the year following performance and such changes in salary, if any, will be instituted in March of the year following performance effective as of January 1 of the year following performance. For sake of clarity, the performance year of 2009 will be reviewed in February of 2010, with changes, if any, effective as of January 1, 2010.
---	---
◦	Living Allowance: An annual living allowance of $60,000 will be paid monthly ($5,000 per month) in addition to your base salary.
---	---
◦	Bonus: Your annual target bonus is 62.5% of base salary. The bonus, if any, is expected to be evaluated annually in February of the calendar year following performance, with bonuses declared shortly thereafter and paid in accordance with the Company's then approved compensation plan. Bonus awards will be based on the Company's performance in relation to targets established by the Board of Directors annually and your individual performance in relation to your assigned duties. Payment of any bonus for the 2009 year of performance will be based on a percentage times actual salary earned during 2009. A complete copy of the Company's current compensation plan will be furnished upon acceptance of this offer. For the 2009 performance year, 30% of your target bonus will be evaluated based on qualitative factors such as personal
---	---

P.O. Box 1109 GT, Grand Cayman, BWI
The Grand Pavilion, Seven Mile Beach
Phone (345)745-4573, Fax (345) 745-4573

goals and objectives and 70% will be based on quantitative factors such as underwriting results. The quantitative portion of the bonus can vary up or down based the Company's underwriting performance.

◦	Performance Shares: In connection with your acceptance of this offer, the Company will recommend to the Board that you will be awarded 6,000 restricted Class A Ordinary shares of the Company's stock. The shares shall be evidenced by, and subject to, the terms and conditions of the Greenlight Capital Re, Ltd. 2004 Stock Incentive Plan, The shares will vest fully on March 15th 2012.
◦	Long-term Incentive Plan: You will be eligible for the Company's Long-term Incentive Plan. As a participant in the plan you will be eligible for further grants of restricted shares as well as option grants, from time to time, subject to the approval of the Board. Vesting of options or restricted shares grants and other terms and conditions of any such awards will be specified in your award agreement(s), if any.
---	---
◦	Pension: The Company has established a Pension plan in compliance with the Cayman Pension Act. The Company will deposit CI$6,000 (roughly $7,200) into your pension account annually. The pension amounts vest 100% after two years of continuous employment with the Company.
---	---
◦	Tax Advice: For US, Canadian and British citizens filing tax returns, the Company has arranged to have Federal Tax returns prepared at the Company's expense, up to $5,000 annually. The service provider will be Price Waterhouse Coopers, unless otherwise specified by the Company.
---	---
◦	Work Permit: AS a non-Caymanian, the Company will be required to obtain a work permit for you from the Caymanian Immigration authorities prior to your employment by the Company, This offer is predicated on the work permit being acquired and becomes null and void if the Company is unable to obtain the work permit from the said Immigration authorities.
---	---
◦	Relocation Expense Allowance: The Company will pay you a one time moving expense allowance of $20,000, to be used as you see fit. The Company will not be obligated to pay relocation costs in excess of this amount. If your period of employment ends prior to 36 months after your commencement of employment, you will be required to re-pay a pro-rata portion of the Relocation Expense Allowance. For the sake of clarity, if you elect to terminate your employment with the Company after 24 months from the commencement of your employment, you will be required to repay 33% of the initial Relocation Expense Allowance.
---	---
◦	Notice: You may terminate your employment with the Company upon 90 clays written notice. Upon your voluntary termination and satisfaction of the 90 day notice period, you will be paid any accrued but unpaid base salary and any unused vacation time. If you do not satisfy the 90 clay notice period, all unused vacation time shall be forfeited.
---	---
◦	Termination Option: If the Company is downgraded by A.M. Best below "A-" (excellent) within twenty-four months of the start of employment, you will have the option to terminate your employment with 30 days written notice. Upon termination, the Company will pay one-year of salary and target bonus.
---	---

P.O. Box 1109 GT, Grand Cayman, BWI
The Grand Pavilion, Seven Mile Beach
Phone (345)745-4573, Fax (345) 745-4573

◦	Contingencies: Your employment will be contingent upon compliance with the Code of Conduct (to be promulgated by the Company), the Tax Operating Guidelines, and any other Operating Guidelines promulgated by the Company.
◦	Representation: YOU represent and warrant to the Company, and you acknowledge that the Company has relied on such representation in offering employment to you, that the performance of your duties to the Company hereunder will not violate the terms of any agreement with any third party.
---	---
o	Restrictive Covenants: Your employment is contingent upon your execution of our Non-competition, Non-solicitation, Intellectual Property and Confidentiality Agreement.
---	---

[SIGNATURE PAGE FOLLOWS]

P.O. Box 1109 GT, Grand Cayman, BWI
The Grand Pavilion, Seven Mile Beach
Phone (345)745-4573, Fax (345) 745-4573

This offer expires, March 18, 2009. If you accept this offer•, please indicate your acceptance by signing below and returning the executed document to the Company.

I accept this offer of employment and all terms and conditions as outlined above,

/s/ Tom Curnock	3/23/2009
Tom Curnock	Dated	/s/ Bart Hedges	3/23/2009
---	---
Bart Hedges	Dated
President & Chief Underwriting Officer<br><br>Greenlight Reinsurance, Ltd.

NON-COMPETITION, NON- SOLICITATION, INTELLECTUAL PROPERTY AND
CONFIDENTIALITY AGREEMENT

AGREEMENT, dated as of March 4, 2009, by and between Greenlight Reinsurance, Ltd. (the "Company") and Tom Curnock ("Employee").

IN CONSIDERATION of the premises and the mutual covenants set forth below, the parties hereby agree as follows:

1.	Employment. In connection with the employment by the Company of the Employee as a professional staff member of the Company in accordance with that certain letter agreement as of a date even herewith, the Employee agrees to the terms and conditions as herein set forth.
2.	Restrictive Covenants.
---	---

a) Acknowledgments. The Employee acknowledges that:

i)	as a result of the Employee's employment by the Company, the Employee has obtained and will obtain Confidential Information (as defined below);
ii)	the Confidential Information has been developed and created by the Company or Greenlight Capital Re Ltd. (the "Parent") or any of their affiliates (the "Group") at substantial expense and the Confidential Information constitutes valuable proprietary assets;
---	---
iii)	the Group will suffer substantial damage and irreparable harm which will be difficult to compute if, during the period of employment of the Employee by the Company (the "Employment Period") and for six months thereafter, the Employee should enter a Competitive Business (as defined below) in violation of the provisions of this Agreement;
---	---
iv)	the nature of the Group's business is such that it could be conducted anywhere in the world and that it is not limited to a geographic scope or region;
---	---
v)	the Group will suffer substantial damage which will be difficult to compute if, during the Employment Period or thereafter for a period of 12 months, the Employee should solicit or interfere with the Group's employees, clients or customers or should divulge Confidential Information relating to the business of the Group;
---	---
vi)	the provisions of this Agreement arc reasonable and necessary for the protection of the business of the Group;
---	---

vii)	the Company would not have hired or continued to employ Employee unless he agreed to be bound by the terms hereof; and

"Competitive Business" as used in this Agreement shall mean any business which competes directly or indirectly with the Company's principal business.

"Confidential Information" as used in this Agreement shall mean any and all confidential and/or proprietary knowledge, data, or information of the Company including, without limitation, any:

(A)trade secrets, drawings, inventions, methodologies, mask works, ideas, processes, formulas, source and object codes, data, programs, software source documents, works of authorship, know-how, improvements, discoveries, developments, designs and techniques, and all other work product of the Company, whether or not patentable or registrable under trademark, copyright, patent or similar laws;

(B)information regarding plans for research, development, new service offerings and/or products, marketing, advertising and selling, distribution, business plans, business forecasts, budgets and unpublished financial statements, licenses, prices and costs, suppliers, customers or distribution arrangements;

(C)any information regarding the skills and compensation of employees, suppliers, agents, and/or independent contractors of the Company;

(D)concepts and ideas relating to the development and distribution of content in any medium or to the current, future and proposed products or services of the Company;

(E)information about the Company's investment program, tracing methodology, or portfolio holdings; or

(F)any other information or data that is labeled confidential or orally disclosed to Employee as confidential.

(b)

Confidentiality. In consideration of the benefits provided for in this Agreement, Employee agrees not to, at any time, either during the Employment Period or for a period of twelve (12) months thereafter, divulge, use, publish or in any other manner reveal, directly or indirectly, to any person, firm, corporation or any other form of business organization or arrangement and keep in the strictest confidence any Confidential Information, except

(i)as may be necessary to the performance of Employee's duties hereunder,

(ii)with the Company's express written consent,

(iii)to the extent that any such information is in or becomes in the public domain other• than as a result of the Employee's breach of any of his obligations hereunder, or

(iv)where required to be disclosed by court order, subpoena or other government process and in such event, the Employee shall cooperate with the Company in attempting to keep such information confidential.

Upon the request of the Company, the Employee agrees to promptly deliver to the Company the originals and all copies, in whatever medium, of all such Confidential Information.

(c)

Non-Compete. In consideration of the benefits provided for in this Agreement, the Employee covenants and agrees that during the Employment Period and for a period of six (6) months following the termination of his employment for whatever reason, or following the date of cessation of the last violation of this Agreement, or from the date of entry by a court of competent jurisdiction of a final, unappealable judgment enforcing this covenant, whichever• of the foregoing is last to occur, he will not, for herself, or in conjunction with any other person, firm, partnership, corporation or other form of business organization or arrangement (whether as a Shareholder', partner, member, principal, agent, lender, director, officer, manager, trustee, representative, employee or consultant), be employed by, provide services to, or give advice or consultation to any Competitive Business.

(d)

Non-Solicitation of the Employees. In consideration of the benefits provided for in this Agreement, the Employee covenants and agrees that during the Employment Period and for a period of twelve (12) months thereafter, the Employee shall not, without the prior written permission of the Company,

---

(i)directly or indirectly solicit, employ or retain or have or cause any other person or entity to solicit, employ or retain, any person who is employed or is providing services to the Group at the time of his termination of employment or was or is providing such services within the twelve (12) month period before or after his termination of employment or

(ii)request or cause any employee of the Group to breach or threaten to breach any terms of said employee's agreements with the Group or to terminate his employment with the Group;

(iii)provided, that nothing in this paragraph shall apply to (x) any solicitation of any person referenced above who responds to general mass solicitations of employment not specifically directed toward the aforementioned persons, or (y) hiring any person who makes contact at his or her own initiative without any prior direct or indirect

encouragement or solicitation or other communication (other than as permitted by clause (x) of this proviso).

(e)

Non-Solicitation of Clients and Customers. In consideration of the benefits provided for in this Agreement, the Employee covenants and agrees that during the Employment Period and for a period of twelve (12) months thereafter, he will not, for herself, or in conjunction with any other person, firm, partnership, corporation or other form of business organization or arrangement (whether as a, partner, member, lender, principal, agent, director, officer, manager, trustee, representative, employee or consultant):

(i)solicit any business that is related to the principal business of the Company, from any person or entity who, at the time of, or at the time during the twelve (12) months preceding such termination, was an existing customer or client of the Company;

(ii)request any of the Company's clients or customers to cancel or terminate any business relationship with the Company involving services or activities which were directly or indirectly the responsibility of the Employee during his employment or

(iii)pursue any Company project known to the Employee upon termination of his employment that the Company is actively pursuing while the Company is actively pursuing such project.

(f)

Post-Employment Property. The parties agree that any work of authorship, invention, design, discovery, development, technique, improvement, source code, hardware, device, data, apparatus, practice, process, method or other work product whatever (whether patentable or subject to copyright, or not, and hereinafter collectively called "discovery") related to the principal business of the Company that the Employee, either solely or in collaboration with others, has made or may make, discover, invent, develop, perfect, or reduce to practice during the Employment Period, whether or not during regular business hours and created, conceived or prepared on the Company's premises or otherwise shall be the sole and complete property of the Company. More particularly, and without limiting the foregoing, the Employee agrees that all of the foregoing and any

(i)inventions (whether patentable or not, and without regard to whether any patent therefor is ever sought),

(ii)marks, names, or logos (whether or not registrable as trade or service marks, and without regard to whether registration therefor is ever sought),

(iii)works of authorship (without regard to whether any claim of copyright therein is ever registered), and

(iv)trade secrets, ideas, and concepts

((i) - (iv) collectively, "Intellectual Property Products") created, conceived, or prepared on the Company's premises, whether or not during normal business hours, shall perpetually be the exclusive property of the Company, as shall all

tangible media (including, but not limited to, papers, computer media of all types, and models) in which such Intellectual Property Products shall be recorded or otherwise fixed. The Employee further agrees promptly to disclose in writing and deliver to the Company all Intellectual Property Products created during his engagement by the Company, whether or not during normal business hours. The Employee agrees that all works of authorship created by the Employee during his engagement by the Company whilst acting as an Employee of the Company, shall be works made for hire of which the Company is the author and owner of copyright. To the extent that any competent decision-making authority should ever determine that any work of authorship created by the Employee during his engagement by the Company is not a work made for hire, the Employee hereby assigns all right, title and interest in the copyright therein, in perpetuity and throughout the world, to the Company. To the extent that this Agreement does not otherwise serve to grant or otherwise vest in the Company all rights in any Intellectual Property Product created by the Employee during his engagement by the Company, the Employee hereby assigns all right, title and interest therein, in perpetuity, to the Company. The Employee agrees to execute, immediately upon the Company's reasonable request and without charge, any further assignments, applications, conveyances or other instruments, at any time after execution of this Agreement, whether or not the Employee is engaged by the Company at the time such request is made, in order to permit the Group and/or its respective assigns to protect, perfect, register, record, maintain, or enhance their rights in any Intellectual Property Product; provided, that, the Company shall bear the cost of any such assignments, applications or consequences. Upon termination of the Employee's employment by the Company for any reason whatsoever, and at any time during the Employee's engagement by the Company, the Employee will immediately deliver to the custody of the person designated by the Company all originals and copies of any documents and other property of the Company in the Employee's possession, under the Employee's control or to which he may have access.

(g)	Non-Disparagement. The Employee acknowledges and agrees that he will not defame or publicly criticize the services, business, integrity, veracity or personal or professional reputation of the Company and its respective officers, directors, partners, the Employees or agents thereof in either a professional or personal manner at any time during or following the Employment Period.
(h)	Enforcement. If the Employee commits a breach, or threatens to commit a breach, of any of the provisions of this Section 2, the Company shall have the right and remedy to have the provisions specifically enforced by any court having jurisdiction, it being acknowledged and agreed by the Employee that the services being rendered hereunder
---	---

to the Company are of a special, unique and extraordinary character and that any such breach or threatened breach will cause irreparable injury to the Company. Such right and remedy shall be in addition to, and not in lieu of, any other rights and remedies available to the Company at law or in equity.

(i)	Severability. This Agreement is severable in that if any provision is determined to be illegal or unenforceable or unreasonable by any court of competent jurisdiction such provision shall be deemed to have been deleted without affecting the remaining provisions of this Agreement.
(j)	EMPLOYEE ACKNOWLEDGES THAT HE HAS CAREFULLY READ THIS SECTION 2 AND HAS I-TAD THE OPPORTUNITY TO REVIEW ITS PROVISIONS WITH ANY ADVISORS AS I-IE CONSIDERED NECESSARY AND THAT EMPLOYEE UNDERSTANDS THIS AGREEMENT'S CONTENTS AND SIGNIFIES SUCH UNDERSTANDING AND AGREEMENT BY SIGNING BELOW.
---	---
3.	Resolution of Differences Over Breaches of Agreement. The parties shall use good faith efforts to resolve any controversy or claim arising out of, or relating to this Agreement or the breach thereof, first in accordance with the Company's internal review procedures, except that this requirement Shall not apply to any claim or dispute under or relating to Section 2 of this Agreement. If despite their good faith efforts, the parties are unable to resolve such controversy or claim through the Company's internal review procedures, then such controversy or claim shall be resolved by binding arbitration for resolution in the Cayman Islands. The decision of the arbitrator shall be final and binding on both parties, and any court of competent jurisdiction may enter judgment upon the award. Each party shall pay its own expenses, including legal fees, in such dispute and shall split the cost of the arbitrator and the arbitration proceedings.
---	---
4.	Successors: Binding Agreement. The rights and benefits of the Employee hereunder shall not be assignable, whether by voluntary or involuntary assignment or transfer by the Employee. This Agreement shall be binding upon, and inure to the benefit of, the successors and assigns of the Company, and the heirs, executors and administrators of the Employee, and Shall be assignable by the Company to Parent or to any entity acquiring substantially all of the assets of the Company or the Parent, whether by merger, consolidation, sale of assets or similar transactions.
---	---
5.	Notice. For the purposes of this Agreement, notices, demands and all other communications provided for in this Agreement shall be in writing and shall be deemed to have been duly given when delivered either personally or by overnight, certified or registered mail, return receipt requested, postage prepaid, addressed, in the case of the Employee, to the last address on file with the Company and if to the Company, to its Employee offices or to such other
---	---

address as any party may have furnished to the other in writing in accordance herewith, except that notices of change of address shall be effective only upon receipt.

Governing Law. This Agreement is governed by, and is to be construed and enforced in accordance with, the laws of the Grand Court of the Cayman Islands without regard to principles of conflicts of laws. If, under such law, any portion of this Agreement is at any time deemed to be in conflict with any applicable statute, rule, regulation or ordinance, such portion shall be deemed to be modified or altered to conform thereto or, if that is not

possible, to be omitted from this Agreement, and the invalidity of any such portion shall not affect the three, effect and validity of the remaining portion hereof.

7.	Amendment. No provisions of this Agreement may be amended, modified, or waived unless such amendment or modification is agreed to in writing and signed by the Employee and the Company, and such waiver is set forth in writing and signed by the party to be charged. No waiver by either party hereto at any time of any breach by the other party hereto of any condition or provision of this Agreement to be performed by such other party shall be deemed a waiver of similar or dissimilar provisions or conditions at the same or at any prior or subsequent time.
8.	Survival. The respective obligations of, and benefits afforded to, the Employee and the Company and Parent as provided in Section 1 of this Agreement shall survive the termination of this Agreement.
---	---
9.	No Conflict of Interest. During the period of employment by the Company, the Employee shall not, directly or indirectly, render service, or undertake any employment or consulting agreement with another entity without the express written consent of the Board.
---	---
10.	Counterparts. This Agreement may be executed in two or more-counterparts, each of which shall be deemed to be an original but all of which together will constitute one and the same instrument.
---	---
11.	Entire Agreement. This Agreement sets forth the entire agreement of the parties hereto in respect of the subject matter contained herein and supersedes all prior agreements, promises, covenants, arrangements, communications, representations or warranties, whether oral or written, by any officer, employee or representative of any party hereto in respect of such subject matter. Any prior agreement of the parties hereto in respect of the subject matter contained herein is hereby terminated and canceled as of the date hereof.
---	---
12.	Section Headings. The section headings in this Agreement are for convenience of
---	---

reference only, and they form no part of this Agreement and shall not affect its interpretation.

13.	Representation. The Employee represents and warrants to the Parent and the

Company, and the Employee acknowledges that the Company has relied on such representations and warranties in employing the Employee, that neither the Employee's duties as an employee of the Company nor his performance of this Agreement will breach any other agreement to which the Employee is a party, including without limitation, any agreement limiting the use or disclosure of any information acquired by the Employee prior to his employment by the Company. In the course of performing the Employee's work for the Company, the Employee will not disclose or make use of any information, documents or materials that the Employee is under any obligation to any other party to maintain in confidence. In addition, the Employee represents and warrants and acknowledges that the Company has relied on such representations and warranties in employing the Employee, that he has not entered into, and will not enter into, any

agreement, either oral or written, in conflict herewith. If it is determined that the Employee is in breach or has breached any of the representations set forth herein, the

Company shall have the right to terminate the Employee's employment for Cause.

14. Review by Counsel. The Employee represents and warrants that this Agreement is the

result of full and otherwise fair faith bargaining over its terms following a full and otherwise fair opportunity to have legal counsel for the Employee review this Agreement and to verify that the terms and provisions of this Agreement are reasonable and enforceable. The Employee acknowledges that he has read and understands the foregoing provisions and that such provisions arc reasonable and enforceable. This Agreement has been jointly drafted by both parties.

[SIGNATURE PAGE FOLLOWS]

IN WITNESS WHEREOF, the parties hereto have executed this Agreement on the date first above written.

GREENLIGHT REINSURANCE, LTD.

By: /s/ Bart Hedges

Name: Bart Hedges

Title: President and CUO

/s/ Tom Curnock 3/9/09

Tom Curnock Dated Employee

Schedule A

Vice President, Underwriter
Description of Duties

The Vice President, Underwriter (the "Underwriter") will be primarily responsible for underwriting analysis and marketing/relationship management. Among other responsibilities as may reasonably be requested by the Company, the Underwriter will:

•	Serve as the primary person responsible for reviewing submissions, coordinating data gathering, actuarial analysis, structuring, and presentation of the opportunity at deal meetings.
•	For each transaction that proceeds to the stage of developing a deal memo, the Underwriter will be responsible for preparation of the deal memo. As such, the Underwriter will seek the input from actuarial resources (internally or externally) for the analysis section and Accounting resources for input on the accounting section. The Underwriter will be responsible for planning the deal meeting and coordinating and disseminating meeting materials in advance of the meetings.
---	---
•	Subject to our Tax Operating Guidelines, maintain a presence in the market place with brokers and clients to ensure that the Company is well positioned within the broker market to receive submissions in its areas of interest. This will include communicating frequently with brokers and clients regarding the Company's risk appetite, areas of interest, and product offering. This may also include trips as necessary to Industry Seminars and client and broker visits.
---	---
•	Be responsible for all facets of contract administration including but not limited to: slip and wording review, processing amendments and endorsements to the contract, cash collection, contract folder creation and maintenance, and electronic contract folder creation and maintenance.
---	---
•	Negotiate, structure, document and monitor private equity investments with strategic partners.
---	---
•	Complete research projects as assigned, in particular, the project to develop an enterprise wide risk management model.
---	---

•Attend underwriting deal meetings to evaluate new and renewal business opportunities.

This position reports directly to the President & Chief Underwriting Officer.

P.O. Box 1109 GT, Grand Cayman, BWI
The Grand Pavilion, Seven Mile Beach
Phone (345)745-4573, Fax (345) 745-4573

		Exhibit

AMENDMENT TO EMPLOYMENT OFFER

This Amendment (this "Amendment") to the Employment Offer dated March 23, 2009 between Greenlight Reinsurance, Ltd. (the "Company"), and Tom Curnock (the "Employee") (the "Employment Offer" attached hereto as Ex. A) is entered into this 31st day of October 2018. Capitalized terms used but not otherwise defined herein shall have the meanings given them in the Employment Offer.

RECITALS

WHEREAS, the Employer hired the Employee as Vice President Underwriter pursuant to the Employment Offer; and

WHEREAS, the Employee's position changed to that of Chief Risk Officer on or about April 1, 2017; and

WHEREAS, the parties have determined it to be in their best interests to make certain amendments to the Employment Offer with an effective date as of January 1, 2018.

NOW, THEREFORE, BE IT RESOLVED, that in consideration of the mutual premises, covenants and agreements herein contained, the parties agree as follows:

RESOLVED, that the first sentence under Employment Status contained in the Employment Offer is hereby amended and restated as follows:

"Employment Status: Employee at will. Your employment may be terminated by the Company for any reason upon 180 days written notice, and may be terminated immediately by the Company for "Cause."

FURTHER RESOLVED, that the Base Salary contained in the Employment Offer is hereby amended and restated in its entirety as follows:

"Base Salary: the Company shall pay the Employee a base salary of US $330,000 per annum (the "Base Salary"). The Employee's Base Salary shall be paid in accordance with the Company's customary payroll practices. Salary reviews will take place, at a minimum, every two years."

FURTHER RESOLVED, the Bonus contained in the Employment Offer is hereby amended and restated in its entirety as follows:

"Bonus: the Employee shall be eligible to be considered for a discretionary Bonus with a target of 45% of Base Salary (the "Target Bonus"). Any Bonus earned during a calendar year shall be paid in accordance with the bonus payment provisions of the Company's applicable compensation plan (the "Compensation Plan"), as amended from time to time, and shall be subject to such other terms and conditions as are set forth therein."

FURTHER RESOLVED, that the Notice period contained in the Employment Offer is hereby amended and restated in its entirety as follows:

"Notice: You may terminate your employment with the Company upon 180 days written notice. Upon your voluntary termination and satisfaction of the 180 day notice period, you will be paid any accrued but unpaid base salary and any unused vacation time. If you do not satisfy the 180 day notice period, all unused vacation time shall be forfeited as well as any remaining salary for that period."

FURTHER RESOLVED, except as otherwise expressly set forth in this Amendment, all provisions, terms and conditions in the Employment Offer remain unmodified and in full force and effect, and the Employment Offer is hereby in all respects ratified and confirmed.

FURTHER RESOLVED, that this Amendment, together with the Employment Offer, sets forth the entire agreement and understanding of the parties relating to the subject matter herein. No modification of or amendment to this Amendment, nor any waiver of any rights under this Amendment, shall be effective unless given in a writing signed by the party to be charged.

FURTHER RESOLVED, that this Amendment may be executed in duplicate counterparts, each of which shall be deemed to be an original and all of which, taken together, shall constitute one agreement.

IN WITNESS WHEREOF, the parties hereto have executed this Amendment as of the date first written above.

GREENLIGHT REINSURANCE, LTD.

By: /s/ Simon Burton

Name: Simon Burton

Title: Chief Executive Officer

EMPLOYEE

/s/ Tom Curnock

Tom Curnock

		Exhibit

SECOND AMENDMENT TO EMPLOYMENT OFFER

This Second Amendment (this "Second Amendment") to the Employment Offer, dated March 23, 2009, by and between Greenlight Reinsurance, Ltd. (the "Company"), and Tom Curnock (the "Employee"), as amended by that certain Amendment to Employment Offer, entered into as of October 31, 2018, by and between the Company and Employee (collectively, the "Employment Offer" attached hereto as Ex. A), is entered into this 10th day of September, 2019 (the "Second Amendment Date").

RECITALS

WHEREAS, the Company and Employee have entered into the Employment Offer; and

WHEREAS, the parties have determined it to be in their best interests to make certain amendments to the Employment Offer, effective as of the Second Amendment Date.

Now, THEREFORE, BE IT RESOLVED, that in consideration of the mutual premises, covenants and agreements herein contained, the parties agree as follows:

SECTION 1. Definitions. All capitalized terms used but not otherwise defined herein shall have the meanings given to them in the Employment Offer.

SECTION 2. Amendment to Employment Offer.

1. Addition of "Additional Compensation Upon Certain Terminations of

Employment" key term. The Employment Offer is hereby amended to add a new key term "Additional Compensation Upon Certain Terminations of Employment" as follows:

"Additional Compensation Upon Certain Terminations of Employment:

Subject to the terms and conditions in this Additional Compensation Upon Certain Terminations of Employment key term and the other terms and conditions of this letter (as amended and as it may be further amended from time to time, the "Employment Offer"), in the event your employment is terminated by the Company without Cause (as defined in the Employment Status key term in the Employment Offer) (other than due to death or disability) or by you for Good Reason (as defined below) (each a "Qualifying Termination"), subject to and conditioned upon your execution and delivery to the Company of a general release of claims against the Company and its affiliates related to your employment and the termination of your employment with the Company in such form as the Company reasonably determines (the "Release") within the time period provided for herein and provided you do not breach the Employment Offer following your date of termination in which case all payments under this Additional Compensation Upon Certain Terminations key term shall cease, the Company shall pay or cause to be paid to you:

o the Target Bonus (as defined in the Bonus key term in the Employment Offer) you would have earned for the year of termination assuming targets have been achieved, pro-rated based on the number of days you were employed by the Company during the year over the number of days in such year payable as soon as practicable following such termination, but in no event later than two and one half months following your date of termination; and

o commencing on the 60^th^ day following your date of termination, an amount equal

to one hundred percent (100%) of the sum of your Base Salary (as defined in the Base Salary key term in the Employment Offer) and Target Bonus (assuming targets have been achieved), payable over twelve (12) months in substantially equal monthly installments.

If you should fail to execute and deliver to the Company the Release within 45 days following the later of (i) the date of such Qualifying Termination or (ii) the date you actually receive an execution copy of such Release (which shall be delivered to you within five (5) business days following the date of the Qualifying Termination and, if not timely delivered, the release condition will be deemed waived by the Company with respect to the payments contemplated under this key term), the Company shall not have any obligation to make the payments contemplated under this key term.

The Company shall provide you the payments set forth in this Additional Compensation upon Certain Terminations of Employment key term and shall not be required to provide any other payments or benefits to you upon your termination; provided, however, that any payments pursuant to this Additional Compensation Upon Certain Terminations key term shall be in addition to any statutory entitlements arising upon termination, including
but not limited to severance pay.

For purposes of the Employment Offer, "Good Reason" shall mean and be limited to the following: (i) any material and adverse change to your title or duties which is inconsistent with your duties set forth herein, (ii) a reduction of your Base Salary, or (iii) a failure by the Company to comply with any other material provisions of the Employment Offer."

2.Addition of "Governing Law" key term. The Employment Offer is hereby amended to add a new key term "Governing Law" as follows:

"Governing Law. The Employment Offer is governed by, and is to be construed and enforced in accordance with, the laws of the Cayman Islands without regard to principles of conflicts of laws. If, under such law, any portion of the Employment Offer is at any time deemed to be in conflict with any applicable statute, rule, regulation or ordinance, such portion shall be deemed to be modified or altered to conform thereto or, if that is not possible, to be omitted from this Employment Offer, and the invalidity of any such portion shall not affect the force, effect and validity of the remaining portion hereof"

3.Addition of "Resolution of Differences over Breaches" key term. The Employment Offer is hereby amended to add a new key term "Resolution of Differences over Breaches" as follows:

"Resolution of Differences over Breaches. The parties shall use good faith efforts to resolve any controversy or claim arising out of, or relating to this Employment Offer or the breach thereof, first in accordance with the Company's internal review procedures, except that this requirement shall not apply to any claim or dispute under or relating to the Restrictive Covenants key term. If despite their good faith efforts, the parties are unable to resolve such controversy or claim through the Company's internal review procedures, then such controversy or claim shall be resolved by binding arbitration for resolution in the Cayman Islands. The decision of the arbitrator shall be final and binding on both parties, and any court of competent jurisdiction may enter judgment upon the

award. Each party shall pay its own expenses, including legal fees, in such dispute and shall split the cost of the arbitrator and the arbitration proceedings."

4.Removal of "Living Allowance" key term. The Living Allowance key term contained in the Employment Offer shall be deleted in its entirety.

5.Removal of "Relocation Expense Allowance" key term. The Relocation Expense Allowance key term contained in the Employment Offer shall be deleted in its entirety.

6.Removal of "Termination Option" key term. The Termination Option key term contained in the Employment Offer shall be deleted in its entirety.

7.Amendment of "Job Description" key term. The Job Description key term contained in the Employment Offer is hereby amended and restated in its entirety as follows:

"Job Description: While employed by the Company, you shall have those powers and duties ordinarily associated with the position of Chief Risk Officer and such other powers and duties as may reasonably be prescribed by the Chief Executive Officer of the Company; provided that, such other powers and duties are consistent with your position as Chief Risk Officer and do not violate any applicable laws or regulations. You shall perform your duties to the best of your ability and shall devote all of your working time, attention and energies to the performance of your duties for the Company. You shall not accept any other post, role or employment while employed by the Company without first having obtained the written consent of the Company."

8.Amendment of "Employment Status" key term. The Employment Status key term contained in the Employment Offer is hereby amended and restated in its entirety as follows:

"Employment Status: Your employment may be terminated by the Company for any reason upon 90 days written notice, and may be terminated immediately by the Company for Cause (as defined below), and such termination in and of itself shall not be, nor shall it be deemed to be, a breach of the Employment Offer. The Company shall have the right to suspend you with pay in order to investigate any event which it reasonably believes may provide a basis to terminate your employment for Cause during which period you may be excluded from the Company's offices and/or business and such action shall not give you Good Reason to terminate your employment.

For purposes of the Employment Offer, "Cause" shall mean any termination within the scope of sections 52 or 53 of the Labour Law (2011 Revision).

9.Amendment of "Vacation" key term. The Vacation key term contained in the Employment Offer is hereby amended and restated in its entirety as follows:

"Vacation: You will be entitled to 25 days of vacation leave per year in addition to Cayman Islands public holidays. Scheduling of vacation time will be subject to prior approval. Vacation time does not rollover without prior approval of your supervisor."

10.Amendment of "Base Salary" key term. The Base Salary key term contained in the Employment Offer is hereby amended and restated in its entirety as follows:

"Base Salary: While employed by the Company, the Company shall pay you a base salary of US $330,000 per annum (the "Base Salary"). Your Base Salary shall be paid in accordance

with the Company's customary payroll practices as in effect from time to time. Salary reviews will take place, at a minimum, every two years."

11.Amendment of "Bonus" key term. The Bonus key term contained in the Employment Offer is hereby amended and restated in its entirety as follows:

^-^Bonus: While employed by the Company, you shall be eligible to be considered for a discretionary bonus (the "Bonus") with a target incentive opportunity of 45% of Base Salary (the "Target Bonus"). Any Bonus earned during a calendar year shall be paid in accordance with the bonus payment provisions of the Company's applicable compensation plan, as amended from time to time, and shall be subject to such other terms and conditions as are set forth therein."

12.Amendment of "Notice" key term. The Notice key term contained in the Employment Offer is hereby amended and restated in its entirety as follows:

"Notice: You may terminate your employment with the Company without Good Reason upon 90 days' prior written notice ("Notice Period"). You may also terminate your employment with the Company for Good Reason (as defined in the Additional Compensation Upon Certain Terminations of Employment key term of the Employment Offer) within 30 days after you have knowledge of the occurrence, without your written consent, of any one of the events set forth in the Good Reason definition that has not been cured, if curable, within 30 days after written notice thereof has been given by you to the Company and such termination, in and of itself shall not be, nor shall it be deemed to be, a breach of the Employment Offer. Your employment may be terminated by the Company for any reason upon 90 days written notice, and may be terminated immediately by the Company for Cause (as defined below in the Employment Status key term), and such termination in and of itself shall not be, nor shall it be deemed to be, a breach of the Employment Offer. The Company shall have the right to suspend you with pay in order to investigate any event which it reasonably believes may provide a basis to terminate your employment for Cause during which period you may be excluded from the Company's offices and/or business and such action shall not give you Good Reason to terminate your employment."

13.Amendment of "Restrictive Covenants" key term. The Restrictive Covenants key term contained in the Employment Offer is hereby amended and restated in its entirety as follows:

"Restrictive Covenants:

Acknowledgement: You acknowledge that: (i) as a result of your employment by the Company, you have obtained and will obtain Confidential Information (as defined below); (ii) the Confidential Information has been developed and created by the Group (as defined below) at substantial expense and the Confidential Information constitutes valuable proprietary assets; (iii) the Group will suffer substantial damage and irreparable harm which will be difficult to compute if, during the period of your employment and thereafter, you should enter a Competitive Business (as defined below) in violation of the provisions of the Employment Offer; (iv) the nature of the Group's business is such that it could be conducted anywhere in the world and that it is not limited to a geographic scope or region; (v) the Group will suffer substantial

damage which will be difficult to compute if, during the period of your employment or thereafter, you should solicit or interfere with the Group's employees, clients or customers or should divulge Confidential Information relating to the business of the Group; (vi) the provisions of the Employment Offer are reasonable and necessary for the protection of the business of the Group; (vii) the Company would not have hired or continued to employ you unless you agreed to be bound by the terms hereof; and (viii) the provisions of the Employment Offer will not preclude you from other gainful employment.

"Group" as used in the Employment Offer shall mean the Company together with Greenlight Capital Re, Ltd., or any of their affiliates.

◦

Confidential Information: You agree not to, at any time, either during the period of your employment or thereafter, divulge, use, publish or in any other manner reveal, directly or indirectly, to any person, firm, corporation or any other form of business organization or arrangement and keep in the strictest confidence any Confidential Information, except: (i) as may have been necessarily disclosed by you in the good faith performance of your duties hereunder; (ii) with the Company's express written consent; (iii) to the extent that any such information is in or becomes in the public domain other than as a result of your breach of any of your obligations hereunder, or (iv) where required to be disclosed by law and in such event, you shall cooperate with the Company in attempting to keep such information confidential.

Upon the request of the Company, you agree to promptly deliver to the Company the originals and all copies, in whatever medium, of all such Confidential Information.

"Confidential Information" as used in the Employment Offer shall mean any and all confidential and/or proprietary knowledge, data, or information of the Group including, without limitation, any (i) trade secrets, drawings, inventions, methodologies, mask works, ideas, processes, formulas, source and object codes, data, programs, software source documents, works of authorship, know-how, improvements, discoveries, developments, designs and techniques, and all other work product of the Group, whether or not patentable or registrable under trademark, copyright, patent or similar laws in any jurisdiction; (ii) information regarding plans for research, development, new service offerings and/or products, marketing, advertising and selling, distribution, business plans, business forecasts, budgets and unpublished financial statements, licenses, prices and costs, suppliers, customers or distribution arrangements; (iii) any information regarding the skills and compensation of employees, suppliers, agents, and/or independent contractors of the Group; (iv) concepts and ideas relating to the development and distribution of content in any medium or to the current, future and proposed products or services of the Group; (v) information about the Group's investment program, trading methodology, or portfolio holdings; or (vi) any other information, data or the like that is labeled confidential or orally disclosed to you on terms of confidentiality.

◦

Non-Competition: In consideration of the benefits provided for in the Employment Offer, you hereby agree and covenant that during the period of your employment and for a period of six (6) months following the termination of your employment for whatever reason, or following the date of cessation of the last violation of the Employment Offer, or from the date of entry by a court of competent jurisdiction of a final, unappealable judgment enforcing the covenant, whichever of the foregoing is

last to occur, you will not, for yourself, or in conjunction with any other person, firm, partnership, corporation or other form of business organization or arrangement (whether as a shareholder, partner, member, principal, agent, lender, director, officer, manager, trustee, representative, employee or consultant), directly or indirectly, be employed by, provide services to, in any way be connected, associated or have any interest in, or give advice or consultation to any Competitive Business.

"Competitive Business" as used in the Employment Offer shall mean any business which competes, directly or indirectly, with any aspect of the Group's business.

◦

Non-Solicitation: In consideration of the benefits provided for in the Employment Offer, you further covenant and agree that during the period of your employment and for a period of one (1) year thereafter, you shall not, without the prior written permission of the Company, (i) directly or indirectly solicit, employ or retain, or have or cause any other person or entity to solicit, employ or retain, any person who is employed or is providing services to the Group at the time of the termination of your employment or was or is providing such services within the twelve (12) month period before or after the termination of your employment or (ii) request or cause any employee of the Group to breach or threaten to breach any terms of said employee's agreements with the Group or to terminate his employment with the Group.

In consideration of the benefits provided for in the Employment Offer, your further covenant and agree that during the period of your employment and for a period of one (1) year thereafter, you will not, for yourself, or in conjunction with any other person, firm, partnership, corporation or other form of business organization or arrangement (whether as a shareholder, partner, member, lender, principal, agent, director, officer, manager, trustee, representative, employee or consultant), directly or indirectly: (i) solicit or accept any business that is directly related to the business of the Group from any person or entity who, at the time of, or at the time during the twenty-four (24) month period preceding, termination was an existing or prospective customer or client of the Group; (ii) request or cause any of the Group's clients or customers to cancel, terminate or change the terms of any business relationship with the Group involving services or activities which were directly or indirectly your responsibility during the period of your employment or (iii) pursue any Group project known to you upon termination of your employment that the Group is actively pursuing (or was actively pursuing within six months of termination) while the Group is (or is contemplating) actively pursuing such project.

◦

Intellectual Property: The Company and you agree that any work of authorship, invention, design, discovery, development, technique, improvement, source code, hardware, device, data, apparatus, practice, process, method or other work product whatever (whether patentable or subject to copyright, or not, and hereinafter collectively called "discovery") related to the business of the Group that you, either solely or in collaboration with others, have made or may make, discover, invent, develop, perfect, or reduce to practice during the course of the period of your employment, whether or not during regular business hours and created, conceived or prepared on the Group's premises or otherwise shall be the sole and complete property of the Group.

More particularly, and without limiting the foregoing, you agree that all of the foregoing and any (i) inventions (whether patentable or not, and without regard to

whether any patent therefor is ever sought), (ii) marks, names, or logos (whether or not registrable as trade or service marks, and without regard to whether registration therefor is ever sought), (iii) works of authorship (without regard to whether any claim of copyright therein is ever registered), and (iv) trade secrets, ideas, and concepts ((i) - (iv) collectively, "Intellectual Property Products") created, conceived, or prepared on the Group's premises or otherwise, whether or not during normal business hours, shall perpetually and throughout the world be the exclusive property of the Group, as shall all tangible media (including, but not limited to, papers, computer media of all types, and models) in which such Intellectual Property Products shall be recorded or otherwise fixed.

You further agree promptly to disclose in writing and deliver to the Company all Intellectual Property Products created during your engagement by the Company, whether or not during normal business hours. You agree that all works of authorship created by you during your engagement by the Company shall be works made for hire of which the Group is the author and owner of copyright.

To the extent that any competent decision-making authority should ever determine that any work of authorship created by you during your engagement by the Company is not a work made for hire, you hereby assign all rights, titles and interests in the copyright therein, in perpetuity and throughout the world, to the applicable Group entity. To the extent that the Employment Offer does not otherwise serve to grant or otherwise vest in the Group all rights in any Intellectual Property Product created by you during your engagement by the Company, you hereby assign all rights, titles and interests therein, in perpetuity and throughout the world, to the Company. You agree to execute, immediately upon the Company's reasonable request and without charge, any further assignments, applications, conveyances or other instruments, at any time after execution hereof, whether or not you are engaged by the Company at the time such request is made, in order to permit the Group and/or its respective assigns to protect, perfect, register, record, maintain, or enhance their rights in any Intellectual Property Product; provided, that, the Company shall bear the cost of any such assignments, applications or consequences.

Upon the termination of your employment with the Company for any reason whatsoever, and at any earlier time the Company so requests, you will immediately deliver to the custody of the person designated by the Company all originals and copies of any documents and other property of the Company in your possession, under your control or to which you may have access.

◦

Non-Disparagement: You acknowledge and agree that you will not defame or publicly criticize the services, business, integrity, veracity or personal or professional reputation of the Group and its respective officers, directors, partners, executives or agents thereof in either a professional or personal manner at any time during or following the period of your employment. The Company acknowledges and agrees that it will not defame, publicly criticize, or cause any of its officers, directors, partners, executives or agents to defame you or publicly criticize your services, integrity, veracity or personal or professional reputation in either a professional or personal manner at any time during or following the period of your employment.

◦

Enforcement: If you commit a breach, or threaten to commit a breach, of any of the provisions of this Restrictive Covenants key term, the Company shall have the right and remedy to have the provisions specifically enforced by any court having jurisdiction by way of injunction or otherwise, it being acknowledged and agreed by you that any such breach or threatened breach will cause irreparable injury to the Group and that money damages will not provide an adequate remedy to the Group. Such right and remedy shall be in addition to, and not in place of, any other rights and remedies available to the Company at law or in equity. Accordingly, you consent to the issuance of an injunction, whether preliminary or permanent, consistent with the terms of the Employment Offer. In

---

addition, the Company shall have the right to cease making any payments or provide any benefits to you under the Employment Offer in the event you wilfully breach any of the provisions hereof (and such action shall not be considered a breach under the Employment Offer).

You acknowledge that the restrictions contained in this Restrictive Covenants key term of the Employment Offer are reasonable and intended to apply after the termination of your employment whether such termination is lawful or otherwise and that the restrictions will apply even where the termination results from a breach of the Employment Offer.

If, at any time, the provisions of this Restrictive Covenants key term shall be determined to be invalid or unenforceable under any applicable law, by reason of being vague or unreasonable as to area, duration or scope of activity, the Employment Offer shall be considered divisible and shall become and be immediately amended to only such area, duration and scope of activity as shall be determined to be reasonable and enforceable by the court or other body having jurisdiction over the matter and you and the Company agree that the Employment Offer as so amended shall be valid and binding as though any invalid or unenforceable provision had not been included herein.

SECTION 3. Miscellaneous.

1.Effect on Employment Offer. Except as otherwise expressly set forth in this Second Amendment, all provisions, terms and conditions in the Employment Offer remain unmodified and in full force and effect, and the Employment Offer is hereby in all respects ratified and confirmed.

2.Entire Agreement; Amendment. The Employment Offer, as amended by the terms of this Second Amendment, will supersede the prior terms of the Employment Offer and that certain Non-competition, Non-solicitation, Intellectual Property and Confidentiality Agreement dated as of March 4, 2009, by and between the Company and you, and sets forth the entire agreement and understanding of the parties relating to the subject matter herein and therein. No modification of or amendment to this Second Amendment, nor any waiver of any rights under this Second Amendment, shall be effective unless given in a writing signed by the party to be charged.

3.Governing Law; Dispute Resolution. This Second Amendment shall be governed by and construed in accordance with the Governing Law Key Term and any controversy or claim related hereto shall be resolved in accordance with the Resolution of Differences over Breaches key term.

4. Counterparts. This Second Amendment may be executed in duplicate

counterparts (including by email and portable document format (.pdf)), each of which shall be deemed to be an original and all of which, taken together, shall constitute one agreement.

[Signature page follows]

IN WITNESS WHEREOF, the parties hereto have executed this Second Amendment as of the Second Amendment Date.

GREENLIGHT REINSURANCE, LTD.

By: /s/ Simon Burton

Name: Simon Burton

Title: CEO

EMPLOYEE

/s/ Tom Curnock

Tom Curnock

Signature Page to Second Amendment to Employment Offer

Exhibit A

Employment Offer, dated March 23, 2009 and Amendment, dated October 31, 2018

		Exhibit

Exhibit 21.1

SUBSIDIARIES OF THE REGISTRANT

AS OF December 31, 2019

Full Name of Subsidiary	Place of Incorporation
Greenlight Reinsurance, Ltd.	Cayman Islands
Greenlight Reinsurance Ireland, Designated Activity Company	Ireland
Verdant Holding Company, Ltd.	Delaware

		Exhibit

Consent of Independent Registered Public Accounting Firm

Greenlight Capital Re, Ltd.

Grand Cayman, Cayman Islands

We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-226022) and Form S-8 (No. 333-231214) of Greenlight Capital Re, Ltd. of our reports dated March 9, 2020 relating to the consolidated financial statements and financial statement schedules, and the effectiveness of Greenlight Capital Re, Ltd.’s internal control over financial reporting, which appear in this Form 10-K.

/s/ BDO USA, LLP

Grand Rapids, Michigan

March 9, 2020

		Exhibit

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the Registration Statement (Form S-3 No. 333-226022) and Form S-8 (No. 333-231214) of Greenlight Capital Re, Ltd. and in the related Prospectus of our report dated March 9, 2020, with respect to the financial statements of Solasglas Investments, LP (an equity method investee of Greenlight Capital Re, Ltd.), included in this Annual Report (Form 10-K) for the year ended December 31, 2019.

/s/ Ernst & Young Ltd. Grand Cayman, Cayman Islands March 9, 2020

		Exhibit

EXHIBIT 31.1

CERTIFICATION OF

CHIEF EXECUTIVE OFFICER OF

GREENLIGHT CAPITAL RE, LTD.

I, Simon Burton, certify that:| 1. | I have reviewed this annual report on Form 10-K of Greenlight Capital Re, Ltd.; | | --- | --- || 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the periods covered by this report; | | --- | --- || 3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; | | --- | --- | | 4. | The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: | | --- | --- |

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated:	March 9, 2020	/s/ SIMON BURTON
		Simon Burton<br>Chief Executive Officer<br>(principal executive officer)

		Exhibit

EXHIBIT 31.2

CERTIFICATION OF

CHIEF FINANCIAL OFFICER OF

GREENLIGHT CAPITAL RE, LTD.

I, Tim Courtis, certify that:	1.
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the periods covered by this report;
---	---	3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
---	---	4.	The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
---	---

5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated:	March 9, 2020	/s/ TIM COURTIS
		Tim Courtis
		Chief Financial Officer

		Exhibit

EXHIBIT 32.1

CERTIFICATION OF

CHIEF EXECUTIVE OFFICER OF

GREENLIGHT CAPITAL RE, LTD.

This certification is provided pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and accompanies the annual report on Form 10-K (the ‘‘Form 10-K’’) for the annual ended December 31, 2019 of Greenlight Capital Re, Ltd. (the ‘‘Issuer’’).

I, Simon Burton, the Principal Executive Officer of the Issuer, certify that to the best of my knowledge:

The Form 10-K fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)), as amended; and
The information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Issuer.

Dated:	March 9, 2020	/s/ SIMON BURTON
		Simon Burton<br>Chief Executive Officer<br>(principal executive officer)

		Exhibit

EXHIBIT 32.2

CERTIFICATION OF

CHIEF FINANCIAL OFFICER OF

GREENLIGHT CAPITAL RE, LTD.

I, Tim Courtis, the Principal Financial Officer of the Issuer, certify that to the best of my knowledge:

The Form 10-K fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)), as amended; and
The information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Issuer.

Dated:	March 9, 2020	/s/ TIM COURTIS
		Tim Courtis
		Chief Financial Officer

solasglasinvestmentslp20

F INANCIAL S TATEMENTS Solasglas Investments, LP For the year ended December 31, 2019 and for the period from September 1, 2018 (Commencement of Operations) to December 31, 2018

Solasglas Investments, LP Financial Statements For the year ended December 31, 2019 and for the period from September 1, 2018 (Commencement of Operations) to December 31, 2018 Contents Report of Independent Auditors…………………………..………………………………… 1 Statements of Assets, Liabilities and Partners’ Capital………………………..………….… 2 Condensed Schedules of Investments………..……………………………….…………….. 3 Statements of Operations…..……………………………………………………………….. 11 Statements of Changes in Partners’ Capital……..………………………………………….. 12 Statements of Cash Flows …………………………………………………...…………….. 13 Notes to Financial Statements………………………………………………...…………….. 14

Ernst & Young Ltd. Main tel: +1 345 949 8444 62 Forum Lane Fax: +1 345 949 8529 Camana Bay ey.com P.O. Box 510 Grand Cayman KY1-1106 CAYMAN ISLANDS Report of Independent Registered Public Accounting Firm The General Partner Solasglas Investments, LP Opinion on the Financial Statements We have audited the statement of assets, liabilities and partners’ capital of Solasglas Investments, LP (the “Partnership”), including the condensed schedule of investments, as of December 31, 2019 and 2018, and the related statements of operations, changes in partners’ capital and cash flows for the year ended December 31, 2019 and for the period from September 1, 2018 (commencement of operations) to December 31, 2018, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Partnership at December 31, 2019 and 2018, and the results of its operations, changes in its partners’ capital and its cash flows for the year ended December 31, 2019 and for the period from September 1, 2018 (commencement of operations) to December 31, 2018 in conformity with U.S. generally accepted accounting principles. Basis of Opinion These financial statements are the responsibility of the Partnership’s management. Our responsibility is to express an opinion on the Partnership’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Partnership in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. We conducted our audits in accordance with the standards of the PCAOB and in accordance with auditing standards generally accepted in the United States of America. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion. We have served as the Partnership’s auditor since 2018. Grand Cayman, Cayman Islands March 9, 2020 1 A member firm of Ernst & Young Global Limited

Solasglas Investments, LP Statements of Assets, Liabilities and Partners’ Capital December 31, 2019 and 2018 (In U.S. Dollars) 2019 2018 Assets Investments, at fair value (cost of $176,850,705 and $423,692,252, respectively) $ 162,927,580 $ 401,317,968 Cash and cash equivalents 111,045,874 13,200,409 Due from brokers 68,060,238 77,820,931 Derivative contracts, at fair value (cost of $14,464,096 and $50,400,176, respectively) 6,324,250 63,143,089 Interest and dividends receivable 47,577 2,357,568 Total assets 348,405,519 557,839,965 Liabilities and partners’ capital Liabilities Investments sold short, at fair value (proceeds of $45,665,728 and $182,024,848, respectively) 47,834,423 198,727,802 Derivative contracts, at fair value (proceeds of $3,243,119 and $15,021,556, respectively) 2,054,245 26,343,827 Due to brokers 1,180,000 23,951,006 Interest and dividends payable 828,139 1,237,610 Other liabilities 100,448 169,404 Notes payable - 30,000,000 Total liabilities 51,997,255 280,429,649 Partners’ capital 296,408,264 277,410,316 Total liabilities and partners’ capital $ 348,405,519 $ 557,839,965 See accompanying notes to financial statements. 2

Solasglas Investments, LP Condensed Schedules of Investments December 31, 2019 (In U.S. Dollars) Number Fair Value Hierarchy % of Partners' of Units Description Level 1 Level 2 Level 3 Capital Fair Value Investments: Common stock: United States of America: Consumer discretionary: 486,000 General Motors Company $ 17,787,600 $ - $ - 6.0 %$ 17,787,600 3,468,133 Green Brick Partners Inc 39,809,532 - - 13.4 39,809,532 Other 310,648 - - 0.1 310,648 Energy 7,558,807 - - 2.5 7,558,807 Financial: 731,863 Brighthouse Financial Inc 28,710,985 - - 9.7 28,710,985 Materials: 1,740,001 The Chemours Company 31,476,618 - - 10.6 31,476,618 Technology 562,708 - - 0.2 562,708 Total United States of America (cost $143,256,342) 126,216,898 - - 42.5 126,216,898 Canada: Materials (cost $4,336,070) 2,564,257 - - 0.9 2,564,257 Ireland: Consumer discretionary 6,842,500 - - 2.3 6,842,500 Industrial 5,267,979 - - 1.8 5,267,979 Total Ireland (cost $9,776,353) 12,110,479 - - 4.1 12,110,479 Total common stock (cost $157,368,765) 140,891,634 - - 47.5 140,891,634 Preferred stock: United States of America: Financial (cost $4,632,300) - 4,726,700 - 1.6 4,726,700 Investment funds: United States of America: Consumer staples (cost $1,802,050) - - 2,084,290 0.7 2,084,290 Investments in private equity: United States of America: Energy - - 1,115,695 0.4 1,115,695 Financial - - 590,504 0.2 590,504 Total investments in private equity (cost $2,006,813) - - 1,706,199 0.6 1,706,199 Mortgage-backed securities: United States of America: Financial (cost $950,589) - - 1,096,803 0.4 1,096,803 Corporate bonds: Portugal: Financial (cost $2,109,337) - 976 - 0.0 976 Total investments subject to fair value hierarchy (cost $168,869,854) $ 140,891,634 $ 4,727,676 $ 4,887,292 50.8 %$ 150,506,602 3

Solasglas Investments, LP Condensed Schedules of Investments (continued) December 31, 2019 (In U.S. Dollars) Number Fair Value Hierarchy % of Partners' of Units Description Level 1 Level 2 Level 3 Capital Fair Value Investments (continued): Investment funds (1): United States of America: Energy 1.4 %$ 4,070,917 Technology 0.3 1,004,632 Cayman Islands: Financial 2.5 7,345,429 Total investment funds (cost $7,980,851) 4.2 12,420,978 Total investments (cost $176,850,705) 55.0 %$ 162,927,580 Derivative contracts: Total return swaps - long exposure: Commodities$ - $ 96,233 $ - 0.0 %$ 96,233 United States of America: Financial 729,300 Brighthouse Financial Inc - 3,677,062 - 1.3 3,677,062 Total total return swaps - long exposure (cost $0) - 3,773,295 - 1.3 3,773,295 Put options: United States of America: Consumer discretionary - 2,408,135 - 0.8 2,408,135 Technology - 5,890 - 0.0 5,890 Total put options (cost $14,463,421) - 2,414,025 - 0.8 2,414,025 Futures contracts - long exposure Commodities (cost $675) 136,930 - - 0.0 136,930 Total derivative contracts (cost $14,464,096) $ 136,930 $ 6,187,320 $ - 2.1 %$ 6,324,250 (1) The Partnership’s investments in investment funds that are valued at their net asset value as reported by the underlying funds are not categorized within the fair value hierarchy. See Note 2. 4

Solasglas Investments, LP Condensed Schedules of Investments (continued) December 31, 2019 (In U.S. Dollars) Number Fair Value Hierarchy % of Partners' of Units Description Level 1 Level 2 Level 3 Capital Fair Value Investments sold, not yet purchased: Common stock: United States of America: Communication services$ 5,662,475 $ - $ - 1.9 %$ 5,662,475 Consumer discretionary: 38,800 Tesla Inc 16,231,204 - - 5.5 16,231,204 Financial 10,784,400 - - 3.6 10,784,400 Industrial 15,156,344 - - 5.1 15,156,344 Total United States of America (proceeds $45,665,728) 47,834,423 - - 16.1 47,834,423 Total common stock (proceeds $45,665,728) 47,834,423 - - 16.1 47,834,423 Total investments sold, not yet purchased (proceeds $45,665,728) $ 47,834,423 $ - $ - 16.1 %$ 47,834,423 Derivative contracts: Total return swaps - short exposure: Interest rates (cost $893)$ - $ 1,121,552 $ - 0.4 %$ 1,121,552 Put options: United States of America: Consumer discretionary: 4,422 Tesla Inc, 100-200, 6/2020-1/2021 - 925,233 - 0.3 925,233 Other - 900 - 0.0 900 Technology - 6,560 - 0.0 6,560 Total put options (proceeds $3,244,012) - 932,693 - 0.3 932,693 Total derivative contracts (proceeds $3,243,119) $ - $ 2,054,245 $ - 0.7 %$ 2,054,245 See accompanying notes to financial statements. 5

Solasglas Investments, LP Condensed Schedules of Investments (continued) December 31, 2018 (In U.S. Dollars) Number Fair Value Hierarchy % of Partners' of Units Description Level 1 Level 2 Level 3 Capital Fair Value Investments: Common stock: United States of America: Communication services: 924,800 Altice USA Inc $ 15,277,696 $ - $ - 5.5 %$ 15,277,696 Consumer discretionary: 3,249,515 General Motors Company 108,696,277 - - 39.2 108,696,277 Other 28,749,033 - - 10.4 28,749,033 Energy 17,406,326 - - 6.3 17,406,326 Financial: 626,363 Brighthouse Financial Inc 19,091,544 - - 6.9 19,091,544 Other 11,985,804 - - 4.3 11,985,804 Healthcare 4,157,208 - - 1.5 4,157,208 Materials 1,701,666 - - 0.6 1,701,666 Technology 12,011,626 - - 4.3 12,011,626 Total United States of America (cost $247,132,191) 219,077,180 - - 79.0 219,077,180 Canada: Materials (cost $4,336,070) 1,587,804 - - 0.6 1,587,804 Germany: Financial 3,666,552 - - 1.3 3,666,552 Healthcare 6,080,868 - - 2.2 6,080,868 Materials 2,356,326 - - 0.8 2,356,326 Technology 7,933,638 - - 2.8 7,933,638 Total Germany (cost $20,700,313) 20,037,384 - - 7.1 20,037,384 Great Britain: Energy: 4,425,300 Ensco PLC (cost $24,074,684) 15,754,068 - - 5.7 15,754,068 Ireland: Consumer discretionary (cost $17,261,135) 6,939,332 - - 2.5 6,939,332 Industrial: 908,392 AerCap Holdings 35,972,323 - - 13.0 35,972,323 Total Ireland (cost $49,816,231) 42,911,655 - - 15.5 42,911,655 Netherlands: Communication services (cost $4,483,178) 4,375,622 - - 1.6 4,375,622 Norway: Materials (cost $1,669,655) 1,145,510 - - 0.4 1,145,510 6

Solasglas Investments, LP Condensed Schedules of Investments (continued) December 31, 2018 (In U.S. Dollars) Number Fair Value Hierarchy % of Partners' of Units Description Level 1 Level 2 Level 3 Capital Fair Value Investments (continued): Common stock (continued): Romania: Utilities (cost $393,402)$ 304,320 $ - $ - 0.1 %$ 304,320 Sweden: Financial (cost $2,767,462) 2,200,065 - - 0.8 2,200,065 Total common stock (cost $355,373,186) 307,393,608 - - 110.8 307,393,608 Commodities: 28,919 Gold (cost $29,492,632) 37,079,793 - - 13.4 37,079,793 Municipal bonds: United States of America (cost $5,653,544) - 12,926,865 - 4.7 12,926,865 Preferred stock: United States of America: Financial (cost $6,538,645) - 11,899,794 - 4.3 11,899,794 Investment funds: United States of America: Consumer staples (cost $1,802,049) - - 2,792,921 1.0 2,792,921 Investments in private equity: United States of America: Financial (cost $704,122) - - 1,412,651 0.5 1,412,651 Corporate bonds: Portugal: Financial (cost $2,109,337) - 12,982 - 0.0 12,982 United States of America: Energy (cost $1,545,429) - 1,342,172 - 0.5 1,342,172 Total corporate bonds (cost $3,654,766) - 1,355,154 - 0.5 1,355,154 Mortgage-backed securities: United States of America: Financial (cost $950,589) - - 1,038,184 0.4 1,038,184 Total investments subject to fair value hierarchy (cost $404,169,533) $ 344,473,401 $ 26,181,813 $ 5,243,756 135.5 %$ 375,898,970 7

Solasglas Investments, LP Condensed Schedules of Investments (continued) December 31, 2018 (In U.S. Dollars) Number Fair Value Hierarchy % of Partners' of Units Description Level 1 Level 2 Level 3 Capital Fair Value Investments (continued): Investment funds (1): United States of America: Energy 1.6$ 4,413,177 Financial 7.4 20,424,657 Technology 0.2 581,164 Total investment funds (cost $19,522,719) 9.2 25,418,998 Total investments (cost $423,692,252) 144.7 %$ 401,317,968 Derivative contracts: Put options: United States of America: Communication services$ - $ 13,454,851 $ - 4.9 %$ 13,454,851 Consumer discretionary: 8,955 Tesla Inc, 200-255, 1/2019-1/2020 - 18,638,687 - 6.7 18,638,687 Other - 9,600,475 - 3.5 9,600,475 Technology - 8,139,057 - 2.9 8,139,057 Total put options (cost $47,947,807) - 49,833,070 - 18.0 49,833,070 Total return swaps - short exposure: South Korea: Healthcare (cost $0) - 7,493,279 - 2.7 7,493,279 Futures contracts - long exposure: Commodities: 553 Gold, 2/2019 (cost $1,781) 3,108,081 - - 1.1 3,108,081 Total return swaps - long exposure: Germany: Technology - 385,641 - 0.2 385,641 Great Britain: Communication services - 1,400,714 - 0.5 1,400,714 Total total return swaps - long exposure (cost $0) - 1,786,355 - 0.7 1,786,355 Call options: Interest rates (cost $2,450,588) - 845,972 - 0.3 845,972 Forward contracts - long exposure: Foreign currency (cost $0) - 76,332 - 0.0 76,332 Total derivative contracts (cost $50,400,176) $ 3,108,081 $ 60,035,008 $ - 22.8 %$ 63,143,089 (1) The Partnership’s investments in investment funds that are valued at their net asset value as reported by the underlying funds are not categorized within the fair value hierarchy. See Note 2. 8

Solasglas Investments, LP Condensed Schedules of Investments (continued) December 31, 2018 (In U.S. Dollars) Number Fair Value Hierarchy % of Partners' of Units Description Level 1 Level 2 Level 3 Capital Fair Value Investments sold, not yet purchased: Common stock: United States of America: Consumer discretionary: 86,815 Tesla Inc $ 28,892,032 $ - $ - 10.4 %$ 28,892,032 Other 7,240,716 - - 2.6 7,240,716 Energy 2,055,800 - - 0.7 2,055,800 Financial: 558,700 Assured Guaranty Ltd 21,387,036 - - 7.7 21,387,036 Other 17,827,760 - - 6.4 17,827,760 Healthcare: 152,417 DexCom Inc 18,259,557 - - 6.6 18,259,557 Other 9,296,768 - - 3.4 9,296,768 Industrial: 155,400 Caterpillar Inc 19,746,678 - - 7.1 19,746,678 278,900 C.H. Robinson Worldwide Inc 23,452,701 - - 8.4 23,452,701 97,200 Snap-On Inc 14,122,188 - - 5.1 14,122,188 Other 13,772,544 - - 5.0 13,772,544 Technology 9,596,929 - - 3.5 9,596,929 Total United States of America (proceeds $168,860,292) 185,650,709 - - 66.9 185,650,709 Norway: Consumer staples (proceeds $2,510,656) 2,795,625 - - 1.0 2,795,625 Total common stock (proceeds $171,370,948) 188,446,334 - - 67.9 188,446,334 Corporate bonds: Netherlands: Communication services (proceeds $10,653,900) - 10,281,468 - 3.7 10,281,468 Total investments sold, not yet purchased (proceeds $182,024,848) $ 188,446,334 $ 10,281,468 $ - 71.6 %$ 198,727,802 9

Solasglas Investments, LP Condensed Schedules of Investments (continued) December 31, 2018 (In U.S. Dollars) Number Fair Value Hierarchy % of Partners' of Units Description Level 1 Level 2 Level 3 Capital Fair Value Derivative contracts: Total return swaps - long exposure: United States of America: Energy $ - $ 2,171,104 $ - 0.8 %$ 2,171,104 Financial - 5,207,639 - 1.9 5,207,639 Total United States of America (proceeds $0) - 7,378,743 - 2.7 7,378,743 Germany: Financial - 5,124,948 - 1.8 5,124,948 Materials - 1,420,123 - 0.5 1,420,123 Total Germany (proceeds $0) - 6,545,071 - 2.3 6,545,071 Romania: Utilities - 34,805 - 0.0 34,805 Spain: Financial - 5,205 - 0.0 5,205 Total total return swaps - long exposure (proceeds $0) - 13,963,824 - 5.0 13,963,824 Put options: United States of America: Communication services - 1,598,529 - 0.6 1,598,529 Consumer discretionary: 15,989 Tesla Inc, 90-280, 1/2019-1/2020 - 7,992,023 - 2.9 7,992,023 Other - 1,022,360 - 0.3 1,022,360 Technology - 1,315,880 - 0.5 1,315,880 Total put options (proceeds $14,703,262) - 11,928,792 - 4.3 11,928,792 Total return swaps - short exposure: Interest rates (cost $893) - 445,745 - 0.2 445,745 Call options: United States of America: Technology (proceeds $319,187) - 5,466 - 0.0 5,466 Total derivative contracts (proceeds $15,021,556) $ - $ 26,343,827 $ - 9.5 %$ 26,343,827 See accompanying notes to financial statements. 10

Solasglas Investments, LP Statements of Operations For the year ended December 31, 2019 and for the period from September 1, 2018 (Commencement of Operations) to December 31, 2018 (In U.S. Dollars) 2019 2018 Investment income Interest $ 3,883,889 $ 1,867,856 Dividends, net of withholding taxes of $664,808 and $713,237 respectively 3,178,505 2,159,811 Total investment income 7,062,394 4,027,667 Expenses Management fee 4,892,950 3,100,318 Interest 2,407,710 2,627,373 Dividends 1,669,502 1,607,364 Professional fees and other 1,140,794 483,059 Total expenses 10,110,956 7,818,114 Net investment loss (3,048,562) (3,790,447) Realized and change in unrealized gains (losses) on investment transactions Net realized gains (losses) on Investments 31,848,942 (89,859,922) Derivative contracts 1,775,443 9,885,504 Currencies 914,069 (1,021,788) Net realized gains (losses) 34,538,454 (80,996,206) Net change in unrealized depreciation on Investments 36,598,325 10,660,207 Derivative contracts (8,371,614) 4,156,003 Currencies 288,453 (26,622) Net change in unrealized depreciation 28,515,164 14,789,588 Net gain (loss) on investment transactions 63,053,618 (66,206,618) Net increase (decrease) in partners’ capital resulting from operations $ 60,005,056 $ (69,997,065) See accompanying notes to financial statements. 11

Solasglas Investments, LP Statements of Changes in Partners’ Capital For the year ended December 31, 2019 and for the period from September 1, 2018 (Commencement of Operations) to December 31, 2018 (In U.S. Dollars) General Limited Partner Partners Total Balance, September 1, 2018 $ - $ - $ - Capital contributions (See Note 1) 51,222,585 392,819,752 444,042,337 Capital withdrawals - (96,634,956) (96,634,956) Allocation of net decrease in net assets resulting from operations (9,423,960) (60,573,105) (69,997,065) Balance, December 31, 2018 $ 41,798,625 $ 235,611,691 $ 277,410,316 Capital contributions (See Note 1) 603,699 90,288,048 90,891,747 Capital withdrawals - (131,898,855) (131,898,855) Allocation of net increase in net assets resulting from operations 8,968,997 51,036,059 60,005,056 Incentive allocation 4,980,619 (4,980,619) - Balance, December 31, 2019 $ 56,351,940 $ 240,056,324 $ 296,408,264 See accompanying notes to financial statements. 12

Solasglas Investments, LP Statement of Cash Flows December 31, 2019 and for the period from September 1, 2018 (Commencement of Operations) to December 31, 2018 (In U.S. Dollars) 2019 2018 Cash flows from operating activities Net increase (decrease) in net assets resulting from operations $ 60,005,056 $ (69,997,065) Adjustments to reconcile net increase (decrease) resulting from operations to net cash provided by operating activities: Net realized gain (loss) on investments and derivative contracts (33,624,385) 79,974,418 Net change in unrealized depreciation on investments and derivative contracts (28,226,711) (14,816,210) Purchase of investments and derivative contracts (163,208,744) (106,699,665) Proceeds from sales of investments and derivative contracts 506,435,494 241,709,854 Proceeds from investments and derivative contracts sold short 213,515,840 131,077,758 Purchase to cover investments and derivative contracts sold short (337,956,867) (440,509,736) Changes in operating assets and liabilities: Due from brokers 9,760,693 207,122,612 Interest and dividends receivable 2,309,991 (761,293) Due to brokers (22,771,006) 17,590,022 Interest and dividends payable (409,471) (459,102) Other liabilities (68,956) 37,774 Net cash provided by operating activities 205,760,934 44,269,367 Cash flows from financing activities Proceeds from notes payable - 10,000,000 Payments of notes payable (30,000,000) (10,000,000) Capital contributions 53,983,386 65,565,998 Capital withdrawals (131,898,855) (96,634,956) Net cash used in financing activities (107,915,469) (31,068,958) Net increase in cash and cash equivalents 97,845,465 13,200,409 Cash and cash equivalents, beginning of year/period 13,200,409 - Cash and cash equivalents, end of year/period $ 111,045,874 $ 13,200,409 Supplemental disclosure of cash flow information Cash paid during the period for interest $ 2,916,173 $ 1,389,763 In-kind contributions (with an unrealized loss of $13,612,907 and $52,472,806, respectively) (See Note 1) $ 36,908,361 $ 378,476,339 See accompanying notes to financial statements. 13

Solasglas Investments, LP Notes to Financial Statements December 31, 2019 and 2018 (In U.S. Dollars) 1. Organization Solasglas Investments, LP (the “Partnership”) is an exempted Cayman Islands limited partnership formed on August 17, 2018 and commenced operations on September 1, 2018. The Partnership is registered with the Cayman Islands Monetary Authority under the Cayman Islands Mutual Funds Law. The Partnership will continue until terminated, wound up or dissolved in accordance with the Partnership Agreement (the “Agreement”). DME Advisors, LP (the “Manager”) is registered as an investment adviser under the Investment Advisers Act of 1940 with the U.S. Securities and Exchange Commission, and serves as the investment manager of the Partnership. DME Advisors II, LLC, is the general partner. Morgan Stanley Fund Services serves as the administrator of the Partnership pursuant to an administration agreement. The Partnership was organized to invest and trade in securities and other investment vehicles and instruments. The Manager is a value-oriented investment management firm that primarily invests and trades in long and short publicly listed equity securities, as well as distressed debt when cyclically attractive. The primary investment objective of the Partnership is to achieve capital appreciation by buying securities with trading values materially lower than their intrinsic values and by selling short securities with trading values materially higher than their intrinsic values. The Partnership aims to achieve high absolute rates of return while minimizing the risk of capital loss. There can be no assurance that such investment objective will be achieved, and investment results may vary substantially. The Partnership was created primarily for the benefit of Greenlight Reinsurance, Ltd. (“GLRE”) and Greenlight Reinsurance Ireland, Designated Activity Company (collectively with GLRE, the “Limited Partners”) and the general partner (and collectively with the Limited Partners, the “Partners”). Prior to September 1, 2018, the Limited Partners, collectively with an affiliate of the general partner, were part of a joint venture arrangement (“Joint Venture”) that executed a substantially identical investment strategy to that of the Partnership. To facilitate the formation of the Partnership, the Partners initially contributed $39,001,851 and the balances shown below from the Joint Venture to the Partnership. In addition, for a limited period of time subsequent to September 1, 2018, the Partnership participated in certain assets and liabilities held by the Joint Venture via a participation agreement. Due from / (to) brokers $ 278,582,559 Investments / (investments sold, short) and derivative contracts, at fair value (with an unrealized loss of $52,472,806) 130,125,847 Notes payable (30,000,000) Other assets / (liabilities) (232,067) Total in-kind contributions on September 1, 2018 $ 378,476,339 14

Solasglas Investments, LP Notes to Financial Statements (continued) 1. Organization (continued) On January 1, 2019, an additional $36,908,361 of Investments, with an unrealized loss of $13,612,907, were contributed in-kind to the Partnership from the Joint Venture. 2. Significant Accounting Policies Basis of Presentation The Partnership is an investment company which applies the specialized accounting and reporting requirements for investment companies. The financial statements have been prepared in accordance with Regulation S-X and accounting principles generally accepted in the United States of America (“U.S. GAAP”) and are expressed in United States (“U.S.”) dollars. Certain prior period amounts may be reclassified to conform to the current presentation, with no effect on the Partnership’s assets, liabilities, partners’ capital, results of operations or cash flows. The Partnership, along with other funds managed by the Manager or its affiliates, may utilize special purpose vehicles (“SPVs”) for tax, regulatory or other purposes. The underlying investments held by SPVs are included within the Condensed Schedule of Investments and reflect the Partnership’s proportionate share of each such underlying investment. Cash and Cash Equivalents The Partnership considers all highly-liquid investments, with original maturities of less than ninety days that are not held for sale in the ordinary course of business, as cash equivalents. Cash and cash equivalents held at financial institutions, at times, may exceed the amount insured by the Federal Deposit Insurance Corporation. At December 31, 2019 and 2018, cash and cash equivalents consist of direct and indirect investments in U.S. Government obligations with a fair value of $111,045,874 and $13,200,409, respectively, which would be considered Level 1 in the fair value hierarchy as described below. Investment Transactions The Partnership records investment transactions on a trade date basis. Realized gains and losses on investment transactions are determined on a specific identification basis. Dividend income, net of withholding taxes, and dividend expense are recognized on the ex-dividend date and interest income and expense are recognized on an accrual basis. Withholding taxes on dividends have been accounted for in accordance with the Partnership’s understanding of the applicable country’s tax rules and rates. Foreign Currency Transactions Investments and derivative contracts denominated in foreign currencies are translated into U.S. dollar amounts at the date of valuation. Purchases and sales of investments denominated in foreign currencies are translated into U.S. dollar amounts on the respective dates of such transactions. 15

Solasglas Investments, LP Notes to Financial Statements (continued) 2. Significant Accounting Policies (continued) Foreign Currency Transactions (continued) The Partnership does not isolate the portion of the results of operations resulting from changes in foreign exchange rates on investments and derivative contracts from the fluctuations arising from changes in market prices of investments and derivative contracts owned or sold short. Such fluctuations are included with applicable net realized gain on investments or derivatives and net change in unrealized depreciation on investments or derivative contracts in the statement of operations. Fair Value Measurements and Investment Valuation The fair values of the Partnership’s assets and liabilities that qualify as financial instruments under U.S. GAAP approximate the carrying amounts presented in the financial statements. The Partnership values all investments and derivative contracts (collectively “investments”) at fair value. U.S. GAAP establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs that market participants would use in pricing investments based on market data obtained from sources independent of the Partnership. Unobservable inputs are inputs that reflect the Partnership’s assumptions about the factors market participants would use in pricing investments based on the best information available in the circumstances. The hierarchy is broken down into three levels based on the reliability of inputs as follows: Level 1 - Valuations based on quoted prices in active markets for identical investments. An active market for the investment is a market in which transactions for the investment occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Valuation adjustments are not applied to Level 1 investments. Level 2 - Valuations based on quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly. Level 2 inputs include: (i) quoted prices for similar investments in active markets; (ii) quoted prices for identical investments traded in non-active markets (i.e., dealer or broker markets); and (iii) inputs other than quoted prices that are observable or inputs derived from or corroborated by market data. Level 3 - Valuations based on inputs that are unobservable, supported by little or no market activity, and significant to the overall fair value measurement (including the Partnership’s assumptions in determining the fair value of investments). The availability of observable inputs can vary from investment to investment and is affected by a wide variety of factors, including, for example, the type of product, whether the product is new and not yet established in the market place, the liquidity of markets, and other characteristics particular to the transaction. 16

Solasglas Investments, LP Notes to Financial Statements (continued) 2. Significant Accounting Policies (continued) Fair Value Measurements and Investment Valuation (continued) The inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value hierarchy is determined based on the lowest level input that is significant to the fair value measurement in its entirety. Fair value is a market-based measure considered from the perspective of a market participant rather than an entity-specific measure. Therefore, even when market assumptions are not readily available, the Partnership’s own assumptions are set to reflect those that market participants would use in pricing the asset or liability at the measurement date. A description of the valuation techniques applied and inputs utilized in measuring fair value of the Partnership’s major categories of assets and liabilities as of December 31, 2019 and 2018 are as follows: Common Stock Common stock is generally valued based on quoted prices from the relevant exchange. To the extent these investments are actively traded, they are categorized in Level 1 of the fair value hierarchy. In instances when investments in common stock are not actively traded or valuation adjustments are applied, they are categorized in Level 2 of the fair value hierarchy and in instances where significant inputs are unobservable, they are categorized in Level 3 of the fair value hierarchy. Corporate Bonds, Mortgage-Backed Securities (“MBS”), Municipal Bonds and Preferred Stock The fair value of corporate bonds, MBS, municipal bonds and preferred stock is estimated using recently executed transactions and market price quotations (where observable). When recent transactions or observable price quotations are not available, fair value is determined based on cash flow models. These investments are generally categorized in Level 2 of the fair value hierarchy; in instances where significant inputs are unobservable, they are categorized in Level 3 of the fair value hierarchy. Commodities Actively traded commodities are valued based on quoted dealer prices and are categorized in Level 1 of the fair value hierarchy. Commodities that are not actively traded are generally included in Level 2 of the fair value hierarchy. 17

Solasglas Investments, LP Notes to Financial Statements (continued) 2. Significant Accounting Policies (continued) Fair Value Measurements and Investment Valuation (continued) Investment Funds Investments in investment funds are valued at their net asset value as reported by the underlying fund’s administrator or manager. Due to restrictions on the transferability and timing of withdrawals from the investment funds, the amounts realized upon liquidation will likely differ from such reported values. As of December 31, 2019, none of the Partnership’s investments in investment funds allow for a voluntary right of withdrawal. As of December 31, 2018, $11,679,375, of the Partnership’s investments in investment funds could be withdrawn quarterly upon 60 days’ notice. The remainder of the Partnership’s investments in investment funds did not contain a voluntary right of withdrawal. Investments valued based on their unadjusted net asset value are not categorized within the fair value hierarchy. The general partner may determine that the net asset value provided by the underlying fund does not represent fair value. In such situations, the fair value of the underlying fund will be valued in accordance with the Partnership’s valuation policy. This may include calculating an independent value of the underlying fund’s assets and liabilities, reviewing secondary market transactions, or other techniques depending upon the circumstances. At December 31, 2019 and 2018, the fair value of an investment fund totaling $2,084,290 and $2,792,921, respectively, is based primarily on the Manager’s valuation of the asset held by the underlying fund and is categorized in Level 3 of the fair value hierarchy. Private Equity The transaction price is used as the best estimate of fair value upon acquisition. Thereafter, valuation is based on an assessment of each investment, incorporating factors that consider the evaluation of financing and sale transactions with third parties, financial information provided by management of the investee company, expected cash flows and market-based information, including comparable transactions, performance multiples and changes in market outlook, among other factors. These investments are included in Level 3 of the fair value hierarchy. 18

Solasglas Investments, LP Notes to Financial Statements (continued) 2. Significant Accounting Policies (continued) Fair Value Measurements and Investment Valuation (continued) Derivative Contracts The fair value of derivatives actively traded on a national exchange and based on quoted prices from the relevant exchange are categorized in Level 1 of the fair value hierarchy. Over-the- counter (“OTC”) derivatives valued based on market price quotations and listed derivatives that are not actively traded are generally categorized in Level 2 of the fair value hierarchy. Fair values for other OTC derivative investments are based on pricing models intended to approximate the amounts that would be paid to or received from a third party in settlement of the respective contract. Factors taken into consideration include credit spreads, market liquidity and concentrations, foreign currency rates, and funding and administrative costs incurred over the lives of the investments. As these inputs are typically observable, these OTC derivatives are also categorized within Level 2 of the fair value hierarchy. Please refer to Note 4 for additional information on the Partnership’s derivative contracts. Investments Sold Short The Partnership has sold investments that it does not own and will, therefore, be obligated to purchase such investments at a future date. A gain, limited to the price at which the Partnership sold the investment, or a loss, unlimited in amount, will be realized upon the liquidation of the investment. The Partnership has recorded this obligation in the financial statements at fair value. There is an element of market risk in that, if the investments increase in value, it will be necessary to purchase the investments at a cost in excess of the obligation reflected in the statement of assets, liabilities and partners’ capital. Use of Estimates The preparation of the financial statements in conformity with U.S. GAAP requires the Partnership to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting year. Actual results could differ from those estimates and those differences could be material. Income Taxes The Partnership is not subject to taxes on income, capital gains or withholding tax in the Cayman Islands. Each partner in the Partnership may be subject to taxation on its share of the Partnership’s ordinary income and capital gains. In certain jurisdictions other than the Cayman Islands, taxes are withheld at the source on dividends and interest received by the Partnership. Capital gains derived by the Partnership in such jurisdictions generally will be exempt from foreign income or withholding taxes at the source. 19

Solasglas Investments, LP Notes to Financial Statements (continued) 2. Significant Accounting Policies (continued) Income Taxes (continued) U.S. GAAP requires the evaluation of tax positions taken or expected to be taken to determine whether it is more likely than not that a tax position will be sustained upon examination, including resolution of any related appeals or litigation processes. In evaluating whether a tax position has met the more likely than not recognition threshold, the Partnership presumes that the position will be examined by the appropriate taxing authority that has full knowledge of all relevant information. Tax positions not deemed to meet a more likely than not threshold would be recorded as an income tax expense in the current period. Upon the completion of any potential examination by U.S. federal, state or foreign tax jurisdiction in which the Partnership trades, tax adjustments may be necessary and retroactive to all open tax years. If an adjustment is necessary, the Partnership would recognize interest and penalties, if any, related to unrecognized tax as income tax expense in the statement of operations. As of December 31, 2019 and 2018, there was no impact to the financial statements relating to accounting for uncertainty in income taxes. 3. Investments and Fair Value The Partnership’s assets and liabilities measured at fair value have been categorized based upon the fair value hierarchy as reflected in the condensed schedule of investments. Changes in Level 3 assets and liabilities for the year ended December 31, 2019 are as follows: Contributions Purchases Sales Transfers Assets Investments: Private equity $ - $ 2,289,597 $ (2,356,614) $ 1,482,675 $ - $ 2,289,597 $ (2,356,614) $ 1,482,675 Changes in Level 3 assets and liabilities for the period from September 1, 2018 (commencement of operations) to December 31, 2018 are as follows: Contributions Purchases Sales Transfers Assets Investments: Investment funds $ 3,890,900 $ - $ (3,237,425) $ - Private equity 1,423,732 - - - MBS 916,098 - - - $ 6,230,730 $ - $ (3,237,425) $ - 20

Solasglas Investments, LP Notes to Financial Statements (continued) 3. Investments and Fair Value (continued) The Manager has established valuation processes and procedures to ensure each investment’s fair value is in accordance with U.S. GAAP. In the event the Partnership has an investment that cannot be readily valued per its valuation procedures as discussed in Note 2, a Valuation Committee has been designated to oversee the valuation process of such investments. The Valuation Committee is comprised of employees of the Manager and meets at least monthly to ensure that each investment is valued in accordance with the Partnership’s valuation policy. The following table summarizes the valuation techniques and significant unobservable inputs used by the Partnership to value its investments categorized within Level 3 as of December 31, 2019. This table is not intended to be all-inclusive, but instead captures the significant unobservable inputs relevant to the Manager’s determination of fair values. Significant Assets Fair value Valuation technique unobservable inputs Investment funds $ 2,084,290 Market approach Earnings multiple Discount rate Private equity $ 891,843 Market approach Earnings multiple The following table summarizes the valuation techniques and significant unobservable inputs used by the Partnership to value its investments categorized within Level 3 as of December 31, 2018. This table is not intended to be all-inclusive, but instead captures the significant unobservable inputs relevant to the Manager’s determination of fair values. Significant Assets Fair value Valuation technique unobservable inputs Investment funds $ 2,792,921 Market approach Earnings multiple Discount rate Private equity $ 663,740 Net realizable value Cash held in escrow Expected transaction value The Partnership’s other Level 3 investments have been valued using unadjusted third-party quotations. No unobservable inputs internally developed by the Partnership have been applied to these investments, thus they have been excluded from the above tables. 4. Derivative Contracts In the normal course of business, the Partnership enters into derivative contracts for investment purposes. The Partnership uses these instruments as part of its trading strategy. The Partnership’s policy is to recognize each derivative contract as either an asset or liability and to measure each contract at fair value. The resulting change in unrealized appreciation or depreciation is included in the statement of operations. 21

Solasglas Investments, LP Notes to Financial Statements (continued) 4. Derivative Contracts (continued) The Partnership utilizes swap contracts as economic substitutes for investments in equity, interest rates, credit and other instruments. Swap contracts are arrangements whose valuation and resultant appreciation or depreciation is based upon the fair value fluctuations of an underlying instrument. The Partnership may buy and write put and call options or warrants through the OTC market or through an exchange. The buyer of an option has the right to purchase (in the case of a call option) or sell (in the case of a put option) a specified quantity of a specific financial instrument at a specified price prior to or on a specified expiration date. The writer of an option is exposed to the risk of loss if the market price of the underlying financial instrument declines (in the case of a put option) or increases (in the case of a call option). The premium received by the Partnership upon writing an option contract is recorded as a liability and marked to market on a daily basis. The writer of an option can never profit by more than the premium paid by the buyer. In the case of a written call option, losses could be unlimited and in the case of written put options, losses are limited to the number of contracts written multiplied by the applicable strike price. As of December 31, 2019 the Partnership had written put options with a fair value of $932,693 and maximum potential payouts of $150,845,000 expiring between January 2020 and January 2021. As of December 31, 2018 the Partnership had written call options with a fair value of $5,466 and had written put options with a fair value of $11,928,792 and maximum potential payouts of $435,479,000 expiring between January 2019 and January 2020. Potential losses on the Partnership’s written put options are not representative of its net economic exposure as the Partnership has long and short exposure across a variety of different financial instruments whereby losses on one instrument are offset by gains in other instruments. Forward contracts obligate the Partnership to either buy or sell an asset at a specified future date and price. Futures contracts are contracts to buy or sell a standardized quantity of a specified instrument on a specified future date. Initial margin deposits are required to trade in the futures market. Futures contracts are marked to market daily. When forward and futures contracts are terminated, the Partnership recognizes a realized gain or loss equal to the difference between the value of the contract at the time it was entered into and the time it was closed. The following tables set forth the gross fair value of derivative asset and liability contracts by primary risk type as of December 31, 2019 and 2018. The fair values of these derivatives are presented on a gross basis, even when derivatives are subject to master netting arrangements. The tables also include information on the volume of derivative activity that is approximated, on an absolute basis, by the average quarterly outstanding notional amounts for the year ended December 31, 2019 and for the period from September 1, 2018 (commencement of operations) to December 31, 2018. 22

Solasglas Investments, LP Notes to Financial Statements (continued) 4. Derivative Contracts (continued) Derivative contracts as of December 31, 2019: Average Gross derivative notional amount Underlying risk type outstanding Assets Liabilities Commodity: Call options(1) 1,198,152 $ - $ - Futures contracts 29,629,941 136,930 - Total return swaps 997,062 96,233 - Equity price: Call options(1) 20,779 - - Put options(1) 68,332,354 2,414,025 932,693 Total return swaps 72,373,228 3,677,062 - Foreign exchange: Forward contracts 6,427,620 - - Interest rate: Call options 492,400,000 - - Futures contracts 115,480,363 - - Total return swaps 21,989,464 - 1,121,552 $ 6,324,250 $ 2,054,245 (1) Average notional amounts presented are based on the quarterly delta-adjusted exposure for the respective underlying investment for the year ended December 31, 2019. Derivative contracts as of December 31, 2018: Average Gross derivative notional amount Underlying risk type outstanding Assets Liabilities Commodity: Futures contracts 62,291,326 $ 3,108,081 $ - Total return swaps 7,343,270 - - Equity price: Call options(1) 317,291 - 5,466 Put options(1) 175,982,211 49,833,070 11,928,792 Total return swaps 108,802,193 9,279,634 13,963,824 Foreign exchange: Forward contracts 22,560,929 76,332 - Interest rate: Call options 1,783,000,000 845,972 - Total return swaps 21,476,984 - 445,745 $ 63,143,089 $ 26,343,827 (1) Average notional amounts presented are based on the quarterly delta-adjusted exposure for the respective underlying investment for the period from September 1, 2018 (commencement of operations) to December 31, 2018. 23

Solasglas Investments, LP Notes to Financial Statements (continued) 4. Derivative Contracts (continued) The following is a summary of the components of the gains and losses on derivative contracts reported in the statement of operations for the year ended December 31, 2019: Net realized Net change in gain on derivative unrealized depreciation Underlying risk type contracts on derivative contracts Commodity: Call options $ (523,260) $ - Futures contracts 3,328,639 (2,970,045) Total return swaps - 96,233 Equity price: Call options 1,177,972 (313,721) Put options (11,267,824) (14,397,810) Total return swaps 12,085,235 8,361,252 Foreign exchange: Forward contracts (972,839) (76,332) Interest rate: Call options (2,180,685) 1,604,616 Futures contracts 259,471 - Total return swaps (131,266) (675,807) $ 1,775,443 $ (8,371,614) The following is a summary of the components of the gains and losses on derivative contracts reported in the statement of operations for the period from September 1, 2018 (commencement of operations) to December 31, 2018: Net realized Net change in gain on derivative unrealized appreciation Underlying risk type contracts on derivative contracts Commodity: Futures contracts $ (65,283) $ 4,319,050 Total return swaps 5,629,555 (1,075,035) Equity price: Call options 518,515 302,697 Put options 3,223,672 15,927,677 Total return swaps 2,974,457 (16,475,896) Foreign exchange: Forward contracts (2,334,531) 1,952,707 Interest rate: Call options - (105,011) Total return swaps (60,881) (690,186) $ 9,885,504 $ 4,156,003 24

Solasglas Investments, LP Notes to Financial Statements (continued) 4. Derivative Contracts (continued) The Partnership’s OTC derivative contracts are generally entered into with its counterparties pursuant to the International Swaps and Derivatives Association (“ISDA”) Master Agreement and related documentation. If the Partnership were to default under a provision of this agreement, the counterparty could terminate the applicable derivative contract and request immediate payment of any amounts due to it or pay the Partnership any amounts due to the Partnership pursuant to such agreement. The Partnership’s statement of assets, liabilities and partners’ capital includes derivative contracts that are eligible for offset and that are subject to a fully-executed master netting arrangement. The Partnership presents these contracts on a gross basis (without taking into account any offset). A master netting arrangement could allow the counterparty to net payment obligations and liabilities (including collateral held by the counterparty) that the counterparty owes to the Partnership against payment obligations and liabilities (including collateral held by the Partnership) that the Partnership owes to the counterparty. As of December 31, 2019, the following table provides, by counterparty, what amounts the counterparties could offset under master netting arrangements against the gross derivative assets set forth in the Partnership’s statement of assets, liabilities and partners’ capital: Gross derivative Gross liabilities subject to master Cash collateral held derivative assets(1) netting arrangements that could be offset Net amounts Counterparty C $ 96,233 $ (96,233) $ - $ - Counterparty D 1,717,570 (661,816) (1,055,754) - Counterparty F 3,677,063 - - 3,677,063 Counterparty G 696,454 (270,877) - 425,577 Total $ 6,187,320 $ (1,028,926) $ (1,055,754) $ 4,102,640 (1) Derivative assets exclude futures of $136,930, which are not subject to master netting arrangements. As of December 31, 2018, the following table provides, by counterparty, what amounts the counterparties could offset under master netting arrangements against the gross derivative assets set forth in the Partnership’s statement of assets, liabilities and partners’ capital: 25

Solasglas Investments, LP Notes to Financial Statements (continued) 4. Derivative Contracts (continued) Gross derivative Gross liabilities subject to master Cash collateral held derivative assets(1) netting arrangements that could be offset Net amounts Counterparty A $ 7,493,278 $ (5,036,851) $ - $ 2,456,427 Counterparty B 385,641 (122,902) - 262,739 Counterparty C 1,616,892 (490,718) - 1,126,174 Counterparty D 10,022,000 (1,735,590) (7,410,000) 876,410 Counterparty E 1,734,578 (358,372) (850,000) 526,206 Counterparty F 1,400,714 (1,400,714) - - Counterparty G 37,305,573 (11,050,144) (14,690,000) 11,565,429 Total $ 59,958,676 $ (20,195,291) $ (22,950,000) $ 16,813,385 (1) Derivative assets exclude futures and forward contracts of $3,184,413, which are not subject to master netting arrangements. As of December 31, 2019, the following table provides, by counterparty, what amounts the Partnership could offset under master netting arrangements against the gross derivative liabilities set forth in the Partnership’s statement of assets, liabilities and partners’ capital: Gross derivative Gross derivative assets subject to master Cash collateral posted liabilities netting arrangements that could be offset Net amounts Counterparty C $ 1,121,552 $ (96,233) $ (1,025,319) $ - Counterparty D 661,816 (661,816) - - Counterparty G 270,877 (270,877) - - Total $ 2,054,245 $ (1,028,926) $ (1,025,319) $ - As of December 31, 2018, the following table provides, by counterparty, what amounts the Partnership could offset under master netting arrangements against the gross derivative liabilities set forth in the Partnership’s statement of assets, liabilities and partners’ capital: Gross derivative Gross derivative assets subject to master Cash collateral posted liabilities netting arrangements that could be offset Net amounts Counterparty A $ 5,036,851 $ (5,036,851) $ - $ - Counterparty B 122,902 (122,902) - - Counterparty C 490,718 (490,718) - - Counterparty D 1,735,590 (1,735,590) - - Counterparty E 358,372 (358,372) - - Counterparty F 7,549,250 (1,400,714) (6,148,536) - Counterparty G 11,050,144 (11,050,144) - - Total $ 26,343,827 $ (20,195,291) $ (6,148,536) $ - 26

Solasglas Investments, LP Notes to Financial Statements (continued) 5. Due From/To Brokers The due from/to brokers balances in the accompanying statement of assets, liabilities and partners’ capital include cash, margin debt balances, collateral pledged or received and amounts receivable or payable for investment transactions that have not yet settled at December 31, 2019 and 2018. At December 31, 2019 and 2018, due from brokers included $6,742,994 and $43,161,953, respectively related to collateral balances which may be restricted in nature. The cash at the brokers, at times, may exceed the amount insured by the Securities Investor Protection Corporation. 6. Notes Payable The Partnership had secured a revolving credit facility (the “Credit Facility”) with a financial institution to provide funding for portfolio investments. The Credit Facility expired in November of 2019 and was not renewed. For the year ended December 31, 2019, the average amount borrowed from the Credit Facility was $11,166,667. As part of the Credit Facility, the Partnership’s gold position was pledged as collateral. For the year ended December 31, 2019, interest expense pursuant to the Credit Facility was $432,135 and is included in interest expense in the statement of operations. As of December 31, 2018, the Partnership had the ability to borrow $50,000,000 under this Credit Facility and had borrowed $30,000,000 at an interest rate of 3.52%. During the period from September 1, 2018 (commencement of operations) to December 31, 2018, the average amount borrowed from the Credit Facility was $26,300,000. As part of the Credit Facility, the Partnership’s gold position was pledged as collateral. For the period from September 1, 2018 (commencement of operations) to December 31, 2018, interest expense pursuant to the Credit Facility was $302,358 and is included in interest expense in the statement of operations. 7. Partnership Terms and Related Party Transactions Management Fees The Partnership pays the Manager, an affiliate of the general partner, a monthly management fee in advance equal to 0.125% (1.5% per annum) of each limited partner’s Investment Portfolio, in accordance with the Partnership Agreement (the “Agreement”). The Investment Portfolio is equal to the product of a limited partner’s capital account at the beginning of each month multiplied by a ratio agreed upon by the Partners in accordance with the Agreement. Effective June 1, 2019, no management fee was charged on the portion of each limited partner’s Investment Portfolio held in cash or cash equivalents. For the year ended December 31, 2019, the Manager earned a management fee of $4,892,950 from the Partnership. For the period from September 1, 2018 (commencement of operations) to December 31, 2018, the Manager earned a management fee of $3,100,318 from the Partnership. 27

Solasglas Investments, LP Notes to Financial Statements (continued) 7. Partnership Terms and Related Party Transactions (continued) Allocation of Income (Loss) and Performance Allocation The Agreement specifies that the net increase or decrease in partners’ capital resulting from operations for each fiscal period shall be allocated to the partners in proportion to the ratio of each partner’s capital account to the sum of all capital accounts with the exception of net income or loss on security transactions deemed new issues (“New Issues”) as defined by the Financial Industry Regulatory Authority, Inc. (“FINRA”). The net increase on New Issues is allocated to the Partners based on each partner’s eligibility to participate in New Issues. The Agreement also specifies that any investment may, from time to time, be deemed a Designated Security by the Manager. The net increase or decrease on Designated Securities will be allocated as deemed appropriate by the Manager. At the end of each calendar year, 20% of the increase in partners’ capital resulting from operations (subject to a reduction to 10% for an amount equal to any carryforward loss as specified in the Agreement) is reallocated to the capital account of the general partner from the capital account of each limited partner as a performance allocation. Effective June 1, 2019, no performance allocation was allocated on the portion of each limited partner’s net increase from cash or cash equivalents. For the year ended December 31, 2019, $4,980,619 was allocated to the general partner under this provision of the Agreement. For the period from September 1, 2018 (commencement of operations) to December 31, 2018, there was no performance allocation allocated to the general partner under this provision of the Agreement. Withdrawal Policy The Limited Partners may withdraw all or part of their capital account with a three day notice period, subject to the terms and restrictions set forth in the Agreement. The general partner shall give ten days written notice to the Limited Partners prior to making a withdrawal that would cause its capital account to be less than ten percent of the aggregate capital accounts of all partners. Contribution Policy The Limited Partners may contribute capital to the Partnership in accordance with the Agreement. From time to time, the general partner may contribute additional capital to ensure that its capital account balance is at least ten percent of the aggregate capital account balances of all partners. Other Related Party Transactions The Partnership is responsible for the payment of its own operating and other expenses. For operational efficiency, an affiliate of the Manager may act as a common pay agent and pay for some of these expenses on behalf of the Partnership and will subsequently be reimbursed. There was no such liability on December 31, 2019 or 2018. 28

Solasglas Investments, LP Notes to Financial Statements (continued) 8. Risks In the normal course of business, the performance of any investment is subject to numerous factors which are not predictable by or within the control of the Partnership. Such factors include a wide range of economic, political, competitive and other conditions that may affect investments in general or specific industries or companies. These investments may include investments sold short, commodities, options, swaps and other derivative contracts. The Partnership’s investment objective necessarily subjects the Partnership to various significant risks, both on and off balance sheet, including those that follow. The following summary is not intended to be a comprehensive summary of all risks relating to the operations and investment activities that the Partnership is exposed to. Market Risk Market risk represents the potential loss that can be caused by a change in the fair value of an investment. The Partnership’s exposure to market risk may be due to many factors, including the movement in interest rates, foreign exchange rates, indices, market volatility, and commodity and security values underlying its investments. Lack of Valuation Data; Limited Liquidity of Investments The Partnership may invest in securities and other assets which are subject to legal or other restrictions on transfer or for which no liquid market exists. The market prices for such investments tend to be volatile and may not be readily ascertainable, and the Partnership may not be able to sell such investments when the Partnership desires to do so or to realize what the Partnership perceives to be the fair value of such investments in the event of a sale. The Partnership may not be able to readily dispose of such illiquid investments and, in some cases, may be contractually prohibited from disposing of such investments for a specified period of time. Restricted securities may sell at a price lower than similar securities that are not subject to restrictions on resale. Potential Concentration of Investments The Partnership seeks to maintain a diversified portfolio. Although the Manager expects to spread the Partnership’s capital among a number of investments, it may depart from such policy from time to time and may hold a few, relatively large positions in relation to the Partnership’s capital (subject to the investment guidelines per the Agreement). Since the Partnership’s portfolio is not necessarily widely diversified, the investments of the Partnership may be subject to more rapid changes in value than would be the case if the Partnership maintained a more diversified investment portfolio. 29

Solasglas Investments, LP Notes to Financial Statements (continued) 8. Risks (continued) Investments in Foreign Securities Investments in foreign securities involve certain risks not typically associated with investing in U.S. securities, such as risks relating to (a) currency exchange matters between the U.S. dollar and the various foreign currencies in which the Partnership’s portfolio securities will be denominated and costs associated with conversion of investment principal and income from one currency into another, (b) differences between the U.S. and foreign securities markets, (c) political, social or economic instability, and (d) certain tax-related risks including, without limitation, uncertainties in the application of tax laws by non-U.S. jurisdictions, the imposition of withholding and other taxes on dividends, interest, capital gains or other income. Investments sold short Short sales require the Partnership to borrow a security that it does not own. If the price of a security sold short increases, the Partnership may have to provide additional collateral to maintain the short position. This could require the Partnership to increase the amount of the Partnership’s leverage or sell other portfolio investments to provide such additional collateral. Also, the lender of the securities sold short can request their return. Under adverse market conditions, the Partnership might not be able to purchase securities to meet the delivery requirement or may not be able to borrow securities from other lenders. In such an event, the Partnership may be subject to a mandatory close-out of the short position, which could result in unintended costs and losses. It may not be possible to borrow securities when the Manager wishes to make a short sale, particularly in illiquid markets. Traditional lenders of securities might be less likely to lend securities under certain market conditions. As a result, the Partnership may not be able to effectively pursue a short selling strategy due to a limited supply of securities available for borrowing. In addition, regulatory authorities may impose restrictions and prohibitions on short selling activities that could adversely affect the Partnership’s ability to engage in short sales or borrow certain securities in connection with short sales. Leverage As part of the Partnership’s investment strategy (subject to the investment guidelines per the Agreement) and subject to applicable margin and other limitations, the Partnership may borrow funds from its counterparties in order to make additional investments and thereby increase both the possibility of gain and risk of loss. Consequently, the effect of fluctuations in the market value of the Partnership’s portfolio would be amplified. In addition, the Partnership could potentially create leverage via the use of instruments such as options, swaps and other derivative contracts. 30

Solasglas Investments, LP Notes to Financial Statements (continued) 8. Risks (continued) Credit Risk Although the Partnership intends to enter into transactions only with counterparties that the Manager believes to be creditworthy, there can be no assurance that a counterparty will not default and that the Partnership will not sustain a loss on a transaction as a result. If an obligor (such as the issuer or a party offering credit enhancement) for an investment held by the Partnership, a counterparty to a derivative contract with the Partnership, or a prime broker or other service provider to the Partnership, fails to pay, otherwise defaults or is perceived to be less creditworthy, a security’s credit rating is downgraded or the credit quality or value of any underlying assets declines, the value of such investment could decline. In addition, the Partnership may incur expenses to protect the Partnership’s interests in securities experiencing these events. Counterparty Risk The Partnership has relationships that provide prime brokerage, derivative intermediation and financing services that permit the Partnership to trade in a variety of markets and asset classes as well as custody its cash, investments and derivatives. However, there can be no assurance that the Partnership will be able to maintain such relationships. An inability to maintain such relationships could limit the Partnership’s trading activities, create losses, preclude the Partnership from engaging in certain transactions or prevent the Partnership from trading at optimal rates and terms. The assets of the Partnership will generally be held in accounts maintained for it by its prime brokers or in accounts with other market participants, including non-U.S. sub-custodians. The accounts generally will not be segregated, bankruptcy-remote accounts titled in the Partnership’s name and, therefore, a failure of any broker or market participant is likely to have a greater adverse impact than if the assets, or the accounts in which they are held, were registered in the name of the Partnership. In addition, because the Partnership’s investments generally will be held in margin accounts, and the prime brokers will have the ability to lend those securities to other market participants, the Partnership’s ability to recover all of its assets in the context of a bankruptcy or other failure of a prime broker may be further limited. Many of the markets in which the Partnership will effect transactions are not exchange-based. The stability and liquidity of OTC transactions will depend in large part on the creditworthiness of the parties to the transactions. OTC transactions could expose the Partnership to the risk that a counterparty will not settle a transaction in accordance with its terms or because of a credit or liquidity problem, causing the Partnership to suffer a loss. Such counterparty risk is accentuated where the Partnership has concentrated its transactions with a single or small group of counterparties. 31

Solasglas Investments, LP Notes to Financial Statements (continued) 8. Risks (continued) If a counterparty defaults, under normal circumstances the Partnership will have contractual remedies against the counterparty. However, exercising such contractual rights may involve delays or costs. Furthermore, there is a risk that a counterparty could become insolvent. In such an event, the Partnership’s ability to recover securities from such counterparty or receive payment of claims therefor may be significantly delayed and the Partnership may recover less than the full value of its securities. This is particularly true with respect to counterparties located in jurisdictions outside the United States where the application of non-U.S. insolvency laws may be subject to substantial limitations and uncertainties. Currency Risk It is expected that the Partnership’s portfolio will contain investments denominated in currencies other than the U. S. dollar. Changes in the value of other currencies against the value of the U.S. dollar could have an adverse impact on the performance of the Partnership. The Partnership may enter into currency hedging transactions, but is not required or expected to do so, and such transactions have an associated cost that could reduce investment returns. Spot and forward currency prices are highly volatile and price movements for spot and forward currency contracts may be influenced by, among other things, the foregoing risks. Commitments In the normal course of business, the Partnership enters into contracts that contain a variety of representations and warranties and which provide general indemnifications. The Partnership’s maximum exposure under these arrangements is unknown, as this would involve future claims against the Partnership that have not yet occurred. However, the Partnership has not had prior claims or losses pursuant to these contracts and expects the risk of loss to be remote. At December 31, 2019 and 2018, the Partnership is committed to invest up to $5,770,925 and $6,718,836, respectively, of additional capital in various investments. Contingencies The Partnership’s investment activities expose the Partnership to legal and tax matters that may result in contingencies including threatened or asserted litigations or claims. Any such matters that give rise to probable litigation and can be reasonably estimated are accrued. Based on its current assessment of any ongoing matters, the Partnership expects the loss from any such contingencies to be remote and there are no accruals for any such matters at December 31, 2019 or 2018. 32

Solasglas Investments, LP Notes to Financial Statements (continued) 9. Financial Highlights The financial highlights represent the Partnership’s financial performance for the year ended December 31, 2019 and for the period from September 1, 2018 (commencement of operations) to December 31, 2018. The stub period of 2018 has not been annualized. An individual limited partner’s performance may vary based on the timing of capital transactions, applicable loss carryforward, participation in New Issues and allocation of Designated Securities. Additionally, at the general partner’s discretion, certain limited partners may not be charged a management fee or a performance allocation and their ratios and returns may vary from the tables below. The net investment loss ratio does not include the effect of any performance allocation. Total return is computed based on geometric linking of monthly returns. Monthly rates of return are compounded to derive total return for the year. The expense and net investment loss ratios are calculated based on the expenses and net investment income allocated to the Limited Partners’ capital accounts during the year ended December 31, 2019 and for the period from September 1, 2018 (commencement of operations) to December 31, 2018. 2019 2018 Percentages to average Limited Partners’ capital: Expenses 3.6% 2.2% Performance allocation 2.0 - Total expenses and performance allocation 5.6% 2.2% Net investment loss (1.3)% (1.1)% Total return before performance allocation 18.9% (18.2)% Performance allocation (1.7) - Total return after performance allocation 17.2% (18.2) % 10. Subsequent Events Subsequent events have been evaluated by the Partnership from January 1, 2020 through March 9, 2020, the date the financial statements were available to be issued. The Partnership has determined that there are no material events that would require disclosure in the Partnership’s financial statements other than those listed below. 33

Solasglas Investments, LP Notes to Financial Statements (continued) 10. Subsequent Events (continued) For the period from January 1, 2020 through March 9, 2020, the Partnership accepted contributions of approximately $11,200,000 and has received approximately $15,700,000 in withdrawal requests. 34